Fidelity Select Multimedia Portfolio NCSR Certified annual shareholder report (management investment company)

Average annual total return reflects the change in the value of an investment, assuming reinvestment of distributions from dividend income and capital gains (the profits earned upon the sale of securities that have grown in value, if any) and assuming a constant rate of performance each year. The hypothetical investment and the average annual total returns do not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares. During periods of reimbursement by Fidelity, a fund's total return will be greater than it would be had the reimbursement not occurred. How a fund did yesterday is no guarantee of how it will do tomorrow.

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Chemicals Portfolio	1.09%	4.16%	8.74%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Chemicals Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Chemicals Portfolio

Market Recap:

U.S. equities returned -7.69% for the 12 months ending February 28, 2023, according to the S&P 500 ® index. The new year began with an encouraging upturn in January (+6.28%), but stocks lost momentum in February (-2.44%) amid higher-than-expected inflation and strong jobs data. Investors took these as signs that the economy continued to run hot, even after a year of historic policy adjustment by the Federal Reserve aimed at cooling economic growth. Record inflation in 2022 prompted the Fed to aggressively tighten monetary policy, and market interest rates eclipsed their highest level in a decade, stoking recession fears and sending stocks into bear market territory. Since March 2022, the central bank has hiked its benchmark rate eight times, by 4.5 percentage points - the fastest-ever pace of monetary tightening - while also shrinking its massive asset portfolio. The latest bump came on February 2, along with a signal that the Fed plans to lift rates in March while it considers whether and when to pause increases. Against this dynamic backdrop, stocks struggled to gain traction until a strong rally ignited heading into the summer. But in September, the index returned -9.21%, one of its worst monthly results ever, before advancing 7.56% in Q4, as risky assets regained favor. For the full 12 months, value stocks handily outpaced growth. The headwind for the latter was most pronounced in the growth-oriented communication services (-25%) and consumer discretionary (-18%) sectors. In sharp contrast, energy gained 24%.

Comments from Portfolio Manager David Wagner:

For the fiscal year ending February 28, 2023, the fund gained 1.09%, trailing the 4.27% advance of the MSCI U.S. IMI Chemicals 25/50 Linked Index, but outperforming the broad-based S&P 500 ® index. Versus the industry index, security selection was the primary detractor, especially within specialty chemicals. Stock selection in commodity chemicals and an overweighting in fertilizers & agricultural chemicals also hampered the fund's relative result. The fund's largest individual relative detractor was our lighter-than-index stake in Air Products & Chemicals, which gained 24% the past 12 months. The company was among our biggest holdings, and we increased the position. Also hampering performance was our overweighting in Huntsman, which returned roughly -34%. Huntsman was not held at period end. Also holding back performance was our overweighting in Element Solutions, which returned -15%. Conversely, the largest contributor to performance versus the industry index was an underweighting in specialty chemicals. Stock selection in fertilizers & agricultural chemicals and an overweighting in industrial gases also helped the fund's relative result. The fund's largest individual relative contributor was an outsized stake in Orion Engineered Carbons, which gained 64% the past year. Also lifting performance was our overweighting in Linde, which gained about 20%. The company was the fund's largest holding. Another notable relative contributor was an outsized stake in Chemours (+28%), which was one of our biggest holdings at period end. Notable changes in positioning include increased exposure to the commodity chemicals subindustry and a lower allocation to diversified chemicals.

The views expressed above reflect those of the portfolio manager(s) only through the end of the period as stated on the cover of this report and do not necessarily represent the views of Fidelity or any other person in the Fidelity organization. Any such views are subject to change at any time based upon market or other conditions and Fidelity disclaims any responsibility to update such views. These views may not be relied on as investment advice and, because investment decisions for a Fidelity fund are based on numerous factors, may not be relied on as an indication of trading intent on behalf of any Fidelity fund.

Chemicals Portfolio

Top Holdings (% of Fund's net assets)

Linde PLC	25.0
Air Products & Chemicals, Inc.	8.5
Corteva, Inc.	8.4
DuPont de Nemours, Inc.	4.9
Celanese Corp. Class A	4.8
Westlake Corp.	4.8
FMC Corp.	4.3
Olin Corp.	3.8
LyondellBasell Industries NV Class A	3.8
The Chemours Co. LLC	3.6
	71.9

Industries (% of Fund's net assets)

Chemicals	98.9

Geographic Diversification (% of Fund's net assets)

* Includes Short-Term investments and Net Other Assets (Liabilities).

Percentages are based on country or territory of incorporation and are adjusted for the effect of derivatives, if applicable.

Chemicals Portfolio

Showing Percentage of Net Assets

Common Stocks - 98.9%
	Shares	Value ($)
Chemicals - 98.9%
Commodity Chemicals - 19.4%
Cabot Corp.	220,700	17,552,271
LyondellBasell Industries NV Class A	268,494	25,772,739
Olin Corp.	448,500	25,900,875
Orion Engineered Carbons SA	672,126	17,139,213
Tronox Holdings PLC	828,269	12,920,996
Westlake Corp. (a)	272,856	32,508,064
		131,794,158
Diversified Chemicals - 3.6%
The Chemours Co. LLC	717,959	24,539,839
Fertilizers & Agricultural Chemicals - 16.4%
CF Industries Holdings, Inc.	148,517	12,756,125
Corteva, Inc.	916,793	57,107,036
FMC Corp.	227,300	29,355,795
The Mosaic Co.	229,000	12,180,510
		111,399,466
Industrial Gases - 33.5%
Air Products & Chemicals, Inc.	202,811	57,999,890
Linde PLC	486,016	169,313,394
		227,313,284
Specialty Chemicals - 26.0%
Albemarle Corp.	74,600	18,971,526
Axalta Coating Systems Ltd. (b)	709,600	21,146,080
Celanese Corp. Class A	281,100	32,672,253
DuPont de Nemours, Inc.	459,094	33,527,635
Ecolab, Inc.	107,200	17,084,464
Element Solutions, Inc.	776,443	15,948,139
International Flavors & Fragrances, Inc. (a)	85,616	7,979,411
Livent Corp. (a)(b)	200	4,690
PPG Industries, Inc.	38,900	5,137,134
Sherwin-Williams Co.	105,999	23,462,879
		175,934,211
TOTAL COMMON STOCKS (Cost $419,011,180)		670,980,958

Money Market Funds - 6.5%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (c)	2,631,044	2,631,570
Fidelity Securities Lending Cash Central Fund 4.63% (c)(d)	41,322,193	41,326,325
TOTAL MONEY MARKET FUNDS (Cost $43,957,895)		43,957,895

TOTAL INVESTMENT IN SECURITIES - 105.4% (Cost $462,969,075)	714,938,853
NET OTHER ASSETS (LIABILITIES) - (5.4)%	(36,829,759)
NET ASSETS - 100.0%	678,109,094

Legend

(a)	Security or a portion of the security is on loan at period end.

(b)	Non-income producing

(c)

Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements, which are not covered by the Fund's Report of Independent Registered Public Accounting Firm, are available on the SEC's website or upon request.

(d)	Investment made with cash collateral received from securities on loan.

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	1,042,443	148,771,348	147,182,221	376,790	-	-	2,631,570	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	2,247,252	145,594,708	106,515,635	7,624	-	-	41,326,325	0.1%
Total	3,289,695	294,366,056	253,697,856	384,414	-	-	43,957,895

Amounts in the dividend income column in the above table include any capital gain distributions from underlying funds, which are presented in the corresponding line item in the Statement of Operations, if applicable.

Amount for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

The following is a summary of the inputs used, as of February 28, 2023, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used below, please refer to the Investment Valuation section in the accompanying Notes to Financial Statements.

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	670,980,958	670,980,958	-	-

Money Market Funds	43,957,895	43,957,895	-	-
Total Investments in Securities:	714,938,853	714,938,853	-	-

Chemicals Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $39,941,579) - See accompanying schedule:
Unaffiliated issuers (cost $419,011,180)	$	670,980,958
Fidelity Central Funds (cost $43,957,895)		43,957,895


Total Investment in Securities (cost $462,969,075)			$	714,938,853
Receivable for investments sold				6,068,859
Receivable for fund shares sold				106,376
Dividends receivable				1,349,688
Distributions receivable from Fidelity Central Funds				33,162
Prepaid expenses				4,988
Other receivables				141,795
Total assets				722,643,721
Liabilities
Payable for investments purchased	$	2,477,027
Payable for fund shares redeemed		141,943
Accrued management fee		296,781
Other affiliated payables		117,593
Other payables and accrued expenses		174,958
Collateral on securities loaned		41,326,325
Total Liabilities				44,534,627
Net Assets			$	678,109,094
Net Assets consist of:
Paid in capital			$	420,461,913
Total accumulated earnings (loss)				257,647,181
Net Assets			$	678,109,094
Net Asset Value , offering price and redemption price per share ($678,109,094 ÷ 43,948,589 shares)			$	15.43

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	11,504,338
Income from Fidelity Central Funds (including $7,624 from security lending)				384,414
Total Income				11,888,752
Expenses
Management fee	$	3,669,372
Transfer agent fees		1,232,002
Accounting fees		230,856
Custodian fees and expenses		7,452
Independent trustees' fees and expenses		2,392
Registration fees		27,058
Audit		48,685
Legal		593
Miscellaneous		5,668
Total expenses before reductions		5,224,078
Expense reductions		(24,670)
Total expenses after reductions				5,199,408
Net Investment income (loss)				6,689,344
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		48,437,834
Foreign currency transactions		(22,734)
Total net realized gain (loss)				48,415,100
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		(52,566,540)
Assets and liabilities in foreign currencies		(19,547)
Total change in net unrealized appreciation (depreciation)				(52,586,087)
Net gain (loss)				(4,170,987)
Net increase (decrease) in net assets resulting from operations			$	2,518,357

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	6,689,344	$	6,746,277
Net realized gain (loss)		48,415,100		54,079,063
Change in net unrealized appreciation (depreciation)		(52,586,087)		56,407,256
Net increase (decrease) in net assets resulting from operations		2,518,357		117,232,596
Distributions to shareholders		(71,422,793)		(9,969,040)
Share transactions
Proceeds from sales of shares		27,760,569		88,405,055
Reinvestment of distributions		67,243,473		9,337,590
Cost of shares redeemed		(106,890,154)		(146,786,766)
Net increase (decrease) in net assets resulting from share transactions		(11,886,112)		(49,044,121)
Total increase (decrease) in net assets		(80,790,548)		58,219,435

Net Assets
Beginning of period		758,899,642		700,680,207
End of period	$	678,109,094	$	758,899,642

Other Information
Shares
Sold		1,728,193		5,113,175
Issued in reinvestment of distributions		4,320,957		520,200
Redeemed		(6,887,077)		(8,619,384)
Net increase (decrease)		(837,927)		(2,986,009)

Financial Highlights

Chemicals Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019 B
Selected Per-Share Data
Net asset value, beginning of period	$	16.94	$	14.67	$	10.47	$	13.57	$	17.34
Income from Investment Operations
Net investment income (loss) C,D		.15		.15		.15		.15		.23
Net realized and unrealized gain (loss)		.01		2.34		4.21		(2.39)		(2.17)
Total from investment operations		.16		2.49		4.36		(2.24)		(1.94)
Distributions from net investment income		(.16)		(.14)		(.16)		(.20)		(.21)
Distributions from net realized gain		(1.51)		(.08)		-		(.66)		(1.62)
Total distributions		(1.67)		(.22)		(.16)		(.86)		(1.83)
Net asset value, end of period	$	15.43	$	16.94	$	14.67	$	10.47	$	13.57
Total Return E		1.09%		16.90%		41.65%		(17.63)%		(11.10)%
Ratios to Average Net Assets D,F,G
Expenses before reductions		.75%		.74%		.79%		.78%		.77%
Expenses net of fee waivers, if any		.75%		.74%		.79%		.78%		.77%
Expenses net of all reductions		.75%		.74%		.78%		.77%		.76%
Net investment income (loss)		.96%		.85%		1.28%		1.21%		1.50%
Supplemental Data
Net assets, end of period (000 omitted)	$	678,109	$	758,900	$	700,680	$	656,441	$	1,153,379
Portfolio turnover rate H		54%		15%		50%		77%		62%

A For the year ended February 29.

B Per share amounts have been adjusted to reflect the impact of the 10 for 1 share split that occurred on August 10, 2018.

C Calculated based on average shares outstanding during the period.

D Net investment income (loss) is affected by the timing of the declaration of dividends by any underlying mutual funds or exchange-traded funds (ETFs). Net investment income (loss) of any mutual funds or ETFs is not included in the Fund's net investment income (loss) ratio.

E Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

F Fees and expenses of any underlying mutual funds or exchange-traded funds (ETFs) are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of these expenses. For additional expense information related to investments in Fidelity Central Funds, please refer to the "Investments in Fidelity Central Funds" note found in the Notes to Financial Statements section of the most recent Annual or Semi-Annual report.

G Expense ratios reflect operating expenses of the class. Expenses before reductions do not reflect amounts reimbursed, waived, or reduced through arrangements with the investment adviser, brokerage services, or other offset arrangements, if applicable, and do not represent the amount paid by the class during periods when reimbursements, waivers or reductions occur.

H Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

For the period ended February 28, 2023

1. Organization.

Chemicals Portfolio (the Fund) is a non-diversified fund of Fidelity Select Portfolios (the Trust) and is authorized to issue an unlimited number of shares. Share transactions on the Statement of Changes in Net Assets may contain exchanges between affiliated funds. The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust. The Fund invests primarily in securities of companies whose principal business activities fall within specific industries.

2. Investments in Fidelity Central Funds.

Funds may invest in Fidelity Central Funds, which are open-end investment companies generally available only to other investment companies and accounts managed by the investment adviser and its affiliates. The Schedule of Investments lists any Fidelity Central Funds held as an investment as of period end, but does not include the underlying holdings of each Fidelity Central Fund. An investing fund indirectly bears its proportionate share of the expenses of the underlying Fidelity Central Funds.

Based on its investment objective, each Fidelity Central Fund may invest or participate in various investment vehicles or strategies that are similar to those of the investing fund. These strategies are consistent with the investment objectives of the investing fund and may involve certain economic risks which may cause a decline in value of each of the Fidelity Central Funds and thus a decline in the value of the investing fund.

Fidelity Central Fund	Investment Manager	Investment Objective	Investment Practices	Expense Ratio A
Fidelity Money Market Central Funds	Fidelity Management & Research Company LLC (FMR)	Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity.	Short-term Investments	Less than .005%

A Expenses expressed as a percentage of average net assets and are as of each underlying Central Fund's most recent annual or semi-annual shareholder report.

A complete unaudited list of holdings for each Fidelity Central Fund is available upon request or at the Securities and Exchange Commission website at www.sec.gov. In addition, the financial statements of the Fidelity Central Funds which contain the significant accounting policies (including investment valuation policies) of those funds, and are not covered by the Report of Independent Registered Public Accounting Firm, are available on the Securities and Exchange Commission website or upon request.

3. Significant Accounting Policies.

The Fund is an investment company and applies the accounting and reporting guidance of the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946 Financial Services - Investment Companies . The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP), which require management to make certain estimates and assumptions at the date of the financial statements. Actual results could differ from those estimates. Subsequent events, if any, through the date that the financial statements were issued have been evaluated in the preparation of the financial statements. The Fund's Schedule of Investments lists any underlying mutual funds or exchange-traded funds (ETFs) but does not include the underlying holdings of these funds. The following summarizes the significant accounting policies of the Fund:

Investment Valuation. Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. The Board of Trustees (the Board) has designated the Fund's investment adviser as the valuation designee responsible for the fair valuation function and performing fair value determinations as needed. The investment adviser has established a Fair Value Committee (the Committee) to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern the fair valuation process and the activities of the Committee. In accordance with these fair valuation policies and procedures, which have been approved by the Board, the Fund attempts to obtain prices from one or more third party pricing services or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with the policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. The frequency that the fair valuation procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee manages the Fund's fair valuation practices and maintains the fair valuation policies and procedures. The Fund's investment adviser reports to the Board information regarding the fair valuation process and related material matters.

The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:

Level 1 - unadjusted quoted prices in active markets for identical investments

Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)

Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value the Fund's investments by major category are as follows:

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. The aggregate value of investments by input level as of February 28, 2023 is included at the end of the Fund's Schedule of Investments.

Foreign Currency. Certain Funds may use foreign currency contracts to facilitate transactions in foreign-denominated securities. Gains and losses from these transactions may arise from changes in the value of the foreign currency or if the counterparties do not perform under the contracts' terms.

Foreign-denominated assets, including investment securities, and liabilities are translated into U.S. dollars at the exchange rates at period end. Purchases and sales of investment securities, income and dividends received, and expenses denominated in foreign currencies are translated into U.S. dollars at the exchange rate in effect on the transaction date.

The effects of exchange rate fluctuations on investments are included with the net realized and unrealized gain (loss) on investment securities. Other foreign currency transactions resulting in realized and unrealized gain (loss) are disclosed separately.

Investment Transactions and Income. For financial reporting purposes, the Fund's investment holdings and NAV include trades executed through the end of the last business day of the period. The NAV per share for processing shareholder transactions is calculated as of the close of business of the New York Stock Exchange (NYSE), normally 4:00 p.m. Eastern time and includes trades executed through the end of the prior business day. Gains and losses on securities sold are determined on the basis of identified cost. Commissions paid to certain brokers with whom the investment adviser, or its affiliates, places trades on behalf of a fund include an amount in addition to trade execution, which may be rebated back to a fund. Any such rebates are included in net realized gain (loss) on investments in the Statement of Operations. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities where the ex-dividend date may have passed, which are recorded as soon as the Fund is informed of the ex-dividend date. Non-cash dividends included in dividend income, if any, are recorded at the fair market value of the securities received. Income and capital gain distributions from Fidelity Central Funds, if any, are recorded on the ex-dividend date. Certain distributions received by the Fund represent a return of capital or capital gain. The Fund determines the components of these distributions subsequent to the ex-dividend date, based upon receipt of tax filings or other correspondence relating to the underlying investment. These distributions are recorded as a reduction of cost of investments and/or as a realized gain. Investment income is recorded net of foreign taxes withheld where recovery of such taxes is uncertain. Funds may file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. Any withholding tax reclaims income is included in the Statement of Operations in dividends. Any receivables for withholding tax reclaims are included in the Statement of Assets and Liabilities in dividends receivable.

Expenses. Expenses directly attributable to a fund are charged to that fund. Expenses attributable to more than one fund are allocated among the respective funds on the basis of relative net assets or other appropriate methods. Expenses included in the accompanying financial statements reflect the expenses of that fund and do not include any expenses associated with any underlying mutual funds or exchange-traded funds. Although not included in a fund's expenses, a fund indirectly bears its proportionate share of these expenses through the net asset value of each underlying mutual fund or exchange-traded fund. Expense estimates are accrued in the period to which they relate and adjustments are made when actual amounts are known.

Deferred Trustee Compensation. Under a Deferred Compensation Plan (the Plan) for certain Funds, certain independent Trustees have elected to defer receipt of a portion of their annual compensation. Deferred amounts are invested in affiliated mutual funds, are marked-to-market and remain in a fund until distributed in accordance with the Plan. The investment of deferred amounts and the offsetting payable to the Trustees presented below are included in the accompanying Statement of Assets and Liabilities in other receivables and other payables and accrued expenses, as applicable.

Chemicals Portfolio

$141,795

Income Tax Information and Distributions to Shareholders. Each year, the Fund intends to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code, including distributing substantially all of its taxable income and realized gains. As a result, no provision for U.S. Federal income taxes is required. As of February 28, 2023, the Fund did not have any unrecognized tax benefits in the financial statements; nor is the Fund aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. The Fund files a U.S. federal tax return, in addition to state and local tax returns as required. The Fund's federal income tax returns are subject to examination by the Internal Revenue Service (IRS) for a period of three fiscal years after they are filed. State and local tax returns may be subject to examination for an additional fiscal year depending on the jurisdiction. Foreign taxes are provided for based on the Fund's understanding of the tax rules and rates that exist in the foreign markets in which it invests.

Distributions are declared and recorded on the ex-dividend date. Income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP. In addition, the Fund claimed a portion of the payment made to redeeming shareholders as a distribution for income tax purposes.

Capital accounts within the financial statements are adjusted for permanent book-tax differences. These adjustments have no impact on net assets or the results of operations. Capital accounts are not adjusted for temporary book-tax differences which will reverse in a subsequent period.

Book-tax differences are primarily due to foreign currency transactions, deferred Trustees compensation and losses deferred due to wash sales.

As of period end, the cost and unrealized appreciation (depreciation) in securities, and derivatives if applicable, for federal income tax purposes were as follows:

Gross unrealized appreciation	$255,745,309
Gross unrealized depreciation	(4,268,823)
Net unrealized appreciation (depreciation)	$251,476,486
Tax Cost	$463,462,367

The tax-based components of distributable earnings as of period end were as follows:

Undistributed ordinary income	$375,046
Undistributed long-term capital gain	$5,979,128
Net unrealized appreciation (depreciation) on securities and other investments	$251,436,703

The tax character of distributions paid was as follows:

	February 28, 2023	February 28, 2022
Ordinary Income	$6,622,169	$ 6,405,447
Long-term Capital Gains	64,800,624	3,563,593
Total	$71,422,793	$ 9,969,040

4. Purchases and Sales of Investments.

Purchases and sales of securities, other than short-term securities and in-kind transactions, as applicable, are noted in the table below.

	Purchases ($)	Sales ($)
Chemicals Portfolio	368,444,547	450,291,682

5. Fees and Other Transactions with Affiliates.

Management Fee. Fidelity Management & Research Company LLC (the investment adviser) and its affiliates provide the Fund with investment management related services for which the Fund pays a monthly management fee. The management fee is the sum of an individual fund fee rate that is based on an annual rate of .30% of the Fund's average net assets and an annualized group fee rate that averaged .23% during the period. The group fee rate is based upon the monthly average net assets of a group of registered investment companies with which the investment adviser has management contracts. The group fee rate decreases as assets under management increase and increases as assets under management decrease. For the reporting period, the total annual management fee rate was .53% of the Fund's average net assets.

Transfer Agent Fees. Fidelity Investments Institutional Operations Company LLC (FIIOC), an affiliate of the investment adviser, is the Fund's transfer, dividend disbursing and shareholder servicing agent. FIIOC receives account fees and asset-based fees that vary according to account size and type of account. FIIOC pays for typesetting, printing and mailing of shareholder reports, except proxy statements. For the period, the transfer agent fees were equivalent to an annual rate of .18% of average net assets.

Accounting Fees. Fidelity Service Company, Inc. (FSC), an affiliate of the investment adviser, maintains the Fund's accounting records. The accounting fee is based on the level of average net assets for each month. For the period, the fees were equivalent to the following annual rates:

	% of Average Net Assets
Chemicals Portfolio	.03

Brokerage Commissions. A portion of portfolio transactions were placed with brokerage firms which are affiliates of the investment adviser. Brokerage commissions are included in net realized gain (loss) and change in net unrealized appreciation (depreciation) in the Statement of Operations. The commissions paid to these affiliated firms were as follows:

	Amount
Chemicals Portfolio	$8,236

Interfund Trades. Funds may purchase from or sell securities to other Fidelity Funds under procedures adopted by the Board. The procedures have been designed to ensure these interfund trades are executed in accordance with Rule 17a-7 of the 1940 Act. Any interfund trades are included within the respective purchases and sales amounts shown in the Purchases and Sales of Investments note. Interfund trades during the period are noted in the table below.

	Purchases ($)	Sales ($)	Realized Gain (Loss) ($)
Chemicals Portfolio	14,920,593	23,445,219	5,158,708

6. Committed Line of Credit.

Certain Funds participate with other funds managed by the investment adviser or an affiliate in a $4.25 billion credit facility (the "line of credit") to be utilized for temporary or emergency purposes to fund shareholder redemptions or for other short-term liquidity purposes. The participating funds have agreed to pay commitment fees on their pro-rata portion of the line of credit, which are reflected in Miscellaneous expenses on the Statement of Operations, and are listed below. During the period, there were no borrowings on this line of credit.

	Amount
Chemicals Portfolio	$1,272

7. Security Lending.

Funds lend portfolio securities from time to time in order to earn additional income. Lending agents are used, including National Financial Services (NFS), an affiliate of the investment adviser. Pursuant to a securities lending agreement, NFS will receive a fee, which is capped at 9.9% of a fund's daily lending revenue, for its services as lending agent. A fund may lend securities to certain qualified borrowers, including NFS. On the settlement date of the loan, a fund receives collateral (in the form of U.S. Treasury obligations, letters of credit and/or cash) against the loaned securities and maintains collateral in an amount not less than 100% of the market value of the loaned securities during the period of the loan. The market value of the loaned securities is determined at the close of business of a fund and any additional required collateral is delivered to a fund on the next business day. A fund or borrower may terminate the loan at any time, and if the borrower defaults on its obligation to return the securities loaned because of insolvency or other reasons, a fund may apply collateral received from the borrower against the obligation. A fund may experience delays and costs in recovering the securities loaned. Any cash collateral received is invested in the Fidelity Securities Lending Cash Central Fund. Any loaned securities are identified as such in the Schedule of Investments, and the value of loaned securities and cash collateral at period end, as applicable, are presented in the Statement of Assets and Liabilities. Security lending income represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities. Security lending income is presented in the Statement of Operations as a component of income from Fidelity Central Funds. Affiliated security lending activity, if any, was as follows:

	Total Security Lending Fees Paid to NFS	Security Lending Income From Securities Loaned to NFS	Value of Securities Loaned to NFS at Period End
Chemicals Portfolio	$807	$-	$-

8. Expense Reductions.

During the period the investment adviser or an affiliate reimbursed and/or waived a portion of operating expenses in the amount of $24,670.

9. Other.

A fund's organizational documents provide former and current trustees and officers with a limited indemnification against liabilities arising in connection with the performance of their duties to the fund. In the normal course of business, a fund may also enter into contracts that provide general indemnifications. A fund's maximum exposure under these arrangements is unknown as this would be dependent on future claims that may be made against a fund. The risk of material loss from such claims is considered remote.

10. Risk and Uncertainties.

Many factors affect a fund's performance. Developments that disrupt global economies and financial markets, such as pandemics, epidemics, outbreaks of infectious diseases, war, terrorism, and environmental disasters, may significantly affect a fund's investment performance. The effects of these developments to a fund will be impacted by the types of securities in which a fund invests, the financial condition, industry, economic sector, and geographic location of an issuer, and a fund's level of investment in the securities of that issuer. Significant concentrations in security types, issuers, industries, sectors, and geographic locations may magnify the factors that affect a fund's performance.

Gold Portfolio

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Class A (incl.5.75% sales charge)	-24.05%	3.00%	-3.15%
Class M (incl.3.50% sales charge)	-22.47%	3.20%	-3.20%
Class C (incl. contingent deferred sales charge)	-20.80%	3.51%	-3.11%
Gold Portfolio	-19.17%	4.56%	-2.27%
Class I	-19.20%	4.56%	-2.26%
Class Z	-19.07%	4.69%	-2.20%

Class C shares' contingent deferred sales charges included in the past one year, past five years and past ten years total return figures are 1%, 0% and 0%, respectively.

The initial offering of Class Z shares took place on October 2, 2018. Returns prior to October 2, 2018, are those of Class I.

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Gold Portfolio, a class of the fund, on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Gold Portfolio

Consolidated Investment Summary February 28, 2023 (Unaudited)

Market Recap:

Comments from Portfolio Manager Steven Calhoun:

For the fiscal year ending February 28, 2023, the fund's share classes (excluding sales charges, if applicable) returned roughly -20% to -19%, roughly in line with the -19.56% return of the S&P Global BMI Gold Capped Index 20/45 Linked Index, but underperforming the broad-based S&P 500 ® index. Versus the industry index, security selection was the primary contributor, led by choices in the diversified metals & mining group. One of the biggest individual relative contributors was an overweight position in Orla Mining (+10%). Orla Mining was among the fund's largest holdings. Another top relative contributor was an out-of-index stake in Gatos Silver (+20%). The fund's non-index investment in Triple Flag Precious Metals also meaningfully contributed, gaining 18%. In contrast, the largest detractor from performance versus the industry index was our stock selection in gold. Weak-performing stock picks in copper also hurt relative performance. The fund's biggest individual relative detractor was an underweighting in Zijin Mining, which gained roughly 2% the past 12 months. The company was among the largest holdings at period end. Another notable relative detractor was an outsized stake in Marathon Gold (-70%). Another notable relative detractor was an overweighting in Wesdome Gold Mines (-58%).

Gold Portfolio

The information in the following tables is based on the consolidated investments of the Fund.

Top Holdings (% of Fund's net assets)

Newmont Corp.	9.8
Agnico Eagle Mines Ltd. (Canada)	8.9
Franco-Nevada Corp.	8.2
Wheaton Precious Metals Corp.	8.0
Barrick Gold Corp. (Canada)	7.3
Zijin Mining Group Co. Ltd. (A Shares)	4.2
Orla Mining Ltd.	4.2
OceanaGold Corp.	3.9
Alamos Gold, Inc.	3.3
Osisko Gold Royalties Ltd.	2.5
	60.3

Industries (% of Fund's net assets)

Gold	88.3
Silver	4.7
Diversified Metals & Mining	3.3
Precious Metals & Minerals	0.8
Commodities & Related Investments*	0.7
Copper	0.7

*Includes gold bullion and/or silver bullion.

Geographic Diversification (% of Fund's net assets)

* Includes Short-Term investments and Net Other Assets (Liabilities).

Percentages are based on country or territory of incorporation and are adjusted for the effect of derivatives, if applicable.

Gold Portfolio

Consolidated Schedule of Investments February 28, 2023

Showing Percentage of Net Assets

Common Stocks - 97.8%
	Shares	Value ($)
Australia - 4.3%
Metals & Mining - 4.3%
Gold - 4.3%
Gold Road Resources Ltd.	12,500,000	12,364,537
Newcrest Mining Ltd.	1,750,000	26,790,307
Northern Star Resources Ltd.	4,000,000	27,911,892
		67,066,736
Canada - 71.7%
Metals & Mining - 71.7%
Copper - 0.4%
Faraday Copper Corp. (a)(b)	10,000,000	6,449,249

Diversified Metals & Mining - 2.3%
BeMetals Corp. (a)	2,000,000	197,875
Foran Mining Corp. (a)	5,000,000	13,741,297
Paycore Minerals, Inc. (a)	2,000,000	3,048,736
Vizsla Silver Corp.	5,000,000	5,936,240
Western Copper & Gold Corp. (TSX) (a)(b)(c)	8,740,500	13,772,133
		36,696,281
Gold - 67.3%
Agnico Eagle Mines Ltd. (Canada) (c)	3,000,000	138,116,526
Alamos Gold, Inc.	5,000,000	50,971,052
Artemis Gold, Inc. (a)(c)	5,000,000	16,086,479
Ascot Resources Ltd. (a)(b)	25,000,000	11,542,690
B2Gold Corp.	7,000,000	23,906,193
Banyan Gold Corp. (a)(b)	21,000,000	6,310,004
Barrick Gold Corp. (Canada) (c)	7,000,000	113,118,358
Bonterra Resources, Inc. (a)(b)	7,500,000	1,786,369
Franco-Nevada Corp.	1,000,000	127,643,826
Fury Gold Mines Ltd. (b)(d)	10,000,000	6,375,962
i-80 Gold Corp. (a)(b)(c)	10,000,000	22,792,232
i-80 Gold Corp. (b)(d)	2,500,000	5,698,058
Lundin Gold, Inc.	2,500,000	25,833,639
Maple Gold Mines Ltd. (a)(b)	20,000,000	2,638,329
Marathon Gold Corp. (a)(b)(c)	25,000,000	16,306,339
Marathon Gold Corp. warrants 9/20/24 (a)(b)	5,000,000	432,958
Novagold Resources, Inc. (a)	3,000,000	16,885,306
OceanaGold Corp.	30,000,000	61,121,290
Orla Mining Ltd. (a)(c)	15,000,000	65,408,575
Osisko Development Corp. (a)(c)	2,000,000	8,647,856
Osisko Development Corp.:
unit(e)	1,144,505	6,223,272
rights(a)	666,666	304,390
Osisko Gold Royalties Ltd. (c)	3,000,000	39,311,103
Osisko Mining, Inc. (a)	9,723,000	22,018,373
Osisko Mining, Inc. unit	2,700,000	5,983,988
Pure Gold Mining, Inc. warrants 3/28/23 (a)	1,500,000	11
Rupert Resources Ltd. (a)	4,000,000	13,660,682
Sabina Gold & Silver Corp. (a)	5,000,000	6,485,892
Seabridge Gold, Inc. (a)	1,000,000	10,978,380
Skeena Resources Ltd. (a)(c)	3,000,000	15,522,169
Torex Gold Resources, Inc. (a)	1,000,000	12,312,202
Triple Flag Precious Metals Corp.	2,000,000	27,145,475
Victoria Gold Corp. (a)(b)	4,000,000	24,829,608
Wesdome Gold Mines, Inc. (a)	3,500,000	16,698,424
Wheaton Precious Metals Corp.	3,000,000	124,990,839
		1,048,086,849
Precious Metals & Minerals - 0.8%
Dolly Varden Silver Corp. (a)(b)	17,000,000	11,835,837

Silver - 0.9%
GoGold Resources, Inc. (a)(c)	9,000,000	13,851,228

TOTAL METALS & MINING		1,116,919,444

China - 4.2%
Metals & Mining - 4.2%
Gold - 4.2%
Zijin Mining Group Co. Ltd. (A Shares)	39,999,964	65,826,231

United Kingdom - 0.3%
Metals & Mining - 0.3%
Copper - 0.3%
Solgold PLC (a)	20,000,000	3,979,028

United States of America - 17.3%
Metals & Mining - 17.3%
Diversified Metals & Mining - 1.0%
Ivanhoe Electric, Inc. (a)(c)	1,000,000	15,030,000

Gold - 12.5%
Dakota Gold Corp. (a)(c)	2,500,000	7,025,000
Newmont Corp.	3,500,000	152,634,997
Royal Gold, Inc. (c)	300,000	35,637,000
		195,296,997
Silver - 3.8%
Gatos Silver, Inc. (a)(b)(c)	6,900,000	27,876,000
Hecla Mining Co. (c)	6,000,000	30,900,000
		58,776,000
TOTAL METALS & MINING		269,102,997

TOTAL COMMON STOCKS (Cost $1,212,110,032)		1,522,894,436

Commodities - 0.7%
	Troy Ounces	Value ($)
Gold Bullion (a) (Cost $4,575,085)	5,582	10,199,654

Money Market Funds - 20.0%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (f)	14,255,006	14,257,857
Fidelity Securities Lending Cash Central Fund 4.63% (f)(g)	297,681,559	297,711,327
TOTAL MONEY MARKET FUNDS (Cost $311,969,184)		311,969,184

TOTAL INVESTMENT IN SECURITIES - 118.5% (Cost $1,528,654,301)	1,845,063,274
NET OTHER ASSETS (LIABILITIES) - (18.5)%	(288,281,971)
NET ASSETS - 100.0%	1,556,781,303

Legend

(a)	Non-income producing

(b)	Affiliated company

(c)	Security or a portion of the security is on loan at period end.

(d)

Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $12,074,020 or 0.8% of net assets.

(e)	Security or a portion of the security purchased on a delayed delivery or when-issued basis.

(f)

(g)	Investment made with cash collateral received from securities on loan.

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	58,603,905	597,039,758	641,385,806	438,329	-	-	14,257,857	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	105,810,777	1,178,638,323	986,737,773	762,133	-	-	297,711,327	0.9%
Total	164,414,682	1,775,678,081	1,628,123,579	1,200,462	-	-	311,969,184

Amounts in the dividend income column in the above table include any capital gain distributions from underlying funds, which are presented in the corresponding line item in the Consolidated Statement of Operations, if applicable.

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Consolidated Subsidiary

Fund	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain /loss ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)
Fidelity Select Gold Cayman Ltd.	13,353,169	-	2,474,914	-	1,074,938	(1,734,410)	10,218,783

Other Affiliated Issuers

An affiliated company is a company in which the Fund has ownership of at least 5% of the voting securities. Fiscal year to date transactions with companies which are or were affiliates are presented in the table below. Certain corporate actions, such as mergers, are excluded from the amounts in this table if applicable. A dash in the Value end of period ($) column means either the issuer is no longer held at period end, or the issuer is held at period end but is no longer an affiliate.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)
Ascot Resources Ltd.	17,199,211	3,907,938	-	-	-	(9,564,459)	11,542,690
Banyan Gold Corp.	-	6,168,986	-	-	-	141,018	6,310,004
Bonterra Resources, Inc.	1,352,663	-	-	-	-	69,807	-
Bonterra Resources, Inc.	6,011,834	-	-	-	-	(5,647,935)	1,786,369
Dolly Varden Silver Corp.	-	4,989,727	-	-	-	6,846,110	11,835,837
Faraday Copper Corp.	-	5,966,439	-	-	-	482,810	6,449,249
Fury Gold Mines Ltd.	-	6,328,113	-	-	-	-	-
Fury Gold Mines Ltd.	-	-	-	-	-	47,849	6,375,962
Gatos Silver, Inc.	16,850,000	7,052,371	-	-	-	3,973,629	27,876,000
Gold Standard Ventures Corp.	10,256,410	767,541	11,621,826	-	(12,324,901)	12,922,776	-
Maple Gold Mines Ltd.	5,285,996	-	-	-	-	(2,647,667)	2,638,329
Marathon Gold Corp.	22,406,312	3,994,624	-	-	-	(17,776,315)	16,306,339
Marathon Gold Corp. warrants 9/20/24	-	-	-	-	-	(240,493)	432,958
Orla Mining Ltd.	51,692,308	12,624,099	4,918,086	-	(728,760)	6,739,014	-
Pure Gold Mining, Inc.	16,173,570	-	4,101,640	-	(24,122,553)	12,050,623	-
Pure Gold Mining, Inc. warrants 3/28/23	58,434	-	-	-	-	(58,423)	-
Victoria Gold Corp.	25,341,223	21,109,331	5,907,354	-	(986,601)	(14,726,991)	24,829,608
Western Copper & Gold Corp. (TSX)	14,327,416	1,130,705	-	-	-	(1,685,988)	13,772,133
i-80 Gold Corp.	5,369,822	-	-	-	-	(78,175)	-
i-80 Gold Corp.	21,696,252	-	-	-	-	1,095,980	22,792,232
i-80 Gold Corp.	-	-	-	-	-	406,411	5,698,058
i-80 Gold Corp. warrants 9/30/22	76,880	-	-	-	(340)	(76,540)	-
Total	214,098,331	74,039,874	26,548,906	-	(38,163,155)	(7,726,959)	158,645,768

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	1,522,894,436	1,477,223,270	45,671,166	-

Commodities	10,199,654	10,199,654	-	-

Money Market Funds	311,969,184	311,969,184	-	-
Total Investments in Securities:	1,845,063,274	1,799,392,108	45,671,166	-

Gold Portfolio

Consolidated Financial Statements

Consolidated Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $283,944,222) - See accompanying schedule:
Unaffiliated issuers (cost $1,018,589,358)	$	1,364,248,668
Fidelity Central Funds (cost $311,969,184)		311,969,184
Commodities (cost $4,575,085)		10,199,654
Other affiliated issuers (cost $193,520,674)		158,645,768


Total Investment in Securities (cost $1,528,654,301)			$	1,845,063,274
Cash				19,429
Foreign currency held at value (cost $724,631)				724,631
Receivable for investments sold				13,958,096
Receivable for fund shares sold				1,662,448
Dividends receivable				2,228,171
Distributions receivable from Fidelity Central Funds				98,226
Prepaid expenses				4,110
Other receivables				131,460
Total assets				1,863,889,845
Liabilities
Payable for investments purchased
Regular delivery	$	779,103
Delayed delivery		5,535,898
Payable for fund shares redeemed		1,799,080
Accrued management fee		723,443
Distribution and service plan fees payable		50,384
Other affiliated payables		305,491
Other payables and accrued expenses		203,110
Collateral on securities loaned		297,712,033
Total Liabilities				307,108,542
Net Assets			$	1,556,781,303
Net Assets consist of:
Paid in capital			$	2,807,202,133
Total accumulated earnings (loss)				(1,250,420,830)
Net Assets			$	1,556,781,303

Net Asset Value and Maximum Offering Price
Class A :
Net Asset Value and redemption price per share ($73,943,387 ÷ 3,501,509 shares) (a)			$	21.12
Maximum offering price per share (100/94.25 of $21.12)			$	22.41
Class M :
Net Asset Value and redemption price per share ($21,586,448 ÷ 1,050,434 shares) (a)			$	20.55
Maximum offering price per share (100/96.50 of $20.55)			$	21.30
Class C :
Net Asset Value and offering price per share ($27,977,723 ÷ 1,445,354 shares) (a)			$	19.36
Gold :
Net Asset Value , offering price and redemption price per share ($1,229,415,990 ÷ 56,191,220 shares)			$	21.88
Class I :
Net Asset Value , offering price and redemption price per share ($110,223,764 ÷ 5,036,837 shares)			$	21.88
Class Z :
Net Asset Value , offering price and redemption price per share ($93,633,991 ÷ 4,271,325 shares)			$	21.92
(a)Redemption price per share is equal to net asset value less any applicable contingent deferred sales charge.

Consolidated Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	27,797,934
Income from Fidelity Central Funds (including $762,133 from security lending)				1,200,462
Income before foreign taxes withheld			$	28,998,396
Less foreign taxes withheld				(2,469,785)
Total Income				26,528,611
Expenses
Management fee	$	7,996,988
Transfer agent fees		2,771,363
Distribution and service plan fees		648,308
Accounting fees		660,646
Custodian fees and expenses		71,865
Independent trustees' fees and expenses		5,125
Registration fees		141,062
Audit		72,523
Legal		907
Interest		2,027
Miscellaneous		8,679
Total expenses before reductions		12,379,493
Expense reductions		(63,432)
Total expenses after reductions				12,316,061
Net Investment income (loss)				14,212,550
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investments:
Unaffiliated issuers		(70,010,728)
Affiliated issuers		(38,163,155)
Commodities		998,453
Foreign currency transactions		(73,020)
Total net realized gain (loss)				(107,248,450)
Change in net unrealized appreciation (depreciation) on:
Investments:
Investments		(274,248,514)
Affiliated issuers		(7,726,959)
Assets and liabilities in foreign currencies		63,595
Commodities		(1,656,941)
Total change in net unrealized appreciation (depreciation)				(283,568,819)
Net gain (loss)				(390,817,269)
Net increase (decrease) in net assets resulting from operations			$	(376,604,719)

Consolidated Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	14,212,550	$	23,266,597
Net realized gain (loss)		(107,248,450)		68,341,551
Change in net unrealized appreciation (depreciation)		(283,568,819)		70,246,590
Net increase (decrease) in net assets resulting from operations		(376,604,719)		161,854,738
Distributions to shareholders		(5,320,281)		(27,126,849)
Share transactions - net increase (decrease)		189,254,819		(106,344,853)
Total increase (decrease) in net assets		(192,670,181)		28,383,036

Net Assets
Beginning of period		1,749,451,484		1,721,068,448
End of period	$	1,556,781,303	$	1,749,451,484

Consolidated Financial Highlights

Fidelity Advisor® Gold Fund Class A

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	26.27	$	24.15	$	21.67	$	18.52	$	18.30
Income from Investment Operations
Net investment income (loss) B,C		.15		.27 D		(.04)		(.01) E		(.03)
Net realized and unrealized gain (loss)		(5.23)		2.20		3.74		3.20		.25
Total from investment operations		(5.08)		2.47		3.70		3.19		.22
Distributions from net investment income		(.07)		(.35)		(1.22)		(.01)		-
Distributions from net realized gain		-		-		-		(.03)		-
Total distributions		(.07)		(.35)		(1.22)		(.04)		-
Net asset value, end of period	$	21.12	$	26.27	$	24.15	$	21.67	$	18.52
Total Return F,G		(19.42)%		10.37%		16.59%		17.23%		1.20%
Ratios to Average Net Assets C,H,I
Expenses before reductions		1.09%		1.07%		1.08%		1.13%		1.19%
Expenses net of fee waivers, if any		1.08%		1.07%		1.08%		1.13%		1.18%
Expenses net of all reductions		1.08%		1.07%		1.07%		1.12%		1.18%
Net investment income (loss)		.67%		1.02% D		(.12)%		(.05)% E		(.15)%
Supplemental Data
Net assets, end of period (000 omitted)	$	73,943	$	86,977	$	82,989	$	64,971	$	50,479
Portfolio turnover rate J		46%		38%		46%		56%		37%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

C Net investment income (loss) is affected by the timing of the declaration of dividends by any underlying mutual funds or exchange-traded funds (ETFs). Net investment income (loss) of any mutual funds or ETFs is not included in the Fund's net investment income (loss) ratio.

D Net investment income per share reflects one or more large, non-recurring dividend(s) which amounted to $.12 per share. Excluding such non-recurring dividend(s), the ratio of net investment income (loss) to average net assets would have been .57%.

E Net investment income per share reflects one or more large, non-recurring dividend(s) which amounted to $.05 per share. Excluding such non-recurring dividend(s), the ratio of net investment income (loss) to average net assets would have been (.26)%.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

G Total returns do not include the effect of the sales charges.

H Fees and expenses of any underlying mutual funds or exchange-traded funds (ETFs) are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of these expenses. For additional expense information related to investments in Fidelity Central Funds, please refer to the "Investments in Fidelity Central Funds" note found in the Notes to Financial Statements section of the most recent Annual or Semi-Annual report.

I Expense ratios reflect operating expenses of the class. Expenses before reductions do not reflect amounts reimbursed, waived, or reduced through arrangements with the investment adviser, brokerage services, or other offset arrangements, if applicable, and do not represent the amount paid by the class during periods when reimbursements, waivers or reductions occur.

J Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Fidelity Advisor® Gold Fund Class M

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	25.63	$	23.57	$	21.16	$	18.11	$	17.94
Income from Investment Operations
Net investment income (loss) B,C		.09		.19 D		(.12)		(.07) E		(.07)
Net realized and unrealized gain (loss)		(5.11)		2.16		3.67		3.12		.24
Total from investment operations		(5.02)		2.35		3.55		3.05		.17
Distributions from net investment income		(.06)		(.29)		(1.14)		-		-
Total distributions		(.06)		(.29)		(1.14)		-		-
Net asset value, end of period	$	20.55	$	25.63	$	23.57	$	21.16	$	18.11
Total Return F,G		(19.66)%		10.08%		16.28%		16.84%		.95%
Ratios to Average Net Assets C,H,I
Expenses before reductions		1.35%		1.36%		1.37%		1.42%		1.48%
Expenses net of fee waivers, if any		1.35%		1.35%		1.37%		1.42%		1.46%
Expenses net of all reductions		1.35%		1.35%		1.36%		1.41%		1.46%
Net investment income (loss)		.40%		.74% D		(.42)%		(.34)% E		(.43)%
Supplemental Data
Net assets, end of period (000 omitted)	$	21,586	$	26,201	$	24,535	$	19,620	$	17,401
Portfolio turnover rate J		46%		38%		46%		56%		37%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Net investment income per share reflects one or more large, non-recurring dividend(s) which amounted to $.11 per share. Excluding such non-recurring dividend(s), the ratio of net investment income (loss) to average net assets would have been .29%.

E Net investment income per share reflects one or more large, non-recurring dividend(s) which amounted to $.04 per share. Excluding such non-recurring dividend(s), the ratio of net investment income (loss) to average net assets would have been (.56)%.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

G Total returns do not include the effect of the sales charges.

J Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Fidelity Advisor® Gold Fund Class C

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	24.24	$	22.30	$	20.07	$	17.24	$	17.15
Income from Investment Operations
Net investment income (loss) B,C		(.01)		.08 D		(.22)		(.14) E		(.13)
Net realized and unrealized gain (loss)		(4.82)		2.05		3.49		2.97		.22
Total from investment operations		(4.83)		2.13		3.27		2.83		.09
Distributions from net investment income		(.05)		(.19)		(1.04)		-		-
Total distributions		(.05)		(.19)		(1.04)		-		-
Net asset value, end of period	$	19.36	$	24.24	$	22.30	$	20.07	$	17.24
Total Return F,G		(20.00)%		9.62%		15.81%		16.42%		.52%
Ratios to Average Net Assets C,H,I
Expenses before reductions		1.79%		1.77%		1.78%		1.80%		1.84%
Expenses net of fee waivers, if any		1.78%		1.77%		1.78%		1.80%		1.83%
Expenses net of all reductions		1.78%		1.77%		1.77%		1.79%		1.83%
Net investment income (loss)		(.03)%		.32% D		(.83)%		(.72)% E		(.80)%
Supplemental Data
Net assets, end of period (000 omitted)	$	27,978	$	43,031	$	51,195	$	52,375	$	67,760
Portfolio turnover rate J		46%		38%		46%		56%		37%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

G Total returns do not include the effect of the contingent deferred sales charge.

J Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Gold Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	27.14	$	24.93	$	22.33	$	19.07	$	18.78
Income from Investment Operations
Net investment income (loss) B,C		.23		.36 D		.06		.06 E		.03
Net realized and unrealized gain (loss)		(5.41)		2.27		3.84		3.30		.26
Total from investment operations		(5.18)		2.63		3.90		3.36		.29
Distributions from net investment income		(.08)		(.42)		(1.30)		(.06)		-
Distributions from net realized gain		-		-		-		(.03)		-
Total distributions		(.08)		(.42)		(1.30)		(.10) F		-
Net asset value, end of period	$	21.88	$	27.14	$	24.93	$	22.33	$	19.07
Total Return G		(19.17)%		10.71%		16.96%		17.60%		1.54%
Ratios to Average Net Assets C,H,I
Expenses before reductions		.78%		.76%		.76%		.79%		.86%
Expenses net of fee waivers, if any		.78%		.76%		.76%		.79%		.85%
Expenses net of all reductions		.77%		.76%		.75%		.78%		.85%
Net investment income (loss)		.97%		1.33% D		.19%		.29% E		.18%
Supplemental Data
Net assets, end of period (000 omitted)	$	1,229,416	$	1,330,602	$	1,319,440	$	1,292,204	$	1,035,697
Portfolio turnover rate J		46%		38%		46%		56%		37%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

F Total distributions per share do not sum due to rounding.

G Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

J Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Fidelity Advisor® Gold Fund Class I

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	27.15	$	24.93	$	22.33	$	19.07	$	18.78
Income from Investment Operations
Net investment income (loss) B,C		.23		.36 D		.05		.06 E		.04
Net realized and unrealized gain (loss)		(5.42)		2.27		3.85		3.30		.25
Total from investment operations		(5.19)		2.63		3.90		3.36		.29
Distributions from net investment income		(.08)		(.41)		(1.30)		(.07)		-
Distributions from net realized gain		-		-		-		(.03)		-
Total distributions		(.08)		(.41)		(1.30)		(.10)		-
Net asset value, end of period	$	21.88	$	27.15	$	24.93	$	22.33	$	19.07
Total Return F		(19.20)%		10.74%		16.96%		17.60%		1.54%
Ratios to Average Net Assets C,G,H
Expenses before reductions		.77%		.76%		.77%		.79%		.84%
Expenses net of fee waivers, if any		.77%		.76%		.77%		.79%		.82%
Expenses net of all reductions		.77%		.76%		.76%		.77%		.82%
Net investment income (loss)		.98%		1.33% D		.18%		.30% E		.21%
Supplemental Data
Net assets, end of period (000 omitted)	$	110,224	$	152,799	$	137,617	$	115,699	$	84,956
Portfolio turnover rate I		46%		38%		46%		56%		37%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

G Fees and expenses of any underlying mutual funds or exchange-traded funds (ETFs) are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of these expenses. For additional expense information related to investments in Fidelity Central Funds, please refer to the "Investments in Fidelity Central Funds" note found in the Notes to Financial Statements section of the most recent Annual or Semi-Annual report.

H Expense ratios reflect operating expenses of the class. Expenses before reductions do not reflect amounts reimbursed, waived, or reduced through arrangements with the investment adviser, brokerage services, or other offset arrangements, if applicable, and do not represent the amount paid by the class during periods when reimbursements, waivers or reductions occur.

I Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Fidelity Advisor® Gold Fund Class Z

Years ended February 28,		2023		2022		2021		2020 A		2019 B
Selected Per-Share Data
Net asset value, beginning of period	$	27.16	$	24.94	$	22.34	$	19.08	$	16.62
Income from Investment Operations
Net investment income (loss) C,D		.26		.40 E		.09		.10 F		.07
Net realized and unrealized gain (loss)		(5.41)		2.27		3.85		3.29		2.39
Total from investment operations		(5.15)		2.67		3.94		3.39		2.46
Distributions from net investment income		(.09)		(.45)		(1.34)		(.10)		-
Distributions from net realized gain		-		-		-		(.03)		-
Total distributions		(.09)		(.45)		(1.34)		(.13)		-
Net asset value, end of period	$	21.92	$	27.16	$	24.94	$	22.34	$	19.08
Total Return G,H		(19.07)%		10.88%		17.12%		17.75%		14.80%
Ratios to Average Net Assets D,I,J
Expenses before reductions		.63%		.63%		.64%		.65%		.68% K
Expenses net of fee waivers, if any		.63%		.62%		.64%		.64%		.68% K
Expenses net of all reductions		.63%		.62%		.62%		.63%		.67% K
Net investment income (loss)		1.12%		1.47% E		.32%		.44% F		.97% K
Supplemental Data
Net assets, end of period (000 omitted)	$	93,634	$	109,842	$	105,293	$	95,076	$	3,037
Portfolio turnover rate L		46%		38%		46%		56%		37%

A For the year ended February 29.

B For the period October 2, 2018 (commencement of sale of shares) through February 28, 2019.

C Calculated based on average shares outstanding during the period.

E Net investment income per share reflects one or more large, non-recurring dividend(s) which amounted to $.12 per share. Excluding such non-recurring dividend(s), the ratio of net investment income (loss) to average net assets would have been 1.02%.

F Net investment income per share reflects one or more large, non-recurring dividend(s) which amounted to $.05 per share. Excluding such non-recurring dividend(s), the ratio of net investment income (loss) to average net assets would have been .22%.

G Total returns for periods of less than one year are not annualized.

H Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

I Fees and expenses of any underlying mutual funds or exchange-traded funds (ETFs) are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of these expenses. For additional expense information related to investments in Fidelity Central Funds, please refer to the "Investments in Fidelity Central Funds" note found in the Notes to Financial Statements section of the most recent Annual or Semi-Annual report.

J Expense ratios reflect operating expenses of the class. Expenses before reductions do not reflect amounts reimbursed, waived, or reduced through arrangements with the investment adviser, brokerage services, or other offset arrangements, if applicable, and do not represent the amount paid by the class during periods when reimbursements, waivers or reductions occur.

K Annualized.

L Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Notes to Consolidated Financial Statements

For the period ended February 28, 2023

1. Organization.

Gold Portfolio (the Fund) is a non-diversified fund of Fidelity Select Portfolios (the Trust) and is authorized to issue an unlimited number of shares. The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust. The Fund invests primarily in securities of companies whose principal business activities fall within specific industries. The Fund offers Fidelity Advisor Gold Fund Class A (Class A), Fidelity Advisor Gold Fund Class M (Class M), Fidelity Advisor Gold Fund Class C (Class C), Gold Portfolio (Gold), Fidelity Advisor Gold Fund Class I (Class I) and Fidelity Advisor Gold Fund Class Z (Class Z) shares, each of which has equal rights as to assets and voting privileges. Each class has exclusive voting rights with respect to matters that affect that class. Class C shares will automatically convert to Class A shares after a holding period of eight years from the initial date of purchase, with certain exceptions.

2. Consolidated Subsidiary.

The Funds included in the table below hold certain commodity-related investments through a wholly owned subsidiary (the "Subsidiary"). As of period end, the investments in the Subsidiaries, were as follows:

	Subsidiary Name	$ Amount	% of Fund's Net Assets
Gold Portfolio	Fidelity Select Gold Cayman Ltd.	10,218,783	.7

The financial statements have been consolidated to include the Subsidiary accounts where applicable. Accordingly, all inter-company transactions and balances have been eliminated.

3. Investments in Fidelity Central Funds.

Funds may invest in Fidelity Central Funds, which are open-end investment companies generally available only to other investment companies and accounts managed by the investment adviser and its affiliates. The Consolidated Schedule of Investments lists any Fidelity Central Funds held as an investment as of period end, but does not include the underlying holdings of each Fidelity Central Fund. An investing fund indirectly bears its proportionate share of the expenses of the underlying Fidelity Central Funds.

Fidelity Central Fund	Investment Manager	Investment Objective	Investment Practices	Expense Ratio A
Fidelity Money Market Central Funds	Fidelity Management & Research Company LLC (FMR)	Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity.	Short-term Investments	Less than .005%

A Expenses expressed as a percentage of average net assets and are as of each underlying Central Fund's most recent annual or semi-annual shareholder report.

4. Significant Accounting Policies.

The Fund is an investment company and applies the accounting and reporting guidance of the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946 Financial Services - Investment Companies . The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP), which require management to make certain estimates and assumptions at the date of the consolidated financial statements. Actual results could differ from those estimates. Subsequent events, if any, through the date that the consolidated financial statements were issued have been evaluated in the preparation of the consolidated financial statements. The Fund's Consolidated Schedule of Investments lists any underlying mutual funds or exchange-traded funds (ETFs) but does not include the underlying holdings of these funds. The following summarizes the significant accounting policies of the Fund:

The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:

Level 1 - unadjusted quoted prices in active markets for identical investments

Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)

Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value the Fund's investments by major category are as follows:

Investments in commodities are valued at their last traded price at 4:00 p.m. Eastern time each business day and are categorized as Level 1 in the hierarchy. Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.

Investment Transactions and Income. For financial reporting purposes, the Fund's investment holdings and NAV include trades executed through the end of the last business day of the period. The NAV per share for processing shareholder transactions is calculated as of the close of business of the New York Stock Exchange (NYSE), normally 4:00 p.m. Eastern time and includes trades executed through the end of the prior business day. Gains and losses on securities sold are determined on the basis of identified cost and include proceeds received from litigation. Commissions paid to certain brokers with whom the investment adviser, or its affiliates, places trades on behalf of a fund include an amount in addition to trade execution, which may be rebated back to a fund. Any such rebates are included in net realized gain (loss) on investments in the Consolidated Statement of Operations. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities where the ex-dividend date may have passed, which are recorded as soon as the Fund is informed of the ex-dividend date. Non-cash dividends included in dividend income, if any, are recorded at the fair market value of the securities received. Income and capital gain distributions from Fidelity Central Funds, if any, are recorded on the ex-dividend date. Investment income is recorded net of foreign taxes withheld where recovery of such taxes is uncertain. Funds may file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. Any withholding tax reclaims income is included in the Consolidated Statement of Operations in foreign taxes withheld. Any receivables for withholding tax reclaims are included in the Consolidated Statement of Assets and Liabilities in dividends receivable.

Class Allocations and Expenses. Investment income, realized and unrealized capital gains and losses, common expenses of a fund, and certain fund-level expense reductions, if any, are allocated daily on a pro-rata basis to each class based on the relative net assets of each class to the total net assets of a fund. Each class differs with respect to transfer agent and distribution and service plan fees incurred, as applicable. Certain expense reductions may also differ by class, if applicable. For the reporting period, the allocated portion of income and expenses to each class as a percent of its average net assets may vary due to the timing of recording these transactions in relation to fluctuating net assets of the classes. Expenses directly attributable to a fund are charged to that fund. Expenses attributable to more than one fund are allocated among the respective funds on the basis of relative net assets or other appropriate methods. Expenses included in the accompanying consolidated financial statements reflect the expenses of that fund and do not include any expenses associated with any underlying mutual funds or exchange-traded funds. Although not included in a fund's expenses, a fund indirectly bears its proportionate share of these expenses through the net asset value of each underlying mutual fund or exchange-traded fund. Expense estimates are accrued in the period to which they relate and adjustments are made when actual amounts are known.

Deferred Trustee Compensation. Under a Deferred Compensation Plan (the Plan) for certain Funds, certain independent Trustees have elected to defer receipt of a portion of their annual compensation. Deferred amounts are invested in affiliated mutual funds, are marked-to-market and remain in a fund until distributed in accordance with the Plan. The investment of deferred amounts and the offsetting payable to the Trustees presented below are included in the accompanying Consolidated Statement of Assets and Liabilities in other receivables and other payables and accrued expenses, as applicable.

Gold Portfolio

$131,460

Income Tax Information and Distributions to Shareholders. Each year, the Fund intends to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code, including distributing substantially all of its taxable income and realized gains. As a result, no provision for U.S. Federal income taxes is required. As of February 28, 2023, the Fund did not have any unrecognized tax benefits in the consolidated financial statements; nor is the Fund aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. The Fund files a U.S. federal tax return, in addition to state and local tax returns as required. The Fund's federal income tax returns are subject to examination by the Internal Revenue Service (IRS) for a period of three fiscal years after they are filed. State and local tax returns may be subject to examination for an additional fiscal year depending on the jurisdiction. Foreign taxes are provided for based on the Fund's understanding of the tax rules and rates that exist in the foreign markets in which it invests.

The Subsidiary is classified as a controlled foreign corporation under Subchapter N of the Internal Revenue Code. Therefore, the Fund is required to increase its taxable income by its share of the Subsidiary's income. Net investment losses of the Subsidiary cannot be deducted by the Fund in the current period nor carried forward to offset taxable income in future periods.

Distributions are declared and recorded on the ex-dividend date. Income and capital gain distributions are declared separately for each class. Income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP. In addition, the Fund claimed a portion of the payment made to redeeming shareholders as a distribution for income tax purposes.

Capital accounts within the consolidated financial statements are adjusted for permanent book-tax differences. These adjustments have no impact on net assets or the results of operations. Capital accounts are not adjusted for temporary book-tax differences which will reverse in a subsequent period.

Book-tax differences are primarily due to foreign currency transactions, passive foreign investment companies (PFIC), controlled foreign corporations, deferred Trustees compensation, capital loss carryforwards and losses deferred due to wash sales.

As of period end, the cost and unrealized appreciation (depreciation) in securities, and derivatives if applicable, for federal income tax purposes were as follows:

Gross unrealized appreciation	$390,850,953
Gross unrealized depreciation	(187,874,314)
Net unrealized appreciation (depreciation)	$202,976,639
Tax Cost	$1,642,086,635

The tax-based components of distributable earnings as of period end were as follows:

Undistributed ordinary income	$8,563,393
Capital loss carryforward	$(1,461,988,083)
Net unrealized appreciation (depreciation) on securities and other investments	$203,138,503

Capital loss carryforwards are only available to offset future capital gains of the Fund to the extent provided by regulations and may be limited. The capital loss carryforward information presented below, including any applicable limitation, is estimated as of fiscal period end and is subject to adjustment.

Short-term	$(274,109,326)
Long-term	(1,187,878,757)
Total capital loss carryforward	$(1,461,988,083)

The tax character of distributions paid was as follows:

	February 28, 2023	February 28, 2022
Ordinary Income	$5,320,281	$27,126,849

Delayed Delivery Transactions and When-Issued Securities. During the period, certain Funds transacted in securities on a delayed delivery or when-issued basis. Payment and delivery may take place after the customary settlement period for that security. The price of the underlying securities and the date when the securities will be delivered and paid for are fixed at the time the transaction is negotiated. Securities purchased on a delayed delivery or when-issued basis are identified as such in the Consolidated Schedule of Investments. Compensation for interest forgone in the purchase of a delayed delivery or when-issued debt security may be received. With respect to purchase commitments, each applicable Fund identifies securities as segregated in its records with a value at least equal to the amount of the commitment. Payables and receivables associated with the purchases and sales of delayed delivery securities having the same coupon, settlement date and broker are offset. Delayed delivery or when-issued securities that have been purchased from and sold to different brokers are reflected as both payables and receivables in the Consolidated Statement of Assets and Liabilities under the caption "Delayed delivery", as applicable. Losses may arise due to changes in the value of the underlying securities or if the counterparty does not perform under the contract's terms, or if the issuer does not issue the securities due to political, economic, or other factors.

Restricted Securities (including Private Placements). Funds may invest in securities that are subject to legal or contractual restrictions on resale. These securities generally may be resold in transactions exempt from registration or to the public if the securities are registered. Disposal of these securities may involve time-consuming negotiations and expense, and prompt sale at an acceptable price may be difficult. Information regarding restricted securities held at period end is included at the end of the Consolidated Schedule of Investments, if applicable.

New Accounting Pronouncement. In June 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2022-03 Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The amendments in this ASU clarify that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. They also clarify that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. They also require additional disclosures for equity securities subject to contractual sale restrictions. ASU 2022-03 will be effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2023, and allows for early adoption. ASU 2022-03 will only be applicable to an equity security in which the contractual arrangement that restricts its sale is executed or modified on or after the adoption date. Management is currently evaluating the potential impact of ASU 2022-03 to the financial statements.

5. Purchases and Sales of Investments.

Purchases and sales of securities, other than short-term securities and in-kind transactions, as applicable, are noted in the table below.

	Purchases ($)	Sales ($)
Gold Portfolio	861,480,974	675,375,560

6. Fees and Other Transactions with Affiliates.

The investment adviser, either through itself or through an affiliate provides investment management related services to the Subsidiary. The Subsidiary does not pay the investment adviser a fee for these services. Under the management contract with the subsidiary, the investment adviser pays all other expenses of the Subsidiary, except custodian fees.

Distribution and Service Plan Fees. In accordance with Rule 12b-1 of the 1940 Act, the Fund has adopted separate Distribution and Service Plans for each class of shares. Certain classes pay Fidelity Distributors Company LLC (FDC), an affiliate of the investment adviser, separate Distribution and Service Fees, each of which is based on an annual percentage of each class' average net assets. In addition, FDC may pay financial intermediaries for selling shares of the Fund and providing shareholder support services. For the period, the Distribution and Service Fee rates, total fees and amounts retained by FDC were as follows:

	Distribution Fee	Service Fee	Total Fees	Retained by FDC
Class A	- %	.25%	$194,867	$4,428
Class M	.25%	.25%	117,966	-
Class C	.75%	.25%	335,475	24,479
			$648,308	$28,907

Sales Load. FDC may receive a front-end sales charge of up to 5.75% for selling Class A shares and 3.50% for selling Class M shares, some of which is paid to financial intermediaries for selling shares of the Fund. Depending on the holding period, FDC may receive contingent deferred sales charges levied on Class A, Class M and Class C redemptions. The deferred sales charges are 1.00% for Class C shares, 1.00% for certain purchases of Class A shares and .25% for certain purchases of Class M shares.

For the period, sales charge amounts retained by FDC were as follows:

	Retained by FDC
Class A	$40,149
Class M	3,412
Class C A	196
	$43,757

A When Class C shares are initially sold, FDC pays commissions from its own resources to financial intermediaries through which the sales are made.

Transfer Agent Fees. Fidelity Investments Institutional Operations Company LLC (FIIOC), an affiliate of the investment adviser, is the transfer, dividend disbursing and shareholder servicing agent for each class of the Fund. FIIOC receives account fees and asset-based fees that vary according to the account size and type of account of the shareholders of the respective classes of the Fund, except for Class Z. FIIOC receives an asset-based fee of Class Z's average net assets. FIIOC pays for typesetting, printing and mailing of shareholder reports, except proxy statements.

For the period, transfer agent fees for each class were as follows:

	Amount	% of Class-Level Average Net Assets
Class A	$192,552	.25
Class M	62,058	.26
Class C	66,798	.20
Gold	2,182,343	.19
Class I	227,241	.18
Class Z	40,371	.04
	$2,771,363

	% of Average Net Assets
Gold Portfolio	.04

Brokerage Commissions. A portion of portfolio transactions were placed with brokerage firms which are affiliates of the investment adviser. Brokerage commissions are included in net realized gain (loss) and change in net unrealized appreciation (depreciation) in the Consolidated Statement of Operations. The commissions paid to these affiliated firms were as follows:

	Amount
Gold Portfolio	$5,875

Interfund Lending Program. Pursuant to an Exemptive Order issued by the Securities and Exchange Commission (the SEC), the Fund, along with other registered investment companies having management contracts with Fidelity Management & Research Company LLC (FMR), or other affiliated entities of FMR, may participate in an interfund lending program. This program provides an alternative credit facility allowing the Fund to borrow from, or lend money to, other participating affiliated funds. At period end, there were no interfund loans outstanding. Activity in this program during the period for which loans were outstanding was as follows:

	Borrower or Lender	Average Loan Balance	Weighted Average Interest Rate	Interest Expense
Gold Portfolio	Borrower	$ 3,344,667	3.64%	$2,027

	Purchases ($)	Sales ($)	Realized Gain (Loss) ($)
Gold Portfolio	8,187,898	37,112,292	(1,397,642)

7. Committed Line of Credit.

Certain Funds participate with other funds managed by the investment adviser or an affiliate in a $4.25 billion credit facility (the "line of credit") to be utilized for temporary or emergency purposes to fund shareholder redemptions or for other short-term liquidity purposes. The participating funds have agreed to pay commitment fees on their pro-rata portion of the line of credit, which are reflected in Miscellaneous expenses on the Consolidated Statement of Operations, and are listed below. During the period, there were no borrowings on this line of credit.

	Amount
Gold Portfolio	$2,689

8. Security Lending.

Funds lend portfolio securities from time to time in order to earn additional income. Lending agents are used, including National Financial Services (NFS), an affiliate of the investment adviser. Pursuant to a securities lending agreement, NFS will receive a fee, which is capped at 9.9% of a fund's daily lending revenue, for its services as lending agent. A fund may lend securities to certain qualified borrowers, including NFS. On the settlement date of the loan, a fund receives collateral (in the form of U.S. Treasury obligations, letters of credit and/or cash) against the loaned securities and maintains collateral in an amount not less than 100% of the market value of the loaned securities during the period of the loan. The market value of the loaned securities is determined at the close of business of a fund and any additional required collateral is delivered to a fund on the next business day. A fund or borrower may terminate the loan at any time, and if the borrower defaults on its obligation to return the securities loaned because of insolvency or other reasons, a fund may apply collateral received from the borrower against the obligation. A fund may experience delays and costs in recovering the securities loaned. Any cash collateral received is invested in the Fidelity Securities Lending Cash Central Fund. Any loaned securities are identified as such in the Consolidated Schedule of Investments, and the value of loaned securities and cash collateral at period end, as applicable, are presented in the Consolidated Statement of Assets and Liabilities. Security lending income represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities. Security lending income is presented in the Consolidated Statement of Operations as a component of income from Fidelity Central Funds. Affiliated security lending activity, if any, was as follows:

	Total Security Lending Fees Paid to NFS	Security Lending Income From Securities Loaned to NFS	Value of Securities Loaned to NFS at Period End
Gold Portfolio	$79,640	$70	$-

9. Expense Reductions.

Through arrangements with the Fund's custodian, credits realized as a result of certain uninvested cash balances were used to reduce the Fund's expenses. During the period, custodian credits reduced the Fund's expenses by $10,043 . During the period, transfer agent credits reduced each class' expenses as noted in the table below.

	Expense reduction

Class M	$255

In addition, during the period the investment adviser or an affiliate reimbursed and/or waived a portion of fund-level operating expenses in the amount of $53,134.

10. Distributions to Shareholders.

Distributions to shareholders of each class were as follows:

	Year ended February 28, 2023	Year ended February 28, 2022
Gold Portfolio
Distributions to shareholders
Class A	$236,581	$1,159,197
Class M	64,063	296,704
Class C	82,259	340,514
Gold	4,119,368	21,360,877
Class I	460,437	2,173,450
Class Z	357,573	1,796,107
Total	$5,320,281	$27,126,849

11. Share Transactions.

Share transactions for each class were as follows and may contain in-kind transactions, automatic conversions between classes or exchanges between affiliated funds:

	Shares	Shares	Dollars	Dollars
	Year ended February 28, 2023	Year ended February 28, 2022	Year ended February 28, 2023	Year ended February 28, 2022
Gold Portfolio
Class A
Shares sold	1,122,921	1,096,721	$27,099,950	$29,272,417
Reinvestment of distributions	7,775	47,654	230,842	1,130,833
Shares redeemed	(939,774)	(1,270,387)	(21,685,894)	(33,037,200)
Net increase (decrease)	190,922	(126,012)	$5,644,898	$(2,633,950)
Class M
Shares sold	371,999	261,284	$8,541,059	$6,743,876
Reinvestment of distributions	2,211	12,798	64,030	296,405
Shares redeemed	(346,180)	(292,712)	(7,235,921)	(7,361,263)
Net increase (decrease)	28,030	(18,630)	$1,369,168	$(320,982)
Class C
Shares sold	330,090	196,401	$7,857,068	$4,759,229
Reinvestment of distributions	2,997	15,464	82,054	339,121
Shares redeemed	(663,298)	(732,472)	(13,627,374)	(17,728,207)
Net increase (decrease)	(330,211)	(520,607)	$(5,688,252)	$(12,629,857)
Gold
Shares sold	24,882,743	15,683,398	$614,447,230	$428,540,719
Reinvestment of distributions	128,260	836,569	3,933,734	20,495,942
Shares redeemed	(17,838,751)	(20,431,260)	(424,861,608)	(537,992,891)
Net increase (decrease)	7,172,252	(3,911,293)	$193,519,356	$(88,956,230)
Class I
Shares sold	1,703,267	1,719,405	$41,572,132	$46,014,104
Reinvestment of distributions	14,570	85,689	447,009	2,100,234
Shares redeemed	(2,309,414)	(1,696,668)	(53,976,142)	(45,357,188)
Net increase (decrease)	(591,577)	108,426	$(11,957,001)	$2,757,150
Class Z
Shares sold	2,207,248	1,719,289	$52,782,706	$46,800,221
Reinvestment of distributions	11,475	72,350	352,174	1,773,309
Shares redeemed	(1,991,473)	(1,969,124)	(46,768,230)	(53,134,514)
Net increase (decrease)	227,250	(177,485)	$6,366,650	$(4,560,984)

12. Other.

13. Risk and Uncertainties.

Materials Portfolio

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Class A (incl.5.75% sales charge)	-5.38%	4.49%	6.23%
Class M (incl.3.50% sales charge)	-3.36%	4.70%	6.18%
Class C (incl. contingent deferred sales charge)	-1.33%	4.95%	6.22%
Materials Portfolio	0.67%	6.03%	7.15%
Class I	0.66%	6.03%	7.17%
Class Z	0.81%	6.17%	7.24%

Class C shares' contingent deferred sales charges included in the past one year, past five years and past ten years total return figures are 1%, 0% and 0%, respectively.

The initial offering of Class Z shares took place on October 2, 2018. Returns prior to October 2, 2018, are those of Class I.

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Materials Portfolio, a class of the fund, on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Materials Portfolio

Market Recap:

U.S. equities returned -7.69% for the 12 months ending February 28, 2023, according to the S&P 500® index. The new year began with an encouraging upturn in January (+6.28%), but stocks lost momentum in February (-2.44%) amid higher-than-expected inflation and strong jobs data. Investors took these as signs that the economy continued to run hot, even after a year of historic policy adjustment by the Federal Reserve aimed at cooling economic growth. Record inflation in 2022 prompted the Fed to aggressively tighten monetary policy, and market interest rates eclipsed their highest level in a decade, stoking recession fears and sending stocks into bear market territory. Since March 2022, the central bank has hiked its benchmark rate eight times, by 4.5 percentage points - the fastest-ever pace of monetary tightening - while also shrinking its massive asset portfolio. The latest bump came on February 2, along with a signal that the Fed plans to lift rates in March while it considers whether and when to pause increases. Against this dynamic backdrop, stocks struggled to gain traction until a strong rally ignited heading into the summer. But in September, the index returned -9.21%, one of its worst monthly results ever, before advancing 7.56% in Q4, as risky assets regained favor. For the full 12 months, value stocks handily outpaced growth. The headwind for the latter was most pronounced in the growth-oriented communication services (-25%) and consumer discretionary (-18%) sectors. In sharp contrast, energy gained 24%.

Comments from Co-Manager Ashley Fernandes:

For the fiscal year ending February 28, 2023, the fund's share classes (excluding sales charges, if applicable) returned about 0% to 1%, roughly in line with the 0.65% advance of the MSCI U.S. IMI Materials 25/50 Linked Index and well ahead of the broad-based S&P 500 ® index. The top contributors to performance versus the sector index were stock selection and an underweighting in specialty chemicals. Also bolstering the fund's relative result was an overweighting in fertilizers & agricultural chemicals. The fund's largest individual relative contributor was an outsized stake in CF Industries Holdings, which gained roughly 9% the past 12 months. The company was among our largest holdings. Also bolstering performance was our overweighting in Albemarle, which gained roughly 27%. We decreased our investment the past year. Another notable relative contributor was an underweighting in Sherwin Williams (-12%), a position not held at period end. In contrast, a notable detractor from performance versus the sector index was an underweighting in steel. An overweighting and security selection in aluminum and stock selection in copper also hindered the fund's relative result. The fund's biggest individual relative detractor was an outsized stake in Alcoa, which returned -34% the past 12 months. Our second-largest relative detractor this period was avoiding Nucor, an index component that gained approximately 29%. Also hindering performance was our overweighting in Tronox Holdings, which returned -21%. Notable changes in positioning include a higher allocation to the commodity chemicals and industrial gases subindustries.

Note to shareholders: On January 1, 2023, Ashley Fernandes assumed sole management responsibilities for the fund after having served as co-manager with Jody Simes since April 2022.

Materials Portfolio

Top Holdings (% of Fund's net assets)

Linde PLC	17.2
Air Products & Chemicals, Inc.	7.5
Freeport-McMoRan, Inc.	7.3
Corteva, Inc.	5.9
First Quantum Minerals Ltd.	5.1
LyondellBasell Industries NV Class A	4.7
DuPont de Nemours, Inc.	3.8
Celanese Corp. Class A	3.5
CF Industries Holdings, Inc.	3.1
Olin Corp.	2.8
	60.9

Industries (% of Fund's net assets)

Chemicals	64.6
Metals & Mining	21.4
Containers & Packaging	8.3
Construction Materials	4.2

Geographic Diversification (% of Fund's net assets)

* Includes Short-Term investments and Net Other Assets (Liabilities).

Percentages are based on country or territory of incorporation and are adjusted for the effect of derivatives, if applicable.

Materials Portfolio

Showing Percentage of Net Assets

Common Stocks - 98.5%
	Shares	Value ($)
Chemicals - 64.6%
Commodity Chemicals - 16.4%
Cabot Corp. (a)	289,600	23,031,888
Chemtrade Logistics Income Fund	1,926,900	12,963,680
Dow, Inc.	210,100	12,017,720
LyondellBasell Industries NV Class A	542,739	52,097,517
Olin Corp.	525,600	30,353,400
Orion Engineered Carbons SA	194,500	4,959,750
Tronox Holdings PLC	1,765,203	27,537,167
Westlake Corp. (a)	139,900	16,667,686
		179,628,808
Diversified Chemicals - 3.4%
Huntsman Corp.	262,500	7,701,750
The Chemours Co. LLC	874,303	29,883,677
		37,585,427
Fertilizers & Agricultural Chemicals - 9.0%
CF Industries Holdings, Inc.	396,300	34,038,207
Corteva, Inc.	1,035,811	64,520,667
		98,558,874
Industrial Gases - 24.7%
Air Products & Chemicals, Inc.	288,200	82,419,436
Linde PLC	541,486	188,637,477
		271,056,913
Specialty Chemicals - 11.1%
Albemarle Corp.	7,900	2,009,049
Ashland, Inc.	179,000	18,218,620
Celanese Corp. Class A	326,500	37,949,095
DuPont de Nemours, Inc.	578,417	42,241,794
Eastman Chemical Co.	70,200	5,981,040
Element Solutions, Inc.	390,200	8,014,708
RPM International, Inc.	85,200	7,551,276
		121,965,582
TOTAL CHEMICALS		708,795,604
Construction Materials - 4.2%
Construction Materials - 4.2%
Martin Marietta Materials, Inc.	61,900	22,275,953
Vulcan Materials Co.	131,700	23,825,847
		46,101,800
Containers & Packaging - 8.3%
Metal & Glass Containers - 5.7%
Aptargroup, Inc.	226,700	26,460,424
Crown Holdings, Inc.	187,959	16,260,333
Greif, Inc. Class A	281,200	19,979,260
		62,700,017
Paper Packaging - 2.6%
Avery Dennison Corp.	103,000	18,765,570
Sealed Air Corp.	203,149	9,877,104
		28,642,674
TOTAL CONTAINERS & PACKAGING		91,342,691
Metals & Mining - 21.4%
Aluminum - 2.1%
Alcoa Corp.	477,100	23,349,274
Copper - 12.4%
First Quantum Minerals Ltd.	2,524,900	55,161,062
Freeport-McMoRan, Inc.	1,960,300	80,313,491
		135,474,553
Diversified Metals & Mining - 1.9%
Glencore PLC	3,396,600	20,250,073
Steel - 5.0%
Commercial Metals Co.	319,700	16,544,475
Reliance Steel & Aluminum Co.	105,200	26,072,768
Steel Dynamics, Inc.	99,000	12,484,890
		55,102,133
TOTAL METALS & MINING		234,176,033
TOTAL COMMON STOCKS (Cost $796,683,232)		1,080,416,128

Money Market Funds - 2.7%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (b)	12,466,384	12,468,877
Fidelity Securities Lending Cash Central Fund 4.63% (b)(c)	17,447,305	17,449,050
TOTAL MONEY MARKET FUNDS (Cost $29,917,927)		29,917,927

TOTAL INVESTMENT IN SECURITIES - 101.2% (Cost $826,601,159)	1,110,334,055
NET OTHER ASSETS (LIABILITIES) - (1.2)%	(13,033,869)
NET ASSETS - 100.0%	1,097,300,186

Legend

(a)	Security or a portion of the security is on loan at period end.

(b)

(c)	Investment made with cash collateral received from securities on loan.

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	1,212,250	270,921,057	259,664,430	245,566	-	-	12,468,877	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	20,127,155	202,620,830	205,298,935	15,081	-	-	17,449,050	0.1%
Total	21,339,405	473,541,887	464,963,365	260,647	-	-	29,917,927

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	1,080,416,128	1,060,166,055	20,250,073	-

Money Market Funds	29,917,927	29,917,927	-	-
Total Investments in Securities:	1,110,334,055	1,090,083,982	20,250,073	-

Materials Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $16,870,503) - See accompanying schedule:
Unaffiliated issuers (cost $796,683,232)	$	1,080,416,128
Fidelity Central Funds (cost $29,917,927)		29,917,927


Total Investment in Securities (cost $826,601,159)			$	1,110,334,055
Foreign currency held at value (cost $19,046)				18,872
Receivable for investments sold				16,053,961
Receivable for fund shares sold				453,744
Dividends receivable				1,564,527
Distributions receivable from Fidelity Central Funds				20,504
Prepaid expenses				5,442
Other receivables				170,960
Total assets				1,128,622,065
Liabilities
Payable for investments purchased	$	11,940,264
Payable for fund shares redeemed		997,681
Accrued management fee		483,068
Distribution and service plan fees payable		56,550
Other affiliated payables		183,135
Other payables and accrued expenses		212,131
Collateral on securities loaned		17,449,050
Total Liabilities				31,321,879
Net Assets			$	1,097,300,186
Net Assets consist of:
Paid in capital			$	773,543,103
Total accumulated earnings (loss)				323,757,083
Net Assets			$	1,097,300,186

Net Asset Value and Maximum Offering Price
Class A :
Net Asset Value and redemption price per share ($124,776,777 ÷ 1,247,999 shares) (a)			$	99.98
Maximum offering price per share (100/94.25 of $99.98)			$	106.08
Class M :
Net Asset Value and redemption price per share ($38,569,794 ÷ 390,508 shares) (a)			$	98.77
Maximum offering price per share (100/96.50 of $98.77)			$	102.35
Class C :
Net Asset Value and offering price per share ($17,052,876 ÷ 177,917 shares) (a)			$	95.85
Materials :
Net Asset Value , offering price and redemption price per share ($603,330,274 ÷ 5,995,367 shares)			$	100.63
Class I :
Net Asset Value , offering price and redemption price per share ($208,630,149 ÷ 2,077,644 shares)			$	100.42
Class Z :
Net Asset Value , offering price and redemption price per share ($104,940,316 ÷ 1,046,539 shares)			$	100.27
(a)Redemption price per share is equal to net asset value less any applicable contingent deferred sales charge.

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	19,398,883
Income from Fidelity Central Funds (including $15,081 from security lending)				260,647
Total Income				19,659,530
Expenses
Management fee	$	5,632,622
Transfer agent fees		1,875,435
Distribution and service plan fees		681,630
Accounting fees		323,931
Custodian fees and expenses		14,513
Independent trustees' fees and expenses		3,645
Registration fees		113,186
Audit		49,937
Legal		804
Interest		201
Miscellaneous		7,525
Total expenses before reductions		8,703,429
Expense reductions		(38,566)
Total expenses after reductions				8,664,863
Net Investment income (loss)				10,994,667
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		108,078,773
Foreign currency transactions		20,417
Total net realized gain (loss)				108,099,190
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		(119,331,153)
Assets and liabilities in foreign currencies		(16,905)
Total change in net unrealized appreciation (depreciation)				(119,348,058)
Net gain (loss)				(11,248,868)
Net increase (decrease) in net assets resulting from operations			$	(254,201)

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	10,994,667	$	8,580,339
Net realized gain (loss)		108,099,190		32,188,411
Change in net unrealized appreciation (depreciation)		(119,348,058)		129,763,897
Net increase (decrease) in net assets resulting from operations		(254,201)		170,532,647
Distributions to shareholders		(33,314,365)		(8,437,183)
Share transactions - net increase (decrease)		(23,554,987)		72,770,453
Total increase (decrease) in net assets		(57,123,553)		234,865,917

Net Assets
Beginning of period		1,154,423,739		919,557,822
End of period	$	1,097,300,186	$	1,154,423,739

Financial Highlights

Fidelity Advisor® Materials Fund Class A

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	102.68	$	87.03	$	59.39	$	69.57	$	88.50
Income from Investment Operations
Net investment income (loss) B,C		.79		.46		.33		.58		.84
Net realized and unrealized gain (loss)		(.54)		15.77		27.72		(10.10)		(12.01)
Total from investment operations		.25		16.23		28.05		(9.52)		(11.17)
Distributions from net investment income		(.80)		(.58)		(.41)		(.66)		(.67)
Distributions from net realized gain		(2.15)		-		-		-		(7.09)
Total distributions		(2.95)		(.58)		(.41)		(.66)		(7.76)
Net asset value, end of period	$	99.98	$	102.68	$	87.03	$	59.39	$	69.57
Total Return D,E		.39%		18.64%		47.27%		(13.81)%		(12.59)%
Ratios to Average Net Assets C,F,G
Expenses before reductions		1.03%		1.03%		1.08%		1.08%		1.06%
Expenses net of fee waivers, if any		1.03%		1.03%		1.08%		1.08%		1.06%
Expenses net of all reductions		1.03%		1.03%		1.08%		1.07%		1.05%
Net investment income (loss)		.81%		.46%		.48%		.87%		1.08%
Supplemental Data
Net assets, end of period (000 omitted)	$	124,777	$	138,219	$	101,238	$	76,869	$	126,182
Portfolio turnover rate H		47%		43%		36%		69%		77% I

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

E Total returns do not include the effect of the sales charges.

H Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

I Portfolio turnover rate excludes securities received or delivered in-kind.

Fidelity Advisor® Materials Fund Class M

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	101.52	$	86.14	$	58.84	$	68.98	$	87.79
Income from Investment Operations
Net investment income (loss) B,C		.54		.20		.14		.39		.61
Net realized and unrealized gain (loss)		(.53)		15.59		27.42		(10.01)		(11.88)
Total from investment operations		.01		15.79		27.56		(9.62)		(11.27)
Distributions from net investment income		(.61)		(.41)		(.26)		(.52)		(.45)
Distributions from net realized gain		(2.15)		-		-		-		(7.09)
Total distributions		(2.76)		(.41)		(.26)		(.52)		(7.54)
Net asset value, end of period	$	98.77	$	101.52	$	86.14	$	58.84	$	68.98
Total Return D,E		.15%		18.32%		46.86%		(14.05)%		(12.84)%
Ratios to Average Net Assets C,F,G
Expenses before reductions		1.28%		1.29%		1.36%		1.37%		1.35%
Expenses net of fee waivers, if any		1.28%		1.29%		1.36%		1.36%		1.35%
Expenses net of all reductions		1.28%		1.29%		1.36%		1.36%		1.34%
Net investment income (loss)		.56%		.20%		.21%		.58%		.79%
Supplemental Data
Net assets, end of period (000 omitted)	$	38,570	$	37,100	$	24,768	$	19,423	$	27,436
Portfolio turnover rate H		47%		43%		36%		69%		77% I

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

E Total returns do not include the effect of the sales charges.

H Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

I Portfolio turnover rate excludes securities received or delivered in-kind.

Fidelity Advisor® Materials Fund Class C

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	98.63	$	83.76	$	57.30	$	67.13	$	85.52
Income from Investment Operations
Net investment income (loss) B,C		.06		(.28)		(.18)		.08		.25
Net realized and unrealized gain (loss)		(.53)		15.15		26.64		(9.76)		(11.50)
Total from investment operations		(.47)		14.87		26.46		(9.68)		(11.25)
Distributions from net investment income		(.16)		-		-		(.15)		(.04)
Distributions from net realized gain		(2.15)		-		-		-		(7.09)
Total distributions		(2.31)		-		-		(.15)		(7.14) D
Net asset value, end of period	$	95.85	$	98.63	$	83.76	$	57.30	$	67.13
Total Return E,F		(.36)%		17.75%		46.18%		(14.46)%		(13.24)%
Ratios to Average Net Assets C,G,H
Expenses before reductions		1.78%		1.78%		1.83%		1.82%		1.81%
Expenses net of fee waivers, if any		1.78%		1.78%		1.83%		1.82%		1.81%
Expenses net of all reductions		1.78%		1.78%		1.83%		1.81%		1.79%
Net investment income (loss)		.06%		(.29)%		(.27)%		.12%		.33%
Supplemental Data
Net assets, end of period (000 omitted)	$	17,053	$	21,261	$	23,296	$	24,239	$	51,659
Portfolio turnover rate I		47%		43%		36%		69%		77% J

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Total distributions per share do not sum due to rounding.

E Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

F Total returns do not include the effect of the contingent deferred sales charge.

I Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

J Portfolio turnover rate excludes securities received or delivered in-kind.

Materials Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	103.29	$	87.46	$	59.63	$	69.84	$	88.90
Income from Investment Operations
Net investment income (loss) B,C		1.07		.75		.53		.77		1.06
Net realized and unrealized gain (loss)		(.55)		15.86		27.87		(10.14)		(12.09)
Total from investment operations		.52		16.61		28.40		(9.37)		(11.03)
Distributions from net investment income		(1.03)		(.78)		(.57)		(.84)		(.93)
Distributions from net realized gain		(2.15)		-		-		-		(7.09)
Total distributions		(3.18)		(.78)		(.57)		(.84)		(8.03) D
Net asset value, end of period	$	100.63	$	103.29	$	87.46	$	59.63	$	69.84
Total Return E		.67%		18.98%		47.68%		(13.57)%		(12.35)%
Ratios to Average Net Assets C,F,G
Expenses before reductions		.76%		.75%		.80%		.80%		.79%
Expenses net of fee waivers, if any		.75%		.74%		.80%		.80%		.79%
Expenses net of all reductions		.75%		.74%		.80%		.79%		.78%
Net investment income (loss)		1.09%		.75%		.76%		1.14%		1.35%
Supplemental Data
Net assets, end of period (000 omitted)	$	603,330	$	645,773	$	533,073	$	405,668	$	626,759
Portfolio turnover rate H		47%		43%		36%		69%		77% I

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Total distributions per share do not sum due to rounding.

E Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

H Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

I Portfolio turnover rate excludes securities received or delivered in-kind.

Fidelity Advisor® Materials Fund Class I

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	103.07	$	87.29	$	59.52	$	69.70	$	88.73
Income from Investment Operations
Net investment income (loss) B,C		1.06		.74		.55		.78		1.07
Net realized and unrealized gain (loss)		(.54)		15.83		27.80		(10.12)		(12.08)
Total from investment operations		.52		16.57		28.35		(9.34)		(11.01)
Distributions from net investment income		(1.02)		(.79)		(.58)		(.84)		(.93)
Distributions from net realized gain		(2.15)		-		-		-		(7.09)
Total distributions		(3.17)		(.79)		(.58)		(.84)		(8.02)
Net asset value, end of period	$	100.42	$	103.07	$	87.29	$	59.52	$	69.70
Total Return D		.66%		18.97%		47.70%		(13.55)%		(12.34)%
Ratios to Average Net Assets C,E,F
Expenses before reductions		.76%		.75%		.78%		.79%		.78%
Expenses net of fee waivers, if any		.76%		.75%		.78%		.79%		.78%
Expenses net of all reductions		.76%		.75%		.78%		.78%		.77%
Net investment income (loss)		1.08%		.74%		.78%		1.16%		1.36%
Supplemental Data
Net assets, end of period (000 omitted)	$	208,630	$	238,282	$	190,132	$	137,887	$	254,240
Portfolio turnover rate G		47%		43%		36%		69%		77% H

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

E Fees and expenses of any underlying mutual funds or exchange-traded funds (ETFs) are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of these expenses. For additional expense information related to investments in Fidelity Central Funds, please refer to the "Investments in Fidelity Central Funds" note found in the Notes to Financial Statements section of the most recent Annual or Semi-Annual report.

F Expense ratios reflect operating expenses of the class. Expenses before reductions do not reflect amounts reimbursed, waived, or reduced through arrangements with the investment adviser, brokerage services, or other offset arrangements, if applicable, and do not represent the amount paid by the class during periods when reimbursements, waivers or reductions occur.

G Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

H Portfolio turnover rate excludes securities received or delivered in-kind.

Fidelity Advisor® Materials Fund Class Z

Years ended February 28,		2023		2022		2021		2020 A		2019 B
Selected Per-Share Data
Net asset value, beginning of period	$	102.92	$	87.14	$	59.40	$	69.58	$	79.81
Income from Investment Operations
Net investment income (loss) C,D		1.20		.88		.67		.88		.62
Net realized and unrealized gain (loss)		(.54)		15.81		27.75		(10.10)		(6.96)
Total from investment operations		.66		16.69		28.42		(9.22)		(6.34)
Distributions from net investment income		(1.16)		(.91)		(.68)		(.96)		(.96)
Distributions from net realized gain		(2.15)		-		-		-		(2.93)
Total distributions		(3.31)		(.91)		(.68)		(.96)		(3.89)
Net asset value, end of period	$	100.27	$	102.92	$	87.14	$	59.40	$	69.58
Total Return E,F		.81%		19.14%		47.92%		(13.43)%		(7.35)%
Ratios to Average Net Assets D,G,H
Expenses before reductions		.62%		.62%		.64%		.63%		.63% I
Expenses net of fee waivers, if any		.61%		.62%		.64%		.63%		.62% I
Expenses net of all reductions		.61%		.62%		.63%		.62%		.61% I
Net investment income (loss)		1.23%		.88%		.93%		1.31%		2.27% I
Supplemental Data
Net assets, end of period (000 omitted)	$	104,940	$	73,790	$	47,051	$	13,267	$	10,039
Portfolio turnover rate J		47%		43%		36%		69%		77% K

A For the year ended February 29.

B For the period October 2, 2018 (commencement of sale of shares) through February 28, 2019.

C Calculated based on average shares outstanding during the period.

E Total returns for periods of less than one year are not annualized.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

I Annualized.

J Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

K Portfolio turnover rate excludes securities received or delivered in-kind.

Report of Independent Registered Public Accounting Firm

For the period ended February 28, 2023

1. Organization.

Materials Portfolio (the Fund) is a non-diversified fund of Fidelity Select Portfolios (the Trust) and is authorized to issue an unlimited number of shares. The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust. The Fund invests primarily in securities of companies whose principal business activities fall within specific industries. The Fund offers Fidelity Advisor Materials Fund Class A (Class A), Fidelity Advisor Materials Fund Class M (Class M), Fidelity Advisor Materials Fund Class C (Class C), Materials Portfolio (Materials), Fidelity Advisor Materials Fund Class I (Class I) and Fidelity Advisor Materials Fund Class Z (Class Z) shares, each of which has equal rights as to assets and voting privileges. Each class has exclusive voting rights with respect to matters that affect that class. Class C shares will automatically convert to Class A shares after a holding period of eight years from the initial date of purchase, with certain exceptions.

2. Investments in Fidelity Central Funds.

Fidelity Central Fund	Investment Manager	Investment Objective	Investment Practices	Expense Ratio A
Fidelity Money Market Central Funds	Fidelity Management & Research Company LLC (FMR)	Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity.	Short-term Investments	Less than .005%

A Expenses expressed as a percentage of average net assets and are as of each underlying Central Fund's most recent annual or semi-annual shareholder report.

3. Significant Accounting Policies.

The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:

Level 1 - unadjusted quoted prices in active markets for identical investments

Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)

Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value the Fund's investments by major category are as follows:

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.

Investment Transactions and Income. For financial reporting purposes, the Fund's investment holdings and NAV include trades executed through the end of the last business day of the period. The NAV per share for processing shareholder transactions is calculated as of the close of business of the New York Stock Exchange (NYSE), normally 4:00 p.m. Eastern time and includes trades executed through the end of the prior business day. Gains and losses on securities sold are determined on the basis of identified cost and include proceeds received from litigation. Commissions paid to certain brokers with whom the investment adviser, or its affiliates, places trades on behalf of a fund include an amount in addition to trade execution, which may be rebated back to a fund. Any such rebates are included in net realized gain (loss) on investments in the Statement of Operations. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities where the ex-dividend date may have passed, which are recorded as soon as the Fund is informed of the ex-dividend date. Non-cash dividends included in dividend income, if any, are recorded at the fair market value of the securities received. Income and capital gain distributions from Fidelity Central Funds, if any, are recorded on the ex-dividend date. Certain distributions received by the Fund represent a return of capital or capital gain. The Fund determines the components of these distributions subsequent to the ex-dividend date, based upon receipt of tax filings or other correspondence relating to the underlying investment. These distributions are recorded as a reduction of cost of investments and/or as a realized gain. Investment income is recorded net of foreign taxes withheld where recovery of such taxes is uncertain. Funds may file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. Any withholding tax reclaims income is included in the Statement of Operations in dividends. Any receivables for withholding tax reclaims are included in the Statement of Assets and Liabilities in dividends receivable.

Class Allocations and Expenses. Investment income, realized and unrealized capital gains and losses, common expenses of a fund, and certain fund-level expense reductions, if any, are allocated daily on a pro-rata basis to each class based on the relative net assets of each class to the total net assets of a fund. Each class differs with respect to transfer agent and distribution and service plan fees incurred, as applicable. Certain expense reductions may also differ by class, if applicable. For the reporting period, the allocated portion of income and expenses to each class as a percent of its average net assets may vary due to the timing of recording these transactions in relation to fluctuating net assets of the classes. Expenses directly attributable to a fund are charged to that fund. Expenses attributable to more than one fund are allocated among the respective funds on the basis of relative net assets or other appropriate methods. Expenses included in the accompanying financial statements reflect the expenses of that fund and do not include any expenses associated with any underlying mutual funds or exchange-traded funds. Although not included in a fund's expenses, a fund indirectly bears its proportionate share of these expenses through the net asset value of each underlying mutual fund or exchange-traded fund. Expense estimates are accrued in the period to which they relate and adjustments are made when actual amounts are known.

Materials Portfolio

$170,960

Book-tax differences are primarily due to foreign currency transactions, deferred Trustees compensation, capital loss carryforwards and losses deferred due to wash sales and excise tax regulations.

As of period end, the cost and unrealized appreciation (depreciation) in securities, and derivatives if applicable, for federal income tax purposes were as follows:

Gross unrealized appreciation	$298,730,549
Gross unrealized depreciation	(17,040,907)
Net unrealized appreciation (depreciation)	$281,689,642
Tax Cost	$828,644,413

The tax-based components of distributable earnings as of period end were as follows:

Undistributed ordinary income	$404,924
Undistributed long-term capital gain	$41,868,671
Net unrealized appreciation (depreciation) on securities and other investments	$281,655,866

The tax character of distributions paid was as follows:

	February 28, 2023	February 28, 2022
Ordinary Income	$10,457,127	$ 8,437,183
Long-term Capital Gains	22,857,238	-
Total	$33,314,365	$ 8,437,183

4. Purchases and Sales of Investments.

Purchases and sales of securities, other than short-term securities and in-kind transactions, as applicable, are noted in the table below.

	Purchases ($)	Sales ($)
Materials Portfolio	504,389,945	559,316,282

5. Fees and Other Transactions with Affiliates.

	Distribution Fee	Service Fee	Total Fees	Retained by FDC
Class A	- %	.25%	$313,970	$5,234
Class M	.25%	.25%	181,244	496
Class C	.75%	.25%	186,416	27,734
			$681,630	$33,464

For the period, sales charge amounts retained by FDC were as follows:

	Retained by FDC
Class A	$20,160
Class M	2,307
Class C A	106
	$22,573

A When Class C shares are initially sold, FDC pays commissions from its own resources to financial intermediaries through which the sales are made.

For the period, transfer agent fees for each class were as follows:

	Amount	% of Class-Level Average Net Assets
Class A	$257,456	.20
Class M	74,589	.21
Class C	38,561	.21
Materials	1,069,263	.18
Class I	402,014	.18
Class Z	33,552	.04
	$1,875,435

	% of Average Net Assets
Materials Portfolio	.03

	Amount
Materials Portfolio	$6,556

	Borrower or Lender	Average Loan Balance	Weighted Average Interest Rate	Interest Expense
Materials Portfolio	Borrower	$ 7,643,667	.32%	$201

	Purchases ($)	Sales ($)	Realized Gain (Loss) ($)
Materials Portfolio	23,186,744	9,817,568	1,313,266

6. Committed Line of Credit.

	Amount
Materials Portfolio	$1,920

7. Security Lending.

	Total Security Lending Fees Paid to NFS	Security Lending Income From Securities Loaned to NFS	Value of Securities Loaned to NFS at Period End
Materials Portfolio	$1,523	$-	$-

8. Expense Reductions.

Through arrangements with the Fund's custodian, credits realized as a result of certain uninvested cash balances were used to reduce the Fund's expenses. During the period, custodian credits reduced the Fund's expenses by $887. During the period, transfer agent credits reduced each class' expenses as noted in the table below.

	Expense reduction
Class M	$73

In addition, during the period the investment adviser or an affiliate reimbursed and/or waived a portion of fund-level operating expenses in the amount of $37,606.

9. Distributions to Shareholders.

Distributions to shareholders of each class were as follows:

	Year ended February 28, 2023	Year ended February 28, 2022
Materials Portfolio
Distributions to shareholders
Class A	$ 3,653,799	$762,533
Class M	1,013,870	147,448
Class C	430,794	-
Materials	18,471,243	5,007,156
Class I	6,523,647	1,869,092
Class Z	3,221,012	650,954
Total	$33,314,365	$8,437,183

10. Share Transactions.

Share transactions for each class were as follows and may contain in-kind transactions, automatic conversions between classes or exchanges between affiliated funds:

	Shares	Shares	Dollars	Dollars
	Year ended February 28, 2023	Year ended February 28, 2022	Year ended February 28, 2023	Year ended February 28, 2022
Materials Portfolio
Class A
Shares sold	174,329	462,367	$17,454,764	$46,208,008
Reinvestment of distributions	37,585	7,168	3,573,539	745,309
Shares redeemed	(310,006)	(286,710)	(30,402,251)	(28,650,346)
Net increase (decrease)	(98,092)	182,825	$(9,373,948)	$18,302,971
Class M
Shares sold	92,789	179,127	$9,181,513	$17,772,580
Reinvestment of distributions	10,767	1,429	1,011,814	147,010
Shares redeemed	(78,482)	(102,671)	(7,550,323)	(10,013,298)
Net increase (decrease)	25,074	77,885	$2,643,004	$7,906,292
Class C
Shares sold	33,396	94,534	$3,198,388	$9,060,563
Reinvestment of distributions	4,589	-	418,955	-
Shares redeemed	(75,621)	(157,099)	(7,005,317)	(14,767,417)
Net increase (decrease)	(37,636)	(62,565)	$(3,387,974)	$(5,706,854)
Materials
Shares sold	1,012,996	5,001,453	$103,105,703	$502,734,189
Reinvestment of distributions	179,022	44,769	17,121,716	4,680,116
Shares redeemed	(1,448,920)	(4,889,252)	(140,887,042)	(485,592,599)
Net increase (decrease)	(256,902)	156,970	$(20,659,623)	$21,821,706
Class I
Shares sold	699,555	1,335,457	$69,977,727	$132,303,721
Reinvestment of distributions	64,549	16,505	6,160,539	1,721,641
Shares redeemed	(998,267)	(1,218,271)	(97,071,794)	(121,416,087)
Net increase (decrease)	(234,163)	133,691	$(20,933,528)	$12,609,275
Class Z
Shares sold	598,908	511,529	$54,583,653	$50,914,703
Reinvestment of distributions	32,902	5,860	3,134,918	610,221
Shares redeemed	(302,227)	(340,358)	(29,561,489)	(33,687,861)
Net increase (decrease)	329,583	177,031	$28,157,082	$17,837,063

11. Other.

12. Risk and Uncertainties.

To the Board of Trustees of Fidelity Select Portfolios and Shareholders of Chemicals Portfolio, Gold Portfolio and Materials Portfolio

Opinions on the Financial Statements

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of each of the funds listed in the table below (three of the funds constituting Fidelity Select Portfolios, hereafter collectively referred to as the "Funds") as of February 28, 2023, the related statements of operations and of changes in net assets for each of the periods indicated in the table below, including the related notes, and the financial highlights for each of the periods indicated in the table below (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Funds as of February 28, 2023, and the results of each of their operations, the changes in each of their net assets, and each of the financial highlights for each of the periods indicated in the table below, in conformity with accounting principles generally accepted in the United States of America.

Chemicals Portfolio (1)

Gold Portfolio (2)

Materials Portfolio (1)

(1) Statement of assets and liabilities, including the schedule of investments, as of February 28, 2023, the related statement of operations for the year ended February 28, 2023, the statement of changes in net assets for each of the two years in the period ended February 28, 2023, and the financial highlights for each of the periods indicated therein.

(2) Consolidated statement of asset and liabilities, including the consolidated schedule of investments, as of February 28, 2023, the related consolidated statement of operations for the year ended February 28, 2023, the consolidated statement of changes in net assets for each of the two years in the period ended February 28, 2023, and the consolidated financial highlights for each of the periods indicated therein.

Basis for Opinions

These financial statements are the responsibility of the Funds' management. Our responsibility is to express an opinion on the Funds' financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Funds in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of February 28, 2023 by correspondence with the custodians and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinions.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

April 13, 2023

We have served as the auditor of one or more investment companies in the Fidelity group of funds since 1932.

TRUSTEES AND OFFICERS

The Trustees, Members of the Advisory Board (if any), and officers of the trust and funds, as applicable, are listed below. The Board of Trustees governs each fund and is responsible for protecting the interests of shareholders. The Trustees are experienced executives who meet periodically throughout the year to oversee each fund's activities, review contractual arrangements with companies that provide services to each fund, oversee management of the risks associated with such activities and contractual arrangements, and review each fund's performance. Each of the Trustees oversees 318 funds.

The Trustees hold office without limit in time except that (a) any Trustee may resign; (b) any Trustee may be removed by written instrument, signed by at least two-thirds of the number of Trustees prior to such removal; (c) any Trustee who requests to be retired or who has become incapacitated by illness or injury may be retired by written instrument signed by a majority of the other Trustees; and (d) any Trustee may be removed at any special meeting of shareholders by a two-thirds vote of the outstanding voting securities of the trust. Each Trustee who is not an interested person (as defined in the 1940 Act) of the trust and the funds is referred to herein as an Independent Trustee. Each Independent Trustee shall retire not later than the last day of the calendar year in which his or her 75th birthday occurs. The Independent Trustees may waive this mandatory retirement age policy with respect to individual Trustees. Officers and Advisory Board Members hold office without limit in time, except that any officer or Advisory Board Member may resign or may be removed by a vote of a majority of the Trustees at any regular meeting or any special meeting of the Trustees. Except as indicated, each individual has held the office shown or other offices in the same company for the past five years.

The funds' Statement of Additional Information (SAI) includes more information about the Trustees. To request a free copy, call Fidelity at 1-800-544-8544 if you're an individual investing directly with Fidelity, call 1-800-835-5092 if you're a plan sponsor or participant with Fidelity as your recordkeeper or call 1-877-208-0098 on institutional accounts or if you're an advisor or invest through one.

Experience, Skills, Attributes, and Qualifications of the Trustees. The Governance and Nominating Committee has adopted a statement of policy that describes the experience, qualifications, attributes, and skills that are necessary and desirable for potential Independent Trustee candidates (Statement of Policy). The Board believes that each Trustee satisfied at the time he or she was initially elected or appointed a Trustee, and continues to satisfy, the standards contemplated by the Statement of Policy. The Governance and Nominating Committee also engages professional search firms to help identify potential Independent Trustee candidates who have the experience, qualifications, attributes, and skills consistent with the Statement of Policy. From time to time, additional criteria based on the composition and skills of the current Independent Trustees, as well as experience or skills that may be appropriate in light of future changes to board composition, business conditions, and regulatory or other developments, have also been considered by the professional search firms and the Governance and Nominating Committee. In addition, the Board takes into account the Trustees' commitment and participation in Board and committee meetings, as well as their leadership of standing and ad hoc committees throughout their tenure.

In determining that a particular Trustee was and continues to be qualified to serve as a Trustee, the Board has considered a variety of criteria, none of which, in isolation, was controlling. The Board believes that, collectively, the Trustees have balanced and diverse experience, qualifications, attributes, and skills, which allow the Board to operate effectively in governing each fund and protecting the interests of shareholders. Information about the specific experience, skills, attributes, and qualifications of each Trustee, which in each case led to the Board's conclusion that the Trustee should serve (or continue to serve) as a trustee of the funds, is provided below.

Board Structure and Oversight Function. Robert A. Lawrence is an interested person and currently serves as Chair. The Trustees have determined that an interested Chair is appropriate and benefits shareholders because an interested Chair has a personal and professional stake in the quality and continuity of services provided to the funds. Independent Trustees exercise their informed business judgment to appoint an individual of their choosing to serve as Chair, regardless of whether the Trustee happens to be independent or a member of management. The Independent Trustees have determined that they can act independently and effectively without having an Independent Trustee serve as Chair and that a key structural component for assuring that they are in a position to do so is for the Independent Trustees to constitute a substantial majority for the Board. The Independent Trustees also regularly meet in executive session. David M. Thomas serves as Lead Independent Trustee and as such (i) acts as a liaison between the Independent Trustees and management with respect to matters important to the Independent Trustees and (ii) with management prepares agendas for Board meetings.

Fidelity ® funds are overseen by different Boards of Trustees. The funds' Board oversees Fidelity's high income and certain equity funds, and other Boards oversee Fidelity's alternative investment, investment-grade bond, money market, asset allocation, and other equity funds. The asset allocation funds may invest in Fidelity ® funds overseen by the funds' Board. The use of separate Boards, each with its own committee structure, allows the Trustees of each group of Fidelity ® funds to focus on the unique issues of the funds they oversee, including common research, investment, and operational issues. On occasion, the separate Boards establish joint committees to address issues of overlapping consequences for the Fidelity ® funds overseen by each Board.

The Trustees operate using a system of committees to facilitate the timely and efficient consideration of all matters of importance to the Trustees, each fund, and fund shareholders and to facilitate compliance with legal and regulatory requirements and oversight of the funds' activities and associated risks. The Board, acting through its committees, has charged FMR and its affiliates with (i) identifying events or circumstances the occurrence of which could have demonstrably adverse effects on the funds' business and/or reputation; (ii) implementing processes and controls to lessen the possibility that such events or circumstances occur or to mitigate the effects of such events or circumstances if they do occur; and (iii) creating and maintaining a system designed to evaluate continuously business and market conditions in order to facilitate the identification and implementation processes described in (i) and (ii) above. Because the day-to-day operations and activities of the funds are carried out by or through FMR, its affiliates, and other service providers, the funds' exposure to risks is mitigated but not eliminated by the processes overseen by the Trustees. While each of the Board's committees has responsibility for overseeing different aspects of the funds' activities, oversight is exercised primarily through the Operations, Audit, and Compliance Committees. Appropriate personnel, including but not limited to the funds' Chief Compliance Officer (CCO), FMR's internal auditor, the independent accountants, the funds' Treasurer and portfolio management personnel, make periodic reports to the Board's committees, as appropriate, including an annual review of Fidelity's risk management program for the Fidelity ® funds. The responsibilities of each standing committee, including their oversight responsibilities, are described further under "Standing Committees of the Trustees."

Interested Trustees*:

Correspondence intended for a Trustee who is an interested person may be sent to Fidelity Investments, 245 Summer Street, Boston, Massachusetts 02210.

Name, Year of Birth; Principal Occupations and Other Relevant Experience+

Bettina Doulton (1964)

Year of Election or Appointment: 2020

Trustee

Ms. Doulton also serves as Trustee of other Fidelity ® funds. Prior to her retirement, Ms. Doulton served in a variety of positions at Fidelity Investments, including as a managing director of research (2006-2007), portfolio manager to certain Fidelity ® funds (1993-2005), equity analyst and portfolio assistant (1990-1993), and research assistant (1987-1990). Ms. Doulton currently owns and operates Phi Builders + Architects and Cellardoor Winery. Previously, Ms. Doulton served as a member of the Board of Brown Capital Management, LLC (2014-2018).

Robert A. Lawrence (1952)

Year of Election or Appointment: 2020

Trustee

Chair of the Board of Trustees

Mr. Lawrence also serves as Trustee of other funds. Previously, Mr. Lawrence served as a Trustee and Member of the Advisory Board of certain funds. Prior to his retirement in 2008, Mr. Lawrence served as Vice President of certain Fidelity ® funds (2006-2008), Senior Vice President, Head of High Income Division of Fidelity Management & Research Company (investment adviser firm, 2006-2008), and President of Fidelity Strategic Investments (investment adviser firm, 2002-2005).

* Determined to be an "Interested Trustee" by virtue of, among other things, his or her affiliation with the trust or various entities under common control with FMR.

+ The information includes the Trustee's principal occupation during the last five years and other information relating to the experience, attributes, and skills relevant to the Trustee's qualifications to serve as a Trustee, which led to the conclusion that the Trustee should serve as a Trustee for each fund.

Independent Trustees:

Correspondence intended for an Independent Trustee may be sent to Fidelity Investments, P.O. Box 55235, Boston, Massachusetts 02205-5235.

Name, Year of Birth; Principal Occupations and Other Relevant Experience+

Thomas P. Bostick (1956)

Year of Election or Appointment: 2021

Trustee

Lieutenant General Bostick also serves as Trustee of other Fidelity ® funds. Prior to his retirement, General Bostick (United States Army, Retired) held a variety of positions within the U.S. Army, including Commanding General and Chief of Engineers, U.S. Army Corps of Engineers (2012-2016) and Deputy Chief of Staff and Director of Human Resources, U.S. Army (2009-2012). General Bostick currently serves as a member of the Board and Finance and Governance & Sustainability Committees of CSX Corporation (transportation, 2020-present) and a member of the Board and Corporate Governance and Nominating Committee of Perma-Fix Environmental Services, Inc. (nuclear waste management, 2020-present). General Bostick serves as Chief Executive Officer of Bostick Global Strategies, LLC (consulting, 2016-present), as a member of the Board of HireVue, Inc. (video interview and assessment, 2020-present), as a member of the Board of Allonnia (biotechnology and engineering solutions, 2022-present) and on the Advisory Board of Solugen, Inc. (specialty bio-based chemicals manufacturer, 2022-present). Previously, General Bostick served as a Member of the Advisory Board of certain Fidelity ® funds (2021), President, Intrexon Bioengineering (2018-2020) and Chief Operating Officer (2017-2020) and Senior Vice President of the Environment Sector (2016-2017) of Intrexon Corporation (biopharmaceutical company).

Dennis J. Dirks (1948)

Year of Election or Appointment: 2018

Trustee

Mr. Dirks also serves as Trustee of other Fidelity ® funds. Prior to his retirement in May 2003, Mr. Dirks served as Chief Operating Officer and as a member of the Board of The Depository Trust & Clearing Corporation (financial markets infrastructure), President, Chief Operating Officer and a member of the Board of The Depository Trust Company (DTC), President and a member of the Board of the National Securities Clearing Corporation (NSCC), Chief Executive Officer and a member of the Board of the Government Securities Clearing Corporation and Chief Executive Officer and a member of the Board of the Mortgage-Backed Securities Clearing Corporation. Mr. Dirks currently serves as a member of the Finance Committee (2016-present) and Board (2017-present) and is Treasurer (2018-present) of the Asolo Repertory Theatre.

Donald F. Donahue (1950)

Year of Election or Appointment: 2018

Trustee

Mr. Donahue also serves as Trustee of other Fidelity ® funds. Mr. Donahue serves as President and Chief Executive Officer of Miranda Partners, LLC (risk consulting for the financial services industry, 2012-present). Previously, Mr. Donahue served as Chief Executive Officer (2006-2012), Chief Operating Officer (2003-2006) and Managing Director, Customer Marketing and Development (1999-2003) of The Depository Trust & Clearing Corporation (financial markets infrastructure). Mr. Donahue currently serves as a member (2007-present) and Co-Chairman (2016-present) of the Board of United Way of New York. Mr. Donahue previously served as a member of the Advisory Board of certain Fidelity ® funds (2015-2018) and as a member of the Board of The Leadership Academy (previously NYC Leadership Academy) (2012-2022).

Vicki L. Fuller (1957)

Year of Election or Appointment: 2020

Trustee

Ms. Fuller also serves as Trustee of other Fidelity ® funds. Previously, Ms. Fuller served as a member of the Advisory Board of certain Fidelity ® funds (2018-2020), Chief Investment Officer of the New York State Common Retirement Fund (2012-2018) and held a variety of positions at AllianceBernstein L.P. (global asset management, 1985-2012), including Managing Director (2006-2012) and Senior Vice President and Senior Portfolio Manager (2001-2006). Ms. Fuller currently serves as a member of the Board, Audit Committee and Nominating and Governance Committee of two Blackstone business development companies (2020-present), as a member of the Board of Treliant, LLC (consulting, 2019-present), as a member of the Board of Ariel Alternatives, LLC (private equity, 2022-present) and as a member of the Board and Chair of the Audit Committee of Gusto, Inc. (software, 2021-present). In addition, Ms. Fuller currently serves as a member of the Board of Roosevelt University (2019-present) and as a member of the Executive Board of New York University's Stern School of Business. Ms. Fuller previously served as a member of the Board, Audit Committee and Nominating and Governance Committee of The Williams Companies, Inc. (natural gas infrastructure, 2018-2021).

Patricia L. Kampling (1959)

Year of Election or Appointment: 2020

Trustee

Ms. Kampling also serves as Trustee of other Fidelity ® funds. Prior to her retirement, Ms. Kampling served as Chairman of the Board and Chief Executive Officer (2012-2019), President and Chief Operating Officer (2011-2012) and Executive Vice President and Chief Financial Officer (2010-2011) of Alliant Energy Corporation. Ms. Kampling currently serves as a member of the Board, Finance Committee and Governance, Compensation and Nominating Committee of Xcel Energy Inc. (utilities company, 2020-present) and as a member of the Board, Audit, Finance and Risk Committee and Safety, Environmental, Technology and Operations Committee and Chair of the Executive Development and Compensation Committee of American Water Works Company, Inc. (utilities company, 2019-present). In addition, Ms. Kampling currently serves as a member of the Board of the Nature Conservancy, Wisconsin Chapter (2019-present). Previously, Ms. Kampling served as a Member of the Advisory Board of certain Fidelity® funds (2020), a member of the Board, Compensation Committee and Executive Committee and Chair of the Audit Committee of Briggs & Stratton Corporation (manufacturing, 2011-2021), a member of the Board of Interstate Power and Light Company (2012-2019) and Wisconsin Power and Light Company (2012-2019) (each a subsidiary of Alliant Energy Corporation) and as a member of the Board and Workforce Development Committee of the Business Roundtable (2018-2019).

Thomas A. Kennedy (1955)

Year of Election or Appointment: 2021

Trustee

Mr. Kennedy also serves as Trustee of other Fidelity ® funds. Previously, Mr. Kennedy served as a Member of the Advisory Board of certain Fidelity ® funds (2020) and held a variety of positions at Raytheon Company (aerospace and defense, 1983-2020), including Chairman and Chief Executive Officer (2014-2020) and Executive Vice President and Chief Operating Officer (2013-2014). Mr. Kennedy served as Executive Chairman of the Board of Directors of Raytheon Technologies Corporation (aerospace and defense, 2020-2021). Mr. Kennedy serves as a Director of the Board of Directors of Textron Inc. (aerospace and defense, 2023-present).

Oscar Munoz (1959)

Year of Election or Appointment: 2021

Trustee

Mr. Munoz also serves as Trustee of other Fidelity ® funds. Prior to his retirement, Mr. Munoz served as Executive Chairman (2020-2021), Chief Executive Officer (2015-2020), President (2015-2016) and a member of the Board (2010-2021) of United Airlines Holdings, Inc. Mr. Munoz currently serves as a member of the Board of CBRE Group, Inc. (commercial real estate, 2020-present), a member of the Board of Univision Communications, Inc. (Hispanic media, 2020-present), a member of the Board of Archer Aviation Inc. (2021-present), a member of the Defense Business Board of the United States Department of Defense (2021-present) and a member of the Board of Salesforce.com, Inc. (cloud-based software, 2022-present). Previously, Mr. Munoz served as a Member of the Advisory Board of certain Fidelity ® funds (2021).

David M. Thomas (1949)

Year of Election or Appointment: 2018

Trustee

Lead Independent Trustee

Mr. Thomas also serves as Trustee of other Fidelity ® funds. Previously, Mr. Thomas served as Executive Chairman (2005-2006) and Chairman and Chief Executive Officer (2000-2005) of IMS Health, Inc. (pharmaceutical and healthcare information solutions). Mr. Thomas currently serves as a member of the Board of Fortune Brands Home and Security (home and security products, 2004-present) and as Director (2013-present) and Non-Executive Chairman of the Board (2022-present) of Interpublic Group of Companies, Inc. (marketing communication).

Susan Tomasky (1953)

Year of Election or Appointment: 2020

Trustee

Ms. Tomasky also serves as Trustee of other Fidelity ® funds. Prior to her retirement, Ms. Tomasky served in various executive officer positions at American Electric Power Company, Inc. (1998-2011), including most recently as President of AEP Transmission (2007-2011). Ms. Tomasky currently serves as a member of the Board and Sustainability Committee and as Chair of the Audit Committee of Marathon Petroleum Corporation (2018-present) and as a member of the Board, Executive Committee, Corporate Governance Committee and Organization and Compensation Committee and as Lead Director of the Board of Public Service Enterprise Group, Inc. (utilities company, 2012-present) and as a member of the Board of its subsidiary company, Public Service Electric and Gas Co. (2021-present). In addition, Ms. Tomasky currently serves as a member (2009-present) and President (2020-present) of the Board of the Royal Shakespeare Company - America (2009-present), as a member of the Board of the Columbus Association for the Performing Arts (2011-present) and as a member of the Board and Kenyon in the World Committee of Kenyon College (2016-present). Previously, Ms. Tomasky served as a Member of the Advisory Board of certain Fidelity ® funds (2020), as a member of the Board of the Columbus Regional Airport Authority (2007-2020), as a member of the Board (2011-2018) and Lead Independent Director (2015-2018) of Andeavor Corporation (previously Tesoro Corporation) (independent oil refiner and marketer) and as a member of the Board of Summit Midstream Partners LP (energy, 2012-2018).

Michael E. Wiley (1950)

Year of Election or Appointment: 2008

Trustee

Mr. Wiley also serves as Trustee of other Fidelity ® funds. Previously, Mr. Wiley served as a member of the Advisory Board of certain Fidelity ® funds (2018-2020), Chairman, President and CEO of Baker Hughes, Inc. (oilfield services, 2000-2004). Mr. Wiley also previously served as a member of the Board of Andeavor Corporation (independent oil refiner and marketer, 2005-2018), a member of the Board of Andeavor Logistics LP (natural resources logistics, 2015-2018) and a member of the Board of High Point Resources (exploration and production, 2005-2020).

Advisory Board Members and Officers:

Correspondence intended for a Member of the Advisory Board (if any) may be sent to Fidelity Investments, P.O. Box 55235, Boston, Massachusetts 02205-5235. Correspondence intended for an officer or Peter S. Lynch may be sent to Fidelity Investments, 245 Summer Street, Boston, Massachusetts 02210. Officers appear below in alphabetical order.

Name, Year of Birth; Principal Occupation

Peter S. Lynch (1944)

Year of Election or Appointment: 2018

Member of the Advisory Board

Mr. Lynch also serves as a Member of the Advisory Board of other Fidelity ® funds. Mr. Lynch is Vice Chairman and a Director of Fidelity Management & Research Company LLC (investment adviser firm). In addition, Mr. Lynch serves as a Trustee of Boston College and as the Chairman of the Inner-City Scholarship Fund. Previously, Mr. Lynch served as Vice Chairman and a Director of FMR Co., Inc. (investment adviser firm) and on the Special Olympics International Board of Directors (1997-2006).

Heather Bonner (1977)

Year of Election or Appointment: 2023

Assistant Treasurer

Ms. Bonner also serves as an officer of other funds. Ms. Bonner serves as Senior Vice President (2022-present), and is an employee of Fidelity Investments. Ms. Bonner serves as Assistant Treasurer of Fidelity CRET Trustee LLC (2022-present). Prior to joining Fidelity, Ms. Bonner served as Managing Director at AQR Capital Management (2013-2022) and was the Treasurer and Principal Financial Officer of the AQR Funds (2013-2022).

Craig S. Brown (1977)

Year of Election or Appointment: 2022

Deputy Treasurer

Mr. Brown also serves as an officer of other funds. Mr. Brown serves as Assistant Treasurer of FIMM, LLC (2021-present) and is an employee of Fidelity Investments (2013-present). Previously, Mr. Brown served as Assistant Treasurer of certain Fidelity ® funds (2019-2022).

John J. Burke III (1964)

Year of Election or Appointment: 2018

Chief Financial Officer

Mr. Burke also serves as Chief Financial Officer of other funds. Mr. Burke serves as Head of Investment Operations for Fidelity Fund and Investment Operations (2018-present) and is an employee of Fidelity Investments (1998-present). Previously Mr. Burke served as head of Asset Management Investment Operations (2012-2018).

Margaret Carey (1973)

Year of Election or Appointment: 2023

Secretary and Chief Legal Officer (CLO)

Ms. Carey also serves as an officer of other funds and as CLO of certain other Fidelity entities. She is a Senior Vice President and Deputy General Counsel of FMR LLC (diversified financial services company, 2019-present), and is an employee of Fidelity Investments.

William C. Coffey (1969)

Year of Election or Appointment: 2019

Assistant Secretary

Mr. Coffey also serves as Assistant Secretary of other funds. He is Senior Vice President and Deputy General Counsel of FMR LLC (diversified financial services company, 2010-present), and is an employee of Fidelity Investments. Previously, Mr. Coffey served as Secretary and CLO of certain funds (2018-2019); CLO, Secretary, and Senior Vice President of Fidelity Management & Research Company and FMR Co., Inc. (investment adviser firms, 2018-2019); Secretary of Fidelity SelectCo, LLC and Fidelity Investments Money Management, Inc. (investment adviser firms, 2018-2019); CLO of Fidelity Management & Research (Hong Kong) Limited, FMR Investment Management (UK) Limited, and Fidelity Management & Research (Japan) Limited (investment adviser firms, 2018-2019); and Assistant Secretary of certain funds (2009-2018).

Timothy M. Cohen (1969)

Year of Election or Appointment: 2018

Vice President

Mr. Cohen also serves as Vice President of other funds. Mr. Cohen serves as Co-Head of Equity (2018-present), a Director of Fidelity Management & Research (Japan) Limited (investment adviser firm, 2016-present), and is an employee of Fidelity Investments. Previously, Mr. Cohen served as Executive Vice President of Fidelity SelectCo, LLC (2019), Head of Global Equity Research (2016-2018), Chief Investment Officer - Equity and a Director of Fidelity Management & Research (U.K.) Inc. (investment adviser firm, 2013-2015) and as a Director of Fidelity Management & Research (Hong Kong) Limited (investment adviser firm, 2017).

Jonathan Davis (1968)

Year of Election or Appointment: 2010

Assistant Treasurer

Mr. Davis also serves as an officer of other funds. Mr. Davis serves as Assistant Treasurer of FIMM, LLC (2021-present), FMR Capital, Inc. (2017-present), FD Funds GP LLC (2021-present), FD Funds Holding LLC (2021-present), and FD Funds Management LLC (2021-present); and is an employee of Fidelity Investments. Previously, Mr. Davis served as Vice President and Associate General Counsel of FMR LLC (diversified financial services company, 2003-2010).

Laura M. Del Prato (1964)

Year of Election or Appointment: 2018

Assistant Treasurer

Ms. Del Prato also serves as an officer of other funds. Ms. Del Prato serves as Assistant Treasurer of FIMM, LLC (2021-present) and is an employee of Fidelity Investments (2017-present). Previously, Ms. Del Prato served as President and Treasurer of The North Carolina Capital Management Trust: Cash Portfolio and Term Portfolio (2018-2020). Prior to joining Fidelity Investments, Ms. Del Prato served as a Managing Director and Treasurer of the JPMorgan Mutual Funds (2014-2017). Prior to JPMorgan, Ms. Del Prato served as a partner at Cohen Fund Audit Services (accounting firm, 2012-2013) and KPMG LLP (accounting firm, 2004-2012).

Colm A. Hogan (1973)

Year of Election or Appointment: 2020

Assistant Treasurer

Mr. Hogan also serves as an officer of other funds. Mr. Hogan serves as Assistant Treasurer of FIMM, LLC (2021-present) and FMR Capital, Inc. (2017-present) and is an employee of Fidelity Investments (2005-present). Previously, Mr. Hogan served as Deputy Treasurer of certain Fidelity ® funds (2016-2020) and Assistant Treasurer of certain Fidelity ® funds (2016-2018).

Pamela R. Holding (1964)

Year of Election or Appointment: 2018

Vice President

Ms. Holding also serves as Vice President of other funds. Ms. Holding serves as Co-Head of Equity (2018-present) and is an employee of Fidelity Investments (2013-present). Previously, Ms. Holding served as Executive Vice President of Fidelity SelectCo, LLC (2019) and as Chief Investment Officer of Fidelity Institutional Asset Management (2013-2018).

Chris Maher (1972)

Year of Election or Appointment: 2020

Deputy Treasurer

Mr. Maher also serves as an officer of other funds. Mr. Maher serves as Assistant Treasurer of FIMM, LLC (2021-present) and FMR Capital, Inc. (2017-present), and is an employee of Fidelity Investments (2008-present). Previously, Mr. Maher served as Assistant Treasurer of certain funds (2013-2020); Vice President of Asset Management Compliance (2013), Vice President of the Program Management Group of FMR (investment adviser firm, 2010-2013), and Vice President of Valuation Oversight (2008-2010).

Jason P. Pogorelec (1975)

Year of Election or Appointment: 2020

Chief Compliance Officer

Mr. Pogorelec also serves as Chief Compliance Officer of other funds. Mr. Pogorelec is a Senior Vice President of Asset Management Compliance for Fidelity Investments and is an employee of Fidelity Investments. Mr. Pogorelec serves as Compliance Officer of Fidelity Management & Research Company LLC (investment adviser firm, 2023-present). Previously, Mr. Pogorelec served as Vice President, Associate General Counsel for Fidelity Investments (2010-2020) and Assistant Secretary of certain Fidelity ® funds (2015-2020).

Brett Segaloff (1972)

Year of Election or Appointment: 2021

Anti-Money Laundering (AML) Officer

Mr. Segaloff also serves as an AML Officer of other funds and other related entities. He is Director, Anti-Money Laundering (2007-present) of FMR LLC (diversified financial services company) and is an employee of Fidelity Investments (1996-present).

Stacie M. Smith (1974)

Year of Election or Appointment: 2018

President and Treasurer

Ms. Smith also serves as an officer of other funds. Ms. Smith serves as Assistant Treasurer of FIMM, LLC (2021-present) and FMR Capital, Inc. (2017-present), is an employee of Fidelity Investments (2009-present), and has served in other fund officer roles. Prior to joining Fidelity Investments, Ms. Smith served as Senior Audit Manager of Ernst & Young LLP (accounting firm, 1996-2009). Previously, Ms. Smith served as Assistant Treasurer (2013-2019) and Deputy Treasurer (2013-2016) of certain Fidelity ® funds.

Jim Wegmann (1979)

Year of Election or Appointment: 2019

Assistant Treasurer

Mr. Wegmann also serves as an officer of other funds. Mr. Wegmann serves as Assistant Treasurer of FIMM, LLC (2021-present) and is an employee of Fidelity Investments (2011-present). Previously, Mr. Wegmann served as Assistant Treasurer of certain Fidelity ® funds (2019-2021).

As a shareholder, you incur two types of costs: (1) transaction costs, which may include sales charges (loads) on purchase payments or redemption proceeds, as applicable and (2) ongoing costs, which generally include management fees, distribution and/or service (12b-1) fees and other Fund expenses. This Example is intended to help you understand your ongoing costs (in dollars) of investing in a fund and to compare these costs with the ongoing costs of investing in other mutual funds.

The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (September 1, 2022 to February 28, 2023).

Actual Expenses

The first line of the accompanying table provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000.00 (for example, an $8,600 account value divided by $1,000.00 = 8.6), then multiply the result by the number in the first line for a class/Fund under the heading entitled "Expenses Paid During Period" to estimate the expenses you paid on your account during this period. If any fund is a shareholder of any underlying mutual funds or exchange-traded funds (ETFs) (the Underlying Funds), such fund indirectly bears its proportional share of the expenses of the Underlying Funds in addition to the direct expenses incurred presented in the table. These fees and expenses are not included in the annualized expense ratio used to calculate the expense estimate in the table below.

Hypothetical Example for Comparison Purposes

The second line of the accompanying table provides information about hypothetical account values and hypothetical expenses based on the actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds. If any fund is a shareholder of any Underlying Funds, such fund indirectly bears its proportional share of the expenses of the Underlying Funds in addition to the direct expenses as presented in the table. These fees and expenses are not included in the annualized expense ratio used to calculate the expense estimate in the table below.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs. Therefore, the second line of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

	Annualized Expense Ratio- A	Beginning Account Value September 1, 2022	Ending Account Value February 28, 2023	Expenses Paid During Period- C September 1, 2022 to February 28, 2023

Chemicals Portfolio	.75%
Actual		$ 1,000	$ 1,077.90	$ 3.86
Hypothetical- B		$ 1,000	$ 1,021.08	$ 3.76
Gold Portfolio
Class A	1.09%
Actual		$ 1,000	$ 1,165.60	$ 5.85
Hypothetical- B		$ 1,000	$ 1,019.39	$ 5.46
Class M	1.35%
Actual		$ 1,000	$ 1,163.60	$ 7.24
Hypothetical- B		$ 1,000	$ 1,018.10	$ 6.76
Class C	1.80%
Actual		$ 1,000	$ 1,161.40	$ 9.65
Hypothetical- B		$ 1,000	$ 1,015.87	$ 9.00
Gold Portfolio	.78%
Actual		$ 1,000	$ 1,166.90	$ 4.19
Hypothetical- B		$ 1,000	$ 1,020.93	$ 3.91
Class I	.77%
Actual		$ 1,000	$ 1,166.90	$ 4.14
Hypothetical- B		$ 1,000	$ 1,020.98	$ 3.86
Class Z	.63%
Actual		$ 1,000	$ 1,167.80	$ 3.39
Hypothetical- B		$ 1,000	$ 1,021.67	$ 3.16
Materials Portfolio
Class A	1.03%
Actual		$ 1,000	$ 1,110.00	$ 5.39
Hypothetical- B		$ 1,000	$ 1,019.69	$ 5.16
Class M	1.28%
Actual		$ 1,000	$ 1,108.60	$ 6.69
Hypothetical- B		$ 1,000	$ 1,018.45	$ 6.41
Class C	1.78%
Actual		$ 1,000	$ 1,105.90	$ 9.29
Hypothetical- B		$ 1,000	$ 1,015.97	$ 8.90
Materials Portfolio	.76%
Actual		$ 1,000	$ 1,111.50	$ 3.98
Hypothetical- B		$ 1,000	$ 1,021.03	$ 3.81
Class I	.76%
Actual		$ 1,000	$ 1,111.60	$ 3.98
Hypothetical- B		$ 1,000	$ 1,021.03	$ 3.81
Class Z	.61%
Actual		$ 1,000	$ 1,112.20	$ 3.19
Hypothetical- B		$ 1,000	$ 1,021.77	$ 3.06

A Annualized expense ratio reflects expenses net of applicable fee waivers.

B 5% return per year before expenses

C Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 181/ 365 (to reflect the one-half year period). The fees and expenses of any Underlying Funds are not included in each annualized expense ratio.

Distributions (Unaudited)

The dividend and capital gains distributions for the fund(s) are available on Fidelity.com or Institutional.Fidelity.com.

The funds hereby designate as capital gain dividend the amounts noted below for the taxable year ended February 28, 2023, or, if subsequently determined to be different, the net capital gain of such year.

Chemicals Portfolio	$48,236,858
Materials Portfolio	$67,863,923

The funds hereby designate the amounts noted below as distributions paid during the fiscal year ended 2023 as qualifying to be taxed as section 163(j) interest dividends:

Gold Portfolio

$97,520

A percentage of the dividends distributed during the fiscal year for the following funds qualify for the dividends-received deduction for corporate shareholders:

	April 2022	December 2022
Chemicals Portfolio	100%	100%
Gold Portfolio
Class A	3%	-
Class M	4%	-
Class C	5%	-
Gold	3%	-
Class I	3%	-
Class Z	3%	-
Materials Portfolio
Class A	-	100%
Class M	-	100%
Class C	-	100%
Materials	-	98%
Class I	-	99%
Class Z	-	87%

A percentage of the dividends distributed during the fiscal year for the following funds may be taken into account as a dividend for purposes of the maximum rate under section 1(h)(11) of the Internal Revenue Code.

	April 2022	December 2022
Chemicals Portfolio	100%	100%
Gold Portfolio
Class A	100%	-
Class M	100%	-
Class C	100%	-
Gold	100%	-
Class I	100%	-
Class Z	100%	-
Materials Portfolio
Class A	-	100%
Class M	-	100%
Class C	-	100%
Materials	-	100%
Class I	-	100%
Class Z	-	100%

The amounts per share which represent income derived from sources within, and taxes paid to, foreign countries or possessions of the United States are as follows:

	Pay Date	Income	Taxes
Gold Portfolio
Class A	04/11/2022	$0.0728	$0.0038
Class M	04/11/2022	$0.0628	$0.0038
Class C	04/11/2022	$0.0488	$0.0038
Gold	04/11/2022	$0.0848	$0.0038
Class I	04/11/2022	$0.0848	$0.0038
Class Z	04/11/2022	$0.0898	$0.0038

The funds will notify shareholders in January 2024 of amounts for use in preparing 2023 income tax returns.

The Securities and Exchange Commission adopted Rule 22e-4 under the Investment Company Act of 1940 (the Liquidity Rule) to promote effective liquidity risk management throughout the open-end investment company industry, thereby reducing the risk that funds will be unable to meet their redemption obligations and mitigating dilution of the interests of fund shareholders.

The Funds have adopted and implemented a liquidity risk management program (the Program) reasonably designed to assess and manage each Fund's liquidity risk and to comply with the requirements of the Liquidity Rule. Each Fund's Board of Trustees (the Board) has designated each Fund's investment adviser as administrator of the Program. The Fidelity advisers have established a Liquidity Risk Management Committee (the LRM Committee) to manage the Program for each of the Fidelity Funds. The LRM Committee monitors the adequacy and effectiveness of implementation of the Program and on a periodic basis assesses each Fund's liquidity risk based on a variety of factors including (1) the Fund's investment strategy, (2) portfolio liquidity and cash flow projections during normal and reasonably foreseeable stressed conditions, (3) shareholder redemptions, (4) borrowings and other funding sources and (5) certain factor specific to ETFs including the effect of the Fund's prices and spreads, market participants, and basket compositions on the overall liquidity of the Fund's portfolio, as applicable.

In accordance with the Program, each of the Fund's portfolio investments is classified into one of four defined liquidity categories based on a determination of a reasonable expectation for how long it would take to convert the investment to cash (or sell or dispose of the investment) without significantly changing its market value.

Highly liquid investments - cash or convertible to cash within three business days or less
Moderately liquid investments - convertible to cash in three to seven calendar days
Less liquid investments - can be sold or disposed of, but not settled, within seven calendar days
Illiquid investments - cannot be sold or disposed of within seven calendar days

Liquidity classification determinations take into account a variety of factors including various market, trading and investment-specific considerations, as well as market depth, and generally utilize analysis from a third-party liquidity metrics service.

The Liquidity Rule places a 15% limit on a fund's illiquid investments and requires funds that do not primarily hold assets that are highly liquid investments to determine and maintain a minimum percentage of the fund's net assets to be invested in highly liquid investments (highly liquid investment minimum or HLIM). The Program includes provisions reasonably designed to comply with the 15% limit on illiquid investments and for determining, periodically reviewing and complying with the HLIM requirement as applicable.

At a recent meeting of the Fund's Board of Trustees, the LRM Committee provided a written report to the Board pertaining to the operation, adequacy, and effectiveness of the Program for the period December 1, 2021 through November 30, 2022. The report concluded that the Program is operating effectively and is reasonably designed to assess and manage the Fund's liquidity risk.

1.846032.116

SELMT-ANN-0423

Fidelity® Select Portfolios®

Consumer Discretionary Sector

Automotive Portfolio

Communication Services Portfolio

Construction and Housing Portfolio

Consumer Discretionary Portfolio

Leisure Portfolio

Retailing Portfolio

Annual Report

February 28, 2023

Includes Fidelity and Fidelity Advisor share classes

Contents

Automotive Portfolio

Communication Services Portfolio

Construction and Housing Portfolio

Consumer Discretionary Portfolio

Leisure Portfolio

Retailing Portfolio

Report of Independent Registered Public Accounting Firm

Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.

Other third-party marks appearing herein are the property of their respective owners.

NOT FDIC INSURED •MAY LOSE VALUE •NO BANK GUARANTEE

Neither the Funds nor Fidelity Distributors Corporation is a bank.

Automotive Portfolio

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Automotive Portfolio	-16.92%	10.56%	10.95%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Automotive Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Automotive Portfolio

Market Recap:

Comments from Portfolio Manager Hiroki Sugihara:

For the fiscal year ending February 28, 2023, the fund returned -16.92%, underperforming the -15.57% result of the FactSet Automotive Linked Index, as well as the broad-based S&P 500 ® index. Versus the industry index, security selection was the primary detractor, especially within auto parts & equipment category. Subpar picks and an underweighting among automotive retail stocks, in addition to an underweighting in motorcycle manufacturers, also hurt. The biggest individual relative detractor was an overweight position in Xpeng (-75%). Outsized exposure to Carvana (-93%) also proved detrimental. Avoiding BorgWarner, an index component that gained roughly 25%, further weighed on relative performance. In contrast, the top contributor to performance versus the industry index proved to be investment choices among automobile manufacturers. An overweighting in auto parts & equipment companies, as well as picks in the trucking group, aided the portfolio's relative result. The biggest individual relative contributor was an underweight position in NIO (-59%), though we reduced our investment during the period. Also adding value was an outsized stake in Tesla, which returned approximately -29% and was among the portfolio's more sizable holdings. Another key relative contributor was an overweighting in O'Reilly Automotive (+28%), one of the fund's largest holdings on February 28. Notable changes in positioning the past 12 months include a higher allocation to both distributors and auto parts & equipment stocks.

Notes to shareholders:

On August 1, 2022, Elliot Mattingly came off the fund, leaving Hiroki Sugihara as sole portfolio manager of the fund.

Automotive Portfolio

Top Holdings (% of Fund's net assets)

Tesla, Inc.	11.9
Toyota Motor Corp. sponsored ADR	10.7
General Motors Co.	8.6
O'Reilly Automotive, Inc.	7.7
Aptiv PLC	5.6
Ferrari NV	4.9
Ford Motor Co.	4.3
AutoZone, Inc.	4.0
Copart, Inc.	3.7
Li Auto, Inc. ADR	3.2
	64.6

Industries (% of Fund's net assets)

Automobiles	55.4
Auto Components	18.2
Specialty Retail	14.8
Distributors	5.0
Commercial Services & Supplies	3.7
Internet & Direct Marketing Retail	1.0
Semiconductors & Semiconductor Equipment	0.8
Electrical Equipment	0.5
Electronic Equipment & Components	0.0

Percentages shown as 0.0% may reflect amounts less than 0.05%.

Geographic Diversification (% of Fund's net assets)

* Includes Short-Term investments and Net Other Assets (Liabilities).

Percentages are based on country or territory of incorporation and are adjusted for the effect of derivatives, if applicable.

Automotive Portfolio

Showing Percentage of Net Assets

Common Stocks - 98.8%
	Shares	Value ($)
Auto Components - 18.2%
Auto Parts & Equipment - 18.2%
Adient PLC (a)	38,245	1,633,826
Aptiv PLC (a)	50,920	5,920,978
Autoliv, Inc.	23,935	2,215,902
Cie Automotive SA	32,800	960,290
DENSO Corp.	33,858	1,800,140
Hanon Systems	104,270	712,659
Lear Corp.	16,762	2,340,813
Magna International, Inc. Class A (sub. vtg.)	48,241	2,688,698
Novem Group SA	117,407	1,092,796
		19,366,102
Automobiles - 54.8%
Automobile Manufacturers - 54.8%
Ferrari NV	20,234	5,268,327
Ford Motor Co.	379,179	4,576,691
General Motors Co.	236,161	9,148,877
Honda Motor Co. Ltd. sponsored ADR	117,000	3,038,490
Li Auto, Inc. ADR (a)(b)	145,852	3,443,566
Lucid Group, Inc. Class A (a)(b)	35,764	326,525
Mercedes-Benz Group AG (Germany)	16,447	1,260,544
NIO, Inc. sponsored ADR (a)(b)	103,784	974,532
Rivian Automotive, Inc. (a)(b)	32,680	630,724
Stellantis NV (b)	144,048	2,523,721
Suzuki Motor Corp.	53,701	1,886,467
Tesla, Inc. (a)	61,848	12,722,752
Toyota Motor Corp. sponsored ADR (b)	83,507	11,350,271
XPeng, Inc. ADR (a)(b)	130,945	1,168,029
		58,319,516
Commercial Services & Supplies - 3.7%
Diversified Support Services - 3.7%
Copart, Inc. (a)	55,597	3,917,365
Distributors - 5.0%
Distributors - 5.0%
Central Automotive Products Ltd.	300	5,927
Genuine Parts Co.	16,721	2,957,276
LKQ Corp.	40,709	2,332,219
		5,295,422
Electrical Equipment - 0.5%
Electrical Components & Equipment - 0.5%
Sensata Technologies, Inc. PLC	11,023	557,543
Internet & Direct Marketing Retail - 1.0%
Internet & Direct Marketing Retail - 1.0%
Uber Technologies, Inc. (a)	33,454	1,112,680
Semiconductors & Semiconductor Equipment - 0.8%
Semiconductors - 0.8%
Mitsui High-Tec, Inc.	16,000	823,767
Specialty Retail - 14.8%
Automotive Retail - 14.8%
Advance Auto Parts, Inc.	2,978	431,691
AutoZone, Inc. (a)	1,706	4,242,037
CarMax, Inc. (a)(b)	13,986	965,593
Carvana Co. Class A (a)(b)	21,410	201,682
Lithia Motors, Inc. Class A (sub. vtg.)	6,638	1,693,885
O'Reilly Automotive, Inc. (a)	9,917	8,232,102
		15,766,990
TOTAL COMMON STOCKS (Cost $77,309,580)		105,159,385

Preferred Stocks - 0.6%
	Shares	Value ($)
Convertible Preferred Stocks - 0.0%
Electronic Equipment & Components - 0.0%
Electronic Components - 0.0%
CelLink Corp. Series D (a)(c)(d)	3,700	48,174

Nonconvertible Preferred Stocks - 0.6%
Automobiles - 0.6%
Automobile Manufacturers - 0.6%
Dr. Ing. h.c. F. Porsche AG Series F (a)	4,864	587,005

TOTAL PREFERRED STOCKS (Cost $482,262)		635,179

Money Market Funds - 18.5%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (e)	311,851	311,913
Fidelity Securities Lending Cash Central Fund 4.63% (e)(f)	19,446,540	19,448,485
TOTAL MONEY MARKET FUNDS (Cost $19,760,398)		19,760,398

TOTAL INVESTMENT IN SECURITIES - 117.9% (Cost $97,552,240)	125,554,962
NET OTHER ASSETS (LIABILITIES) - (17.9)%	(19,075,791)
NET ASSETS - 100.0%	106,479,171

Legend

(a)	Non-income producing

(b)	Security or a portion of the security is on loan at period end.

(c)	Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $48,174 or 0.0% of net assets.

(d)	Level 3 security

(e)

(f)	Investment made with cash collateral received from securities on loan.

Additional information on each restricted holding is as follows:
Security	Acquisition Date	Acquisition Cost ($)
CelLink Corp. Series D	1/20/22	77,048

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	252,289	33,405,522	33,345,898	12,217	-	-	311,913	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	18,145,010	179,259,737	177,956,262	291,519	-	-	19,448,485	0.1%
Total	18,397,299	212,665,259	211,302,160	303,736	-	-	19,760,398

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	105,159,385	103,898,841	1,260,544	-

Preferred Stocks	635,179	587,005	-	48,174

Money Market Funds	19,760,398	19,760,398	-	-
Total Investments in Securities:	125,554,962	124,246,244	1,260,544	48,174

Automotive Portfolio

Communication Services Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $19,098,673) - See accompanying schedule:
Unaffiliated issuers (cost $77,791,842)	$	105,794,564
Fidelity Central Funds (cost $19,760,398)		19,760,398


Total Investment in Securities (cost $97,552,240)			$	125,554,962
Foreign currency held at value (cost $10,651)				10,651
Receivable for fund shares sold				168,722
Dividends receivable				305,078
Distributions receivable from Fidelity Central Funds				29,707
Prepaid expenses				230
Other receivables				2,213
Total assets				126,071,563
Liabilities
Payable for investments purchased	$	10,649
Payable for fund shares redeemed		30,330
Accrued management fee		46,050
Other affiliated payables		23,466
Other payables and accrued expenses		33,822
Collateral on securities loaned		19,448,075
Total Liabilities				19,592,392
Net Assets			$	106,479,171
Net Assets consist of:
Paid in capital			$	92,929,377
Total accumulated earnings (loss)				13,549,794
Net Assets			$	106,479,171
Net Asset Value , offering price and redemption price per share ($106,479,171 ÷ 2,315,078 shares)			$	45.99

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	1,342,022
Special dividends				222,964
Income from Fidelity Central Funds (including $291,519 from security lending)				303,736
Total Income				1,868,722
Expenses
Management fee	$	606,539
Transfer agent fees		289,869
Accounting fees		41,943
Custodian fees and expenses		15,351
Independent trustees' fees and expenses		407
Registration fees		28,143
Audit		40,354
Legal		738
Miscellaneous		696
Total expenses before reductions		1,024,040
Expense reductions		(4,274)
Total expenses after reductions				1,019,766
Net Investment income (loss)				848,956
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		(14,151,090)
Foreign currency transactions		3,546
Total net realized gain (loss)				(14,147,544)
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		(16,315,495)
Assets and liabilities in foreign currencies		(713)
Total change in net unrealized appreciation (depreciation)				(16,316,208)
Net gain (loss)				(30,463,752)
Net increase (decrease) in net assets resulting from operations			$	(29,614,796)

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	848,956	$	753,430
Net realized gain (loss)		(14,147,544)		10,793,755
Change in net unrealized appreciation (depreciation)		(16,316,208)		607,122
Net increase (decrease) in net assets resulting from operations		(29,614,796)		12,154,307
Distributions to shareholders		(2,701,513)		(6,137,128)
Share transactions
Proceeds from sales of shares		45,458,045		189,559,902
Reinvestment of distributions		2,537,929		5,872,623
Cost of shares redeemed		(74,376,081)		(234,498,841)
Net increase (decrease) in net assets resulting from share transactions		(26,380,107)		(39,066,316)
Total increase (decrease) in net assets		(58,696,416)		(33,049,137)

Net Assets
Beginning of period		165,175,587		198,224,724
End of period	$	106,479,171	$	165,175,587

Other Information
Shares
Sold		949,641		3,055,146
Issued in reinvestment of distributions		51,998		95,061
Redeemed		(1,606,800)		(3,886,592)
Net increase (decrease)		(605,161)		(736,385)

Financial Highlights

Automotive Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	56.56	$	54.21	$	34.91	$	33.29	$	37.52
Income from Investment Operations
Net investment income (loss) B,C		.34 D		.23 E		.05 F		.46 G		.36
Net realized and unrealized gain (loss)		(9.86)		3.82		23.73		2.67 H		(2.15)
Total from investment operations		(9.52)		4.05		23.78		3.13		(1.79)
Distributions from net investment income		(.28)		(.29)		(.01)		(.49) I		(.38)
Distributions from net realized gain		(.77)		(1.40)		(4.47)		(1.02) I		(2.06)
Total distributions		(1.05)		(1.70) J		(4.48)		(1.51)		(2.44)
Net asset value, end of period	$	45.99	$	56.56	$	54.21	$	34.91	$	33.29
Total Return K		(16.92)%		7.20%		78.19%		9.14% H		(4.66)%
Ratios to Average Net Assets C,L,M
Expenses before reductions		.89%		.80%		.88%		1.00%		.97%
Expenses net of fee waivers, if any		.88%		.80%		.88%		1.00%		.97%
Expenses net of all reductions		.88%		.80%		.87%		.99%		.97%
Net investment income (loss)		.73% D		.37% E		.10% F		1.33% G		1.04%
Supplemental Data
Net assets, end of period (000 omitted)	$	106,479	$	165,176	$	198,225	$	36,480	$	40,781
Portfolio turnover rate N		54%		69%		56%		45%		31%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Net investment income per share reflects one or more large, non-recurring dividend(s) which amounted to $.09 per share. Excluding such non-recurring dividend(s), the ratio of net investment income (loss) to average net assets would have been .54%.

E Net investment income per share reflects one or more large, non-recurring dividend(s) which amounted to $.10 per share. Excluding such non-recurring dividend(s), the ratio of net investment income (loss) to average net assets would have been .20%.

F Net investment income per share reflects one or more large, non-recurring dividend(s) which amounted to $.14 per share. Excluding such non-recurring dividend(s), the ratio of net investment income (loss) to average net assets would have been (.21)%.

G Net investment income per share reflects one or more large, non-recurring dividend(s) which amounted to $.09 per share. Excluding such non-recurring dividend(s), the ratio of net investment income (loss) to average net assets would have been 1.07%.

H Net realized and unrealized gain (loss) per share reflects proceeds received from litigation which amounted to $.19 per share. Excluding these litigation proceeds, the total return would have been 8.58%.

I The amount shown reflects reclassifications related to book to tax differences that were made in the year shown.

J Total distributions per share do not sum due to rounding.

K Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

L Fees and expenses of any underlying mutual funds or exchange-traded funds (ETFs) are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of these expenses. For additional expense information related to investments in Fidelity Central Funds, please refer to the "Investments in Fidelity Central Funds" note found in the Notes to Financial Statements section of the most recent Annual or Semi-Annual report.

M Expense ratios reflect operating expenses of the class. Expenses before reductions do not reflect amounts reimbursed, waived, or reduced through arrangements with the investment adviser, brokerage services, or other offset arrangements, if applicable, and do not represent the amount paid by the class during periods when reimbursements, waivers or reductions occur.

N Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Class A (incl.5.75% sales charge)	-25.15%	5.32%	8.70%
Class M (incl.3.50% sales charge)	-23.55%	5.59%	8.84%
Class C (incl. contingent deferred sales charge)	-21.93%	5.91%	9.00%
Communication Services Portfolio	-20.36%	6.84%	9.48%
Class I	-20.32%	6.85%	9.49%
Class Z	-20.23%	6.97%	9.55%

Class C shares' contingent deferred sales charges included in the past one year, past five years and past ten years total return figures are 1%, 0% and 0%, respectively.

The initial offering of Class A, Class M, Class C, Class I and Class Z shares took place on November 30, 2018. Returns prior to November 30, 2018, are those of Communication Services Portfolio, the original class of the fund.

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Communication Services Portfolio, a class of the fund, on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Communication Services Portfolio

Market Recap:

Comments from Portfolio Manager Matthew Drukker:

For the fiscal year ending February 28, 2023, the fund's share classes (excluding sales charges, if applicable) returned roughly -21% to -20%, outperforming the -23.61% result of the MSCI US IMI Communication Services 25/50 (Media Linked) Index, but underperforming the broad-based S&P 500 ® index. The primary contributors to performance versus the sector index were security selection and an overweight in the movies & entertainment industry. Picks among trucking stocks and an overweight in the wireless telecommunication services category also lifted the fund's relative result. The biggest individual relative contributor was an overweight position in T-Mobile U.S. (+14%), one portfolio's more sizable holdings at period end. Also lifting performance was an outsized stake in Netflix, which returned approximately -18%. We added to our position in the company this past year. Adding further value was the fund's non-index investment in Uber Technologies (-6%), one of our largest holdings as of February 28. In contrast, the largest detractor from performance versus the sector index was an underweighting among integrated telecommunication services firms. Stock picks and an overweighting in the interactive media & services group, as well as investment choices in the internet & direct marketing retail industry, also hindered relative performance. The biggest individual relative detractor was an overweight position in Snap (-75%). A smaller-than-index stake in AT&T (+11%), where we reduced our holding size this period, hurt as well. Another notable relative detractor was a larger-than-index position in Liberty Broadband (-40%), which was among the fund's biggest holdings. Notable changes in positioning include a higher allocation to the cable & satellite industry and movies & entertainment stocks.

Communication Services Portfolio

Top Holdings (% of Fund's net assets)

Meta Platforms, Inc. Class A	17.8
Alphabet, Inc. Class A	17.8
Netflix, Inc.	8.9
Activision Blizzard, Inc.	5.8
Liberty Broadband Corp. Class A	4.4
T-Mobile U.S., Inc.	4.4
Charter Communications, Inc. Class A	4.4
Comcast Corp. Class A	4.2
The Walt Disney Co.	3.9
Uber Technologies, Inc.	2.4
	74.0

Industries (% of Fund's net assets)

Interactive Media & Services	39.9
Entertainment	29.5
Media	15.7
Internet & Direct Marketing Retail	4.7
Wireless Telecommunication Services	4.4
Diversified Telecommunication Services	4.0
Real Estate Management & Development	0.3
Software	0.1
IT Services	0.1

Communication Services Portfolio

Showing Percentage of Net Assets

Common Stocks - 98.4%
	Shares	Value ($)
Diversified Telecommunication Services - 4.0%
Alternative Carriers - 4.0%
EchoStar Holding Corp. Class A (a)(b)	129,700	2,588,812
Iridium Communications, Inc.	28,600	1,755,182
Liberty Global PLC Class C (a)	677,300	14,392,625
Liberty Latin America Ltd. Class C (a)	1,274,786	11,192,621
		29,929,240
Integrated Telecommunication Services - 0.0%
AT&T, Inc.	4,000	75,640
TOTAL DIVERSIFIED TELECOMMUNICATION SERVICES		30,004,880
Entertainment - 29.5%
Interactive Home Entertainment - 7.8%
Activision Blizzard, Inc.	579,400	44,179,250
Roblox Corp. (a)(b)	61,100	2,238,704
Skillz, Inc. (a)	26,600	16,638
Take-Two Interactive Software, Inc. (a)	118,300	12,959,765
		59,394,357
Movies & Entertainment - 21.7%
Cinemark Holdings, Inc. (a)(b)	590,000	8,029,900
Endeavor Group Holdings, Inc. (a)(b)	306,500	6,838,015
Liberty Media Corp. Liberty Formula One Class A (a)	222,262	13,504,639
Lions Gate Entertainment Corp.:
Class A (a)	34,500	366,045
Class B (a)	562,434	5,596,218
Marcus Corp. (b)	297,200	4,781,948
Netflix, Inc. (a)	209,400	67,454,022
The Walt Disney Co. (a)	300,971	29,979,721
Warner Bros Discovery, Inc. (a)	427,014	6,669,959
Warner Music Group Corp. Class A	501,600	15,830,496
World Wrestling Entertainment, Inc. Class A (b)	68,700	5,770,800
		164,821,763
TOTAL ENTERTAINMENT		224,216,120
Interactive Media & Services - 39.6%
Interactive Media & Services - 39.6%
Alphabet, Inc. Class A (a)	1,504,400	135,486,264
Angi, Inc. (a)(b)	2,088,100	5,345,536
Match Group, Inc. (a)(b)	237,070	9,819,439
Meta Platforms, Inc. Class A (a)	774,900	135,561,007
Shutterstock, Inc. (b)	19,600	1,474,312
Snap, Inc. Class A (a)	895,600	9,090,340
Vimeo, Inc. (a)	51,464	197,107
Zoominfo Technologies, Inc. (a)	172,800	4,176,576
		301,150,581
Internet & Direct Marketing Retail - 4.7%
Internet & Direct Marketing Retail - 4.7%
Amazon.com, Inc. (a)	187,700	17,686,971
Uber Technologies, Inc. (a)	553,100	18,396,106
		36,083,077
IT Services - 0.1%
Internet Services & Infrastructure - 0.1%
X Holdings I, Inc. (c)(d)	1,724	629,950
Media - 15.7%
Advertising - 0.6%
S4 Capital PLC (a)	1,876,500	4,636,182
TechTarget, Inc. (a)	12,100	456,533
		5,092,715
Broadcasting - 0.3%
Fox Corp. Class A (b)	58,600	2,052,172
Cable & Satellite - 14.8%
Altice U.S.A., Inc. Class A (a)	1,361,600	5,391,936
Charter Communications, Inc. Class A (a)	90,200	33,158,422
Comcast Corp. Class A	865,400	32,166,918
DISH Network Corp. Class A (a)	44,539	508,190
Liberty Broadband Corp. Class A (a)	389,123	33,748,638
Liberty Media Corp. Liberty SiriusXM Series A (a)	232,800	7,540,392
		112,514,496
TOTAL MEDIA		119,659,383
Real Estate Management & Development - 0.3%
Real Estate Services - 0.3%
Zillow Group, Inc. Class A (a)	59,600	2,464,460
Software - 0.1%
Application Software - 0.1%
Viant Technology, Inc. (a)	257,200	1,010,796
Wireless Telecommunication Services - 4.4%
Wireless Telecommunication Services - 4.4%
T-Mobile U.S., Inc. (a)	235,750	33,518,935
TOTAL COMMON STOCKS (Cost $674,835,934)		748,738,182

Convertible Preferred Stocks - 0.3%
	Shares	Value ($)
Interactive Media & Services - 0.3%
Interactive Media & Services - 0.3%
Reddit, Inc. Series F (a)(c)(d) (Cost $3,584,075)	58,000	2,209,800

Money Market Funds - 5.2%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (e)	10,669,917	10,672,051
Fidelity Securities Lending Cash Central Fund 4.63% (e)(f)	29,123,764	29,126,676
TOTAL MONEY MARKET FUNDS (Cost $39,798,727)		39,798,727

TOTAL INVESTMENT IN SECURITIES - 103.9% (Cost $718,218,736)	790,746,709
NET OTHER ASSETS (LIABILITIES) - (3.9)%	(29,498,696)
NET ASSETS - 100.0%	761,248,013

Legend

(a)	Non-income producing

(b)	Security or a portion of the security is on loan at period end.

(c)	Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $2,839,750 or 0.4% of net assets.

(d)	Level 3 security

(e)

(f)	Investment made with cash collateral received from securities on loan.

Additional information on each restricted holding is as follows:
Security	Acquisition Date	Acquisition Cost ($)
Reddit, Inc. Series F	8/11/21	3,584,075

X Holdings I, Inc.	10/27/21	1,266,192

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	605	252,151,916	241,480,470	138,792	-	-	10,672,051	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	30,567,219	304,774,181	306,214,724	32,570	-	-	29,126,676	0.1%
Total	30,567,824	556,926,097	547,695,194	171,362	-	-	39,798,727

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	748,738,182	748,108,232	-	629,950

Convertible Preferred Stocks	2,209,800	-	-	2,209,800

Money Market Funds	39,798,727	39,798,727	-	-
Total Investments in Securities:	790,746,709	787,906,959	-	2,839,750

Communication Services Portfolio

Construction and Housing Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $28,132,058) - See accompanying schedule:
Unaffiliated issuers (cost $678,420,009)	$	750,947,982
Fidelity Central Funds (cost $39,798,727)		39,798,727


Total Investment in Securities (cost $718,218,736)			$	790,746,709
Foreign currency held at value (cost $799)				797
Receivable for fund shares sold				632,792
Dividends receivable				94,144
Distributions receivable from Fidelity Central Funds				39,302
Prepaid expenses				1,869
Total assets				791,515,613
Liabilities
Payable for fund shares redeemed	$	587,717
Accrued management fee		346,801
Distribution and service plan fees payable		13,210
Other affiliated payables		154,278
Other payables and accrued expenses		39,812
Collateral on securities loaned		29,125,782
Total Liabilities				30,267,600
Net Assets			$	761,248,013
Net Assets consist of:
Paid in capital			$	734,201,364
Total accumulated earnings (loss)				27,046,649
Net Assets			$	761,248,013

Net Asset Value and Maximum Offering Price
Class A :
Net Asset Value and redemption price per share ($24,285,213 ÷ 390,186 shares) (a)			$	62.24
Maximum offering price per share (100/94.25 of $62.24)			$	66.04
Class M :
Net Asset Value and redemption price per share ($3,499,049 ÷ 56,665 shares) (a)			$	61.75
Maximum offering price per share (100/96.50 of $61.75)			$	63.99
Class C :
Net Asset Value and offering price per share ($7,478,221 ÷ 123,463 shares) (a)			$	60.57
Communication Services :
Net Asset Value , offering price and redemption price per share ($710,710,435 ÷ 11,299,039 shares)			$	62.90
Class I :
Net Asset Value , offering price and redemption price per share ($11,960,813 ÷ 190,199 shares)			$	62.89
Class Z :
Net Asset Value , offering price and redemption price per share ($3,314,282 ÷ 52,456 shares)			$	63.18
(a)Redemption price per share is equal to net asset value less any applicable contingent deferred sales charge.

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	2,373,848
Income from Fidelity Central Funds (including $32,570 from security lending)				171,362
Total Income				2,545,210
Expenses
Management fee	$	4,130,707
Transfer agent fees		1,693,195
Distribution and service plan fees		159,757
Accounting fees		253,372
Custodian fees and expenses		8,848
Independent trustees' fees and expenses		2,720
Registration fees		98,848
Audit		45,964
Legal		1,915
Interest		993
Miscellaneous		4,948
Total expenses before reductions		6,401,267
Expense reductions		(27,974)
Total expenses after reductions				6,373,293
Net Investment income (loss)				(3,828,083)
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		(27,501,704)
Foreign currency transactions		(65,206)
Total net realized gain (loss)				(27,566,910)
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		(178,868,019)
Assets and liabilities in foreign currencies		29
Total change in net unrealized appreciation (depreciation)				(178,867,990)
Net gain (loss)				(206,434,900)
Net increase (decrease) in net assets resulting from operations			$	(210,262,983)

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	(3,828,083)	$	(4,780,267)
Net realized gain (loss)		(27,566,910)		19,842,720
Change in net unrealized appreciation (depreciation)		(178,867,990)		(98,753,641)
Net increase (decrease) in net assets resulting from operations		(210,262,983)		(83,691,188)
Distributions to shareholders		-		(63,905,764)
Share transactions - net increase (decrease)		(73,791,815)		267,487,210
Total increase (decrease) in net assets		(284,054,798)		119,890,258

Net Assets
Beginning of period		1,045,302,811		925,412,553
End of period	$	761,248,013	$	1,045,302,811

Financial Highlights

Fidelity Advisor® Communication Services Fund Class A

Years ended February 28,		2023		2022		2021		2020 A		2019 B
Selected Per-Share Data
Net asset value, beginning of period	$	78.37	$	87.31	$	60.63	$	74.85	$	78.20
Income from Investment Operations
Net investment income (loss) C,D		(.48)		(.60)		(.59)		(.30)		(.12)
Net realized and unrealized gain (loss)		(15.65)		(3.18)		30.37		8.77		2.68
Total from investment operations		(16.13)		(3.78)		29.78		8.47		2.56
Distributions from net investment income		-		-		-		-		(.14)
Distributions from net realized gain		-		(5.16)		(3.10)		(22.69)		(5.77)
Total distributions		-		(5.16)		(3.10)		(22.69)		(5.91)
Net asset value, end of period	$	62.24	$	78.37	$	87.31	$	60.63	$	74.85
Total Return E,F,G		(20.58)%		(5.05)%		50.81%		11.90%		3.83%
Ratios to Average Net Assets D,H,I
Expenses before reductions		1.07%		1.03%		1.08%		1.07%		1.13% J
Expenses net of fee waivers, if any		1.07%		1.03%		1.08%		1.07%		1.12% J
Expenses net of all reductions		1.07%		1.03%		1.07%		1.06%		1.11% J
Net investment income (loss)		(.74)%		(.65)%		(.81)%		(.47)%		(.68)% J
Supplemental Data
Net assets, end of period (000 omitted)	$	24,285	$	33,679	$	22,962	$	9,947	$	715
Portfolio turnover rate K		45%		57%		63%		73%		107%

A For the year ended February 29.

B For the period November 30, 2018 (commencement of sale of shares) through February 28, 2019.

C Calculated based on average shares outstanding during the period.

E Total returns for periods of less than one year are not annualized.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

G Total returns do not include the effect of the sales charges.

J Annualized.

K Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Fidelity Advisor® Communication Services Fund Class M

Years ended February 28,		2023		2022		2021		2020 A		2019 B
Selected Per-Share Data
Net asset value, beginning of period	$	77.94	$	86.94	$	60.52	$	74.82	$	78.20
Income from Investment Operations
Net investment income (loss) C,D		(.63)		(.82)		(.77)		(.48)		(.16)
Net realized and unrealized gain (loss)		(15.56)		(3.15)		30.29		8.75		2.67
Total from investment operations		(16.19)		(3.97)		29.52		8.27		2.51
Distributions from net investment income		-		-		-		-		(.12)
Distributions from net realized gain		-		(5.03)		(3.10)		(22.57)		(5.77)
Total distributions		-		(5.03)		(3.10)		(22.57)		(5.89)
Net asset value, end of period	$	61.75	$	77.94	$	86.94	$	60.52	$	74.82
Total Return E,F,G		(20.77)%		(5.28)%		50.47%		11.58%		3.76%
Ratios to Average Net Assets D,H,I
Expenses before reductions		1.31%		1.27%		1.32%		1.35%		1.36% J
Expenses net of fee waivers, if any		1.31%		1.27%		1.32%		1.35%		1.35% J
Expenses net of all reductions		1.31%		1.27%		1.32%		1.34%		1.34% J
Net investment income (loss)		(.98)%		(.88)%		(1.06)%		(.75)%		(.90)% J
Supplemental Data
Net assets, end of period (000 omitted)	$	3,499	$	5,817	$	5,386	$	2,264	$	485
Portfolio turnover rate K		45%		57%		63%		73%		107%

A For the year ended February 29.

B For the period November 30, 2018 (commencement of sale of shares) through February 28, 2019.

C Calculated based on average shares outstanding during the period.

E Total returns for periods of less than one year are not annualized.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

G Total returns do not include the effect of the sales charges.

J Annualized.

K Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Fidelity Advisor® Communication Services Fund Class C

Years ended February 28,		2023		2022		2021		2020 A		2019 B
Selected Per-Share Data
Net asset value, beginning of period	$	76.81	$	86.05	$	60.20	$	74.76	$	78.20
Income from Investment Operations
Net investment income (loss) C,D		(.90)		(1.27)		(1.12)		(.81)		(.25)
Net realized and unrealized gain (loss)		(15.34)		(3.07)		30.07		8.74		2.67
Total from investment operations		(16.24)		(4.34)		28.95		7.93		2.42
Distributions from net investment income		-		-		-		-		(.09)
Distributions from net realized gain		-		(4.90)		(3.10)		(22.49)		(5.77)
Total distributions		-		(4.90)		(3.10)		(22.49)		(5.86)
Net asset value, end of period	$	60.57	$	76.81	$	86.05	$	60.20	$	74.76
Total Return E,F,G		(21.14)%		(5.76)%		49.77%		11.01%		3.63%
Ratios to Average Net Assets D,H,I
Expenses before reductions		1.78%		1.78%		1.80%		1.86%		1.87% J
Expenses net of fee waivers, if any		1.78%		1.78%		1.80%		1.86%		1.85% J
Expenses net of all reductions		1.78%		1.78%		1.79%		1.85%		1.84% J
Net investment income (loss)		(1.45)%		(1.39)%		(1.53)%		(1.26)%		(1.37)% J
Supplemental Data
Net assets, end of period (000 omitted)	$	7,478	$	8,938	$	6,856	$	1,982	$	377
Portfolio turnover rate K		45%		57%		63%		73%		107%

A For the year ended February 29.

B For the period November 30, 2018 (commencement of sale of shares) through February 28, 2019.

C Calculated based on average shares outstanding during the period.

E Total returns for periods of less than one year are not annualized.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

G Total returns do not include the effect of the contingent deferred sales charge.

J Annualized.

K Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Communication Services Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	78.98	$	87.88	$	60.82	$	74.88	$	79.70
Income from Investment Operations
Net investment income (loss) B,C		(.30)		(.34)		(.36)		(.12)		.13
Net realized and unrealized gain (loss)		(15.78)		(3.22)		30.52		8.79		5.31
Total from investment operations		(16.08)		(3.56)		30.16		8.67		5.44
Distributions from net investment income		-		-		-		-		(.20)
Distributions from net realized gain		-		(5.34)		(3.10)		(22.73)		(10.06)
Total distributions		-		(5.34)		(3.10)		(22.73)		(10.26)
Net asset value, end of period	$	62.90	$	78.98	$	87.88	$	60.82	$	74.88
Total Return D		(20.36)%		(4.79)%		51.29%		12.22%		8.12%
Ratios to Average Net Assets C,E,F
Expenses before reductions		.80%		.75%		.77%		.78%		.82%
Expenses net of fee waivers, if any		.79%		.74%		.77%		.78%		.81%
Expenses net of all reductions		.79%		.74%		.76%		.77%		.80%
Net investment income (loss)		(.47)%		(.36)%		(.51)%		(.18)%		.17%
Supplemental Data
Net assets, end of period (000 omitted)	$	710,710	$	958,304	$	859,871	$	577,157	$	562,422
Portfolio turnover rate G		45%		57%		63%		73%		107%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

G Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Fidelity Advisor® Communication Services Fund Class I

Years ended February 28,		2023		2022		2021		2020 A		2019 B
Selected Per-Share Data
Net asset value, beginning of period	$	78.93	$	87.86	$	60.80	$	74.89	$	78.20
Income from Investment Operations
Net investment income (loss) C,D		(.28)		(.34)		(.39)		(.11)		(.06)
Net realized and unrealized gain (loss)		(15.76)		(3.22)		30.55		8.78		2.67
Total from investment operations		(16.04)		(3.56)		30.16		8.67		2.61
Distributions from net investment income		-		-		-		-		(.15)
Distributions from net realized gain		-		(5.37)		(3.10)		(22.76)		(5.77)
Total distributions		-		(5.37)		(3.10)		(22.76)		(5.92)
Net asset value, end of period	$	62.89	$	78.93	$	87.86	$	60.80	$	74.89
Total Return E,F		(20.32)%		(4.79)%		51.31%		12.22%		3.91%
Ratios to Average Net Assets D,G,H
Expenses before reductions		.76%		.75%		.78%		.77%		.70% I
Expenses net of fee waivers, if any		.75%		.75%		.77%		.77%		.69% I
Expenses net of all reductions		.75%		.75%		.77%		.76%		.68% I
Net investment income (loss)		(.43)%		(.37)%		(.51)%		(.17)%		(.30)% I
Supplemental Data
Net assets, end of period (000 omitted)	$	11,961	$	32,089	$	26,521	$	2,493	$	452
Portfolio turnover rate J		45%		57%		63%		73%		107%

A For the year ended February 29.

B For the period November 30, 2018 (commencement of sale of shares) through February 28, 2019.

C Calculated based on average shares outstanding during the period.

E Total returns for periods of less than one year are not annualized.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

I Annualized.

J Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Fidelity Advisor® Communication Services Fund Class Z

Years ended February 28,		2023		2022		2021		2020 A		2019 B
Selected Per-Share Data
Net asset value, beginning of period	$	79.20	$	88.04	$	60.85	$	74.89	$	78.20
Income from Investment Operations
Net investment income (loss) C,D		(.19)		(.22)		(.28)		(.03)		(.03)
Net realized and unrealized gain (loss)		(15.83)		(3.23)		30.57		8.80		2.65
Total from investment operations		(16.02)		(3.45)		30.29		8.77		2.62
Distributions from net investment income		-		-		-		-		(.16)
Distributions from net realized gain		-		(5.39)		(3.10)		(22.81)		(5.77)
Total distributions		-		(5.39)		(3.10)		(22.81)		(5.93)
Net asset value, end of period	$	63.18	$	79.20	$	88.04	$	60.85	$	74.89
Total Return E,F		(20.23)%		(4.65)%		51.48%		12.38%		3.92%
Ratios to Average Net Assets C,G,H
Expenses before reductions		.62%		.62%		.64%		.65%		.64% I
Expenses net of fee waivers, if any		.62%		.61%		.64%		.65%		.62% I
Expenses net of all reductions		.62%		.61%		.63%		.64%		.61% I
Net investment income (loss)		(.29)%		(.23)%		(.38)%		(.05)%		(.16)% I
Supplemental Data
Net assets, end of period (000 omitted)	$	3,314	$	6,477	$	3,817	$	1,833	$	529
Portfolio turnover rate J		45%		57%		63%		73%		107%

A For the year ended February 29.

B For the period November 30, 2018 (commencement of sale of shares) through February 28, 2019.

D Calculated based on average shares outstanding during the period.

E Total returns for periods of less than one year are not annualized.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

I Annualized.

J Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Construction and Housing Portfolio	-0.70%	16.08%	13.75%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Construction and Housing Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Construction and Housing Portfolio

Market Recap:

Comments from Portfolio Manager Jordan Michaels:

For the fiscal year ending February 28, 2023, the fund returned -0.70%, outperforming the -2.34% result of the MSCI US IMI Construction & Housing 25/50 Index, as well as the broad-based S&P 500 ® index. Versus the industry index, security selection was the primary contributor, led by choices in the construction & engineering group. Also helping was stock selection and an underweighting in residential REITs. The fund's biggest individual relative contributor was an overweighting in WillScot Mobile Mini Holdings, which gained 44% the past year. Though we decreased our stake, the company was among the biggest holdings as of February 28. Our second-largest relative contributor this period was avoiding AvalonBay Communities, an index component that returned approximately -25%. Another top relative contributor was an out-of-index position in Tempur Sealy International (+31%). We reduced the size of our position this period. In contrast, the largest detractor from performance versus the industry index was security selection in internet services & infrastructure. An underweighting in the outperforming construction & engineering group also modestly hurt, as did stock selection in real estate services. Our non-index stake in Cyxtera Technologies was the fund's largest individual relative detractor, due to its roughly -82% result. Also hurting performance was our outsized stake in Elme Communities, which returned about -17%. We reduced our holdings this period. The fund's non-index investment in Cushman & Wakefield returned -41%, and we increased the fund's holdings. Notable changes in positioning include a higher allocation to the homebuilding and construction & engineering subindustries.

Construction and Housing Portfolio

Top Holdings (% of Fund's net assets)

The Home Depot, Inc.	16.8
Lowe's Companies, Inc.	15.4
Johnson Controls International PLC	5.8
Trane Technologies PLC	4.0
Vulcan Materials Co.	3.3
Invitation Homes, Inc.	3.2
Willscot Mobile Mini Holdings	3.1
Floor & Decor Holdings, Inc. Class A	3.0
Builders FirstSource, Inc.	3.0
Essex Property Trust, Inc.	2.6
	60.2

Industries (% of Fund's net assets)

Specialty Retail	36.2
Building Products	23.4
Equity Real Estate Investment Trusts (Reits)	12.8
Household Durables	12.6
Construction & Engineering	8.7
Construction Materials	3.7
Real Estate Management & Development	0.9
Chemicals	0.5
Electrical Equipment	0.3
Trading Companies & Distributors	0.3
IT Services	0.1

Geographic Diversification (% of Fund's net assets)

* Includes Short-Term investments and Net Other Assets (Liabilities).

Percentages are based on country or territory of incorporation and are adjusted for the effect of derivatives, if applicable.

Construction and Housing Portfolio

Showing Percentage of Net Assets

Common Stocks - 99.5%
	Shares	Value ($)
Building Products - 23.4%
Building Products - 23.4%
Apogee Enterprises, Inc.	96,400	4,411,264
Armstrong World Industries, Inc. (a)	64,400	5,077,940
Builders FirstSource, Inc. (b)	174,935	14,830,989
Carlisle Companies, Inc.	46,100	11,903,942
Carrier Global Corp.	216,400	9,744,492
Fortune Brands Home & Security, Inc.	77,100	4,776,345
Johnson Controls International PLC	459,951	28,848,127
MasterBrand, Inc. (b)	219,600	2,138,904
Resideo Technologies, Inc. (b)	85,200	1,562,568
Simpson Manufacturing Co. Ltd.	50,900	5,490,074
The AZEK Co., Inc. (a)(b)	145,000	3,493,050
Trane Technologies PLC	107,700	19,921,269
UFP Industries, Inc.	55,326	4,732,033
		116,930,997
Chemicals - 0.5%
Specialty Chemicals - 0.5%
PPG Industries, Inc.	8,500	1,122,510
Sherwin-Williams Co.	6,400	1,416,640
		2,539,150
Construction & Engineering - 8.7%
Construction & Engineering - 8.7%
AECOM	62,600	5,406,136
EMCOR Group, Inc.	41,370	6,917,891
Fluor Corp. (b)	17,100	627,057
Granite Construction, Inc.	96,818	4,182,538
Quanta Services, Inc.	66,599	10,749,079
Willscot Mobile Mini Holdings (b)	303,350	15,592,190
		43,474,891
Construction Materials - 3.7%
Construction Materials - 3.7%
Summit Materials, Inc.	75,558	2,231,983
Vulcan Materials Co.	89,876	16,259,467
		18,491,450
Electrical Equipment - 0.3%
Electrical Components & Equipment - 0.3%
Generac Holdings, Inc. (b)	13,200	1,584,132
Equity Real Estate Investment Trusts (REITs) - 12.8%
Residential REITs - 12.8%
Elme Communities (SBI)	482,400	8,977,464
Equity Lifestyle Properties, Inc.	129,700	8,885,747
Equity Residential (SBI)	83,000	5,189,160
Essex Property Trust, Inc.	56,600	12,908,196
Invitation Homes, Inc.	515,100	16,102,026
Mid-America Apartment Communities, Inc.	72,200	11,559,220
		63,621,813
Household Durables - 12.6%
Home Furnishings - 1.9%
Tempur Sealy International, Inc.	215,500	9,210,470
Homebuilding - 10.4%
Blu Investments LLC (b)(c)(d)	11,990,913	3,717
D.R. Horton, Inc.	44,156	4,083,547
Installed Building Products, Inc.	57,938	6,684,886
KB Home	172,700	6,091,129
Lennar Corp. Class A	11,000	1,064,140
NVR, Inc. (b)	2,421	12,525,334
PulteGroup, Inc.	224,485	12,272,595
Toll Brothers, Inc.	154,400	9,254,736
		51,980,084
Household Appliances - 0.3%
Whirlpool Corp. (a)	10,400	1,434,992
TOTAL HOUSEHOLD DURABLES		62,625,546
IT Services - 0.1%
Internet Services & Infrastructure - 0.1%
Cyxtera Technologies, Inc. Class A (b)	200,000	448,000
Real Estate Management & Development - 0.9%
Diversified Real Estate Activities - 0.3%
The RMR Group, Inc.	56,060	1,577,528
Real Estate Services - 0.6%
Cushman & Wakefield PLC (b)	219,895	2,845,441
TOTAL REAL ESTATE MANAGEMENT & DEVELOPMENT		4,422,969
Specialty Retail - 36.2%
Home Improvement Retail - 35.2%
Floor & Decor Holdings, Inc. Class A (a)(b)	162,900	14,955,849
Lowe's Companies, Inc.	372,695	76,681,996
The Home Depot, Inc.	283,190	83,977,164
		175,615,009
Homefurnishing Retail - 1.0%
Williams-Sonoma, Inc. (a)	40,400	5,046,768
TOTAL SPECIALTY RETAIL		180,661,777
Trading Companies & Distributors - 0.3%
Trading Companies & Distributors - 0.3%
Beacon Roofing Supply, Inc. (b)	19,903	1,293,695
TOTAL COMMON STOCKS (Cost $328,519,990)		496,094,420

Money Market Funds - 5.8%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (e)	3,548,798	3,549,508
Fidelity Securities Lending Cash Central Fund 4.63% (e)(f)	25,264,199	25,266,725
TOTAL MONEY MARKET FUNDS (Cost $28,816,233)		28,816,233

TOTAL INVESTMENT IN SECURITIES - 105.3% (Cost $357,336,223)	524,910,653
NET OTHER ASSETS (LIABILITIES) - (5.3)%	(26,213,732)
NET ASSETS - 100.0%	498,696,921

Legend

(a)	Security or a portion of the security is on loan at period end.

(b)	Non-income producing

(c)	Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $3,717 or 0.0% of net assets.

(d)	Level 3 security

(e)

(f)	Investment made with cash collateral received from securities on loan.

Additional information on each restricted holding is as follows:
Security	Acquisition Date	Acquisition Cost ($)
Blu Investments LLC	5/21/20	20,739

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	5,377,678	135,395,564	137,223,734	43,281	-	-	3,549,508	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	2,014,150	161,339,327	138,086,752	15,855	-	-	25,266,725	0.1%
Total	7,391,828	296,734,891	275,310,486	59,136	-	-	28,816,233

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	496,094,420	496,090,703	-	3,717

Money Market Funds	28,816,233	28,816,233	-	-
Total Investments in Securities:	524,910,653	524,906,936	-	3,717

Construction and Housing Portfolio

Consumer Discretionary Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $24,852,288) - See accompanying schedule:
Unaffiliated issuers (cost $328,519,990)	$	496,094,420
Fidelity Central Funds (cost $28,816,233)		28,816,233


Total Investment in Securities (cost $357,336,223)			$	524,910,653
Receivable for investments sold				6,093,975
Receivable for fund shares sold				290,632
Dividends receivable				97,561
Distributions receivable from Fidelity Central Funds				13,250
Prepaid expenses				1,202
Total assets				531,407,273
Liabilities
Payable for investments purchased	$	6,930,955
Payable for fund shares redeemed		164,442
Accrued management fee		222,923
Other affiliated payables		91,966
Other payables and accrued expenses		33,341
Collateral on securities loaned		25,266,725
Total Liabilities				32,710,352
Net Assets			$	498,696,921
Net Assets consist of:
Paid in capital			$	347,408,093
Total accumulated earnings (loss)				151,288,828
Net Assets			$	498,696,921
Net Asset Value , offering price and redemption price per share ($498,696,921 ÷ 5,636,414 shares)			$	88.48

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	8,517,917
Income from Fidelity Central Funds (including $15,855 from security lending)				59,136
Total Income				8,577,053
Expenses
Management fee	$	2,702,438
Transfer agent fees		955,911
Accounting fees		183,832
Custodian fees and expenses		9,809
Independent trustees' fees and expenses		1,802
Registration fees		45,219
Audit		39,151
Legal		1,525
Interest		952
Miscellaneous		2,937
Total expenses before reductions		3,943,576
Expense reductions		(18,633)
Total expenses after reductions				3,924,943
Net Investment income (loss)				4,652,110
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		(12,450,749)
Total net realized gain (loss)				(12,450,749)
Change in net unrealized appreciation (depreciation) on investment securities				(9,276,236)
Net gain (loss)				(21,726,985)
Net increase (decrease) in net assets resulting from operations			$	(17,074,875)

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	4,652,110	$	3,741,270
Net realized gain (loss)		(12,450,749)		26,178,157
Change in net unrealized appreciation (depreciation)		(9,276,236)		24,955,718
Net increase (decrease) in net assets resulting from operations		(17,074,875)		54,875,145
Distributions to shareholders		(3,697,710)		(39,900,442)
Share transactions
Proceeds from sales of shares		79,113,675		712,970,980
Reinvestment of distributions		3,425,079		37,862,407
Cost of shares redeemed		(276,407,546)		(395,931,225)
Net increase (decrease) in net assets resulting from share transactions		(193,868,792)		354,902,162
Total increase (decrease) in net assets		(214,641,377)		369,876,865

Net Assets
Beginning of period		713,338,298		343,461,433
End of period	$	498,696,921	$	713,338,298

Other Information
Shares
Sold		926,693		7,347,600
Issued in reinvestment of distributions		40,601		384,753
Redeemed		(3,274,232)		(4,219,107)
Net increase (decrease)		(2,306,938)		3,513,246

Financial Highlights

Construction and Housing Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	89.80	$	77.53	$	58.56	$	54.22	$	59.88
Income from Investment Operations
Net investment income (loss) B,C		.76		.57		.59		.53		.49
Net realized and unrealized gain (loss)		(1.42)		17.59		21.82		8.71		1.32
Total from investment operations		(.66)		18.16		22.41		9.24		1.81
Distributions from net investment income		(.66)		(.53)		(.61)		(.60)		(.55)
Distributions from net realized gain		-		(5.36)		(2.83)		(4.31)		(6.92)
Total distributions		(.66)		(5.89)		(3.44)		(4.90) D		(7.47)
Net asset value, end of period	$	88.48	$	89.80	$	77.53	$	58.56	$	54.22
Total Return E		(.70)%		22.95%		41.70%		17.10%		4.03%
Ratios to Average Net Assets C,F,G
Expenses before reductions		.77%		.75%		.78%		.79%		.80%
Expenses net of fee waivers, if any		.76%		.75%		.78%		.79%		.80%
Expenses net of all reductions		.76%		.75%		.77%		.79%		.79%
Net investment income (loss)		.90%		.60%		.94%		.88%		.86%
Supplemental Data
Net assets, end of period (000 omitted)	$	498,697	$	713,338	$	343,461	$	318,905	$	225,255
Portfolio turnover rate H		20%		70%		93%		161%		90%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Total distributions per share do not sum due to rounding.

E Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

H Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Consumer Discretionary Portfolio	-16.87%	7.13%	11.20%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Consumer Discretionary Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Consumer Discretionary Portfolio

Market Recap:

Comments from Portfolio Manager Jordan Michaels:

For the fiscal year ending February 28, 2023, the fund returned -16.87%, trailing the -15.75% result of the MSCI US IMI Consumer Discretionary 25/50 Index, as well as the broad-based S&P 500 ® index. The largest detractors from performance versus the sector index were an underweighting and security selection in the restaurants group. An underweighting and stock picks in automotive retail and security selection in apparel retail also hurt. The fund's biggest individual relative detractor was our lighter-than-index stake in Mcdonalds, which gained about 10% the past year. We increased our stake this period, and it was among the fund's largest holdings as of February 28. Our second-largest relative detractor this period was avoiding Starbucks, an index component that gained 14%. Also hindering performance was our overweighting in Capri Holdings, which returned -27%. We reduced our stake in Capri Holdings the past 12 months. Conversely, the biggest contributor to performance versus the sector index was stock selection in hotels, resorts & cruise lines. Stock selection and an overweighting in footwear and an overweighting in apparel retail also bolstered the fund's relative performance. The fund's biggest individual relative contributor was an outsized stake in Deckers Outdoor, which gained about 45% the past 12 months. Also helping performance was our overweighting in TJX Companies, which gained 18%. TJX Companies was among the fund's biggest holdings. Another notable relative contributor was an outsized stake in Dicks Sporting Goods (+26%). This period we added to our stake. Notable changes in positioning include increased exposure to the general merchandise stores subindustry and a lower allocation to apparel, accessories & luxury goods.

Note to shareholders: On October 1, 2022, Jordan Michaels assumed sole management responsibilities for the fund after having served as co-manager with Katherine Shaw since July 2022.

Consumer Discretionary Portfolio

Top Holdings (% of Fund's net assets)

Amazon.com, Inc.	21.1
Tesla, Inc.	12.4
The Home Depot, Inc.	4.9
Lowe's Companies, Inc.	4.9
NIKE, Inc. Class B	4.1
TJX Companies, Inc.	3.9
Hilton Worldwide Holdings, Inc.	2.9
Booking Holdings, Inc.	2.6
Dollar Tree, Inc.	2.5
Target Corp.	2.2
	61.5

Industries (% of Fund's net assets)

Internet & Direct Marketing Retail	21.9
Specialty Retail	21.9
Hotels, Restaurants & Leisure	17.5
Automobiles	12.8
Textiles, Apparel & Luxury Goods	12.0
Multiline Retail	7.1
Household Durables	3.1
Auto Components	2.0
Food & Staples Retailing	0.8
Building Products	0.4

Consumer Discretionary Portfolio

Showing Percentage of Net Assets

Common Stocks - 99.5%
	Shares	Value ($)
Auto Components - 2.0%
Auto Parts & Equipment - 2.0%
Adient PLC (a)	73,900	3,157,008
Aptiv PLC (a)	17,400	2,023,272
Magna International, Inc. Class A (b)	60,090	3,348,816
		8,529,096
Automobiles - 12.8%
Automobile Manufacturers - 12.8%
Ferrari NV	6,127	1,595,287
Tesla, Inc. (a)	255,951	52,651,680
		54,246,967
Building Products - 0.4%
Building Products - 0.4%
The AZEK Co., Inc. (a)(b)	68,146	1,641,637
Food & Staples Retailing - 0.8%
Food Distributors - 0.8%
Performance Food Group Co. (a)	62,778	3,552,607
Hotels, Restaurants & Leisure - 17.5%
Casinos & Gaming - 3.1%
Caesars Entertainment, Inc. (a)	57,448	2,916,060
Churchill Downs, Inc.	26,581	6,533,078
Penn Entertainment, Inc. (a)	112,374	3,430,778
		12,879,916
Hotels, Resorts & Cruise Lines - 7.8%
Booking Holdings, Inc. (a)	4,312	10,883,488
Hilton Worldwide Holdings, Inc.	86,081	12,439,565
Marriott International, Inc. Class A	51,179	8,661,534
Royal Caribbean Cruises Ltd. (a)	17,400	1,229,136
		33,213,723
Leisure Facilities - 0.5%
Planet Fitness, Inc. (a)	25,233	2,045,135
Restaurants - 6.1%
ARAMARK Holdings Corp.	127,664	4,698,035
Brinker International, Inc. (a)	25,830	981,540
Chipotle Mexican Grill, Inc. (a)	3,855	5,748,113
Domino's Pizza, Inc.	17,194	5,055,208
Dutch Bros, Inc. (a)(b)	19,571	652,693
McDonald's Corp.	33,425	8,821,192
		25,956,781
TOTAL HOTELS, RESTAURANTS & LEISURE		74,095,555
Household Durables - 3.1%
Home Furnishings - 1.4%
Tempur Sealy International, Inc.	136,687	5,842,002
Homebuilding - 1.7%
KB Home	81,330	2,868,509
PulteGroup, Inc.	84,060	4,595,560
		7,464,069
TOTAL HOUSEHOLD DURABLES		13,306,071
Internet & Direct Marketing Retail - 21.9%
Internet & Direct Marketing Retail - 21.9%
Amazon.com, Inc. (a)	953,605	89,858,201
eBay, Inc.	70,656	3,243,110
Wayfair LLC Class A (a)	1,500	60,735
		93,162,046
Multiline Retail - 7.1%
General Merchandise Stores - 7.1%
Dollar General Corp.	32,104	6,944,095
Dollar Tree, Inc. (a)	73,200	10,634,496
Ollie's Bargain Outlet Holdings, Inc. (a)	55,682	3,203,942
Target Corp.	54,625	9,204,313
		29,986,846
Specialty Retail - 21.9%
Apparel Retail - 5.7%
Burlington Stores, Inc. (a)	23,587	5,053,515
TJX Companies, Inc.	217,297	16,644,950
Victoria's Secret & Co. (a)	69,439	2,752,562
		24,451,027
Automotive Retail - 0.5%
O'Reilly Automotive, Inc. (a)	2,410	2,000,541
Home Improvement Retail - 11.6%
Floor & Decor Holdings, Inc. Class A (a)(b)	84,567	7,764,096
Lowe's Companies, Inc.	100,441	20,665,736
The Home Depot, Inc.	70,531	20,915,263
		49,345,095
Homefurnishing Retail - 0.6%
Williams-Sonoma, Inc. (b)	19,020	2,375,978
Specialty Stores - 3.5%
Bath & Body Works, Inc.	39,688	1,622,049
Dick's Sporting Goods, Inc. (b)	67,837	8,725,873
Five Below, Inc. (a)	18,052	3,688,024
Sally Beauty Holdings, Inc. (a)	53,100	854,379
		14,890,325
TOTAL SPECIALTY RETAIL		93,062,966
Textiles, Apparel & Luxury Goods - 12.0%
Apparel, Accessories & Luxury Goods - 5.9%
Capri Holdings Ltd. (a)	147,768	7,324,860
lululemon athletica, Inc. (a)	20,130	6,224,196
LVMH Moet Hennessy Louis Vuitton SE	2,833	2,355,150
PVH Corp.	36,578	2,935,019
Tapestry, Inc.	149,128	6,488,559
		25,327,784
Footwear - 6.1%
Deckers Outdoor Corp. (a)	16,527	6,881,016
NIKE, Inc. Class B	144,202	17,129,756
On Holding AG (a)	41,093	898,704
Skechers U.S.A., Inc. Class A (sub. vtg.) (a)	20,500	912,455
		25,821,931
TOTAL TEXTILES, APPAREL & LUXURY GOODS		51,149,715
TOTAL COMMON STOCKS (Cost $296,361,047)		422,733,506

Money Market Funds - 4.2%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (c)	1,290,574	1,290,832
Fidelity Securities Lending Cash Central Fund 4.63% (c)(d)	16,276,186	16,277,814
TOTAL MONEY MARKET FUNDS (Cost $17,568,646)		17,568,646

TOTAL INVESTMENT IN SECURITIES - 103.7% (Cost $313,929,693)	440,302,152
NET OTHER ASSETS (LIABILITIES) - (3.7)%	(15,510,805)
NET ASSETS - 100.0%	424,791,347

Legend

(a)	Non-income producing

(b)	Security or a portion of the security is on loan at period end.

(c)

(d)	Investment made with cash collateral received from securities on loan.

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	-	82,765,441	81,474,609	48,808	-	-	1,290,832	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	6,819,964	125,949,027	116,491,177	230,764	-	-	16,277,814	0.1%
Total	6,819,964	208,714,468	197,965,786	279,572	-	-	17,568,646

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	422,733,506	420,378,356	2,355,150	-

Money Market Funds	17,568,646	17,568,646	-	-
Total Investments in Securities:	440,302,152	437,947,002	2,355,150	-

Consumer Discretionary Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $16,046,701) - See accompanying schedule:
Unaffiliated issuers (cost $296,361,047)	$	422,733,506
Fidelity Central Funds (cost $17,568,646)		17,568,646


Total Investment in Securities (cost $313,929,693)			$	440,302,152
Cash				16,056
Foreign currency held at value (cost $1)				1
Receivable for investments sold				3,563,098
Receivable for fund shares sold				173,902
Dividends receivable				273,971
Distributions receivable from Fidelity Central Funds				17,868
Prepaid expenses				2,350
Other receivables				15,085
Total assets				444,364,483
Liabilities
Payable for investments purchased	$	2,441,904
Payable for fund shares redeemed		562,994
Accrued management fee		190,921
Other affiliated payables		70,259
Other payables and accrued expenses		33,533
Collateral on securities loaned		16,273,525
Total Liabilities				19,573,136
Net Assets			$	424,791,347
Net Assets consist of:
Paid in capital			$	296,165,809
Total accumulated earnings (loss)				128,625,538
Net Assets			$	424,791,347
Net Asset Value , offering price and redemption price per share ($424,791,347 ÷ 8,936,375 shares)			$	47.54

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	2,849,741
Income from Fidelity Central Funds (including $230,764 from security lending)				279,572
Total Income				3,129,313
Expenses
Management fee	$	2,109,514
Transfer agent fees		681,929
Accounting fees		144,975
Custodian fees and expenses		12,064
Independent trustees' fees and expenses		1,364
Registration fees		50,963
Audit		40,160
Legal		3,356
Interest		966
Miscellaneous		3,196
Total expenses before reductions		3,048,487
Expense reductions		(14,515)
Total expenses after reductions				3,033,972
Net Investment income (loss)				95,341
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		14,819,825
Foreign currency transactions		3,643
Total net realized gain (loss)				14,823,468
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		(78,173,699)
Assets and liabilities in foreign currencies		(1,786)
Total change in net unrealized appreciation (depreciation)				(78,175,485)
Net gain (loss)				(63,352,017)
Net increase (decrease) in net assets resulting from operations			$	(63,256,676)

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	95,341	$	(1,380,277)
Net realized gain (loss)		14,823,468		69,875,616
Change in net unrealized appreciation (depreciation)		(78,175,485)		(55,774,464)
Net increase (decrease) in net assets resulting from operations		(63,256,676)		12,720,875
Distributions to shareholders		(36,965,013)		(57,919,716)
Share transactions
Proceeds from sales of shares		214,276,530		211,466,743
Reinvestment of distributions		34,220,095		54,428,730
Cost of shares redeemed		(142,158,153)		(385,959,972)
Net increase (decrease) in net assets resulting from share transactions		106,338,472		(120,064,499)
Total increase (decrease) in net assets		6,116,783		(165,263,340)

Net Assets
Beginning of period		418,674,564		583,937,904
End of period	$	424,791,347	$	418,674,564

Other Information
Shares
Sold		4,618,411		2,966,018
Issued in reinvestment of distributions		617,903		780,014
Redeemed		(2,921,858)		(5,710,596)
Net increase (decrease)		2,314,456		(1,964,564)

Financial Highlights

Consumer Discretionary Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	63.23	$	68.01	$	45.58	$	44.31	$	43.65
Income from Investment Operations
Net investment income (loss) B,C		.01		(.16)		(.03)		.11		.12
Net realized and unrealized gain (loss)		(9.85)		1.92		23.23		2.26		1.87
Total from investment operations		(9.84)		1.76		23.20		2.37		1.99
Distributions from net investment income		(.02)		-		-		(.11)		(.15)
Distributions from net realized gain		(5.83)		(6.54)		(.77)		(.99)		(1.18)
Total distributions		(5.85)		(6.54)		(.77)		(1.10)		(1.33)
Net asset value, end of period	$	47.54	$	63.23	$	68.01	$	45.58	$	44.31
Total Return D		(16.87)%		1.88%		50.96%		5.30%		4.81%
Ratios to Average Net Assets C,E,F
Expenses before reductions		.76%		.73%		.76%		.76%		.78%
Expenses net of fee waivers, if any		.76%		.73%		.76%		.76%		.77%
Expenses net of all reductions		.76%		.73%		.75%		.76%		.77%
Net investment income (loss)		.02%		(.22)%		(.06)%		.23%		.27%
Supplemental Data
Net assets, end of period (000 omitted)	$	424,791	$	418,675	$	583,938	$	402,403	$	433,188
Portfolio turnover rate G		46%		38%		55%		41% H		46% H

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

G Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

H Portfolio turnover rate excludes securities received or delivered in-kind.

Leisure Portfolio

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Leisure Portfolio	-0.22%	10.02%	12.63%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Leisure Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Leisure Portfolio

Market Recap:

Comments from Portfolio Manager Kevin Francfort:

For the fiscal year ending February 28, 2023, the fund returned -0.22%, roughly in line with the -0.19% return of the MSCI US IMI Consumer Services 25/50 Index, but outperforming the broad-based S&P 500 ® index. Versus the industry index, security selection was the primary contributor, led by choices in the hotels, resorts & cruise lines group. Also helping was stock selection and an underweighting in leisure facilities. Our lighter-than-index investment in Expedia, a position we established this period, was the fund's largest individual relative contributor because the stock returned about -44% the past 12 months. Our second-largest contributor this period was Wingstop, an investment we established this period. The stock gained 95% the past year and contributed meaningfully to relative performance. Another notable relative contributor was our lighter-than-index position in Carnival (-48%). We established a small position later in the period and our stake gained 5%. The fund's foreign holdings also contributed overall despite a broadly strong U.S. dollar. In contrast, the largest detractor from performance versus the industry index was our stock selection in casinos & gaming. An underweighting and security selection in restaurants and stock picks in soft drinks also hurt the fund's relative performance. The biggest individual relative detractor was an overweight position in Caesars Entertainment (-39%). Caesars Entertainment was among the fund's largest holdings the past 12 months, though we reduced our stake. Also hurting performance was our lighter-than-index stake in Starbucks, which gained 14%. We added to our stake the past year. Another notable relative detractor was an overweighting in Dominos Pizza (-31%), which was among our biggest holdings even though we trimmed the position this period.

Note to shareholders: On March 1, 2023, Kevin Francfort assumed sole management responsibilities for the fund after having served as co-manager with Will Hilkert since September 2022.

Leisure Portfolio

Top Holdings (% of Fund's net assets)

McDonald's Corp.	16.7
Booking Holdings, Inc.	11.5
Hilton Worldwide Holdings, Inc.	7.9
Starbucks Corp.	7.1
Yum! Brands, Inc.	6.3
Marriott International, Inc. Class A	4.7
Airbnb, Inc. Class A	4.7
Chipotle Mexican Grill, Inc.	3.7
Las Vegas Sands Corp.	3.4
Domino's Pizza, Inc.	3.3
	69.3

Industries (% of Fund's net assets)

Hotels, Restaurants & Leisure	91.5
Food & Staples Retailing	2.5
Diversified Consumer Services	2.1
Beverages	1.8
IT Services	0.7
Specialty Retail	0.3

Leisure Portfolio

Showing Percentage of Net Assets

Common Stocks - 98.9%
	Shares	Value ($)
Beverages - 1.8%
Soft Drinks - 1.8%
The Coca-Cola Co.	168,900	10,051,239
Diversified Consumer Services - 2.1%
Specialized Consumer Services - 2.1%
H&R Block, Inc.	117,200	4,312,960
OneSpaWorld Holdings Ltd. (a)(b)	464,500	5,383,555
Service Corp. International	35,400	2,390,562
		12,087,077
Food & Staples Retailing - 2.5%
Food Distributors - 2.5%
U.S. Foods Holding Corp. (a)	368,300	13,822,299
Hotels, Restaurants & Leisure - 91.5%
Casinos & Gaming - 12.9%
Bally's Corp. (a)(b)	130,900	2,585,275
Boyd Gaming Corp.	200	13,026
Caesars Entertainment, Inc. (a)	216,949	11,012,331
Churchill Downs, Inc.	64,648	15,889,185
Draftkings Holdings, Inc. (a)	32,400	611,064
Flutter Entertainment PLC (a)	48,600	7,795,442
Las Vegas Sands Corp. (a)(b)	337,200	19,378,884
MGM Resorts International	212,500	9,139,625
Penn Entertainment, Inc. (a)	87,708	2,677,725
Red Rock Resorts, Inc. (b)	87,200	3,808,024
		72,910,581
Hotels, Resorts & Cruise Lines - 32.3%
Airbnb, Inc. Class A (a)	215,300	26,542,184
Booking Holdings, Inc. (a)	25,576	64,553,824
Carnival Corp. (a)(b)	100,000	1,062,000
Expedia, Inc. (a)	25,800	2,811,426
Hilton Grand Vacations, Inc. (a)	63,400	3,026,716
Hilton Worldwide Holdings, Inc.	308,532	44,585,959
Marriott International, Inc. Class A	157,525	26,659,531
Royal Caribbean Cruises Ltd. (a)(b)	176,400	12,460,896
		181,702,536
Leisure Facilities - 2.0%
Planet Fitness, Inc. (a)	38,744	3,140,201
Vail Resorts, Inc.	33,682	7,864,410
		11,004,611
Restaurants - 44.3%
ARAMARK Holdings Corp.	61,200	2,252,160
Brinker International, Inc. (a)	218,300	8,295,400
Chipotle Mexican Grill, Inc. (a)	14,009	20,888,540
Darden Restaurants, Inc.	26,900	3,846,431
Domino's Pizza, Inc.	63,642	18,711,384
Dutch Bros, Inc. (a)(b)	135,300	4,512,255
First Watch Restaurant Group, Inc. (a)	235,000	3,590,800
McDonald's Corp.	357,493	94,345,980
Noodles & Co. (a)	628,700	3,671,608
Restaurant Brands International, Inc.	154,674	9,980,979
Ruth's Hospitality Group, Inc.	79,800	1,488,270
Starbucks Corp.	394,456	40,270,013
Wingstop, Inc.	15,300	2,606,355
Yum! Brands, Inc.	278,400	35,401,344
		249,861,519
TOTAL HOTELS, RESTAURANTS & LEISURE		515,479,247
IT Services - 0.7%
Data Processing & Outsourced Services - 0.7%
Toast, Inc. (a)(b)	211,000	3,992,120
Specialty Retail - 0.3%
Automotive Retail - 0.3%
Diversified Royalty Corp. (b)	782,000	1,931,359
TOTAL COMMON STOCKS (Cost $402,647,832)		557,363,341

Money Market Funds - 3.0%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (c)	4,288,587	4,289,445
Fidelity Securities Lending Cash Central Fund 4.63% (c)(d)	12,552,861	12,554,116
TOTAL MONEY MARKET FUNDS (Cost $16,843,561)		16,843,561

TOTAL INVESTMENT IN SECURITIES - 101.9% (Cost $419,491,393)	574,206,902
NET OTHER ASSETS (LIABILITIES) - (1.9)%	(10,826,226)
NET ASSETS - 100.0%	563,380,676

Legend

(a)	Non-income producing

(b)	Security or a portion of the security is on loan at period end.

(c)

(d)	Investment made with cash collateral received from securities on loan.

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	1,262,544	75,531,284	72,504,383	49,634	-	-	4,289,445	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	19,544,251	292,662,916	299,653,051	775,162	-	-	12,554,116	0.0%
Total	20,806,795	368,194,200	372,157,434	824,796	-	-	16,843,561

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	557,363,341	557,363,341	-	-

Money Market Funds	16,843,561	16,843,561	-	-
Total Investments in Securities:	574,206,902	574,206,902	-	-

Leisure Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $12,235,162) - See accompanying schedule:
Unaffiliated issuers (cost $402,647,832)	$	557,363,341
Fidelity Central Funds (cost $16,843,561)		16,843,561


Total Investment in Securities (cost $419,491,393)			$	574,206,902
Cash				3,460
Foreign currency held at value (cost $498)				497
Receivable for investments sold				4,438,124
Receivable for fund shares sold				99,887
Dividends receivable				847,195
Distributions receivable from Fidelity Central Funds				34,220
Prepaid expenses				1,753
Total assets				579,632,038
Liabilities
Payable for investments purchased	$	3,062,964
Payable for fund shares redeemed		257,516
Accrued management fee		251,791
Other affiliated payables		89,986
Other payables and accrued expenses		34,989
Collateral on securities loaned		12,554,116
Total Liabilities				16,251,362
Net Assets			$	563,380,676
Net Assets consist of:
Paid in capital			$	409,344,281
Total accumulated earnings (loss)				154,036,395
Net Assets			$	563,380,676
Net Asset Value , offering price and redemption price per share ($563,380,676 ÷ 35,542,715 shares)			$	15.85

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	5,720,008
Income from Fidelity Central Funds (including $775,162 from security lending)				824,796
Total Income				6,544,804
Expenses
Management fee	$	2,896,810
Transfer agent fees		906,194
Accounting fees		194,142
Custodian fees and expenses		10,583
Independent trustees' fees and expenses		1,889
Registration fees		33,005
Audit		40,049
Legal		1,835
Interest		7,139
Miscellaneous		3,469
Total expenses before reductions		4,095,115
Expense reductions		(19,474)
Total expenses after reductions				4,075,641
Net Investment income (loss)				2,469,163
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		1,162,305
Foreign currency transactions		(15,965)
Total net realized gain (loss)				1,146,340
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		(15,645,084)
Assets and liabilities in foreign currencies		(3,349)
Total change in net unrealized appreciation (depreciation)				(15,648,433)
Net gain (loss)				(14,502,093)
Net increase (decrease) in net assets resulting from operations			$	(12,032,930)

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	2,469,163	$	336,640
Net realized gain (loss)		1,146,340		141,336,647
Change in net unrealized appreciation (depreciation)		(15,648,433)		(91,223,907)
Net increase (decrease) in net assets resulting from operations		(12,032,930)		50,449,380
Distributions to shareholders		(18,288,153)		(140,839,314)
Share transactions
Proceeds from sales of shares		73,923,002		249,737,495
Reinvestment of distributions		17,168,093		130,602,409
Cost of shares redeemed		(144,189,598)		(296,858,478)
Net increase (decrease) in net assets resulting from share transactions		(53,098,503)		83,481,426
Total increase (decrease) in net assets		(83,419,586)		(6,908,508)

Net Assets
Beginning of period		646,800,262		653,708,770
End of period	$	563,380,676	$	646,800,262

Other Information
Shares
Sold		4,908,793		13,101,449
Issued in reinvestment of distributions		1,119,877		7,680,514
Redeemed		(9,983,968)		(15,791,115)
Net increase (decrease)		(3,955,298)		4,990,848

Financial Highlights

Leisure Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019 B
Selected Per-Share Data
Net asset value, beginning of period	$	16.38	$	18.94	$	13.89	$	14.53	$	16.58
Income from Investment Operations
Net investment income (loss) C,D		.07		.01		.07		.12		.16
Net realized and unrealized gain (loss)		(.12)		1.41		5.40		.25		.39
Total from investment operations		(.05)		1.42		5.47		.37		.55
Distributions from net investment income		(.05)		(.02)		(.08)		(.11)		(.16)
Distributions from net realized gain		(.42)		(3.96)		(.34)		(.89)		(2.44)
Total distributions		(.48) E		(3.98)		(.42)		(1.01) E		(2.60)
Redemption fees added to paid in capital C		-		-		-		-		- F
Net asset value, end of period	$	15.85	$	16.38	$	18.94	$	13.89	$	14.53
Total Return G		(.22)%		7.53%		41.30%		1.76%		4.48%
Ratios to Average Net Assets D,H,I
Expenses before reductions		.74%		.73%		.77%		.76%		.76%
Expenses net of fee waivers, if any		.74%		.73%		.77%		.75%		.76%
Expenses net of all reductions		.74%		.73%		.76%		.75%		.76%
Net investment income (loss)		.45%		.05%		.48%		.79%		1.05%
Supplemental Data
Net assets, end of period (000 omitted)	$	563,381	$	646,800	$	653,709	$	431,146	$	472,923
Portfolio turnover rate J		46%		79%		72%		53%		41%

A For the year ended February 29.

B Per share amounts have been adjusted to reflect the impact of the 10 for 1 share split that occurred on August 10, 2018.

C Calculated based on average shares outstanding during the period.

E Total distributions per share do not sum due to rounding.

F Amount represents less than $.005 per share.

G Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

J Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Retailing Portfolio

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Retailing Portfolio	-13.86%	9.24%	14.66%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Retailing Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Retailing Portfolio

Market Recap:

Comments from Portfolio Manager Boris Shepov:

For the fiscal year ending February 28, 2023, the fund returned -13.86%, trailing the -11.69% result of the MSCI US IMI Retailing 25/50 Index, as well as the broad-based S&P 500 ® index. Versus the industry index, subindustry allocation decisions proved to be the primary detractor, especially an underweighting within automotive retail. Security selection in apparel retail and an underweighting in distributors also hurt. Not owning AutoZone, an index component that gained approximately 33%, was the largest individual relative detractor. Also hampering performance was an overweight in Amazon.com, which returned about -39% and was the fund's biggest holding on February 28. Avoiding Genuine Parts, an index component that increased roughly 48%, further pressured the portfolio's relative result. In contrast, the largest contributors to performance versus the industry index were an overweighting and security selection among department stores. Investment choices and outsized exposure to general merchandise stores, along with favorable picks in the footwear category, also bolstered the fund's relative return. The top individual relative contributor within the portfolio was an outsized investment in Nordstrom, which gained 16%. This is a position that was sold the past year. Also lifting performance was a larger-than-index stake in Ollie's Bargain Outlet Holdings, which gained rose 33%. Another notable relative contributor was an overweight in Five Below (+22%), where we reduced our stake this period. Noteworthy changes in positioning the past 12 months include increased exposure to general merchandise stores and a lower allocation to apparel, accessories & luxury goods stocks.

Notes to shareholders:

On June 1, 2023, following an update to the Global Industry Classification Standard (GICS), the fund's benchmark will change from the MSCI U.S. IMI Retailing 25/50 Index to the MSCI U.S. IMI Multi-Sector Retailing 25/50 Index. This new benchmark will better reflect the fund's investment mandate by capturing retailers across multiple industries.

Retailing Portfolio

Top Holdings (% of Fund's net assets)

Amazon.com, Inc.	23.8
The Home Depot, Inc.	11.6
Lowe's Companies, Inc.	7.5
Target Corp.	5.3
TJX Companies, Inc.	4.8
Dollar General Corp.	4.8
O'Reilly Automotive, Inc.	4.3
Dollar Tree, Inc.	4.3
Capri Holdings Ltd.	2.9
eBay, Inc.	2.8
	72.1

Industries (% of Fund's net assets)

Specialty Retail	39.3
Internet & Direct Marketing Retail	30.3
Multiline Retail	18.6
Textiles, Apparel & Luxury Goods	6.2
Food & Staples Retailing	1.5
Interactive Media & Services	0.4

Retailing Portfolio

Showing Percentage of Net Assets

Common Stocks - 96.3%
	Shares	Value ($)
Food & Staples Retailing - 1.5%
Food Retail - 1.0%
Alimentation Couche-Tard, Inc. Class A (multi-vtg.)	562,300	26,378,031
Hypermarkets & Super Centers - 0.5%
Walmart, Inc.	100,600	14,298,278
TOTAL FOOD & STAPLES RETAILING		40,676,309
Interactive Media & Services - 0.4%
Interactive Media & Services - 0.4%
Pinterest, Inc. Class A (a)	507,100	12,733,281
Internet & Direct Marketing Retail - 30.3%
Internet & Direct Marketing Retail - 30.3%
Amazon.com, Inc. (a)	7,006,900	660,260,186
eBay, Inc.	1,662,600	76,313,340
Etsy, Inc. (a)	276,560	33,577,150
MercadoLibre, Inc. (a)	54,400	66,368,000
thredUP, Inc. (a)(b)	677,862	1,077,801
Wayfair LLC Class A (a)	48,100	1,947,569
		839,544,046
Multiline Retail - 18.6%
Department Stores - 1.0%
Kohl's Corp. (b)	966,100	27,089,444
General Merchandise Stores - 17.6%
Dollar General Corp.	618,900	133,868,070
Dollar Tree, Inc. (a)	828,200	120,320,896
Dollarama, Inc.	412,900	23,851,065
Ollie's Bargain Outlet Holdings, Inc. (a)(b)	1,106,864	63,688,955
Target Corp. (b)	872,000	146,932,000
		488,660,986
TOTAL MULTILINE RETAIL		515,750,430
Specialty Retail - 39.3%
Apparel Retail - 9.4%
American Eagle Outfitters, Inc. (b)	1,604,000	23,049,480
Burlington Stores, Inc. (a)	176,394	37,792,415
TJX Companies, Inc.	1,748,232	133,914,571
Victoria's Secret & Co. (a)	1,685,533	66,814,528
		261,570,994
Automotive Retail - 4.4%
CarMax, Inc. (a)(b)	30,200	2,085,008
O'Reilly Automotive, Inc. (a)	146,000	121,194,600
		123,279,608
Home Improvement Retail - 19.6%
Floor & Decor Holdings, Inc. Class A (a)(b)	150,737	13,839,164
Lowe's Companies, Inc.	1,019,900	209,844,425
The Home Depot, Inc.	1,083,700	321,360,398
		545,043,987
Homefurnishing Retail - 0.9%
RH (a)(b)	79,800	23,862,594
Specialty Stores - 5.0%
Bath & Body Works, Inc.	1,027,200	41,981,664
Dick's Sporting Goods, Inc. (b)	135,000	17,365,050
Five Below, Inc. (a)	133,800	27,335,340
Ulta Beauty, Inc. (a)	97,700	50,686,760
		137,368,814
TOTAL SPECIALTY RETAIL		1,091,125,997
Textiles, Apparel & Luxury Goods - 6.2%
Apparel, Accessories & Luxury Goods - 5.0%
Canada Goose Holdings, Inc. (a)(b)	274,800	5,165,716
Capri Holdings Ltd. (a)	1,640,300	81,309,671
lululemon athletica, Inc. (a)	80,557	24,908,224
Tapestry, Inc. (b)	622,300	27,076,273
		138,459,884
Footwear - 1.2%
Deckers Outdoor Corp. (a)	79,300	33,016,555
TOTAL TEXTILES, APPAREL & LUXURY GOODS		171,476,439
TOTAL COMMON STOCKS (Cost $1,532,466,845)		2,671,306,502

Money Market Funds - 7.2%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (c)	87,145,065	87,162,494
Fidelity Securities Lending Cash Central Fund 4.63% (c)(d)	112,251,534	112,262,759
TOTAL MONEY MARKET FUNDS (Cost $199,425,253)		199,425,253

TOTAL INVESTMENT IN SECURITIES - 103.5% (Cost $1,731,892,098)	2,870,731,755
NET OTHER ASSETS (LIABILITIES) - (3.5)%	(96,641,369)
NET ASSETS - 100.0%	2,774,090,386

Legend

(a)	Non-income producing

(b)	Security or a portion of the security is on loan at period end.

(c)

(d)	Investment made with cash collateral received from securities on loan.

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	-	563,016,645	475,854,151	551,894	-	-	87,162,494	0.2%
Fidelity Securities Lending Cash Central Fund 4.63%	262,083,095	1,748,991,828	1,898,812,164	185,199	-	-	112,262,759	0.4%
Total	262,083,095	2,312,008,473	2,374,666,315	737,093	-	-	199,425,253

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	2,671,306,502	2,671,306,502	-	-

Money Market Funds	199,425,253	199,425,253	-	-
Total Investments in Securities:	2,870,731,755	2,870,731,755	-	-

Retailing Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $108,125,906) - See accompanying schedule:
Unaffiliated issuers (cost $1,532,466,845)	$	2,671,306,502
Fidelity Central Funds (cost $199,425,253)		199,425,253


Total Investment in Securities (cost $1,731,892,098)			$	2,870,731,755
Receivable for investments sold				17,476,425
Receivable for fund shares sold				316,258
Dividends receivable				1,873,752
Distributions receivable from Fidelity Central Funds				114,068
Prepaid expenses				7,983
Total assets				2,890,520,241
Liabilities
Payable for investments purchased	$	334,907
Payable for fund shares redeemed		2,067,609
Accrued management fee		1,273,782
Other affiliated payables		459,664
Other payables and accrued expenses		35,468
Collateral on securities loaned		112,258,425
Total Liabilities				116,429,855
Net Assets			$	2,774,090,386
Net Assets consist of:
Paid in capital			$	1,634,485,112
Total accumulated earnings (loss)				1,139,605,274
Net Assets			$	2,774,090,386
Net Asset Value , offering price and redemption price per share ($2,774,090,386 ÷ 165,601,459 shares)			$	16.75

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	29,926,342
Income from Fidelity Central Funds (including $185,199 from security lending)				737,093
Total Income				30,663,435
Expenses
Management fee	$	15,701,471
Transfer agent fees		4,957,643
Accounting fees		797,545
Custodian fees and expenses		17,004
Independent trustees' fees and expenses		10,324
Registration fees		31,718
Audit		40,053
Legal		2,876
Interest		3,488
Miscellaneous		18,359
Total expenses before reductions		21,580,481
Expense reductions		(106,174)
Total expenses after reductions				21,474,307
Net Investment income (loss)				9,189,128
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		3,484,457
Foreign currency transactions		9,603
Total net realized gain (loss)				3,494,060
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		(524,806,259)
Unfunded commitments		1,090,000
Assets and liabilities in foreign currencies		(1,526)
Total change in net unrealized appreciation (depreciation)				(523,717,785)
Net gain (loss)				(520,223,725)
Net increase (decrease) in net assets resulting from operations			$	(511,034,597)

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	9,189,128	$	(3,062,137)
Net realized gain (loss)		3,494,060		530,772,015
Change in net unrealized appreciation (depreciation)		(523,717,785)		(548,230,610)
Net increase (decrease) in net assets resulting from operations		(511,034,597)		(20,520,732)
Distributions to shareholders		(83,419,587)		(645,718,415)
Share transactions
Proceeds from sales of shares		155,857,098		589,399,734
Reinvestment of distributions		78,542,305		608,923,199
Cost of shares redeemed		(570,045,662)		(883,831,786)
Net increase (decrease) in net assets resulting from share transactions		(335,646,259)		314,491,147
Total increase (decrease) in net assets		(930,100,443)		(351,748,000)

Net Assets
Beginning of period		3,704,190,829		4,055,938,829
End of period	$	2,774,090,386	$	3,704,190,829

Other Information
Shares
Sold		9,021,587		24,397,911
Issued in reinvestment of distributions		4,134,935		26,457,673
Redeemed		(33,503,885)		(37,526,804)
Net increase (decrease)		(20,347,363)		13,328,780

Financial Highlights

Retailing Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019 B
Selected Per-Share Data
Net asset value, beginning of period	$	19.92	$	23.50	$	15.71	$	15.01	$	14.35
Income from Investment Operations
Net investment income (loss) C,D		.05		(.02)		(.01)		.04		.03
Net realized and unrealized gain (loss)		(2.76)		.11		9.35		1.02		.93
Total from investment operations		(2.71)		.09		9.34		1.06		.96
Distributions from net investment income		(.06)		-		-		(.05)		(.02)
Distributions from net realized gain		(.41)		(3.67)		(1.55)		(.31)		(.27)
Total distributions		(.46) E		(3.67)		(1.55)		(.36)		(.30) E
Net asset value, end of period	$	16.75	$	19.92	$	23.50	$	15.71	$	15.01
Total Return F		(13.86)%		(1.23)%		59.90%		7.02%		6.83%
Ratios to Average Net Assets D,G,H
Expenses before reductions		.72%		.70%		.73%		.74%		.76%
Expenses net of fee waivers, if any		.72%		.70%		.73%		.74%		.75%
Expenses net of all reductions		.72%		.70%		.73%		.74%		.75%
Net investment income (loss)		.31%		(.07)%		(.07)%		.26%		.20%
Supplemental Data
Net assets, end of period (000 omitted)	$	2,774,090	$	3,704,191	$	4,055,939	$	2,698,998	$	3,035,591
Portfolio turnover rate I		32%		33%		46%		17%		34%

A For the year ended February 29.

B Per share amounts have been adjusted to reflect the impact of the 10 for 1 share split that occurred on May 11, 2018.

C Calculated based on average shares outstanding during the period.

E Total distributions per share do not sum due to rounding.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

I Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Report of Independent Registered Public Accounting Firm

For the period ended February 28, 2023

1. Organization.

Automotive Portfolio, Communication Services Portfolio, Construction and Housing Portfolio, Consumer Discretionary Portfolio, Leisure Portfolio, and Retailing Portfolio (the Funds) are non-diversified funds of Fidelity Select Portfolios (the Trust). The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust. Each Fund is authorized to issue an unlimited number of shares. Each Fund offers a single class of shares, with the exception of Communication Services Portfolio. Communication Services Portfolio offers Fidelity Advisor Communication Services Fund Class A (Class A), Fidelity Advisor Communication Services Fund Class M (Class M), Fidelity Advisor Communication Services Fund Class C (Class C), Communication Services Portfolio (Communication Services), Fidelity Advisor Communication Services Fund Class I (Class I) and Fidelity Advisor Communication Services Class Z (Class Z) shares. Each class of Communication Services Portfolio has equal rights as to assets and voting privileges, and each class has exclusive voting rights with respect to matters that affect that class. Class C shares will automatically convert to Class A shares after a holding period of eight years from the initial date of purchase, with certain exceptions. The Funds invest primarily in securities of companies whose principal business activities fall within specific industries. Share transactions on the Statement of Changes in Net Assets and Share Transactions note may contain exchanges between affiliated funds.

2. Investments in Fidelity Central Funds.

Fidelity Central Fund	Investment Manager	Investment Objective	Investment Practices	Expense Ratio A
Fidelity Money Market Central Funds	Fidelity Management & Research Company LLC (FMR)	Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity.	Short-term Investments	Less than .005%

A Expenses expressed as a percentage of average net assets and are as of each underlying Central Fund's most recent annual or semi-annual shareholder report.

3. Significant Accounting Policies.

Each Fund is an investment company and applies the accounting and reporting guidance of the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946 Financial Services - Investment Companies . The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP), which require management to make certain estimates and assumptions at the date of the financial statements. Actual results could differ from those estimates. Subsequent events, if any, through the date that the financial statements were issued have been evaluated in the preparation of the financial statements. Each Fund's Schedule of Investments lists any underlying mutual funds or exchange-traded funds (ETFs) but does not include the underlying holdings of these funds. The following summarizes the significant accounting policies of each Fund:

Investment Valuation. Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. The Board of Trustees (the Board) has designated each Fund's investment adviser as the valuation designee responsible for the fair valuation function and performing fair value determinations as needed. The investment adviser has established a Fair Value Committee (the Committee) to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern the fair valuation process and the activities of the Committee. In accordance with these fair valuation policies and procedures, which have been approved by the Board, each Fund attempts to obtain prices from one or more third party pricing services or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with the policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. The frequency that the fair valuation procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee manages each Fund's fair valuation practices and maintains the fair valuation policies and procedures. Each Fund's investment adviser reports to the Board information regarding the fair valuation process and related material matters.

Each Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:

Level 1 - unadjusted quoted prices in active markets for identical investments

Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)

Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value each Fund's investments by major category are as follows:

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.

Investment Transactions and Income. For financial reporting purposes, the Funds' investment holdings and NAV include trades executed through the end of the last business day of the period. The NAV per share for processing shareholder transactions is calculated as of the close of business of the New York Stock Exchange (NYSE), normally 4:00 p.m. Eastern time and includes trades executed through the end of the prior business day. Gains and losses on securities sold are determined on the basis of identified cost and for certain Funds include proceeds received from litigation. Commissions paid to certain brokers with whom the investment adviser, or its affiliates, places trades on behalf of a fund include an amount in addition to trade execution, which may be rebated back to a fund. Any such rebates are included in net realized gain (loss) on investments in the Statement of Operations. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities where the ex-dividend date may have passed, which are recorded as soon as the Funds are informed of the ex-dividend date. Non-cash dividends included in dividend income, if any, are recorded at the fair market value of the securities received. Income and capital gain distributions from Fidelity Central Funds, if any, are recorded on the ex-dividend date. Certain distributions received by the Funds represent a return of capital or capital gain. The Funds determine the components of these distributions subsequent to the ex-dividend date, based upon receipt of tax filings or other correspondence relating to the underlying investment. These distributions are recorded as a reduction of cost of investments and/or as a realized gain. Large, non-recurring dividends recognized by the Funds are presented separately on the Statement of Operations as "Special Dividends" and the impact of these dividends is presented in the Financial Highlights. Investment income is recorded net of foreign taxes withheld where recovery of such taxes is uncertain. Funds may file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. Any withholding tax reclaims income is included in the Statement of Operations in dividends. Any receivables for withholding tax reclaims are included in the Statement of Assets and Liabilities in dividends receivable.

Class Allocations and Expenses. Expenses directly attributable to a fund are charged to that fund. Expenses attributable to more than one fund are allocated among the respective funds on the basis of relative net assets or other appropriate methods. Expenses included in the accompanying financial statements reflect the expenses of that fund and do not include any expenses associated with any underlying mutual funds or exchange-traded funds. Although not included in a fund's expenses, a fund indirectly bears its proportionate share of these expenses through the net asset value of each underlying mutual fund or exchange-traded fund. Expense estimates are accrued in the period to which they relate and adjustments are made when actual amounts are known.

For Communication Services Portfolio, investment income, realized and unrealized capital gains and losses, common expenses, and certain fund-level expense reductions, if any, are allocated daily on a pro-rata basis to each class based on the relative net assets of each class to the total net assets. Each class differs with respect to transfer agent and distribution and service plan fees incurred. Certain expense reductions may also differ by class. For the reporting period, the allocated portion of income and expenses to each class as a percent of its average net assets may vary due to the timing of recording these transactions in relation to fluctuating net assets of the classes.

Income Tax Information and Distributions to Shareholders. Each year, each Fund intends to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code, including distributing substantially all of its taxable income and realized gains. As a result, no provision for U.S. Federal income taxes is required. As of February 28, 2023, each Fund did not have any unrecognized tax benefits in the financial statements; nor is each Fund aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. Each Fund files a U.S. federal tax return, in addition to state and local tax returns as required. Each Fund's federal income tax returns are subject to examination by the Internal Revenue Service (IRS) for a period of three fiscal years after they are filed. State and local tax returns may be subject to examination for an additional fiscal year depending on the jurisdiction. Foreign taxes are provided for based on each Fund's understanding of the tax rules and rates that exist in the foreign markets in which it invests.

Distributions are declared and recorded on the ex-dividend date. Income and capital gain distributions are declared separately for each class. Income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP. In addition, certain Funds claimed a portion of the payment made to redeeming shareholders as a distribution for income tax purposes.

Book-tax differences are primarily due to foreign currency transactions, passive foreign investment companies (PFIC), net operating losses, capital loss carryforwards and losses deferred due to wash sales and excise tax regulations.

As of period end, the cost and unrealized appreciation (depreciation) in securities, and derivatives if applicable, for federal income tax purposes were as follows for each Fund:

	Tax cost	Gross unrealized appreciation	Gross unrealized depreciation	Net unrealized appreciation (depreciation)
Automotive Portfolio	$98,166,405	$34,016,849	$ (6,628,292)	$27,388,557
Communication Services Portfolio	745,607,110	170,561,391	(125,421,792)	45,139,599
Construction and Housing Portfolio	359,157,041	192,962,924	(27,209,312)	165,753,612
Consumer Discretionary Portfolio	317,301,952	137,226,512	(14,226,312)	123,000,200
Leisure Portfolio	423,253,375	170,793,304	(19,839,777)	150,953,527
Retailing Portfolio	1,739,310,620	1,261,124,421	(129,703,286)	1,131,421,135

The tax-based components of distributable earnings as of period end were as follows for each Fund:

	Undistributed ordinary income	Undistributed long-term capital gain	Capital loss carryforward	Net unrealized appreciation (depreciation) on securities and other investments
Automotive Portfolio	$30,141	$-	$(13,865,998)	$27,385,652
Communication Services Portfolio	-	-	(17,461,483)	45,139,430
Construction and Housing Portfolio	-	-	(14,661,781)	165,753,612
Consumer Discretionary Portfolio	-	5,720,978	-	122,995,881
Leisure Portfolio	699,955	2,386,264	-	150,950,176
Retailing Portfolio	-	8,369,938	-	1,131,419,620

Capital loss carryforwards are only available to offset future capital gains of the Funds to the extent provided by regulations and may be limited. The capital loss carryforward information presented below, including any applicable limitation, is estimated as of fiscal period end and is subject to adjustment.

	Short-term	Long-term	Total capital loss carryforward
Automotive Portfolio	$ (9,853,453)	$ (4,012,545)	$(13,865,998)
Communication Services Portfolio	(17,461,483)	-	(17,461,483)
Construction and Housing Portfolio	(14,661,781)	-	(14,661,781)

Certain of the Funds intend to elect to defer to the next fiscal year ordinary losses recognized during the period January 1, 2023 to February 28, 2023. Loss deferrals were as follows:

	Ordinary losses
Communication Services Portfolio	$(631,297)
Consumer Discretionary Portfolio	(91,321)
Retailing Portfolio	(184,284)

The tax character of distributions paid was as follows:

February 28, 2023
	Ordinary Income	Long-term Capital Gains	Total
Automotive Portfolio	$634,736	$2,066,777	$2,701,513
Construction and Housing Portfolio	3,697,710	-	3,697,710
Consumer Discretionary Portfolio	190,305	36,774,708	36,965,013
Leisure Portfolio	1,954,866	16,333,287	18,288,153
Retailing Portfolio	9,439,958	73,979,629	83,419,587

February 28, 2022
	Ordinary Income	Long-term Capital Gains	Total
Automotive Portfolio	$1,558,029	$4,579,099	$6,137,128
Communication Services Portfolio	29,776,343	34,129,421	63,905,764
Construction and Housing Portfolio	14,753,592	25,146,850	39,900,442
Consumer Discretionary Portfolio	1,098,748	56,820,968	57,919,716
Leisure Portfolio	26,867,028	113,972,286	140,839,314
Retailing Portfolio	157,489,329	488,229,086	645,718,415

Special Purpose Acquisition Companies. Funds may invest in stock, warrants, and other securities of special purpose acquisition companies (SPACs) or similar special purpose entities. A SPAC is a publicly traded company that raises investment capital via an initial public offering (IPO) for the purpose of acquiring the equity securities of one or more existing companies via merger, business combination, acquisition or other similar transactions within a designated time frame.

Private Investment in Public Equity. Funds may acquire equity securities of an issuer through a private investment in a public equity (PIPE) transaction, including through commitments to purchase securities on a when-issued basis. A PIPE typically involves the purchase of securities directly from a publicly traded company in a private placement transaction. Securities purchased through PIPE transactions will be restricted from trading and considered illiquid until a resale registration statement for the shares is filed and declared effective.

At the current and/or prior period end, Retailing Portfolio had commitments to purchase when-issued securities through PIPE transactions with SPACs. The commitments are contingent upon the SPACs acquiring the securities of target companies. Unrealized appreciation (depreciation) on any commitments outstanding at period end is separately presented in the Statements of Assets and Liabilities as Unrealized appreciation (depreciation) on unfunded commitments, and any change in unrealized appreciation (depreciation) on unfunded commitments during the period is separately presented in the Statement of Operations, as applicable.

4. Purchases and Sales of Investments.

Purchases and sales of securities, other than short-term securities and in-kind transactions, as applicable, are noted in the table below.

	Purchases ($)	Sales ($)
Automotive Portfolio	63,784,327	93,165,795
Communication Services Portfolio	355,925,584	440,179,830
Construction and Housing Portfolio	102,428,686	296,780,970
Consumer Discretionary Portfolio	248,907,854	185,143,873
Leisure Portfolio	253,896,509	327,657,234
Retailing Portfolio	944,520,411	1,440,265,904

5. Fees and Other Transactions with Affiliates.

Management Fee. Fidelity Management & Research Company LLC (the investment adviser) and its affiliates provide the Funds with investment management related services for which the Funds pay a monthly management fee. The management fee is the sum of an individual fund fee rate and an annualized group fee rate. The individual fund fee rate is applied to each Fund's average net assets. The group fee rate is based upon the monthly average net assets of a group of registered investment companies with which the investment adviser has management contracts. The group fee rate decreases as assets under management increase and increases as assets under management decrease. For the reporting period, each Fund's annual management fee rate expressed as a percentage of each Fund's average net assets was as follows:

	Individual Rate	Group Rate	Total
Automotive Portfolio	.30%	.23%	.52%
Communication Services Portfolio	.30%	.23%	.53%
Construction and Housing Portfolio	.30%	.23%	.53%
Consumer Discretionary Portfolio	.30%	.23%	.53%
Leisure Portfolio	.30%	.23%	.53%
Retailing Portfolio	.30%	.23%	.53%

Distribution and Service Plan Fees. In accordance with Rule 12b-1 of the 1940 Act, Communication Services Portfolio has adopted separate Distribution and Service Plans for each class of shares. Certain classes pay Fidelity Distributors Company LLC (FDC), an affiliate of the investment adviser, separate Distribution and Service Fees, each of which is based on an annual percentage of each class' average net assets. In addition, FDC may pay financial intermediaries for selling shares of each Fund and providing shareholder support services. For the period, the Distribution and Service Fee rates, total fees and amounts retained by FDC were as follows:

	Distribution Fee	Service Fee	Total Fees	Retained by FDC
Communication Services Portfolio
Class A	-%	.25%	$63,176	$1,611
Class M	.25%	.25%	21,462	-
Class C	.75%	.25%	75,119	19,487
			$159,757	$21,098

Sales Load. For Communication Services Portfolio, FDC may receive a front-end sales charge of up to 5.75% for selling Class A shares and 3.50% for selling Class M shares, some of which is paid to financial intermediaries for selling shares of the Fund. Depending on the holding period, FDC may receive contingent deferred sales charges levied on Class A, Class M and Class C redemptions. The deferred sales charges are 1.00% for Class C shares, 1.00% for certain purchases of Class A shares and .25% for certain purchases of Class M shares.

For the period, sales charge amounts retained by FDC were as follows:

	Retained by FDC
Communication Services Portfolio
Class A	$10,526
Class M	739
Class C A	398
	$11,663

A When Class C shares are initially sold, FDC pays commissions from its own resources to financial intermediaries through which the sales are made.

Transfer Agent Fees. Fidelity Investments Institutional Operations Company LLC (FIIOC), an affiliate of the investment adviser, is the transfer, dividend disbursing and shareholder servicing agent for each class (Communication Services Portfolio) or Fund (all other Funds). FIIOC receives account fees and asset-based fees that vary according to the account size and type of account of the shareholders of the respective class or Fund, except for Class Z. FIIOC receives an asset-based fee of Class Z's average net assets. FIIOC pays for typesetting, printing and mailing of shareholder reports, except proxy statements. For the period, transfer agent fees were as follows:

	Amount	% of Average Net Assets
Automotive Portfolio	$289,869	.25
Communication Services Portfolio
Class A	61,436	.24
Class M	10,175	.24
Class C	15,346	.20
Communication Services	1,575,629	.22
Class I	28,925	.18
Class Z	1,684	.04
	1,693,195
Construction and Housing Portfolio	955,911	.19
Consumer Discretionary Portfolio	681,929	.17
Leisure Portfolio	906,194	.16
Retailing Portfolio	4,957,643	.17

Accounting Fees. Fidelity Service Company, Inc. (FSC), an affiliate of the investment adviser, maintains each Fund's accounting records. The accounting fee is based on the level of average net assets for each month. For the period, the fees were equivalent to the following annual rates:

	% of Average Net Assets
Automotive Portfolio	.04
Communication Services Portfolio	.03
Construction and Housing Portfolio	.04
Consumer Discretionary Portfolio	.04
Leisure Portfolio	.04
Retailing Portfolio	.03

	Amount
Automotive Portfolio	$2,114
Communication Services Portfolio	9,791
Construction and Housing Portfolio	2,144
Consumer Discretionary Portfolio	3,231
Leisure Portfolio	5,770
Retailing Portfolio	12,106

Interfund Lending Program. Pursuant to an Exemptive Order issued by the Securities and Exchange Commission (the SEC), each Fund, along with other registered investment companies having management contracts with Fidelity Management & Research Company LLC (FMR), or other affiliated entities of FMR, may participate in an interfund lending program. This program provides an alternative credit facility allowing each Fund to borrow from, or lend money to, other participating affiliated funds. At period end, there were no interfund loans outstanding. Activity in this program during the period for which loans were outstanding was as follows:

	Borrower or Lender	Average Loan Balance	Weighted Average Interest Rate	Interest Expense
Communication Services Portfolio	Borrower	$13,940,000	2.57%	$993
Construction and Housing Portfolio	Borrower	$8,880,000	1.93%	$952
Consumer Discretionary Portfolio	Borrower	$3,766,000	.75%	$866
Leisure Portfolio	Borrower	$9,977,000	4.29%	$7,139
Retailing Portfolio	Borrower	$6,545,864	.87%	$3,488

	Purchases ($)	Sales ($)	Realized Gain (Loss) ($)
Automotive Portfolio	2,067,487	1,521,202	(382,780)
Communication Services Portfolio	5,862,139	19,203,525	176,263
Construction and Housing Portfolio	8,565,222	13,309,552	1,282,292
Consumer Discretionary Portfolio	21,503,056	10,570,951	(4,953,312)
Leisure Portfolio	10,544,150	12,232,907	(3,452,866)
Retailing Portfolio	87,932,284	71,324,019	(2,442,672)

6. Committed Line of Credit.

	Amount
Automotive Portfolio	$234
Communication Services Portfolio	1,510
Construction and Housing Portfolio	1,014
Consumer Discretionary Portfolio	741
Leisure Portfolio	1,009
Retailing Portfolio	5,620

7. Security Lending.

	Total Security Lending Fees Paid to NFS	Security Lending Income From Securities Loaned to NFS	Value of Securities Loaned to NFS at Period End
Automotive Portfolio	$30,647	$3,806	$314,985
Communication Services Portfolio	$3,175	$148	$-
Construction and Housing Portfolio	$1,616	$-	$-
Consumer Discretionary Portfolio	$24,073	$23,071	$-
Leisure Portfolio	$80,257	$129,817	$-
Retailing Portfolio	$18,762	$24	$-

8. Bank Borrowings.

Each Fund is permitted to have bank borrowings for temporary or emergency purposes to fund shareholder redemptions or for other short-term liquidity requirements. Each Fund has established borrowing arrangements with certain banks. The interest rate on the borrowings is the bank's base rate, as revised from time to time. Any open loans, including accrued interest, at period end are presented under the caption "Notes payable" in the Statement of Assets and Liabilities, if applicable. Activity in this program during the period for which loans were outstanding was as follows:

	Average Loan Balance	Weighted Average Interest Rate	Interest Expense
Consumer Discretionary Portfolio	$288,000	.83%	$100

9. Expense Reductions.

During the period the investment adviser or an affiliate reimbursed and/or waived a portion of operating expenses as follows:

	Amount
Automotive Portfolio	$4,274
Construction and Housing Portfolio	18,633
Consumer Discretionary Portfolio	14,515
Leisure Portfolio	19,474
Retailing Portfolio	106,174

In addition, during the period the investment adviser or an affiliate reimbursed and/or waived a portion of fund-level operating expenses as follows:

	Fund-Level Amount
Communication Services Portfolio	27,974

10. Distributions to Shareholders.

Distributions to shareholders of each class were as follows:

	Year ended February 28, 2023	Year ended February 28, 2022
Communication Services Portfolio
Distributions to shareholders
Class A	$-	$1,776,273
Class M	-	363,201
Class C	-	474,822
Communication Services	-	59,014,431
Class I	-	1,922,707
Class Z	-	354,330
Total	$-	$63,905,764

11. Share Transactions.

Share transactions for each class were as follows and may contain in-kind transactions, automatic conversions between classes or exchanges between affiliated funds:

	Shares	Shares	Dollars	Dollars
	Year ended February 28, 2023	Year ended February 28, 2022	Year ended February 28, 2023	Year ended February 28, 2022
Communication Services Portfolio
Class A
Shares sold	106,946	288,312	$6,909,623	$27,200,334
Reinvestment of distributions	-	19,346	-	1,740,757
Shares redeemed	(146,490)	(140,910)	(9,350,947)	(12,635,364)
Net increase (decrease)	(39,544)	166,748	$(2,441,324)	$16,305,727
Class M
Shares sold	11,811	38,436	$749,050	$3,599,648
Reinvestment of distributions	-	3,956	-	355,421
Shares redeemed	(29,773)	(29,716)	(1,798,790)	(2,591,005)
Net increase (decrease)	(17,962)	12,676	$(1,049,740)	$1,364,064
Class C
Shares sold	44,574	59,277	$2,778,261	$5,482,069
Reinvestment of distributions	-	5,320	-	471,861
Shares redeemed	(37,470)	(27,914)	(2,303,544)	(2,486,600)
Net increase (decrease)	7,104	36,683	$474,717	$3,467,330
Communication Services
Shares sold	2,037,740	6,404,833	$131,199,352	$608,572,415
Reinvestment of distributions	-	621,227	-	56,410,302
Shares redeemed	(2,871,553)	(4,677,647)	(185,590,458)	(433,498,431)
Net increase (decrease)	(833,813)	2,348,413	$(54,391,106)	$231,484,286
Class I
Shares sold	74,777	316,400	$4,946,728	$30,080,975
Reinvestment of distributions	-	19,631	-	1,780,227
Shares redeemed	(291,105)	(231,351)	(19,399,461)	(20,888,532)
Net increase (decrease)	(216,328)	104,680	$(14,452,733)	$10,972,670
Class Z
Shares sold	19,696	98,916	$1,307,319	$9,255,551
Reinvestment of distributions	-	3,767	-	340,659
Shares redeemed	(49,019)	(64,255)	(3,238,948)	(5,703,077)
Net increase (decrease)	(29,323)	38,428	$(1,931,629)	$3,893,133

12. Other.

13. Risk and Uncertainties.

To the Board of Trustees of Fidelity Select Portfolios and the Shareholders of Automotive Portfolio, Communication Services Portfolio, Construction and Housing Portfolio, Consumer Discretionary Portfolio, Leisure Portfolio and Retailing Portfolio

Opinions on the Financial Statements

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of Automotive Portfolio, Communication Services Portfolio, Construction and Housing Portfolio, Consumer Discretionary Portfolio, Leisure Portfolio and Retailing Portfolio (six of the funds constituting Fidelity Select Portfolios, hereafter collectively referred to as the "Funds") as of February 28, 2023, the related statements of operations for the year ended February 28, 2023, the statements of changes in net assets for each of the two years in the period ended February 28, 2023, including the related notes, and the financial highlights for each of the periods indicated therein (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Funds as of February 28, 2023, the results of each of their operations for the year then ended, the changes in each of their net assets for each of the two years in the period ended February 28, 2023 and each of the financial highlights for each of the periods indicated therein in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinions

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of February 28, 2023 by correspondence with the custodian, issuers of privately offered securities and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinions.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

April 13, 2023

We have served as the auditor of one or more investment companies in the Fidelity group of funds since 1932.

TRUSTEES AND OFFICERS

Interested Trustees*:

Correspondence intended for a Trustee who is an interested person may be sent to Fidelity Investments, 245 Summer Street, Boston, Massachusetts 02210.

Name, Year of Birth; Principal Occupations and Other Relevant Experience+

Bettina Doulton (1964)

Year of Election or Appointment: 2020

Trustee

Robert A. Lawrence (1952)

Year of Election or Appointment: 2020

Trustee

Chair of the Board of Trustees

* Determined to be an "Interested Trustee" by virtue of, among other things, his or her affiliation with the trust or various entities under common control with FMR.

Independent Trustees:

Correspondence intended for an Independent Trustee may be sent to Fidelity Investments, P.O. Box 55235, Boston, Massachusetts 02205-5235.

Name, Year of Birth; Principal Occupations and Other Relevant Experience+

Thomas P. Bostick (1956)

Year of Election or Appointment: 2021

Trustee

Dennis J. Dirks (1948)

Year of Election or Appointment: 2018

Trustee

Donald F. Donahue (1950)

Year of Election or Appointment: 2018

Trustee

Vicki L. Fuller (1957)

Year of Election or Appointment: 2020

Trustee

Patricia L. Kampling (1959)

Year of Election or Appointment: 2020

Trustee

Thomas A. Kennedy (1955)

Year of Election or Appointment: 2021

Trustee

Oscar Munoz (1959)

Year of Election or Appointment: 2021

Trustee

David M. Thomas (1949)

Year of Election or Appointment: 2018

Trustee

Lead Independent Trustee

Susan Tomasky (1953)

Year of Election or Appointment: 2020

Trustee

Michael E. Wiley (1950)

Year of Election or Appointment: 2008

Trustee

Advisory Board Members and Officers:

Name, Year of Birth; Principal Occupation

Peter S. Lynch (1944)

Year of Election or Appointment: 2018

Member of the Advisory Board

Heather Bonner (1977)

Year of Election or Appointment: 2023

Assistant Treasurer

Craig S. Brown (1977)

Year of Election or Appointment: 2022

Deputy Treasurer

John J. Burke III (1964)

Year of Election or Appointment: 2018

Chief Financial Officer

Margaret Carey (1973)

Year of Election or Appointment: 2023

Secretary and Chief Legal Officer (CLO)

William C. Coffey (1969)

Year of Election or Appointment: 2019

Assistant Secretary

Timothy M. Cohen (1969)

Year of Election or Appointment: 2018

Vice President

Jonathan Davis (1968)

Year of Election or Appointment: 2010

Assistant Treasurer

Laura M. Del Prato (1964)

Year of Election or Appointment: 2018

Assistant Treasurer

Colm A. Hogan (1973)

Year of Election or Appointment: 2020

Assistant Treasurer

Pamela R. Holding (1964)

Year of Election or Appointment: 2018

Vice President

Chris Maher (1972)

Year of Election or Appointment: 2020

Deputy Treasurer

Jason P. Pogorelec (1975)

Year of Election or Appointment: 2020

Chief Compliance Officer

Brett Segaloff (1972)

Year of Election or Appointment: 2021

Anti-Money Laundering (AML) Officer

Stacie M. Smith (1974)

Year of Election or Appointment: 2018

President and Treasurer

Jim Wegmann (1979)

Year of Election or Appointment: 2019

Assistant Treasurer

The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (September 1, 2022 to February 28, 2023).

Actual Expenses

Hypothetical Example for Comparison Purposes

	Annualized Expense Ratio- A	Beginning Account Value September 1, 2022	Ending Account Value February 28, 2023	Expenses Paid During Period- C September 1, 2022 to February 28, 2023

Automotive Portfolio	.89%
Actual		$ 1,000	$ 984.10	$ 4.38
Hypothetical- B		$ 1,000	$ 1,020.38	$ 4.46
Communication Services Portfolio
Class A	1.08%
Actual		$ 1,000	$ 987.80	$ 5.32
Hypothetical- B		$ 1,000	$ 1,019.44	$ 5.41
Class M	1.33%
Actual		$ 1,000	$ 986.60	$ 6.55
Hypothetical- B		$ 1,000	$ 1,018.20	$ 6.66
Class C	1.78%
Actual		$ 1,000	$ 984.40	$ 8.76
Hypothetical- B		$ 1,000	$ 1,015.97	$ 8.90
Communication Services Portfolio	.81%
Actual		$ 1,000	$ 989.10	$ 3.99
Hypothetical- B		$ 1,000	$ 1,020.78	$ 4.06
Class I	.76%
Actual		$ 1,000	$ 989.60	$ 3.75
Hypothetical- B		$ 1,000	$ 1,021.03	$ 3.81
Class Z	.62%
Actual		$ 1,000	$ 990.10	$ 3.06
Hypothetical- B		$ 1,000	$ 1,021.72	$ 3.11

Construction and Housing Portfolio	.77%
Actual		$ 1,000	$ 1,108.30	$ 4.03
Hypothetical- B		$ 1,000	$ 1,020.98	$ 3.86

Consumer Discretionary Portfolio	.75%
Actual		$ 1,000	$ 988.40	$ 3.70
Hypothetical- B		$ 1,000	$ 1,021.08	$ 3.76

Leisure Portfolio	.74%
Actual		$ 1,000	$ 1,126.90	$ 3.90
Hypothetical- B		$ 1,000	$ 1,021.12	$ 3.71

Retailing Portfolio	.72%
Actual		$ 1,000	$ 1,023.00	$ 3.61
Hypothetical- B		$ 1,000	$ 1,021.22	$ 3.61

A Annualized expense ratio reflects expenses net of applicable fee waivers.

B 5% return per year before expenses

Distributions (Unaudited)

The dividend and capital gains distributions for the fund(s) are available on Fidelity.com or Institutional.Fidelity.com.

Leisure Portfolio	$2,661,213
Retailing Portfolio	$8,641,370
Consumer Discretionary Portfolio	$6,203,283

A percentage of the dividends distributed during the fiscal year for the following funds qualify for the dividends-received deduction for corporate shareholders:

Leisure Portfolio
April 2022 December 2022	100% 100%
Retailing Portfolio
December 2022	100%
Automotive Portfolio
December 2022	77%
Construction and Housing Portfolio
December 2022	100%
Consumer Discretionary Portfolio
December 2022	100%

Leisure Portfolio
April 2022	100%
December 2022	100%
Retailing Portfolio
December 2022	100%
Automotive Portfolio
December 2022	100%
Construction and Housing Portfolio
December 2022	100%
Consumer Discretionary Portfolio
December 2022	100%

The funds will notify shareholders in January 2024 of amounts for use in preparing 2023 income tax returns.

Highly liquid investments - cash or convertible to cash within three business days or less
Moderately liquid investments - convertible to cash in three to seven calendar days
Less liquid investments - can be sold or disposed of, but not settled, within seven calendar days
Illiquid investments - cannot be sold or disposed of within seven calendar days

1.813633.118

SELCON-ANN-0423

Fidelity® Select Portfolios®

Health Care Sector

Biotechnology Portfolio

Health Care Portfolio

Health Care Services Portfolio

Medical Technology and Devices Portfolio

Pharmaceuticals Portfolio

Annual Report

February 28, 2023

Contents

Biotechnology Portfolio

Health Care Portfolio

Health Care Services Portfolio

Medical Technology and Devices Portfolio

Pharmaceuticals Portfolio

Report of Independent Registered Public Accounting Firm

You may also call 1-800-544-8544 to request a free copy of the proxy voting guidelines.

Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.

Other third-party marks appearing herein are the property of their respective owners.

NOT FDIC INSURED •MAY LOSE VALUE •NO BANK GUARANTEE

Neither the Funds nor Fidelity Distributors Corporation is a bank.

Biotechnology Portfolio

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Biotechnology Portfolio	1.14%	2.58%	10.64%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Biotechnology Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Biotechnology Portfolio

Market Recap:

Comments from Portfolio Manager Rajiv Kaul:

For the fiscal year, the fund gained 1.14%, trailing the 10.57% advance of the MSCI US IMI Biotechnology 25/50 Index, but outperforming the broad-based S&P 500 ® index. Versus the industry index, security selection was the primary detractor, especially within biotechnology. We also had weak stock picks in pharmaceuticals and life sciences tools & services. The fund's biggest individual relative detractor was a lighter-than-index stake in Gilead Sciences, which gained about 39% the past year. We decreased our stake this period. Also hindering performance was an overweighting in Arcus Biosciences, which returned -51%. Also holding back performance was our lighter-than-index investment in Horizon Therapeutics, which gained 20%. Horizon Therapeutics was not held at period end. The fund's top individual relative contributor was our outsized position in Biohaven Pharmaceutical Holding, which gained 19%. The company was acquired by Pfizer in October and then spun out as a newly independent company, trading under the same ticker symbol. The fund retained a position in the new company at period end. Also lifting performance was an underweighting in Novavax, which returned -89%. Novavax was not held at period end. Another key contributor was our out-of-index position in Roivant Sciences (+28%).

Biotechnology Portfolio

Top Holdings (% of Fund's net assets)

AbbVie, Inc.	12.6
Regeneron Pharmaceuticals, Inc.	5.1
Vertex Pharmaceuticals, Inc.	5.0
Alnylam Pharmaceuticals, Inc.	5.0
Krystal Biotech, Inc.	3.5
Argenx SE ADR	2.9
Biogen, Inc.	2.5
Moderna, Inc.	2.3
Apellis Pharmaceuticals, Inc.	2.0
Cytokinetics, Inc.	1.7
	42.6

Industries (% of Fund's net assets)

Biotechnology	92.1
Pharmaceuticals	7.1
Health Care Technology	0.2
Health Care Providers & Services	0.2
Health Care Equipment & Supplies	0.1
Life Sciences Tools & Services	0.0
Food & Staples Retailing	0.0

Percentages shown as 0.0% may reflect amounts less than 0.05%.

Geographic Diversification (% of Fund's net assets)

* Includes Short-Term investments and Net Other Assets (Liabilities).

Percentages are based on country or territory of incorporation and are adjusted for the effect of derivatives, if applicable.

Biotechnology Portfolio

Showing Percentage of Net Assets

Common Stocks - 98.4%
	Shares	Value ($)
Biotechnology - 91.0%
Biotechnology - 91.0%
2seventy bio, Inc. (a)	103,752	1,399,614
AbbVie, Inc.	4,077,678	627,554,646
Absci Corp. (a)(b)	993,000	2,105,160
ADC Therapeutics SA (a)	546,270	1,966,572
Adverum Biotechnologies, Inc. (a)(c)	7,472,259	5,380,026
Aerovate Therapeutics, Inc. (a)(b)	174,813	4,295,155
Aldeyra Therapeutics, Inc. (a)(b)	888,537	6,006,510
Alector, Inc. (a)	1,351,818	11,544,526
Alkermes PLC (a)	640,536	17,127,933
Allena Pharmaceuticals, Inc. (a)	93,683	56
Allogene Therapeutics, Inc. (a)(b)	1,556,685	9,884,950
Allovir, Inc. (a)(b)	852,383	5,753,585
Alnylam Pharmaceuticals, Inc. (a)	1,298,706	248,637,264
ALX Oncology Holdings, Inc. (a)	1,280,549	8,477,234
Ambrx Biopharma, Inc. ADR (a)(b)	1,361,508	8,754,496
Amgen, Inc.	40,497	9,381,535
Amicus Therapeutics, Inc. (a)	2,268,301	29,918,890
AnaptysBio, Inc. (a)(b)	289,228	7,201,777
Apellis Pharmaceuticals, Inc. (a)(b)	1,487,684	97,413,548
Applied Therapeutics, Inc. (a)(b)(c)	2,639,536	2,665,931
Arcellx, Inc.	643,801	18,032,866
Arcturus Therapeutics Holdings, Inc. (a)(b)	794,024	12,902,890
Arcus Biosciences, Inc. (a)(b)	3,193,396	58,151,741
Arcutis Biotherapeutics, Inc. (a)	802,774	12,988,883
Argenx SE ADR (a)	393,547	144,046,073
Arrowhead Pharmaceuticals, Inc. (a)	1,337,032	43,186,134
Ars Pharmaceuticals, Inc. (a)(b)	1,541,977	13,754,435
Ascendis Pharma A/S sponsored ADR (a)	659,409	73,253,746
Astria Therapeutics, Inc. (a)	1,177,041	14,336,359
aTyr Pharma, Inc. (a)(b)	2,258,063	4,764,513
Aura Biosciences, Inc. (a)	356,492	3,561,355
Avidity Biosciences, Inc. (a)(b)	762,250	18,065,325
Axcella Health, Inc. (a)(b)	1,661,354	963,918
Beam Therapeutics, Inc. (a)(b)	669,379	26,935,811
BeiGene Ltd. ADR (a)	37,198	8,355,787
BELLUS Health, Inc. (a)	1,621,196	12,483,209
Bicycle Therapeutics PLC ADR (a)(b)	377,647	8,583,916
BioCryst Pharmaceuticals, Inc. (a)(b)	2,693,042	23,833,422
Biogen, Inc. (a)	467,336	126,115,293
Biohaven Ltd. (a)(b)	2,038,409	31,146,890
BioInvent International AB (a)	153,043	423,251
BioMarin Pharmaceutical, Inc. (a)	402,236	40,058,683
Biomea Fusion, Inc. (a)(b)	358,129	4,598,376
BioNTech SE ADR	60,750	7,900,538
BioXcel Therapeutics, Inc. (a)(b)	351,727	11,227,126
Blueprint Medicines Corp. (a)	1,254,408	53,149,267
BridgeBio Pharma, Inc. (a)(b)	820,042	9,364,880
Candel Therapeutics, Inc. (a)(b)	716,096	1,288,973
Celldex Therapeutics, Inc. (a)	819,700	35,074,963
Centessa Pharmaceuticals PLC ADR (a)(b)	1,230,909	4,332,800
Century Therapeutics, Inc. (a)	834,618	3,764,127
Cerevel Therapeutics Holdings (a)	1,028,280	27,444,793
Chinook Therapeutics, Inc. (a)(b)	303,781	6,628,501
Chinook Therapeutics, Inc. rights (a)(d)	115,821	1
Codiak Biosciences, Inc. (a)(b)	448,539	215,299
Codiak Biosciences, Inc. warrants 9/15/27 (a)	46,000	2,611
Cogent Biosciences, Inc. (a)	1,096,367	14,504,935
Compass Therapeutics, Inc. (a)(b)	1,709,500	6,479,005
Crinetics Pharmaceuticals, Inc. (a)	891,534	17,509,728
CRISPR Therapeutics AG (a)(b)	295,222	14,560,349
Cyclerion Therapeutics, Inc. (a)	837,285	545,073
Cyclerion Therapeutics, Inc. (a)(e)	94,809	61,721
Cytokinetics, Inc. (a)(b)	1,922,671	83,367,015
Day One Biopharmaceuticals, Inc. (a)	664,771	12,245,082
Denali Therapeutics, Inc. (a)	333,369	9,050,968
Design Therapeutics, Inc. (a)(b)	1,119,405	7,914,193
Disc Medicine, Inc. (a)(b)	155,590	3,889,750
Disc Medicine, Inc. rights (a)(b)(d)	1,555,907	16
Dyne Therapeutics, Inc. (a)	380,913	4,906,159
Enanta Pharmaceuticals, Inc. (a)	212,946	10,327,881
Entrada Therapeutics, Inc. (a)(b)	503,853	6,424,126
EQRx, Inc. (a)	507,567	1,147,101
EQRx, Inc.:
rights (a)(d)	116,649	75,822
rights (a)(d)	49,993	22,497
Erasca, Inc. (a)(b)	583,402	2,100,247
Evelo Biosciences, Inc. (a)(b)	1,098,999	681,269
Exact Sciences Corp. (a)	27,000	1,682,910
Exelixis, Inc. (a)	1,040,134	17,765,489
Fate Therapeutics, Inc. (a)	516,787	3,162,736
FibroGen, Inc. (a)	76,500	1,698,300
Foghorn Therapeutics, Inc. (a)(b)	178,719	1,024,060
Fusion Pharmaceuticals, Inc. (a)	1,142,702	5,050,743
Fusion Pharmaceuticals, Inc. (e)	1,483,000	5,899,374
Generation Bio Co. (a)	137,100	542,916
Geron Corp. (a)	3,753,406	10,434,469
Geron Corp. warrants 12/31/25 (a)	2,100,000	1,828,679
Gilead Sciences, Inc.	558,701	44,992,192
Gritstone Bio, Inc. (a)	669,785	1,640,973
Halozyme Therapeutics, Inc. (a)	478,800	22,977,612
Hookipa Pharma, Inc. (a)	1,480,200	1,280,373
Icosavax, Inc. (a)(b)	788,357	6,448,760
Ideaya Biosciences, Inc. (a)(b)	647,657	11,431,146
Idorsia Ltd. (a)(b)	1,092,661	14,455,121
IGM Biosciences, Inc. (a)(b)	690,509	14,514,499
Immuneering Corp. (a)(b)	476,458	2,329,880
Immunocore Holdings PLC ADR (a)	248,518	13,631,212
ImmunoGen, Inc. (a)	922,023	3,577,449
Incyte Corp. (a)	434,700	33,463,206
Inhibrx, Inc. (a)(b)	210,609	5,067,253
Inozyme Pharma, Inc. (a)	640,812	1,813,498
Insmed, Inc. (a)	412,092	8,398,435
Instil Bio, Inc. (a)	1,173,143	911,649
Intellia Therapeutics, Inc. (a)	885,001	35,550,490
Ionis Pharmaceuticals, Inc. (a)	987,777	35,461,194
Iovance Biotherapeutics, Inc. (a)	136,800	997,272
iTeos Therapeutics, Inc. (a)	211,500	3,745,665
Iveric Bio, Inc. (a)	356,209	7,402,023
Janux Therapeutics, Inc. (a)(b)	498,148	8,284,201
Karuna Therapeutics, Inc. (a)	328,542	65,517,846
Keros Therapeutics, Inc. (a)	466,029	24,802,063
Kiniksa Pharmaceuticals Ltd. (a)	177,166	2,278,355
Kinnate Biopharma, Inc. (a)	979,677	5,172,695
Kronos Bio, Inc. (a)(b)	279,857	486,951
Krystal Biotech, Inc. (a)(c)	2,097,722	171,824,409
Kymera Therapeutics, Inc. (a)(b)	647,713	20,325,234
Legend Biotech Corp. ADR (a)	839,216	38,754,995
Madrigal Pharmaceuticals, Inc. (a)	153,340	41,556,673
MannKind Corp. (a)(b)	6,449,301	34,052,309
Merus BV (a)(b)	597,056	11,385,858
Mirati Therapeutics, Inc. (a)(b)	321,748	14,748,928
Moderna, Inc. (a)	822,986	114,238,687
Monte Rosa Therapeutics, Inc. (a)(b)	1,257,805	7,647,454
Morphic Holding, Inc. (a)	809,437	34,417,261
Natera, Inc. (a)	356,133	17,290,257
Nkarta, Inc. (a)(b)	63,730	267,666
Nurix Therapeutics, Inc. (a)(b)	739,346	6,972,033
Nuvalent, Inc. Class A (a)	218,574	6,620,606
Omega Therapeutics, Inc. (a)(b)	1,088,551	7,032,039
Oragenics, Inc. (a)	2,596	11,942
PepGen, Inc.	440,591	6,727,825
Poseida Therapeutics, Inc. (a)	570,083	3,243,772
Prelude Therapeutics, Inc. (a)	359,156	2,032,823
Prime Medicine, Inc. (b)	53,800	883,934
Prometheus Biosciences, Inc. (a)	397,555	48,656,756
Prothena Corp. PLC (a)	933,189	52,034,619
PTC Therapeutics, Inc. (a)	1,621,544	70,812,826
Rallybio Corp. (a)(b)	1,550,692	12,203,946
RAPT Therapeutics, Inc. (a)	724,582	21,338,940
Recursion Pharmaceuticals, Inc. (a)	89,200	726,980
Regeneron Pharmaceuticals, Inc. (a)	333,148	253,332,402
Regulus Therapeutics, Inc. (a)(b)(c)	2,195,000	2,941,300
Relay Therapeutics, Inc. (a)(b)	632,189	10,209,852
Repare Therapeutics, Inc. (a)(b)	174,960	1,793,340
Replimune Group, Inc. (a)	1,121,714	24,565,537
Revolution Medicines, Inc. (a)	517,472	13,847,551
Rezolute, Inc. (a)	200	496
Rhythm Pharmaceuticals, Inc. (a)(b)	752,703	18,298,210
Rocket Pharmaceuticals, Inc. (a)	223,736	4,297,969
Roivant Sciences Ltd. (a)	6,582,325	53,251,009
Sage Therapeutics, Inc. (a)	989,753	41,213,315
Sarepta Therapeutics, Inc. (a)	552,604	67,489,527
Scholar Rock Holding Corp. (a)(b)	1,693,925	14,533,877
Scholar Rock Holding Corp. warrants 12/31/25 (a)(e)	17,850	64,915
Seagen, Inc. (a)	420,136	75,494,238
Selecta Biosciences, Inc. (a)	395,568	644,776
Sensorion SA (a)(b)	1,973,044	813,887
Seres Therapeutics, Inc. (a)(b)	854,347	4,314,452
Shattuck Labs, Inc. (a)	110,936	523,618
SpringWorks Therapeutics, Inc. (a)(b)	463,611	14,789,191
SpringWorks Therapeutics, Inc. (e)	54,800	1,573,308
Stoke Therapeutics, Inc. (a)	146,536	1,302,705
Sutro Biopharma, Inc. (a)	304,500	1,717,380
Tango Therapeutics, Inc. (a)	1,289,988	6,746,637
Taysha Gene Therapies, Inc. (a)(b)	811,647	819,763
Tenaya Therapeutics, Inc. (a)	2,081,279	6,389,527
TG Therapeutics, Inc. (a)(b)	1,718,820	27,535,496
Travere Therapeutics, Inc. (a)	167,028	3,701,340
Twist Bioscience Corp. (a)	681,332	13,258,721
Tyra Biosciences, Inc. (a)	301,101	3,977,544
Ultragenyx Pharmaceutical, Inc. (a)	876,351	38,988,856
uniQure B.V. (a)	255,608	5,357,544
United Therapeutics Corp. (a)	269,569	66,324,757
Vaxcyte, Inc. (a)	1,319,350	54,053,770
Vera Therapeutics, Inc. (a)(b)	910,368	6,764,034
Vertex Pharmaceuticals, Inc. (a)	861,862	250,189,920
Verve Therapeutics, Inc. (a)(b)	348,293	6,617,567
Vigil Neuroscience, Inc. (a)(b)	86,610	1,039,320
Viking Therapeutics, Inc. (a)	25,000	275,250
Viridian Therapeutics, Inc. (a)	60,700	1,988,532
Vor Biopharma, Inc. (a)(b)	1,194,902	6,667,553
Werewolf Therapeutics, Inc. (a)	2,100	6,059
X4 Pharmaceuticals, Inc. warrants 4/12/24 (a)	450,000	5
Xencor, Inc. (a)	179,643	5,771,930
Xenon Pharmaceuticals, Inc. (a)	977,333	38,565,560
Zealand Pharma A/S (a)	776,333	24,755,988
Zentalis Pharmaceuticals, Inc. (a)	638,433	12,085,537
		4,522,643,626
Food & Staples Retailing - 0.0%
Drug Retail - 0.0%
MedAvail Holdings, Inc. (a)	2,777	1,032
Health Care Equipment & Supplies - 0.1%
Health Care Equipment - 0.1%
Alpha Tau Medical Ltd. Class A (a)(b)	362,046	1,144,065
Novocure Ltd. (a)	11,113	855,368
		1,999,433
Health Care Providers & Services - 0.1%
Health Care Services - 0.1%
23andMe Holding Co. Class A (a)(b)	1,488,074	3,735,066
Health Care Technology - 0.2%
Health Care Technology - 0.2%
Akili, Inc. (a)(b)	1,500	2,475
Schrodinger, Inc. (a)	539,101	11,714,665
		11,717,140
Life Sciences Tools & Services - 0.0%
Life Sciences Tools & Services - 0.0%
Olink Holding AB ADR (a)	53,800	1,261,072
Pharmaceuticals - 7.0%
Pharmaceuticals - 7.0%
Acelyrin, Inc. (d)	2,378,678	14,795,615
Acelyrin, Inc. rights (a)(d)	289,045	1,713,028
Adimab LLC (a)(d)(e)(f)	1,954,526	79,959,659
Afferent Pharmaceuticals, Inc. rights 12/31/24 (a)(d)	8,274,568	9,184,770
Aradigm Corp. (a)(d)	11,945	549
Aradigm Corp. (a)(d)	148,009	6,808
Arvinas Holding Co. LLC (a)	297,316	9,112,735
Atea Pharmaceuticals, Inc. (a)	66,800	236,472
Axsome Therapeutics, Inc. (a)(b)	369,673	25,208,002
Corcept Therapeutics, Inc. (a)	88,400	1,841,372
DICE Therapeutics, Inc. (a)	338,246	10,093,261
Edgewise Therapeutics, Inc. (a)	1,177,285	11,278,390
Fulcrum Therapeutics, Inc. (a)(b)	1,448,597	8,749,526
GH Research PLC (a)(b)	893,124	8,556,128
Harmony Biosciences Holdings, Inc. (a)	124,525	5,482,836
Ikena Oncology, Inc. (a)	416,547	1,670,353
Intra-Cellular Therapies, Inc. (a)	464,276	22,763,452
Longboard Pharmaceuticals, Inc. (a)	869,289	4,520,303
Nuvation Bio, Inc. (a)	2,913,126	5,651,464
Ocular Therapeutix, Inc. (a)	45,654	275,750
OptiNose, Inc. (a)(b)	794,031	1,429,256
OptiNose, Inc. warrants (a)	91,712	60,319
Pharvaris BV (a)	353,507	2,937,643
Pliant Therapeutics, Inc. (a)	314,631	10,024,144
Rain Oncology, Inc. (a)(b)	349,069	3,124,168
Reata Pharmaceuticals, Inc. (a)(b)	116,773	3,639,814
Royalty Pharma PLC	52,920	1,897,182
Structure Therapeutics, Inc. ADR (b)	301,997	7,719,043
Terns Pharmaceuticals, Inc. (a)	1,140,467	11,552,931
Theseus Pharmaceuticals, Inc. (a)(b)	1,343,694	12,469,480
UCB SA	95,777	8,244,065
Ventyx Biosciences, Inc. (a)	785,545	33,974,821
Verona Pharma PLC ADR (a)	548,295	11,755,445
Verrica Pharmaceuticals, Inc. (a)(b)	1,451,876	11,252,039
WAVE Life Sciences (a)(b)	1,477,633	6,206,059
		347,386,882
TOTAL COMMON STOCKS (Cost $3,731,521,360)		4,888,744,251

Convertible Preferred Stocks - 1.3%
	Shares	Value ($)
Biotechnology - 1.1%
Biotechnology - 1.1%
ElevateBio LLC Series C (a)(d)(e)	216,600	688,788
Korro Bio, Inc.:
Series B1 (a)(d)(e)	957,854	2,059,386
Series B2 (a)(d)(e)	899,280	1,978,416
National Resilience, Inc. Series B (a)(d)(e)	732,064	44,458,247
SalioGen Therapeutics, Inc. Series B (a)(d)(e)	94,461	7,047,735
		56,232,572
Health Care Providers & Services - 0.1%
Health Care Services - 0.1%
Scorpion Therapeutics, Inc. Series B (a)(d)(e)	3,099,905	4,804,853
Pharmaceuticals - 0.1%
Pharmaceuticals - 0.1%
Afferent Pharmaceuticals, Inc. Series C (a)(d)(e)	8,274,568	83
Aristea Therapeutics, Inc. Series B (a)(d)(e)	836,400	4,608,564
		4,608,647
TOTAL CONVERTIBLE PREFERRED STOCKS (Cost $38,020,306)		65,646,072

Money Market Funds - 7.5%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (g)	16,572,078	16,575,392
Fidelity Securities Lending Cash Central Fund 4.63% (g)(h)	353,586,391	353,621,750
TOTAL MONEY MARKET FUNDS (Cost $370,163,501)		370,197,142

TOTAL INVESTMENT IN SECURITIES - 107.2% (Cost $4,139,705,167)	5,324,587,465
NET OTHER ASSETS (LIABILITIES) - (7.2)%	(355,480,379)
NET ASSETS - 100.0%	4,969,107,086

Legend

(a)	Non-income producing

(b)	Security or a portion of the security is on loan at period end.

(c)	Affiliated company

(d)	Level 3 security

(e)	Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $153,205,049 or 3.1% of net assets.

(f)	Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.

(g)

(h)	Investment made with cash collateral received from securities on loan.

Additional information on each restricted holding is as follows:
Security	Acquisition Date	Acquisition Cost ($)
Adimab LLC	9/17/14 - 6/05/15	31,091,029

Afferent Pharmaceuticals, Inc. Series C	7/01/15	0

Aristea Therapeutics, Inc. Series B	10/06/20	4,611,659

Cyclerion Therapeutics, Inc.	4/02/19	1,404,026

ElevateBio LLC Series C	3/09/21	908,637

Fusion Pharmaceuticals, Inc.	2/13/23	5,042,200

Korro Bio, Inc. Series B1	12/17/21	2,499,999

Korro Bio, Inc. Series B2	12/17/21	2,499,998

National Resilience, Inc. Series B	12/01/20	9,999,994

SalioGen Therapeutics, Inc. Series B	12/10/21	10,000,019

Scholar Rock Holding Corp. warrants 12/31/25	6/17/22	0

Scorpion Therapeutics, Inc. Series B	1/08/21	7,500,000

SpringWorks Therapeutics, Inc.	9/07/22	1,425,348

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	42,446,755	1,036,118,462	1,061,989,825	598,495	3,258	(3,258)	16,575,392	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	492,109,261	2,216,802,618	2,355,290,129	7,098,036	-	-	353,621,750	1.1%
Total	534,556,016	3,252,921,080	3,417,279,954	7,696,531	3,258	(3,258)	370,197,142

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Other Affiliated Issuers

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)
Adverum Biotechnologies, Inc.	-	14,311,388	2,132,127	-	(2,107,259)	(4,691,976)	5,380,026
Applied Therapeutics, Inc.	1,070,923	2,575,660	1,176,547	-	(14,439,872)	14,635,767	2,665,931
Candel Therapeutics, Inc.	8,593,545	-	6,186,049	-	(4,771,678)	3,653,155	-
Krystal Biotech, Inc.	126,760,516	6,531,325	631,314	-	13,464	39,150,418	171,824,409
Regulus Therapeutics, Inc.	-	4,631,450	-	-	-	(1,690,150)	2,941,300
Total	136,424,984	28,049,823	10,126,037	-	(21,305,345)	51,057,214	182,811,666

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	4,888,744,251	4,773,556,275	9,429,211	105,758,765

Convertible Preferred Stocks	65,646,072	-	-	65,646,072

Money Market Funds	370,197,142	370,197,142	-	-
Total Investments in Securities:	5,324,587,465	5,143,753,417	9,429,211	171,404,837

The following is a reconciliation of Investments in Securities for which Level 3 inputs were used in determining value:


Investments in Securities:
Common Stocks
Beginning Balance	$	90,662,671
Net Realized Gain (Loss) on Investment Securities		109,862
Net Unrealized Gain (Loss) on Investment Securities		4,185,734
Cost of Purchases		23,265
Proceeds of Sales		(109,876)
Amortization/Accretion		-
Transfers into Level 3		10,887,109
Transfers out of Level 3		-
Ending Balance	$	105,758,765
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at February 28, 2023	$	4,185,734
Convertible Preferred Stocks
Beginning Balance	$	80,070,979
Net Realized Gain (Loss) on Investment Securities		-
Net Unrealized Gain (Loss) on Investment Securities		(3,537,798)
Cost of Purchases		-
Proceeds of Sales		-
Amortization/Accretion		-
Transfers into Level 3		-
Transfers out of Level 3		(10,887,109)
Ending Balance	$	65,646,072
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at February 28, 2023	$	(3,537,798)
The information used in the above reconciliation represents fiscal year to date activity for any Investments in Securities identified as using Level 3 inputs at either the beginning or the end of the current fiscal period. Cost of purchases and proceeds of sales may include securities received and/or delivered through in-kind transactions. Transfers into Level 3 were attributable to a lack of observable market data resulting from decreases in market activity, decreases in liquidity, security restructurings or corporate actions. Transfers out of Level 3 were attributable to observable market data becoming available for those securities. Transfers in or out of Level 3 represent the beginning value of any Security or Instrument where a change in the pricing level occurred from the beginning to the end of the period. The cost of purchases and the proceeds of sales may include securities received or delivered through corporate actions or exchanges. Realized and unrealized gains (losses) disclosed in the reconciliation are included in Net Gain (Loss) on the Fund's Statement of Operations.

Biotechnology Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $342,668,967) - See accompanying schedule:
Unaffiliated issuers (cost $3,666,478,431)	$	4,771,578,657
Fidelity Central Funds (cost $370,163,501)		370,197,142
Other affiliated issuers (cost $103,063,235)		182,811,666


Total Investment in Securities (cost $4,139,705,167)			$	5,324,587,465
Foreign currency held at value (cost $748)				748
Receivable for investments sold				34,503,570
Receivable for fund shares sold				199,281
Dividends receivable				284,333
Distributions receivable from Fidelity Central Funds				340,399
Prepaid expenses				26,248
Other receivables				1,094,128
Total assets				5,361,036,172
Liabilities
Payable for investments purchased	$	31,855,192
Payable for fund shares redeemed		2,427,899
Accrued management fee		2,245,745
Other affiliated payables		771,070
Other payables and accrued expenses		1,168,498
Collateral on securities loaned		353,460,682
Total Liabilities				391,929,086
Net Assets			$	4,969,107,086
Net Assets consist of:
Paid in capital			$	4,464,873,986
Total accumulated earnings (loss)				504,233,100
Net Assets			$	4,969,107,086
Net Asset Value , offering price and redemption price per share ($4,969,107,086 ÷ 311,304,219 shares)			$	15.96

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	26,156,334
Income from Fidelity Central Funds (including $7,098,036 from security lending)				7,696,531
Total Income				33,852,865
Expenses
Management fee	$	26,913,334
Transfer agent fees		8,279,353
Accounting fees		993,571
Custodian fees and expenses		137,419
Independent trustees' fees and expenses		17,490
Registration fees		67,130
Audit		116,132
Legal		4,678
Miscellaneous		37,989
Total expenses before reductions		36,567,096
Expense reductions		(185,851)
Total expenses after reductions				36,381,245
Net Investment income (loss)				(2,528,380)
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		(525,539,837)
Fidelity Central Funds		3,258
Other affiliated issuers		(21,305,345)
Foreign currency transactions		(13,547)
Total net realized gain (loss)				(546,855,471)
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		557,700,901
Fidelity Central Funds		(3,258)
Other affiliated issuers		51,057,214
Assets and liabilities in foreign currencies		(8,889)
Total change in net unrealized appreciation (depreciation)				608,745,968
Net gain (loss)				61,890,497
Net increase (decrease) in net assets resulting from operations			$	59,362,117

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	(2,528,380)	$	(10,105,462)
Net realized gain (loss)		(546,855,471)		288,016,862
Change in net unrealized appreciation (depreciation)		608,745,968		(2,639,724,294)
Net increase (decrease) in net assets resulting from operations		59,362,117		(2,361,812,894)
Distributions to shareholders		-		(951,630,731)
Share transactions
Proceeds from sales of shares		544,996,692		514,676,797
Reinvestment of distributions		-		898,472,847
Cost of shares redeemed		(915,943,690)		(1,692,638,148)
Net increase (decrease) in net assets resulting from share transactions		(370,946,998)		(279,488,504)
Total increase (decrease) in net assets		(311,584,881)		(3,592,932,129)

Net Assets
Beginning of period		5,280,691,967		8,873,624,096
End of period	$	4,969,107,086	$	5,280,691,967

Other Information
Shares
Sold		35,714,869		24,447,337
Issued in reinvestment of distributions		-		43,520,026
Redeemed		(58,965,046)		(81,104,304)
Net increase (decrease)		(23,250,177)		(13,136,941)

Financial Highlights

Biotechnology Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019 B
Selected Per-Share Data
Net asset value, beginning of period	$	15.78	$	25.52	$	21.02	$	21.14	$	23.45
Income from Investment Operations
Net investment income (loss) C,D		(.01)		(.03)		(.01)		.05		(.04)
Net realized and unrealized gain (loss)		.19		(6.91)		9.41		1.79		(.29) E
Total from investment operations		.18		(6.94)		9.40		1.84		(.33)
Distributions from net investment income		-		(.03)		(.07)		(.03)		-
Distributions from net realized gain		-		(2.77)		(4.84)		(1.93)		(1.98)
Total distributions		-		(2.80)		(4.90) F		(1.96)		(1.98)
Net asset value, end of period	$	15.96	$	15.78	$	25.52	$	21.02	$	21.14
Total Return G		1.14%		(29.49)%		47.35%		8.57%		(.46)% E
Ratios to Average Net Assets D,H,I
Expenses before reductions		.72%		.69%		.70%		.72%		.72%
Expenses net of fee waivers, if any		.71%		.69%		.70%		.72%		.72%
Expenses net of all reductions		.71%		.69%		.69%		.72%		.72%
Net investment income (loss)		(.05)%		(.14)%		(.03)%		.22%		(.20)%
Supplemental Data
Net assets, end of period (000 omitted)	$	4,969,107	$	5,280,692	$	8,873,624	$	6,624,752	$	7,583,722
Portfolio turnover rate J		51%		46%		78%		50%		37%

A For the year ended February 29.

B Per share amounts have been adjusted to reflect the impact of the 10 for 1 share split that occurred on August 10, 2018.

C Calculated based on average shares outstanding during the period.

E Net realized and unrealized gain (loss) per share reflects proceeds received from litigation which amounted to $.01 per share. Excluding these litigation proceeds, the total return would have been (.53)%.

F Total distributions per share do not sum due to rounding.

G Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

J Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Health Care Portfolio

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Health Care Portfolio	-2.05%	9.82%	14.38%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Health Care Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Health Care Portfolio

Market Recap:

Comments from Portfolio Manager Eddie Yoon:

For the fiscal year ending February 28, 2023, the fund returned -2.05%, roughly in line with the -1.92% result of the MSCI US IMI Health Care 25/50 Index, but outperforming the broad-based S&P 500 ® index. Versus the sector index, security selection was the primary contributor, led by the health care equipment sector. Security selection in health care services also helped. The fund's largest individual relative contributor was an overweighting in Oak Street Health, which gained 99% the past 12 months. We decreased our stake in this company. Also adding value was our outsized stake in Penumbra, which gained about 17%. Penumbra was among the fund's largest holdings. Another notable relative contributor was an overweighting in Humana (+15%). This period we reduced our stake. Conversely, the primary detractor from performance versus the sector index were stock picks in biotechnology. An underweighting in pharmaceuticals and security selection in health care facilities also hindered the fund's relative result. An underweighting in Merck, a stake we established this period, was the fund's biggest individual relative detractor because the stock gained 43% the past year. Also hampering performance was our outsized stake in Tandem Diabetes Care, which returned -68%. We added to our investment the past 12 months. Avoiding Gilead Sciences, an index component that gained approximately 39%, also hurt relative performance. The fund's foreign holdings modestly detracted overall, partly due to a broadly strong U.S. dollar. Notable changes in positioning include a higher allocation to the health care services and health care equipment subindustries.

Health Care Portfolio

Top Holdings (% of Fund's net assets)

UnitedHealth Group, Inc.	9.4
Boston Scientific Corp.	6.1
Thermo Fisher Scientific, Inc.	6.0
Eli Lilly & Co.	5.5
Danaher Corp.	4.7
Penumbra, Inc.	4.6
Regeneron Pharmaceuticals, Inc.	3.9
Cigna Group	3.3
Insulet Corp.	3.2
Centene Corp.	2.8
	49.5

Industries (% of Fund's net assets)

Health Care Providers & Services	25.5
Health Care Equipment & Supplies	21.8
Biotechnology	19.5
Life Sciences Tools & Services	15.8
Pharmaceuticals	14.4
Health Care Technology	2.2
Personal Products	0.4
Specialty Retail	0.2
Diversified Financial Services	0.1

Health Care Portfolio

Showing Percentage of Net Assets

Common Stocks - 98.7%
	Shares	Value ($)
Biotechnology - 18.8%
Biotechnology - 18.8%
ADC Therapeutics SA (a)(b)	825,782	2,972,815
Alnylam Pharmaceuticals, Inc. (a)	280,000	53,606,000
Ambrx Biopharma, Inc. ADR (a)(b)	354,700	2,280,721
Arcutis Biotherapeutics, Inc. (a)	900,000	14,562,000
Argenx SE ADR (a)	485,000	177,519,700
Ascendis Pharma A/S sponsored ADR (a)	900,000	99,981,000
Avidity Biosciences, Inc. (a)	400,000	9,480,000
Beam Therapeutics, Inc. (a)(b)	400,000	16,096,000
Blueprint Medicines Corp. (a)	1,000,000	42,370,000
Caris Life Sciences, Inc. (c)(d)	1,420,479	7,954,682
Celldex Therapeutics, Inc. (a)	672,066	28,757,704
Cerevel Therapeutics Holdings (a)	1,363,500	36,391,815
Cytokinetics, Inc. (a)	1,500,000	65,040,000
Exact Sciences Corp. (a)	585,000	36,463,050
Generation Bio Co. (a)	509,353	2,017,038
Instil Bio, Inc. (a)	570,745	443,526
Janux Therapeutics, Inc. (a)	500,000	8,315,000
Karuna Therapeutics, Inc. (a)	240,000	47,860,800
Keros Therapeutics, Inc. (a)	540,000	28,738,800
Legend Biotech Corp. ADR (a)	1,800,000	83,124,000
Morphic Holding, Inc. (a)	320,000	13,606,400
Nuvalent, Inc. Class A (a)	382,530	11,586,834
Poseida Therapeutics, Inc. (a)(b)	1,922,313	10,937,961
PTC Therapeutics, Inc. (a)	670,000	29,258,900
Regeneron Pharmaceuticals, Inc. (a)	415,000	315,574,300
Relay Therapeutics, Inc. (a)(b)	800,000	12,920,000
Repligen Corp. (a)	320,000	55,798,400
Sarepta Therapeutics, Inc. (a)	460,000	56,179,800
Scholar Rock Holding Corp. (a)	155,315	1,332,603
Shattuck Labs, Inc. (a)	1,162,800	5,488,416
Stoke Therapeutics, Inc. (a)(b)	500,000	4,445,000
uniQure B.V. (a)(b)	670,000	14,043,200
Vaxcyte, Inc. (a)	900,000	36,873,000
Vertex Pharmaceuticals, Inc. (a)	280,000	81,281,200
Verve Therapeutics, Inc. (a)(b)	280,000	5,320,000
Xencor, Inc. (a)	1,400,000	44,982,000
Xenon Pharmaceuticals, Inc. (a)	528,214	20,843,324
Zai Lab Ltd. (a)(e)	6,700,000	24,532,952
Zentalis Pharmaceuticals, Inc. (a)	1,200,000	22,716,000
		1,531,694,941
Health Care Equipment & Supplies - 21.8%
Health Care Equipment - 21.8%
Boston Scientific Corp. (a)	10,600,000	495,232,000
Inspire Medical Systems, Inc. (a)	145,000	37,689,850
Insulet Corp. (a)	950,000	262,542,000
Intuitive Surgical, Inc. (a)	100,000	22,939,000
iRhythm Technologies, Inc. (a)	291,067	34,252,765
Masimo Corp. (a)	1,000,000	167,310,000
Nevro Corp. (a)	850,000	26,724,000
Novocure Ltd. (a)	488,501	37,599,922
Outset Medical, Inc. (a)	1,000,000	22,810,000
Penumbra, Inc. (a)	1,460,000	379,585,400
PROCEPT BioRobotics Corp. (a)	600,000	22,470,000
ResMed, Inc.	540,000	115,020,000
Stryker Corp.	400,000	105,152,000
Tandem Diabetes Care, Inc. (a)	1,400,000	50,204,000
		1,779,530,937
Health Care Providers & Services - 25.5%
Health Care Facilities - 2.4%
Acadia Healthcare Co., Inc. (a)	720,000	52,207,200
HCA Holdings, Inc.	75,000	18,258,750
Surgery Partners, Inc. (a)	3,756,500	125,654,925
The Oncology Institute, Inc. (a)(c)	2,232,581	3,147,939
		199,268,814
Health Care Services - 7.1%
agilon health, Inc. (a)(b)	9,400,000	199,374,000
Cigna Group	920,000	268,732,000
CVS Health Corp.	650,000	54,301,000
LifeStance Health Group, Inc. (a)	3,816,138	19,538,627
Oak Street Health, Inc. (a)	1,000,000	35,400,000
		577,345,627
Managed Health Care - 16.0%
Alignment Healthcare, Inc. (a)	3,800,000	37,772,000
Centene Corp. (a)	3,300,000	225,720,000
Humana, Inc.	440,000	217,808,800
Molina Healthcare, Inc. (a)	190,000	52,312,700
UnitedHealth Group, Inc.	1,620,000	771,022,801
		1,304,636,301
TOTAL HEALTH CARE PROVIDERS & SERVICES		2,081,250,742
Health Care Technology - 1.9%
Health Care Technology - 1.9%
Doximity, Inc. (a)(b)	850,000	28,585,500
Evolent Health, Inc. (a)	450,000	15,754,500
Medlive Technology Co. Ltd. (f)	3,000,000	3,661,426
Phreesia, Inc. (a)	1,080,000	39,744,000
Veeva Systems, Inc. Class A (a)	400,000	66,264,000
		154,009,426
Life Sciences Tools & Services - 15.8%
Life Sciences Tools & Services - 15.8%
10X Genomics, Inc. Class B (a)(f)	500,000	23,760,000
Bruker Corp.	1,200,000	82,704,000
Danaher Corp.	1,560,000	386,146,800
IQVIA Holdings, Inc. (a)	670,000	139,674,900
Lonza Group AG	75,000	44,673,128
Olink Holding AB ADR (a)	1,156,600	27,110,704
Sartorius Stedim Biotech	60,000	19,590,719
Thermo Fisher Scientific, Inc.	900,000	487,584,000
West Pharmaceutical Services, Inc.	235,000	74,502,050
		1,285,746,301
Personal Products - 0.4%
Personal Products - 0.4%
The Beauty Health Co. (a)(b)	479,105	6,041,514
The Beauty Health Co. (a)(c)	1,800,000	22,698,000
		28,739,514
Pharmaceuticals - 14.3%
Pharmaceuticals - 14.3%
Arvinas Holding Co. LLC (a)	750,000	22,987,500
AstraZeneca PLC (United Kingdom)	1,500,000	195,417,133
Eli Lilly & Co.	1,450,000	451,269,000
Merck & Co., Inc.	1,400,000	148,736,000
Novo Nordisk A/S Series B	500,000	70,627,636
Pharvaris BV (a)	620,000	5,152,200
Royalty Pharma PLC	5,700,000	204,345,000
UCB SA	600,000	51,645,376
Ventyx Biosciences, Inc. (a)	250,000	10,812,500
Verona Pharma PLC ADR (a)	400,000	8,576,000
		1,169,568,345
Specialty Retail - 0.2%
Specialty Stores - 0.2%
Warby Parker, Inc. (a)	1,000,000	13,010,000
TOTAL COMMON STOCKS (Cost $5,503,766,184)		8,043,550,206

Preferred Stocks - 1.2%
	Shares	Value ($)
Convertible Preferred Stocks - 1.1%
Biotechnology - 0.7%
Biotechnology - 0.7%
Asimov, Inc. Series B (a)(c)(d)	101,438	5,166,237
Caris Life Sciences, Inc. Series D (a)(c)(d)	3,206,021	17,953,718
Cleerly, Inc. Series C (c)(d)	1,285,367	14,935,965
Element Biosciences, Inc. Series C (a)(c)(d)	572,265	9,413,759
ElevateBio LLC Series C (a)(c)(d)	254,900	810,582
Inscripta, Inc. Series E (a)(c)(d)	1,282,228	5,423,824
		53,704,085
Health Care Providers & Services - 0.0%
Health Care Services - 0.0%
dMed Biopharmaceutical Co. Ltd. Series C (a)(c)(d)	380,451	4,127,893

Health Care Technology - 0.3%
Health Care Technology - 0.3%
Aledade, Inc.:
Series B1(a)(c)(d)	201,220	10,733,075
Series E1(c)(d)	56,664	3,022,458
Omada Health, Inc. Series E (a)(c)(d)	2,153,073	7,708,001
Wugen, Inc. Series B (a)(c)(d)	454,342	2,421,643
		23,885,177
Pharmaceuticals - 0.1%
Pharmaceuticals - 0.1%
Aristea Therapeutics, Inc. Series B (a)(c)(d)	1,037,400	5,716,074
Galvanize Therapeutics Series B (c)(d)	3,696,429	6,246,965
		11,963,039
TOTAL CONVERTIBLE PREFERRED STOCKS		93,680,194
Nonconvertible Preferred Stocks - 0.1%
Diversified Financial Services - 0.1%
Other Diversified Financial Services - 0.1%
Thriveworks TopCo LLC Series B (a)(c)(d)(g)	473,270	7,794,757

TOTAL PREFERRED STOCKS (Cost $132,756,423)		101,474,951

Money Market Funds - 2.3%
	Shares	Value ($)
Fidelity Securities Lending Cash Central Fund 4.63% (h)(i) (Cost $189,952,575)	189,935,332	189,954,325

TOTAL INVESTMENT IN SECURITIES - 102.2% (Cost $5,826,475,182)	8,334,979,482
NET OTHER ASSETS (LIABILITIES) - (2.2)%	(181,515,079)
NET ASSETS - 100.0%	8,153,464,403

Legend

(a)	Non-income producing

(b)	Security or a portion of the security is on loan at period end.

(c)	Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $135,275,572 or 1.7% of net assets.

(d)	Level 3 security

(e)	Affiliated company

(f)

(g)	Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.

(h)

(i)	Investment made with cash collateral received from securities on loan.

Additional information on each restricted holding is as follows:
Security	Acquisition Date	Acquisition Cost ($)
Aledade, Inc. Series B1	5/07/21	7,704,855

Aledade, Inc. Series E1	5/20/22	2,822,683

Aristea Therapeutics, Inc. Series B	10/06/20	5,719,912

Asimov, Inc. Series B	10/29/21	9,401,345

Caris Life Sciences, Inc.	10/06/22	7,954,682

Caris Life Sciences, Inc. Series D	5/11/21	25,968,770

Cleerly, Inc. Series C	7/08/22	15,142,394

dMed Biopharmaceutical Co. Ltd. Series C	12/01/20	5,403,602

Element Biosciences, Inc. Series C	6/21/21	11,763,880

ElevateBio LLC Series C	3/09/21	1,069,306

Galvanize Therapeutics Series B	3/29/22	6,399,572

Inscripta, Inc. Series E	3/30/21	11,322,073

Omada Health, Inc. Series E	12/22/21	12,908,103

The Beauty Health Co.	12/08/20	18,000,000

The Oncology Institute, Inc.	6/28/21	22,325,810

Thriveworks TopCo LLC Series B	7/23/21 - 2/25/22	13,584,368

Wugen, Inc. Series B	7/09/21	3,523,377

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	36,264,694	1,123,481,826	1,159,746,520	1,215,198	-	-	-	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	202,861,851	1,295,221,054	1,308,128,580	1,754,556	-	-	189,954,325	0.6%
Total	239,126,545	2,418,702,880	2,467,875,100	2,969,754	-	-	189,954,325

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Other Affiliated Issuers

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)
Zai Lab Ltd.	26,625,199	15,386,597	4,441,986	-	(22,717,266)	9,680,408	24,532,952
Total	26,625,199	15,386,597	4,441,986	-	(22,717,266)	9,680,408	24,532,952

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	8,043,550,206	7,700,344,675	335,250,849	7,954,682

Preferred Stocks	101,474,951	-	-	101,474,951

Money Market Funds	189,954,325	189,954,325	-	-
Total Investments in Securities:	8,334,979,482	7,890,299,000	335,250,849	109,429,633

The following is a reconciliation of Investments in Securities for which Level 3 inputs were used in determining value:


Investments in Securities:
Preferred Stocks
Beginning Balance	$	99,854,613
Net Realized Gain (Loss) on Investment Securities		-
Net Unrealized Gain (Loss) on Investment Securities		(22,766,495)
Cost of Purchases		24,386,833
Proceeds of Sales		-
Amortization/Accretion		-
Transfers into Level 3		-
Transfers out of Level 3		-
Ending Balance	$	101,474,951
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at February 28, 2023	$	(22,766,495)
Other Investments in Securities
Beginning Balance	$	-
Net Realized Gain (Loss) on Investment Securities		-
Net Unrealized Gain (Loss) on Investment Securities		-
Cost of Purchases		7,954,682
Proceeds of Sales		-
Amortization/Accretion		-
Transfers into Level 3		-
Transfers out of Level 3		-
Ending Balance	$	7,954,682
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at February 28, 2023	$	-
The information used in the above reconciliation represents fiscal year to date activity for any Investments in Securities identified as using Level 3 inputs at either the beginning or the end of the current fiscal period. Cost of purchases and proceeds of sales may include securities received and/or delivered through in-kind transactions. Transfers into Level 3 were attributable to a lack of observable market data resulting from decreases in market activity, decreases in liquidity, security restructurings or corporate actions. Transfers out of Level 3 were attributable to observable market data becoming available for those securities. Transfers in or out of Level 3 represent the beginning value of any Security or Instrument where a change in the pricing level occurred from the beginning to the end of the period. The cost of purchases and the proceeds of sales may include securities received or delivered through corporate actions or exchanges. Realized and unrealized gains (losses) disclosed in the reconciliation are included in Net Gain (Loss) on the Fund's Statement of Operations.

Health Care Portfolio

Health Care Services Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $186,141,172) - See accompanying schedule:
Unaffiliated issuers (cost $5,600,449,554)	$	8,120,492,205
Fidelity Central Funds (cost $189,952,575)		189,954,325
Other affiliated issuers (cost $36,073,053)		24,532,952


Total Investment in Securities (cost $5,826,475,182)			$	8,334,979,482
Foreign currency held at value (cost $8)				8
Receivable for investments sold				41,227,458
Receivable for fund shares sold				1,146,495
Dividends receivable				5,955,720
Reclaims receivable				5,412,240
Distributions receivable from Fidelity Central Funds				227,672
Prepaid expenses				23,661
Other receivables				761,986
Total assets				8,389,734,722
Liabilities
Payable to custodian bank	$	1,425,616
Payable for investments purchased		35,003,078
Payable for fund shares redeemed		4,264,695
Accrued management fee		3,706,834
Other affiliated payables		1,106,774
Other payables and accrued expenses		830,822
Collateral on securities loaned		189,932,500
Total Liabilities				236,270,319
Net Assets			$	8,153,464,403
Net Assets consist of:
Paid in capital			$	5,757,809,383
Total accumulated earnings (loss)				2,395,655,020
Net Assets			$	8,153,464,403
Net Asset Value , offering price and redemption price per share ($8,153,464,403 ÷ 299,940,737 shares)			$	27.18

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	45,809,321
Income from Fidelity Central Funds (including $1,754,556 from security lending)				2,969,754
Total Income				48,779,075
Expenses
Management fee	$	44,295,591
Transfer agent fees		12,171,724
Accounting fees		1,128,857
Custodian fees and expenses		97,261
Independent trustees' fees and expenses		28,748
Registration fees		69,017
Audit		55,185
Legal		7,343
Interest		4,620
Miscellaneous		49,613
Total expenses before reductions		57,907,959
Expense reductions		(300,032)
Total expenses after reductions				57,607,927
Net Investment income (loss)				(8,828,852)
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		(54,216,767)
Affiliated issuers		(22,717,266)
Foreign currency transactions		(128,287)
Total net realized gain (loss)				(77,062,320)
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		(119,731,988)
Affiliated issuers		9,680,408
Assets and liabilities in foreign currencies		(335,389)
Total change in net unrealized appreciation (depreciation)				(110,386,969)
Net gain (loss)				(187,449,289)
Net increase (decrease) in net assets resulting from operations			$	(196,278,141)

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	(8,828,852)	$	(10,700,587)
Net realized gain (loss)		(77,062,320)		831,099,766
Change in net unrealized appreciation (depreciation)		(110,386,969)		(1,151,771,898)
Net increase (decrease) in net assets resulting from operations		(196,278,141)		(331,372,719)
Distributions to shareholders		(185,553,756)		(929,859,235)
Share transactions
Proceeds from sales of shares		519,950,859		1,043,831,682
Reinvestment of distributions		171,960,992		861,023,255
Cost of shares redeemed		(1,155,824,340)		(1,997,490,811)
Net increase (decrease) in net assets resulting from share transactions		(463,912,489)		(92,635,874)
Total increase (decrease) in net assets		(845,744,386)		(1,353,867,828)

Net Assets
Beginning of period		8,999,208,789		10,353,076,617
End of period	$	8,153,464,403	$	8,999,208,789

Other Information
Shares
Sold		19,098,646		32,480,198
Issued in reinvestment of distributions		5,803,593		27,447,935
Redeemed		(42,956,929)		(63,667,769)
Net increase (decrease)		(18,054,690)		(3,739,636)

Financial Highlights

Health Care Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019 B
Selected Per-Share Data
Net asset value, beginning of period	$	28.30	$	32.18	$	26.53	$	24.48	$	23.56
Income from Investment Operations
Net investment income (loss) C,D		(.03)		(.03)		- E		.04		.02
Net realized and unrealized gain (loss)		(.50)		(.92)		9.23		2.40		2.90
Total from investment operations		(.53)		(.95)		9.23		2.44		2.92
Distributions from net investment income		-		(.04) F		(.18)		(.03)		(.03)
Distributions from net realized gain		(.59)		(2.89) F		(3.40)		(.36)		(1.97)
Total distributions		(.59)		(2.93)		(3.58)		(.39)		(2.00)
Net asset value, end of period	$	27.18	$	28.30	$	32.18	$	26.53	$	24.48
Total Return G		(2.05)%		(3.67)%		36.00%		9.84%		13.30%
Ratios to Average Net Assets D,H,I
Expenses before reductions		.69%		.68%		.69%		.70%		.71%
Expenses net of fee waivers, if any		.68%		.67%		.69%		.70%		.71%
Expenses net of all reductions		.68%		.67%		.69%		.70%		.71%
Net investment income (loss)		(.10)%		(.10)%		(.01)%		.16%		.10%
Supplemental Data
Net assets, end of period (000 omitted)	$	8,153,464	$	8,999,209	$	10,353,077	$	7,220,187	$	7,450,707
Portfolio turnover rate J		40%		31%		52%		36% K		60% K

A For the year ended February 29.

B Per share amounts have been adjusted to reflect the impact of the 10 for 1 share split that occurred on August 10, 2018.

C Calculated based on average shares outstanding during the period.

E Amount represents less than $.005 per share.

F The amount shown reflects reclassifications related to book to tax differences that were made in the year shown.

G Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

J Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

K Portfolio turnover rate excludes securities received or delivered in-kind.

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Health Care Services Portfolio	-0.64%	11.87%	14.63%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Health Care Services Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Health Care Services Portfolio

Market Recap:

Comments from Portfolio Manager Justin Segalini:

For the fiscal year ending February 28, 2023, the fund returned -0.64%, trailing the -0.37% result of the MSCI US IMI Health Care Providers & Services 25/50 Index, but outperforming the broad-based S&P 500 ® index. Versus the industry index, stock selection in health care facilities hurt most, followed by an underweighting within health care distributors. The fund's biggest individual relative detractor was an overweighting in Surgery Partners, which returned roughly -36% the past year. We increased our stake in this company. Also holding back performance was our overweighting in Tenet Healthcare, which returned -45%. Tenet Healthcare was not held at period end. Avoiding Cardinal Health, an index component that gained about 45%, also hurt relative performance. Conversely, the top contributor to performance versus the industry index was stock selection in health care services. Security selection in health care technology and health care distributors also boosted the fund's relative performance. The biggest individual relative contributor was an underweight position in CVS Health (-17%), which was among our largest holdings. Also adding value was our outsized stake in Cigna Group, which gained roughly 24%. Cigna was among the fund's biggest holdings. Another notable relative contributor was an overweighting in Humana (+15%), which was one of our largest holdings. Notable changes in positioning include increased exposure to the health care distributors subindustry and a lower allocation to health care facilities.

Health Care Services Portfolio

Top Holdings (% of Fund's net assets)

UnitedHealth Group, Inc.	24.6
CVS Health Corp.	8.9
Humana, Inc.	8.2
Centene Corp.	7.7
Cigna Group	4.8
Elevance Health, Inc.	4.7
Molina Healthcare, Inc.	4.4
AmerisourceBergen Corp.	4.3
McKesson Corp.	4.3
HCA Holdings, Inc.	3.5
	75.4

Industries (% of Fund's net assets)

Health Care Providers & Services	96.5
Health Care Technology	2.0
Diversified Financial Services	0.1

Health Care Services Portfolio

Showing Percentage of Net Assets

Common Stocks - 98.2%
	Shares	Value ($)
Health Care Providers & Services - 96.5%
Health Care Distributors & Services - 8.6%
AmerisourceBergen Corp.	475,300	73,937,668
McKesson Corp.	207,500	72,585,575
		146,523,243
Health Care Facilities - 12.1%
Acadia Healthcare Co., Inc. (a)	532,600	38,618,826
Encompass Health Corp.	446,600	25,241,832
HCA Holdings, Inc.	247,200	60,180,840
Surgery Partners, Inc. (a)	1,304,400	43,632,180
U.S. Physical Therapy, Inc. (b)	180,300	18,269,799
Universal Health Services, Inc. Class B	164,000	21,905,480
		207,848,957
Health Care Services - 24.0%
agilon health, Inc. (a)(b)	2,325,673	49,327,524
Andlauer Healthcare Group, Inc.	184,939	6,477,270
Chemed Corp.	52,200	27,226,476
Cigna Group	282,572	82,539,281
CVS Health Corp.	1,824,570	152,424,578
DaVita HealthCare Partners, Inc. (a)	99,900	8,217,774
LifeStance Health Group, Inc. (a)	3,643,950	18,657,024
Option Care Health, Inc. (a)	1,298,932	39,838,244
Privia Health Group, Inc. (a)(b)	654,800	18,288,564
Quest Diagnostics, Inc.	48,000	6,641,280
		409,638,015
Managed Health Care - 51.8%
Alignment Healthcare, Inc. (a)	828,696	8,237,238
Centene Corp. (a)	1,918,284	131,210,626
Elevance Health, Inc.	171,802	80,690,245
HealthEquity, Inc. (a)	460,900	30,036,853
Humana, Inc.	282,900	140,041,158
Molina Healthcare, Inc. (a)	271,500	74,752,095
UnitedHealth Group, Inc.	883,950	420,707,164
		885,675,379
TOTAL HEALTH CARE PROVIDERS & SERVICES		1,649,685,594
Health Care Technology - 1.7%
Health Care Technology - 1.7%
Evolent Health, Inc. (a)(b)	581,900	20,372,319
Phreesia, Inc. (a)	239,335	8,807,528
		29,179,847
TOTAL COMMON STOCKS (Cost $1,085,319,586)		1,678,865,441

Preferred Stocks - 0.4%
	Shares	Value ($)
Convertible Preferred Stocks - 0.3%
Health Care Technology - 0.3%
Health Care Technology - 0.3%
Aledade, Inc.:
Series B1(a)(c)(d)	52,232	2,786,055
Series E1(c)(d)	40,149	2,141,548
		4,927,603
Nonconvertible Preferred Stocks - 0.1%
Diversified Financial Services - 0.1%
Other Diversified Financial Services - 0.1%
Thriveworks TopCo LLC Series B (a)(c)(d)(e)	69,639	1,146,954

TOTAL PREFERRED STOCKS (Cost $6,021,044)		6,074,557

Money Market Funds - 4.8%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (f)	18,113,222	18,116,844
Fidelity Securities Lending Cash Central Fund 4.63% (f)(g)	63,164,293	63,170,610
TOTAL MONEY MARKET FUNDS (Cost $81,287,454)		81,287,454

TOTAL INVESTMENT IN SECURITIES - 103.4% (Cost $1,172,628,084)	1,766,227,452
NET OTHER ASSETS (LIABILITIES) - (3.4)%	(57,525,285)
NET ASSETS - 100.0%	1,708,702,167

Legend

(a)	Non-income producing

(b)	Security or a portion of the security is on loan at period end.

(c)	Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $6,074,557 or 0.4% of net assets.

(d)	Level 3 security

(e)	Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.

(f)

(g)	Investment made with cash collateral received from securities on loan.

Additional information on each restricted holding is as follows:
Security	Acquisition Date	Acquisition Cost ($)
Aledade, Inc. Series B1	5/07/21	2,000,000

Aledade, Inc. Series E1	5/20/22	1,999,998

Thriveworks TopCo LLC Series B	7/23/21 - 2/25/22	1,998,863

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	1,067,186	580,484,359	563,434,701	1,076,184	-	-	18,116,844	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	47,754,630	445,979,300	430,563,320	235,417	-	-	63,170,610	0.2%
Total	48,821,816	1,026,463,659	993,998,021	1,311,601	-	-	81,287,454

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	1,678,865,441	1,678,865,441	-	-

Preferred Stocks	6,074,557	-	-	6,074,557

Money Market Funds	81,287,454	81,287,454	-	-
Total Investments in Securities:	1,766,227,452	1,760,152,895	-	6,074,557

Health Care Services Portfolio

Medical Technology and Devices Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $61,908,240) - See accompanying schedule:
Unaffiliated issuers (cost $1,091,340,630)	$	1,684,939,998
Fidelity Central Funds (cost $81,287,454)		81,287,454


Total Investment in Securities (cost $1,172,628,084)			$	1,766,227,452
Receivable for investments sold				8,761,110
Receivable for fund shares sold				1,664,275
Dividends receivable				164,686
Distributions receivable from Fidelity Central Funds				60,883
Prepaid expenses				3,156
Other receivables				81,398
Total assets				1,776,962,960
Liabilities
Payable for investments purchased	$	2,292,067
Payable for fund shares redeemed		1,625,946
Accrued management fee		772,314
Other affiliated payables		289,699
Other payables and accrued expenses		113,586
Collateral on securities loaned		63,167,181
Total Liabilities				68,260,793
Net Assets			$	1,708,702,167
Net Assets consist of:
Paid in capital			$	1,155,599,730
Total accumulated earnings (loss)				553,102,437
Net Assets			$	1,708,702,167
Net Asset Value , offering price and redemption price per share ($1,708,702,167 ÷ 13,694,715 shares)			$	124.77

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	13,140,050
Income from Fidelity Central Funds (including $235,417 from security lending)				1,311,601
Total Income				14,451,651
Expenses
Management fee	$	8,157,383
Transfer agent fees		2,462,813
Accounting fees		440,095
Custodian fees and expenses		11,182
Independent trustees' fees and expenses		5,168
Registration fees		135,537
Audit		39,601
Legal		1,783
Miscellaneous		7,423
Total expenses before reductions		11,260,985
Expense reductions		(54,520)
Total expenses after reductions				11,206,465
Net Investment income (loss)				3,245,186
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		(18,499,864)
Foreign currency transactions		(1,200)
Total net realized gain (loss)				(18,501,064)
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		(28,481,279)
Assets and liabilities in foreign currencies		(180)
Total change in net unrealized appreciation (depreciation)				(28,481,459)
Net gain (loss)				(46,982,523)
Net increase (decrease) in net assets resulting from operations			$	(43,737,337)

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	3,245,186	$	2,679,968
Net realized gain (loss)		(18,501,064)		122,701,804
Change in net unrealized appreciation (depreciation)		(28,481,459)		56,927,180
Net increase (decrease) in net assets resulting from operations		(43,737,337)		182,308,952
Distributions to shareholders		(70,592,721)		(87,625,390)
Share transactions
Proceeds from sales of shares		1,010,359,737		148,662,940
Reinvestment of distributions		65,526,668		81,964,453
Cost of shares redeemed		(466,886,272)		(212,192,301)
Net increase (decrease) in net assets resulting from share transactions		609,000,133		18,435,092
Total increase (decrease) in net assets		494,670,075		113,118,654

Net Assets
Beginning of period		1,214,032,092		1,100,913,438
End of period	$	1,708,702,167	$	1,214,032,092

Other Information
Shares
Sold		7,599,624		1,120,061
Issued in reinvestment of distributions		474,418		621,521
Redeemed		(3,577,704)		(1,608,688)
Net increase (decrease)		4,496,338		132,894

Financial Highlights

Health Care Services Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	131.98	$	121.44	$	94.72	$	89.28	$	92.21
Income from Investment Operations
Net investment income (loss) B,C		.28		.29		.06		.23		.13
Net realized and unrealized gain (loss)		(.47)		20.01		27.59		5.50		8.27
Total from investment operations		(.19)		20.30		27.65		5.73		8.40
Distributions from net investment income		(.31)		(.22) D		(.93)		(.29)		(.10)
Distributions from net realized gain		(6.71)		(9.55) D		-		-		(11.23)
Total distributions		(7.02)		(9.76) E		(.93)		(.29)		(11.33)
Net asset value, end of period	$	124.77	$	131.98	$	121.44	$	94.72	$	89.28
Total Return F		(.64)%		16.85%		29.43%		6.39%		9.61%
Ratios to Average Net Assets C,G,H
Expenses before reductions		.73%		.71%		.73%		.75%		.76%
Expenses net of fee waivers, if any		.73%		.71%		.73%		.75%		.76%
Expenses net of all reductions		.73%		.71%		.73%		.75%		.76%
Net investment income (loss)		.21%		.22%		.05%		.25%		.14%
Supplemental Data
Net assets, end of period (000 omitted)	$	1,708,702	$	1,214,032	$	1,100,913	$	1,003,206	$	1,343,070
Portfolio turnover rate I		30%		35%		34%		37%		60%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D The amount shown reflects reclassifications related to book to tax differences that were made in the year shown.

E Total distributions per share do not sum due to rounding.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

I Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Medical Technology and Devices Portfolio	-11.64%	11.79%	15.99%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Medical Technology and Devices Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Medical Technology and Devices Portfolio

Market Recap:

Comments from Portfolio Manager Eddie Yoon:

For the fiscal year ending February 28, 2023, the fund returned -11.64%, outperforming the -13.45% result of the MSCI U.S. IMI Custom Health Care Technology and Equipment 25/50 Linked Index, but underperforming the broad-based S&P 500 ® index. The top contributor to performance versus the industry index were stock picks in health care equipment. An overweighting in life sciences tools & services and security selection in health care technology also helped. The fund's biggest individual relative contributor was an outsized stake in Penumbra, which gained about 18% the past year. The company was among our biggest holdings. Also bolstering performance was our overweighting in Boston Scientific, which gained 6%. Boston Scientific was among our largest holdings. Avoiding Baxter Intl, an index component that returned -52%, also helped relative performance. The fund's foreign holdings also contributed overall despite a broadly strong U.S. dollar. In contrast, the biggest detractor from performance versus the industry index was stock selection in life sciences tools & services. Weak stock selection in specialty stores and personal products - two groups that were not part of the index - also hindered the fund's relative result. The fund's biggest individual relative detractor was an outsized stake in Tandem Diabetes Care, which returned -68% the past 12 months. Also hindering performance was our overweighting in Nevro, which returned -56%. Also hurting performance was an underweighting in Dexcom, which gained roughly 7%. We decreased our position the past year.

Medical Technology and Devices Portfolio

Top Holdings (% of Fund's net assets)

Thermo Fisher Scientific, Inc.	16.3
Danaher Corp.	11.6
Boston Scientific Corp.	11.4
Stryker Corp.	5.7
Penumbra, Inc.	5.1
Insulet Corp.	4.6
IQVIA Holdings, Inc.	4.4
Masimo Corp.	3.5
Abbott Laboratories	3.5
ResMed, Inc.	3.3
	69.4

Industries (% of Fund's net assets)

Health Care Equipment & Supplies	48.2
Life Sciences Tools & Services	41.2
Biotechnology	4.6
Health Care Technology	4.2
Personal Products	0.6
Health Care Providers & Services	0.5
Textiles, Apparel & Luxury Goods	0.4
Specialty Retail	0.2
Professional Services	0.2
Pharmaceuticals	0.1

Medical Technology and Devices Portfolio

Showing Percentage of Net Assets

Common Stocks - 96.9%
	Shares	Value ($)
Biotechnology - 3.2%
Biotechnology - 3.2%
Abcam PLC ADR (a)	2,800,000	40,348,000
Exact Sciences Corp. (a)	600,000	37,398,000
Natera, Inc. (a)(b)	840,000	40,782,000
Repligen Corp. (a)(b)	600,000	104,622,000
Saluda Medical Pty Ltd. warrants (a)(c)(d)	235,185	585,611
		223,735,611
Health Care Equipment & Supplies - 47.7%
Health Care Equipment - 46.8%
Abbott Laboratories	2,340,000	238,024,800
Angelalign Technology, Inc. (e)	1,000,000	13,708,054
Boston Scientific Corp. (a)	16,800,000	784,896,000
DexCom, Inc. (a)	700,000	77,707,000
Inspire Medical Systems, Inc. (a)	250,000	64,982,500
Insulet Corp. (a)(b)	1,140,000	315,050,400
Intuitive Surgical, Inc. (a)	700,000	160,573,000
iRhythm Technologies, Inc. (a)	424,559	49,962,103
Masimo Corp. (a)	1,450,000	242,599,500
Nevro Corp. (a)(f)	2,000,000	62,880,000
Novocure Ltd. (a)	800,000	61,576,000
Outset Medical, Inc. (a)	1,000,000	22,810,000
Penumbra, Inc. (a)(b)	1,342,460	349,026,175
PROCEPT BioRobotics Corp. (a)(b)	1,280,000	47,936,000
ResMed, Inc.	1,063,647	226,556,811
Shockwave Medical, Inc. (a)	210,000	39,950,400
Stryker Corp.	1,500,000	394,320,000
Tandem Diabetes Care, Inc. (a)	2,180,000	78,174,800
		3,230,733,543
Health Care Supplies - 0.9%
Nanosonics Ltd. (a)	8,500,000	25,967,211
The Cooper Companies, Inc.	118,000	38,582,460
		64,549,671
TOTAL HEALTH CARE EQUIPMENT & SUPPLIES		3,295,283,214
Health Care Providers & Services - 0.3%
Health Care Services - 0.3%
LifeStance Health Group, Inc. (a)	3,861,743	19,772,124
Health Care Technology - 3.5%
Health Care Technology - 3.5%
DNA Script (a)(c)(d)	1,220	845,492
DNA Script (a)(c)(d)	4,668	3,235,046
Doximity, Inc. (a)(b)	1,080,000	36,320,400
Evolent Health, Inc. (a)	396,500	13,881,465
Medlive Technology Co. Ltd. (e)	5,000,000	6,102,377
Phreesia, Inc. (a)	1,670,000	61,456,000
Veeva Systems, Inc. Class A (a)	700,000	115,962,000
		237,802,780
Life Sciences Tools & Services - 41.2%
Life Sciences Tools & Services - 41.2%
10X Genomics, Inc. Class B (a)(e)	392,772	18,664,525
Agilent Technologies, Inc.	500,000	70,985,000
Bio-Techne Corp.	870,000	63,196,800
Bruker Corp.	1,800,000	124,056,000
Danaher Corp.	3,240,000	801,997,200
Eurofins Scientific SA	500,000	34,904,100
IQVIA Holdings, Inc. (a)	1,475,000	307,493,250
Lonza Group AG	90,000	53,607,754
Olink Holding AB ADR (a)(b)	1,227,800	28,779,632
Pacific Biosciences of California, Inc. (a)(b)	2,000,000	18,160,000
Sartorius Stedim Biotech	160,000	52,241,918
Seer, Inc. (a)(b)	2,800,000	11,452,000
Thermo Fisher Scientific, Inc.	2,080,000	1,126,860,800
West Pharmaceutical Services, Inc.	435,000	137,908,050
		2,850,307,029
Personal Products - 0.6%
Personal Products - 0.6%
The Beauty Health Co. (a)(b)	155,239	1,957,564
The Beauty Health Co. (a)(c)	3,000,000	37,830,000
		39,787,564
Professional Services - 0.2%
Research & Consulting Services - 0.2%
Clarivate Analytics PLC (a)(b)	1,500,000	15,195,000
Specialty Retail - 0.2%
Specialty Stores - 0.2%
Warby Parker, Inc. (a)(b)	1,200,000	15,612,000
TOTAL COMMON STOCKS (Cost $4,107,275,816)		6,697,495,322

Convertible Preferred Stocks - 3.0%
	Shares	Value ($)
Biotechnology - 1.4%
Biotechnology - 1.4%
Asimov, Inc. Series B (a)(c)(d)	97,985	4,990,376
Caris Life Sciences, Inc. Series D (a)(c)(d)	2,803,935	15,702,036
Element Biosciences, Inc. Series B (a)(c)(d)	2,385,223	39,236,918
ElevateBio LLC Series C (a)(c)(d)	214,700	682,746
Inscripta, Inc. Series D (a)(c)(d)	3,938,731	16,660,832
Saluda Medical Pty Ltd. Series D (a)(c)(d)	1,567,904	18,140,649
		95,413,557
Health Care Equipment & Supplies - 0.2%
Health Care Supplies - 0.2%
Kardium, Inc. Series D6 (a)(c)(d)	13,783,189	13,645,357
Health Care Providers & Services - 0.2%
Health Care Services - 0.2%
Conformal Medical, Inc. Series C (a)(c)(d)	2,605,625	9,276,025
dMed Biopharmaceutical Co. Ltd. Series C (a)(c)(d)	309,255	3,355,417
		12,631,442
Health Care Technology - 0.7%
Health Care Technology - 0.7%
Aledade, Inc.:
Series B1 (a)(c)(d)	175,232	9,346,875
Series E1 (c)(d)	58,567	3,123,964
DNA Script:
Series B (a)(c)(d)	59	40,889
Series C (a)(c)(d)	28,249	19,577,297
Omada Health, Inc. Series E (a)(c)(d)	2,182,939	7,814,922
PrognomIQ, Inc.:
Series A5 (a)(c)(d)	833,333	1,366,666
Series B (a)(c)(d)	2,735,093	6,372,767
Series C (c)(d)	752,098	2,000,581
		49,643,961
Pharmaceuticals - 0.1%
Pharmaceuticals - 0.1%
Galvanize Therapeutics Series B (c)(d)	3,641,139	6,153,525
Textiles, Apparel & Luxury Goods - 0.4%
Textiles - 0.4%
Freenome, Inc.:
Series C (a)(c)(d)	2,268,156	17,668,935
Series D (a)(c)(d)	1,325,855	10,832,235
		28,501,170
TOTAL CONVERTIBLE PREFERRED STOCKS (Cost $198,835,399)		205,989,012

Preferred Securities - 0.3%
	Principal Amount (g)	Value ($)
Health Care Equipment & Supplies - 0.3%
Health Care Supplies - 0.3%
Kardium, Inc. 0% (c)(d)(h) (Cost $19,551,861)	19,551,861	19,043,513

Money Market Funds - 1.7%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (i)	12,566,738	12,569,252
Fidelity Securities Lending Cash Central Fund 4.63% (i)(j)	104,968,993	104,979,490
TOTAL MONEY MARKET FUNDS (Cost $117,548,742)		117,548,742

TOTAL INVESTMENT IN SECURITIES - 101.9% (Cost $4,443,211,818)	7,040,076,589
NET OTHER ASSETS (LIABILITIES) - (1.9)%	(128,591,920)
NET ASSETS - 100.0%	6,911,484,669

Legend

(a)	Non-income producing

(b)	Security or a portion of the security is on loan at period end.

(c)	Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $267,528,674 or 3.9% of net assets.

(d)	Level 3 security

(e)

(f)	Affiliated company

(g)	Amount is stated in United States dollars unless otherwise noted.

(h)	Security is perpetual in nature with no stated maturity date.

(i)

(j)	Investment made with cash collateral received from securities on loan.

Additional information on each restricted holding is as follows:
Security	Acquisition Date	Acquisition Cost ($)
Aledade, Inc. Series B1	5/07/21	6,709,756

Aledade, Inc. Series E1	5/20/22	2,917,480

Asimov, Inc. Series B	10/29/21	9,081,318

Caris Life Sciences, Inc. Series D	5/11/21	22,711,874

Conformal Medical, Inc. Series C	7/24/20	9,554,996

dMed Biopharmaceutical Co. Ltd. Series C	12/01/20	4,392,395

DNA Script	12/17/21	4,714,776

DNA Script Series B	12/17/21	47,244

DNA Script Series C	10/01/21	24,572,393

Element Biosciences, Inc. Series B	12/13/19	12,500,000

ElevateBio LLC Series C	3/09/21	900,667

Freenome, Inc. Series C	8/14/20	14,999,996

Freenome, Inc. Series D	11/22/21	9,999,996

Galvanize Therapeutics Series B	3/29/22	6,303,849

Inscripta, Inc. Series D	11/13/20	18,000,001

Kardium, Inc. Series D6	12/30/20	14,001,515

Kardium, Inc. 0%	12/30/20	19,551,861

Omada Health, Inc. Series E	12/22/21	13,087,156

PrognomIQ, Inc. Series A5	8/20/20	503,333

PrognomIQ, Inc. Series B	9/11/20	6,249,999

PrognomIQ, Inc. Series C	2/16/22	2,301,420

Saluda Medical Pty Ltd. Series D	1/20/22	20,000,011

Saluda Medical Pty Ltd. warrants	1/20/22	0

The Beauty Health Co.	12/08/20	30,000,000

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	21,433,102	1,229,311,033	1,238,174,883	1,366,847	-	-	12,569,252	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	73,452,626	1,009,017,643	977,490,779	2,117,441	-	-	104,979,490	0.3%
Total	94,885,728	2,238,328,676	2,215,665,662	3,484,288	-	-	117,548,742

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Other Affiliated Issuers

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)
Nanosonics Ltd.	63,907,137	-	37,068,368	-	5,841,844	(6,713,402)	-
Nevro Corp.	91,776,000	63,146,247	30,147,923	-	(49,499,645)	(12,394,679)	62,880,000
Total	155,683,137	63,146,247	67,216,291	-	(43,657,801)	(19,108,081)	62,880,000

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	6,697,495,322	6,639,221,419	53,607,754	4,666,149

Convertible Preferred Stocks	205,989,012	-	-	205,989,012

Preferred Securities	19,043,513	-	-	19,043,513

Money Market Funds	117,548,742	117,548,742	-	-
Total Investments in Securities:	7,040,076,589	6,756,770,161	53,607,754	229,698,674

The following is a reconciliation of Investments in Securities for which Level 3 inputs were used in determining value:


Investments in Securities:
Convertible Preferred Stocks
Beginning Balance	$	240,783,918
Net Realized Gain (Loss) on Investment Securities		-
Net Unrealized Gain (Loss) on Investment Securities		(44,016,235)
Cost of Purchases		9,221,329
Proceeds of Sales		-
Amortization/Accretion		-
Transfers into Level 3		-
Transfers out of Level 3		-
Ending Balance	$	205,989,012
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at February 28, 2023	$	(44,016,235)
Other Investments in Securities
Beginning Balance	$	25,605,694
Net Realized Gain (Loss) on Investment Securities		-
Net Unrealized Gain (Loss) on Investment Securities		(1,896,032)
Cost of Purchases		-
Proceeds of Sales		-
Amortization/Accretion		-
Transfers into Level 3		-
Transfers out of Level 3		-
Ending Balance	$	23,709,662
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at February 28, 2023	$	(1,896,032)
The information used in the above reconciliation represents fiscal year to date activity for any Investments in Securities identified as using Level 3 inputs at either the beginning or the end of the current fiscal period. Cost of purchases and proceeds of sales may include securities received and/or delivered through in-kind transactions. Transfers into Level 3 were attributable to a lack of observable market data resulting from decreases in market activity, decreases in liquidity, security restructurings or corporate actions. Transfers out of Level 3 were attributable to observable market data becoming available for those securities. Transfers in or out of Level 3 represent the beginning value of any Security or Instrument where a change in the pricing level occurred from the beginning to the end of the period. The cost of purchases and the proceeds of sales may include securities received or delivered through corporate actions or exchanges. Realized and unrealized gains (losses) disclosed in the reconciliation are included in Net Gain (Loss) on the Fund's Statement of Operations.

Medical Technology and Devices Portfolio

Pharmaceuticals Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $103,361,313) - See accompanying schedule:
Unaffiliated issuers (cost $4,207,610,407)	$	6,859,647,847
Fidelity Central Funds (cost $117,548,742)		117,548,742
Other affiliated issuers (cost $118,052,669)		62,880,000


Total Investment in Securities (cost $4,443,211,818)			$	7,040,076,589
Foreign currency held at value (cost $84)				83
Receivable for investments sold				60,512,509
Receivable for fund shares sold				734,870
Dividends receivable				851,175
Distributions receivable from Fidelity Central Funds				376,931
Prepaid expenses				15,703
Other receivables				230,636
Total assets				7,102,798,496
Liabilities
Payable for investments purchased	$	66,888,599
Payable for fund shares redeemed		14,995,911
Accrued management fee		3,158,294
Other affiliated payables		1,025,159
Other payables and accrued expenses		274,939
Collateral on securities loaned		104,970,925
Total Liabilities				191,313,827
Net Assets			$	6,911,484,669
Net Assets consist of:
Paid in capital			$	4,664,629,971
Total accumulated earnings (loss)				2,246,854,698
Net Assets			$	6,911,484,669
Net Asset Value , offering price and redemption price per share ($6,911,484,669 ÷ 112,133,731 shares)			$	61.64

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	19,804,120
Income from Fidelity Central Funds (including $2,117,441 from security lending)				3,484,288
Total Income				23,288,408
Expenses
Management fee	$	38,848,557
Transfer agent fees		11,566,502
Accounting fees		1,086,483
Custodian fees and expenses		75,956
Independent trustees' fees and expenses		25,455
Registration fees		32,525
Audit		41,138
Legal		4,741
Interest		2,108
Miscellaneous		41,425
Total expenses before reductions		51,724,890
Expense reductions		(266,416)
Total expenses after reductions				51,458,474
Net Investment income (loss)				(28,170,066)
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		(202,286,083)
Affiliated issuers		(43,657,801)
Foreign currency transactions		(91,142)
Total net realized gain (loss)				(246,035,026)
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		(752,446,539)
Affiliated issuers		(19,108,081)
Assets and liabilities in foreign currencies		(7,069)
Total change in net unrealized appreciation (depreciation)				(771,561,689)
Net gain (loss)				(1,017,596,715)
Net increase (decrease) in net assets resulting from operations			$	(1,045,766,781)

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	(28,170,066)	$	(44,939,672)
Net realized gain (loss)		(246,035,026)		498,712,415
Change in net unrealized appreciation (depreciation)		(771,561,689)		(241,663,649)
Net increase (decrease) in net assets resulting from operations		(1,045,766,781)		212,109,094
Distributions to shareholders		(137,786,409)		(808,325,364)
Share transactions
Proceeds from sales of shares		418,873,849		1,949,163,820
Reinvestment of distributions		128,702,740		757,192,690
Cost of shares redeemed		(1,358,373,047)		(1,877,605,232)
Net increase (decrease) in net assets resulting from share transactions		(810,796,458)		828,751,278
Total increase (decrease) in net assets		(1,994,349,648)		232,535,008

Net Assets
Beginning of period		8,905,834,317		8,673,299,309
End of period	$	6,911,484,669	$	8,905,834,317

Other Information
Shares
Sold		6,616,291		24,345,738
Issued in reinvestment of distributions		1,786,046		9,855,790
Redeemed		(22,012,597)		(24,120,700)
Net increase (decrease)		(13,610,260)		10,080,828

Financial Highlights

Medical Technology and Devices Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	70.83	$	74.99	$	55.88	$	52.92	$	46.09
Income from Investment Operations
Net investment income (loss) B,C		(.24)		(.37)		(.24)		(.08)		(.04)
Net realized and unrealized gain (loss)		(7.84)		2.97		24.19		4.10		10.40
Total from investment operations		(8.08)		2.60		23.95		4.02		10.36
Distributions from net realized gain		(1.11)		(6.76)		(4.84)		(1.06)		(3.53)
Total distributions		(1.11)		(6.76)		(4.84)		(1.06)		(3.53)
Net asset value, end of period	$	61.64	$	70.83	$	74.99	$	55.88	$	52.92
Total Return D		(11.64)%		2.95%		44.20%		7.46%		23.85%
Ratios to Average Net Assets C,E,F
Expenses before reductions		.70%		.68%		.70%		.71%		.73%
Expenses net of fee waivers, if any		.70%		.68%		.70%		.71%		.73%
Expenses net of all reductions		.70%		.68%		.70%		.71%		.73%
Net investment income (loss)		(.38)%		(.46)%		(.36)%		(.15)%		(.07)%
Supplemental Data
Net assets, end of period (000 omitted)	$	6,911,485	$	8,905,834	$	8,673,299	$	6,058,766	$	6,787,645
Portfolio turnover rate G		37%		32%		58%		35%		43%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

G Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Pharmaceuticals Portfolio	1.60%	10.48%	10.57%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Pharmaceuticals Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Pharmaceuticals Portfolio

Market Recap:

Comments from Portfolio Manager Karim Suwwan de Felipe:

For the fiscal year ending February 28, 2023, the fund gained 1.60%, outperforming the -1.60% result of the MSCI North America IMI + ADR Custom Pharmaceuticals 25/50 Linked Index, as well as the broad-based S&P 500 ® index. Versus the industry index, security selection was the primary contributor, led by the pharmaceuticals sector. The fund's largest individual relative contributor was an outsized stake in Eli Lilly, which gained roughly 25% the past year. It was the fund's largest holding. Also helping performance was an underweighting in GSK, which returned -32%. Avoiding Pfizer, an index component that returned about -11%, also helped relative performance. Conversely, the largest detractor from performance versus the industry index were stock picks in life sciences tools & services. Weak stock picks in health care equipment also hurt the fund's relative performance. Our non-index investment in Roche Holdings was the fund's biggest individual relative detractor, due to its roughly -23% result. This was among our largest holdings. Another notable relative detractor was our lighter-than-index stake in Merck (+43%). The company was among the fund's biggest holdings. Also hurting performance was an underweighting in Novo-Nordisk, which gained about 39%. The company was among the largest holdings at period end. The fund's foreign holdings also detracted overall, partly due to a broadly strong U.S. dollar. Notable changes in positioning include increased exposure to the biotechnology subindustry.

Pharmaceuticals Portfolio

Top Holdings (% of Fund's net assets)

Eli Lilly & Co.	14.3
AstraZeneca PLC sponsored ADR	10.9
Novo Nordisk A/S Series B sponsored ADR	8.8
Sanofi SA sponsored ADR	8.2
Merck & Co., Inc.	7.1
Royalty Pharma PLC	4.2
Roche Holding AG (participation certificate)	4.0
Gilead Sciences, Inc.	3.8
UCB SA	3.4
Merck KGaA	3.1
	67.8

Industries (% of Fund's net assets)

Pharmaceuticals	74.4
Biotechnology	20.9
Health Care Providers & Services	1.9
Diversified Financial Services	0.3
Software	0.0
Food & Staples Retailing	0.0

Percentages shown as 0.0% may reflect amounts less than 0.05%.

Geographic Diversification (% of Fund's net assets)

* Includes Short-Term investments and Net Other Assets (Liabilities).

Percentages are based on country or territory of incorporation and are adjusted for the effect of derivatives, if applicable.

Pharmaceuticals Portfolio

Showing Percentage of Net Assets

Common Stocks - 97.0%
	Shares	Value ($)
Biotechnology - 20.7%
Biotechnology - 20.7%
2seventy bio, Inc. (a)	183,600	2,476,764
ADC Therapeutics SA (a)(b)	419,700	1,510,920
Alnylam Pharmaceuticals, Inc. (a)	29,471	5,642,223
Apellis Pharmaceuticals, Inc. (a)	60,400	3,954,992
Arcus Biosciences, Inc. (a)	115,100	2,095,971
Argenx SE (a)	15,200	5,532,882
Argenx SE ADR (a)	11,000	4,026,220
Ascendis Pharma A/S sponsored ADR (a)	40,500	4,499,145
Avidity Biosciences, Inc. (a)	302,800	7,176,360
Biogen, Inc. (a)	61,100	16,488,446
BioInvent International AB (a)	396,505	1,096,563
Blueprint Medicines Corp. (a)	153,900	6,520,743
Cullinan Oncology, Inc. (a)	88,100	994,649
Cytokinetics, Inc. (a)	67,100	2,909,456
Galapagos NV sponsored ADR (a)	36,900	1,383,197
Generation Bio Co. (a)	387,856	1,535,910
Gilead Sciences, Inc.	356,100	28,676,733
Intellia Therapeutics, Inc. (a)	15,400	618,618
iTeos Therapeutics, Inc. (a)	116,000	2,054,360
Kalvista Pharmaceuticals, Inc. (a)	374,800	2,747,284
Leap Therapeutics, Inc. warrants 1/31/26 (a)	606,000	22,749
Legend Biotech Corp. ADR (a)	293,400	13,549,212
Moderna, Inc. (a)	15,100	2,096,031
Natera, Inc. (a)	96,000	4,660,800
Oxurion NV (a)(b)	3,128,819	41,698
PepGen, Inc.	243,600	3,719,772
Prothena Corp. PLC (a)	104,100	5,804,616
PTC Therapeutics, Inc. (a)	49,500	2,161,665
Relay Therapeutics, Inc. (a)(b)	168,000	2,713,200
Sarepta Therapeutics, Inc. (a)	101,100	12,347,343
Synlogic, Inc. (a)	520,500	364,350
uniQure B.V. (a)	150,300	3,150,288
Xencor, Inc. (a)	123,168	3,957,388
XOMA Corp. (a)(b)	53,300	1,134,224
		157,664,772
Food & Staples Retailing - 0.0%
Drug Retail - 0.0%
MedAvail Holdings, Inc. (a)	3,333	1,239
Health Care Providers & Services - 1.9%
Health Care Services - 1.9%
Cigna Group	49,500	14,458,950
Pharmaceuticals - 74.4%
Pharmaceuticals - 74.4%
Acelyrin, Inc. (c)	317,157	1,972,748
Acelyrin, Inc. rights (a)(c)	38,539	228,402
Arvinas Holding Co. LLC (a)	55,600	1,704,140
AstraZeneca PLC sponsored ADR	1,268,300	82,667,794
Axsome Therapeutics, Inc. (a)(b)	43,400	2,959,446
Bristol-Myers Squibb Co.	234,280	16,155,949
Edgewise Therapeutics, Inc. (a)	532,200	5,098,476
Eli Lilly & Co.	349,561	108,790,372
GSK PLC sponsored ADR	345,060	11,825,206
Harmony Biosciences Holdings, Inc. (a)	73,077	3,217,580
Intra-Cellular Therapies, Inc. (a)	11,200	549,136
Jazz Pharmaceuticals PLC (a)	31,600	4,436,640
Johnson & Johnson	41,550	6,367,953
Merck & Co., Inc.	508,136	53,984,369
Merck KGaA	124,300	23,579,523
Novartis AG sponsored ADR	150,096	12,626,076
Novo Nordisk A/S Series B sponsored ADR	477,800	67,365,022
Reata Pharmaceuticals, Inc. (a)	52,100	1,623,957
Roche Holding AG (participation certificate)	105,596	30,447,443
Royalty Pharma PLC	888,500	31,852,725
Sanofi SA sponsored ADR	1,329,022	62,264,681
Sosei Group Corp. (a)	181,400	2,939,065
Structure Therapeutics, Inc. ADR	98,000	2,504,880
UCB SA	302,000	25,994,839
Zoetis, Inc. Class A	29,500	4,926,500
		566,082,922
TOTAL COMMON STOCKS (Cost $579,287,424)		738,207,883

Convertible Preferred Stocks - 0.5%
	Shares	Value ($)
Biotechnology - 0.2%
Biotechnology - 0.2%
Castle Creek Biosciences, Inc.:
Series D1 (c)(d)	6,308	1,285,192
Series D2 (c)(d)	85	17,318
		1,302,510
Diversified Financial Services - 0.3%
Other Diversified Financial Services - 0.3%
Paragon Biosciences Emalex Capital, Inc.:
Series C (a)(c)(d)	158,879	1,720,660
Series D1 (c)(d)	14,400	155,952
Series D2 (c)(d)	22,477	243,426
		2,120,038
Pharmaceuticals - 0.0%
Pharmaceuticals - 0.0%
Castle Creek Pharmaceutical Holdings, Inc. Series C (a)(c)(d)	200	44,304
Software - 0.0%
Systems Software - 0.0%
Evozyne LLC Series A (a)(c)(d)	5,900	91,981
TOTAL CONVERTIBLE PREFERRED STOCKS (Cost $3,635,756)		3,558,833

Money Market Funds - 3.1%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (e)	16,714,569	16,717,912
Fidelity Securities Lending Cash Central Fund 4.63% (e)(f)	7,205,438	7,206,158
TOTAL MONEY MARKET FUNDS (Cost $23,924,070)		23,924,070

TOTAL INVESTMENT IN SECURITIES - 100.6% (Cost $606,847,250)	765,690,786
NET OTHER ASSETS (LIABILITIES) - (0.6)%	(4,511,787)
NET ASSETS - 100.0%	761,178,999

Legend

(a)	Non-income producing

(b)	Security or a portion of the security is on loan at period end.

(c)	Level 3 security

(d)	Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $3,558,833 or 0.5% of net assets.

(e)

(f)	Investment made with cash collateral received from securities on loan.

Additional information on each restricted holding is as follows:
Security	Acquisition Date	Acquisition Cost ($)
Castle Creek Biosciences, Inc. Series D1	4/19/22	1,356,409

Castle Creek Biosciences, Inc. Series D2	6/28/21	14,700

Castle Creek Pharmaceutical Holdings, Inc. Series C	12/09/19	82,370

Evozyne LLC Series A	4/09/21	132,573

Paragon Biosciences Emalex Capital, Inc. Series C	2/26/21	1,700,005

Paragon Biosciences Emalex Capital, Inc. Series D1	10/21/22	155,952

Paragon Biosciences Emalex Capital, Inc. Series D2	5/18/22	193,747

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	10,726,575	345,673,519	339,682,182	260,885	-	-	16,717,912	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	7,039,136	316,048,806	315,881,784	70,984	-	-	7,206,158	0.0%
Total	17,765,711	661,722,325	655,563,966	331,869	-	-	23,924,070

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Other Affiliated Issuers

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)
Oxurion NV	-	4,984,659	-	-	-	(4,942,961)	-
Total	-	4,984,659	-	-	-	(4,942,961)	-

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	738,207,883	700,003,659	36,003,074	2,201,150

Convertible Preferred Stocks	3,558,833	-	-	3,558,833

Money Market Funds	23,924,070	23,924,070	-	-
Total Investments in Securities:	765,690,786	723,927,729	36,003,074	5,759,983

Pharmaceuticals Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $6,996,498) - See accompanying schedule:
Unaffiliated issuers (cost $582,923,180)	$	741,766,716
Fidelity Central Funds (cost $23,924,070)		23,924,070


Total Investment in Securities (cost $606,847,250)			$	765,690,786
Cash				159,847
Foreign currency held at value (cost $412)				407
Receivable for investments sold				1,230,882
Receivable for fund shares sold				248,073
Dividends receivable				2,043,399
Reclaims receivable				1,581,798
Distributions receivable from Fidelity Central Funds				20,089
Prepaid expenses				2,521
Other receivables				152,095
Total assets				771,129,897
Liabilities
Payable for investments purchased	$	1,626,236
Payable for fund shares redeemed		392,504
Accrued management fee		346,935
Other affiliated payables		140,229
Other payables and accrued expenses		239,544
Collateral on securities loaned		7,205,450
Total Liabilities				9,950,898
Net Assets			$	761,178,999
Net Assets consist of:
Paid in capital			$	568,675,833
Total accumulated earnings (loss)				192,503,166
Net Assets			$	761,178,999
Net Asset Value , offering price and redemption price per share ($761,178,999 ÷ 34,967,627 shares)			$	21.77

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	15,133,055
Foreign Tax Reclaims				1,005,089
Interest				64
Income from Fidelity Central Funds (including $70,984 from security lending)				331,869
Income before foreign taxes withheld			$	16,470,077
Less foreign taxes withheld				(1,896,569)
Total Income				14,573,508
Expenses
Management fee	$	4,390,775
Transfer agent fees		1,461,483
Accounting fees		264,946
Custodian fees and expenses		126,989
Independent trustees' fees and expenses		2,865
Registration fees		42,492
Audit		55,353
Legal		5,429
Interest		3,363
Miscellaneous		4,916
Total expenses before reductions		6,358,611
Expense reductions		(29,167)
Total expenses after reductions				6,329,444
Net Investment income (loss)				8,244,064
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		67,953,495
Foreign currency transactions		71,322
Total net realized gain (loss)				68,024,817
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		(55,955,025)
Affiliated issuers		(4,942,961)
Assets and liabilities in foreign currencies		(71,565)
Total change in net unrealized appreciation (depreciation)				(60,969,551)
Net gain (loss)				7,055,266
Net increase (decrease) in net assets resulting from operations			$	15,299,330

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	8,244,064	$	9,312,735
Net realized gain (loss)		68,024,817		66,607,987
Change in net unrealized appreciation (depreciation)		(60,969,551)		(29,793,616)
Net increase (decrease) in net assets resulting from operations		15,299,330		46,127,106
Distributions to shareholders		(41,990,940)		(87,692,898)
Share transactions
Proceeds from sales of shares		164,880,948		223,427,519
Reinvestment of distributions		39,396,332		83,261,883
Cost of shares redeemed		(351,154,587)		(163,755,378)
Net increase (decrease) in net assets resulting from share transactions		(146,877,307)		142,934,024
Total increase (decrease) in net assets		(173,568,917)		101,368,232

Net Assets
Beginning of period		934,747,916		833,379,684
End of period	$	761,178,999	$	934,747,916

Other Information
Shares
Sold		7,124,169		9,855,327
Issued in reinvestment of distributions		1,698,146		3,596,826
Redeemed		(15,341,002)		(6,801,557)
Net increase (decrease)		(6,518,687)		6,650,596

Financial Highlights

Pharmaceuticals Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	22.53	$	23.92	$	21.71	$	21.07	$	18.82
Income from Investment Operations
Net investment income (loss) B,C		.23		.27		.27		.29		.29
Net realized and unrealized gain (loss)		.19		.97		4.04		2.29		2.34
Total from investment operations		.42		1.24		4.31		2.58		2.63
Distributions from net investment income		(.30)		(.28)		(.31)		(.31)		(.28)
Distributions from net realized gain		(.88)		(2.35)		(1.79)		(1.64)		(.10)
Total distributions		(1.18)		(2.63)		(2.10)		(1.94) D		(.38)
Net asset value, end of period	$	21.77	$	22.53	$	23.92	$	21.71	$	21.07
Total Return E		1.60%		5.15%		20.46%		12.06%		14.15%
Ratios to Average Net Assets C,F,G
Expenses before reductions		.76%		.75%		.77%		.78%		.80%
Expenses net of fee waivers, if any		.76%		.75%		.77%		.78%		.79%
Expenses net of all reductions		.76%		.75%		.76%		.77%		.79%
Net investment income (loss)		.99%		1.10%		1.13%		1.36%		1.48%
Supplemental Data
Net assets, end of period (000 omitted)	$	761,179	$	934,748	$	833,380	$	764,285	$	747,604
Portfolio turnover rate H		45%		29%		32%		52%		55%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Total distributions per share do not sum due to rounding.

E Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

H Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Report of Independent Registered Public Accounting Firm

For the period ended February 28, 2023

1. Organization.

Biotechnology Portfolio, Health Care Portfolio, Health Care Services Portfolio, Medical Technology and Devices Portfolio, and Pharmaceuticals Portfolio (the Funds) are non-diversified funds of Fidelity Select Portfolios (the Trust). The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust. The Funds invest primarily in securities of companies whose principal business activities fall within specific industries. Each Fund is authorized to issue an unlimited number of shares. Share transactions on the Statement of Changes in Net Assets may contain exchanges between affiliated funds.

2. Investments in Fidelity Central Funds.

Fidelity Central Fund	Investment Manager	Investment Objective	Investment Practices	Expense Ratio A
Fidelity Money Market Central Funds	Fidelity Management & Research Company LLC (FMR)	Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity.	Short-term Investments	Less than .005%

A Expenses expressed as a percentage of average net assets and are as of each underlying Central Fund's most recent annual or semi-annual shareholder report.

3. Significant Accounting Policies.

Each Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:

Level 1 - unadjusted quoted prices in active markets for identical investments

Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)

Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value each Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing service on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, ETFs and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy. Securities, including private placements or other restricted securities, for which observable inputs are not available are valued using alternate valuation approaches, including the market approach, the income approach and cost approach, and are categorized as Level 3 in the hierarchy. The market approach considers factors including the price of recent investments in the same or a similar security or financial metrics of comparable securities. The income approach considers factors including expected future cash flows, security specific risks and corresponding discount rates. The cost approach considers factors including the value of the security's underlying assets and liabilities.

Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing services or from brokers who make markets in such securities. Preferred securities are valued by pricing services who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing services. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.

The following provides information on Level 3 securities held by the Fund that were valued at period end based on unobservable inputs. These amounts exclude valuations provided by a broker.

Biotechnology Portfolio:

Asset Type	Fair Value	Valuation Technique(s)	Unobservable Input	Amount or Range/Weighted Average	Impact to Valuation from an Increase in Input A
Equities	$171,404,837	Market comparable	Enterprise value/Revenue multiple (EV/R)	18.0	Increase
		Recovery value	Recovery value	$0.00 - $5.51 / $5.50	Increase
		Market Approach	Transaction price	$2.42 - $105.86 / $46.47	Increase
			Discount rate	4.7% - 40.0% / 32.0%	Decrease
			Parity Price	$0.00	Increase
		Discounted cash flow	Discount rate	4.9% - 14.1% / 10.5%	Decrease
			Probability rate	0.0% - 90.0% / 39.0%	Increase
			Term	0.1 - 7.8 / 4.3	Increase
		Black scholes	Discount rate	4.2% - 4.4% / 4.4%	Increase
			Volatility	80.0% - 85.0% / 82.8%	Increase
			Term	2.0 - 3.0 / 3.0	Increase

Health Care Portfolio:

Asset Type	Fair Value	Valuation Technique(s)	Unobservable Input	Amount or Range/Weighted Average	Impact to Valuation from an Increase in Input A
Equities	$ 109,429,633	Market comparable	Enterprise value/Revenue multiple (EV/R)	3.6 - 18.0/6.7	Increase
		Recovery Value	Recovery Value	$5.51	Increase
		Market Approach	Transaction price Discount rate	$7.75 - $20.56 / $13.55 20.0%-50.0% / 31.0%	Increase Decrease
		Black scholes	Discount rate	4.3%-4.9% / 4.5%	Increase
			Term	1.5-4.0/3.2	Increase
			Volatility	45.0%-90.0% / 52.3%	Increase

A Represents the directional change in the fair value of the Level 3 investments that could have resulted from an increase in the corresponding input as of period end. A decrease to the unobservable input would have had the opposite effect. Significant changes in these inputs may have resulted in a significantly higher or lower fair value measurement at period end.

Medical Technology and Devices Portfolio:

Asset Type	Fair Value	Valuation Technique(s)	Unobservable Input	Amount or Range/Weighted Average	Impact to Valuation from an Increase in Input A
Equities	$210,655,161	Market Comparable	Enterprise value/Revenue multiple (EV/R)	3.6% - 18.0 / 6.4	Increase
		Market approach	Transaction price	$1.02 - $20.56 / $11.75	Increase
			Discount rate	15.0% - 50.0% / 23.6%	Decrease
		Discounted cash flow	Weighted average cost of capital (WACC)	28.3%	Decrease
			Exit multiple	2.0	Increase
		Black scholes	Discount rate	4.3% - 4.9% /4.6%	Increase
			Volatility	55.0% - 80.0% /67.3%	Increase
			Term	1.5 - 4.0 / 2.5	Increase
Preferred Securities	$19,043,513	Market approach	Transaction price	$100.00	Increase
		Black scholes	Discount rate	4.4%	Increase
			Volatility	70.0%	Increase
			Term	3.0	Increase

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. The aggregate value of investments by input level as of February 28, 2023, as well as a roll forward of Level 3 investments, is included at the end of each Fund's Schedule of Investments.

Investment Transactions and Income. For financial reporting purposes, the Funds' investment holdings and NAV include trades executed through the end of the last business day of the period. The NAV per share for processing shareholder transactions is calculated as of the close of business of the New York Stock Exchange (NYSE), normally 4:00 p.m. Eastern time and includes trades executed through the end of the prior business day. Gains and losses on securities sold are determined on the basis of identified cost and for certain Funds include proceeds received from litigation. Commissions paid to certain brokers with whom the investment adviser, or its affiliates, places trades on behalf of a fund include an amount in addition to trade execution, which may be rebated back to a fund. Any such rebates are included in net realized gain (loss) on investments in the Statement of Operations. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities where the ex-dividend date may have passed, which are recorded as soon as the Funds are informed of the ex-dividend date. Non-cash dividends included in dividend income, if any, are recorded at the fair market value of the securities received. Income and capital gain distributions from Fidelity Central Funds, if any, are recorded on the ex-dividend date. Interest income is accrued as earned and includes coupon interest and amortization of premium and accretion of discount on debt securities as applicable. Investment income is recorded net of foreign taxes withheld where recovery of such taxes is uncertain. Funds may file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. Any withholding tax reclaims income is included in the Statement of Operations in dividends or foreign tax reclaims. Any receivables for withholding tax reclaims are included in the Statement of Assets and Liabilities in dividends receivable or reclaims receivable.

Biotechnology Portfolio	$1,065,322
Health Care Portfolio	702,098
Health Care Services Portfolio	79,036
Medical Technology and Devices Portfolio	230,636
Pharmaceuticals Portfolio	144,281

Distributions are declared and recorded on the ex-dividend date. Income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP. These differences resulted in distribution reclassifications. In addition, certain Funds claimed a portion of the payment made to redeeming shareholders as a distribution for income tax purposes.

Book-tax differences are primarily due to foreign currency transactions, passive foreign investment companies (PFIC), deferred Trustee compensation, capital loss carryforwards, partnerships, net operating losses and losses deferred due to wash sales and excise tax regulations.

As of period end, the cost and unrealized appreciation (depreciation) in securities, and derivatives if applicable, for federal income tax purposes were as follows for each Fund:

	Tax cost	Gross unrealized appreciation	Gross unrealized depreciation	Net unrealized appreciation (depreciation)
Biotechnology Portfolio	$4,168,288,756	$1,702,606,798	$(546,308,089)	$1,156,298,709)
Health Care Portfolio	5,843,402,990	2,997,884,694	(506,308,202)	2,491,576,492
Health Care Services Portfolio	1,188,870,647	654,128,922	(76,772,117)	577,356,805
Medical Technology and Devices Portfolio	4,456,431,098	2,844,407,593	(260,762,102)	2,583,645,491
Pharmaceuticals Portfolio	608,145,883	208,618,302	(51,073,399)	157,544,903

The tax-based components of distributable earnings as of period end were as follows for each Fund:

	Undistributed long-term capital gain	Capital loss carryforward	Net unrealized appreciation (depreciation) on securities and other investments
Biotechnology Portfolio	$-	$(648,368,714)	$1,156,284,868
Health Care Portfolio	-	(82,842,812)	2,491,637,226
Health Care Services Portfolio	-	-	577,354,880
Medical Technology and Devices Portfolio	-	(330,894,459)	2,583,640,172
Pharmaceuticals Portfolio	35,641,716	-	157,539,749

	Short-term	Long-term	Total capital loss carryforward
Biotechnology Portfolio	$(486,419,734)	$(161,948,980)	$(648,368,714)
Health Care Portfolio	(82,842,812)	-	(82,842,812)
Medical Technology and Devices Portfolio	(323,788,266)	(7,106,193)	(330,894,459)

Certain of the Funds intend to elect to defer to the next fiscal year capital losses recognized during the period November 1, 2022 to February 28, 2023 and ordinary losses recognized during the period of January 1, 2023 to February 28, 2023. Loss deferrals were as follows:

	Capital Losses	Ordinary Losses
Biotechnology Portfolio	$-	$(2,587,831)
Health Care Portfolio	-	(12,417,992)
Health Care Services Portfolio	(23,317,441)	(854,077)
Medical Technology and Devices Portfolio	-	(5,653,348)
Pharmaceuticals Portfolio	-	(529,772)

The tax character of distributions paid was as follows:

February 28, 2023
	Ordinary Income	Long-term Capital Gains	Total
Health Care Portfolio	-	185,553,756	185,553,756
Health Care Services Portfolio	6,851,701	63,741,020	70,592,721
Medical Technology and Devices Portfolio	-	137,786,409	137,786,409
Pharmaceuticals Portfolio	10,747,779	31,243,161	41,990,940

February 28, 2022
	Ordinary Income	Long-term Capital Gains	Total
Biotechnology Portfolio	$44,710,367	$906,920,364	$951,630,731
Health Care Portfolio	30,213,050	899,646,185	929,859,235
Health Care Services Portfolio	2,649,600	84,975,790	87,625,390
Medical Technology and Devices Portfolio	80,106,652	728,218,712	808,325,364
Pharmaceuticals Portfolio	14,327,993	73,364,905	87,692,898

Consolidated Subsidiary. The Funds included in the table below hold certain investments through a wholly-owned subsidiary ("Subsidiary"), which may be subject to federal and state taxes upon disposition.

As of period end, investments in Subsidiaries were as follows:

	$ Amount	% of Net Assets
Biotechnology Portfolio	79,959,659	1.61
Health Care Portfolio	7,794,757	.10
Health Care Services Portfolio	1,146,954	.07

The financial statements have been consolidated to include the Subsidiary accounts where applicable. Accordingly, all inter-company transactions and balances have been eliminated.

At period end, any estimated tax liability for these investments is presented as "Deferred taxes" in the Statement of Assets and Liabilities and included in "Change in net unrealized appreciation (depreciation) on investment securities" in the Statement of Operations. The tax liability incurred may differ materially depending on conditions when these investments are disposed. Any cash held by a Subsidiary is restricted as to its use and is presented as "Restricted cash" in the Statement of Assets and Liabilities, if applicable.

4. Purchases and Sales of Investments.

Purchases and sales of securities, other than short-term securities and in-kind transactions, as applicable, are noted in the table below.

	Purchases ($)	Sales ($)
Biotechnology Portfolio	2,560,920,434	2,902,731,897
Health Care Portfolio	3,354,725,863	3,936,409,570
Health Care Services Portfolio	990,960,891	452,917,413
Medical Technology and Devices Portfolio	2,735,274,233	3,629,714,765
Pharmaceuticals Portfolio	372,188,874	556,621,213

5. Fees and Other Transactions with Affiliates.

	Individual Rate	Group Rate	Total
Biotechnology Portfolio	.30%	.23%	.53%
Health Care Portfolio	.30%	.23%	.53%
Health Care Services Portfolio	.30%	.23%	.53%
Medical Technology and Devices Portfolio	.30%	.23%	.53%
Pharmaceuticals Portfolio	.30%	.23%	.53%

Transfer Agent Fees. Fidelity Investments Institutional Operations Company LLC (FIIOC), an affiliate of the investment adviser, is the Funds' transfer, dividend disbursing and shareholder servicing agent. FIIOC receives account fees and asset-based fees that vary according to account size and type of account. FIIOC pays for typesetting, printing and mailing of shareholder reports, except proxy statements. For the period, transfer agent fees were equivalent to the following annual rates expressed as a percentage of average net assets:

Biotechnology Portfolio	.16%
Health Care Portfolio	.14%
Health Care Services Portfolio	.16%
Medical Technology and Devices Portfolio	.16%
Pharmaceuticals Portfolio	.18%

	% of Average Net Assets
Biotechnology Portfolio	.02
Health Care Portfolio	.01
Health Care Services Portfolio	.03
Medical Technology and Devices Portfolio	.01
Pharmaceuticals Portfolio	.03

	Amount
Biotechnology Portfolio	$181,009
Health Care Portfolio	71,796
Health Care Services Portfolio	17,269
Medical Technology and Devices Portfolio	54,685
Pharmaceuticals Portfolio	10,984

	Borrower or Lender	Average Loan Balance	Weighted Average Interest Rate	Interest Expense
Health Care Portfolio	Borrower	$6,682,938	1.56%	$4,620
Medical Technology and Devices Portfolio	Borrower	$8,557,857	1.27%	$2,108
Pharmaceuticals Portfolio	Borrower	$13,288,500	2.28%	$3,363

	Purchases ($)	Sales ($)	Realized Gain (Loss) ($)
Biotechnology Portfolio	133,000,609	166,195,767	(10,338,109)
Health Care Portfolio	225,043,889	352,657,619	61,499,881
Health Care Services Portfolio	101,703,304	75,854,331	16,713,553
Medical Technology and Devices Portfolio	124,184,811	173,350,227	47,346
Pharmaceuticals Portfolio	41,271,572	51,407,690	5,208,222

6. Committed Line of Credit.

	Amount
Biotechnology Portfolio	$9,236
Health Care Portfolio	15,190
Health Care Services Portfolio	2,581
Medical Technology and Devices Portfolio	13,710
Pharmaceuticals Portfolio	1,500

7. Security Lending.

	Total Security Lending Fees Paid to NFS	Security Lending Income From Securities Loaned to NFS	Value of Securities Loaned to NFS at Period End
Biotechnology Portfolio	$739,889	$101,109	$492,191
Health Care Portfolio	$183,363	$50,233	$-
Health Care Services Portfolio	$24,291	$8,760	$-
Medical Technology and Devices Portfolio	$222,443	$13,812	$-
Pharmaceuticals Portfolio	$7,328	$6,855	$821,408

8. Expense Reductions.

Through arrangements with each applicable Fund's custodian, credits realized as a result of certain uninvested cash balances were used to reduce each applicable Fund's expenses. All of the applicable expense reductions are noted in the table below.

	Custodian credits
Biotechnology Portfolio	$4,661
Health Care Portfolio	2,216
Health Care Services Portfolio	909
Medical Technology and Devices Portfolio	1,917

In addition, during the period the investment adviser or an affiliate reimbursed and/or waived a portion of operating expenses as follows:

	Amount
Biotechnology Portfolio	$181,190
Health Care Portfolio	297,816
Health Care Services Portfolio	53,611
Medical Technology and Devices Portfolio	264,499
Pharmaceuticals Portfolio	29,167

9. Other.

10. Risk and Uncertainties.

To the Board of Trustees of Fidelity Select Portfolios and Shareholders of Biotechnology Portfolio, Health Care Portfolio, Health Care Services Portfolio, Medical Technology and Devices Portfolio and Pharmaceuticals Portfolio

Opinions on the Financial Statements

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of Biotechnology Portfolio, Health Care Portfolio, Health Care Services Portfolio, Medical Technology and Devices Portfolio, and Pharmaceuticals Portfolio (five of the funds constituting Fidelity Select Portfolios, hereafter collectively referred to as the "Funds") as of February 28, 2023, the related statements of operations for the year ended February 28, 2023, the statements of changes in net assets for each of the two years in the period ended February 28, 2023, including the related notes, and the financial highlights for each of the five years in the period ended February 28, 2023 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Funds as of February 28, 2023, the results of each of their operations for the year then ended, the changes in each of their net assets for each of the two years in the period ended February 28, 2023 and each of the financial highlights for each of the five years in the period ended February 28, 2023 in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinions

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of February 28, 2023 by correspondence with the custodians, issuers of privately offered securities and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinions.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

April 12, 2023

We have served as the auditor of one or more investment companies in the Fidelity group of funds since 1932.

TRUSTEES AND OFFICERS

The funds' Statement of Additional Information (SAI) includes more information about the Trustees. To request a free copy, call Fidelity at 1-800-544-8544.

Interested Trustees*:

Correspondence intended for a Trustee who is an interested person may be sent to Fidelity Investments, 245 Summer Street, Boston, Massachusetts 02210.

Name, Year of Birth; Principal Occupations and Other Relevant Experience+

Bettina Doulton (1964)

Year of Election or Appointment: 2020

Trustee

Robert A. Lawrence (1952)

Year of Election or Appointment: 2020

Trustee

Chair of the Board of Trustees

* Determined to be an "Interested Trustee" by virtue of, among other things, his or her affiliation with the trust or various entities under common control with FMR.

Independent Trustees:

Correspondence intended for an Independent Trustee may be sent to Fidelity Investments, P.O. Box 55235, Boston, Massachusetts 02205-5235.

Name, Year of Birth; Principal Occupations and Other Relevant Experience+

Thomas P. Bostick (1956)

Year of Election or Appointment: 2021

Trustee

Dennis J. Dirks (1948)

Year of Election or Appointment: 2018

Trustee

Donald F. Donahue (1950)

Year of Election or Appointment: 2018

Trustee

Vicki L. Fuller (1957)

Year of Election or Appointment: 2020

Trustee

Patricia L. Kampling (1959)

Year of Election or Appointment: 2020

Trustee

Thomas A. Kennedy (1955)

Year of Election or Appointment: 2021

Trustee

Oscar Munoz (1959)

Year of Election or Appointment: 2021

Trustee

David M. Thomas (1949)

Year of Election or Appointment: 2018

Trustee

Lead Independent Trustee

Susan Tomasky (1953)

Year of Election or Appointment: 2020

Trustee

Michael E. Wiley (1950)

Year of Election or Appointment: 2008

Trustee

Advisory Board Members and Officers:

Name, Year of Birth; Principal Occupation

Peter S. Lynch (1944)

Year of Election or Appointment: 2018

Member of the Advisory Board

Heather Bonner (1977)

Year of Election or Appointment: 2023

Assistant Treasurer

Craig S. Brown (1977)

Year of Election or Appointment: 2022

Deputy Treasurer

John J. Burke III (1964)

Year of Election or Appointment: 2018

Chief Financial Officer

Margaret Carey (1973)

Year of Election or Appointment: 2023

Secretary and Chief Legal Officer (CLO)

William C. Coffey (1969)

Year of Election or Appointment: 2019

Assistant Secretary

Timothy M. Cohen (1969)

Year of Election or Appointment: 2018

Vice President

Jonathan Davis (1968)

Year of Election or Appointment: 2010

Assistant Treasurer

Laura M. Del Prato (1964)

Year of Election or Appointment: 2018

Assistant Treasurer

Colm A. Hogan (1973)

Year of Election or Appointment: 2020

Assistant Treasurer

Pamela R. Holding (1964)

Year of Election or Appointment: 2018

Vice President

Chris Maher (1972)

Year of Election or Appointment: 2020

Deputy Treasurer

Jason P. Pogorelec (1975)

Year of Election or Appointment: 2020

Chief Compliance Officer

Brett Segaloff (1972)

Year of Election or Appointment: 2021

Anti-Money Laundering (AML) Officer

Stacie M. Smith (1974)

Year of Election or Appointment: 2018

President and Treasurer

Jim Wegmann (1979)

Year of Election or Appointment: 2019

Assistant Treasurer

The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (September 1, 2022 to February 28, 2023).

Actual Expenses

Hypothetical Example for Comparison Purposes

	Annualized Expense Ratio- A	Beginning Account Value September 1, 2022	Ending Account Value February 28, 2023	Expenses Paid During Period- C September 1, 2022 to February 28, 2023

Biotechnology Portfolio	.71%
Actual		$ 1,000	$ 1,008.20	$ 3.54
Hypothetical- B		$ 1,000	$ 1,021.27	$ 3.56

Health Care Portfolio	.69%
Actual		$ 1,000	$ 1,019.90	$ 3.46
Hypothetical- B		$ 1,000	$ 1,021.37	$ 3.46

Health Care Services Portfolio	.73%
Actual		$ 1,000	$ 945.70	$ 3.52
Hypothetical- B		$ 1,000	$ 1,021.17	$ 3.66

Medical Technology and Devices Portfolio	.70%
Actual		$ 1,000	$ 1,038.90	$ 3.54
Hypothetical- B		$ 1,000	$ 1,021.32	$ 3.51

Pharmaceuticals Portfolio	.77%
Actual		$ 1,000	$ 1,027.50	$ 3.87
Hypothetical- B		$ 1,000	$ 1,020.98	$ 3.86

A Annualized expense ratio reflects expenses net of applicable fee waivers.

B 5% return per year before expenses

Distributions (Unaudited)

The dividend and capital gains distributions for the fund(s) are available on Fidelity.com or Institutional.Fidelity.com.

Health Care Services Portfolio	$8,714,096
Pharmaceuticals Portfolio	$66,573,883

A percentage of the dividends distributed during the fiscal year for the following funds qualify for the dividends-received deduction for corporate shareholders:

Health Care Services Portfolio
April 2022 December 2022	100% 100%
Pharmaceuticals Portfolio
April 2022 December 2022	62% 54%

Health Care Services Portfolio
April 2022 December 2022	100% 100%
Pharmaceuticals Portfolio
April 2022 December 2022	100% 100%

The funds hereby designate the percentages noted below of the short-term capital gain dividends distributed during the fiscal year as qualifying to be taxed as short-term capital gain dividends for nonresident alien shareholders:

	April, 2022
Health Care Services Portfolio	100%

The funds hereby designate the amounts noted below as distributions paid during the fiscal year ended 2023 as qualifying to be taxed as section 163(j) interest dividends:

Pharmaceuticals Portfolio

$81,637

The funds will notify shareholders in January 2024 of amounts for use in preparing 2023 income tax returns.

Highly liquid investments - cash or convertible to cash within three business days or less
Moderately liquid investments - convertible to cash in three to seven calendar days
Less liquid investments - can be sold or disposed of, but not settled, within seven calendar days
Illiquid investments - cannot be sold or disposed of within seven calendar days

1.813640.118

SELHC-ANN-0423

Fidelity® Select Portfolios®

Financials Sector

Banking Portfolio

Brokerage and Investment Management Portfolio

Financial Services Portfolio

FinTech Portfolio

Insurance Portfolio

(Financial Services Portfolio to be renamed Financials Portfolio effective April 28, 2023)

Annual Report

February 28, 2023

Contents

Banking Portfolio

Brokerage and Investment Management Portfolio

Financial Services Portfolio

FinTech Portfolio

Insurance Portfolio

Report of Independent Registered Public Accounting Firm

You may also call 1-800-544-8544 to request a free copy of the proxy voting guidelines.

Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.

Other third-party marks appearing herein are the property of their respective owners.

NOT FDIC INSURED •MAY LOSE VALUE •NO BANK GUARANTEE

Neither the Funds nor Fidelity Distributors Corporation is a bank.

Banking Portfolio

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Banking Portfolio	-11.27%	3.88%	9.81%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Banking Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Banking Portfolio

Market Recap:

Comments from Portfolio Manager Matthew Reed:

For the fiscal year, the fund returned -11.27%, outperforming the -12.37% result of the MSCI US IMI Banks 5% Capped Linked Index, but underperforming the broad-based S&P 500 ® index. The top contributor to performance versus the industry index was an overweighting in diversified banks. Stock selection and an underweighting in regional banks and stock picks in thrifts & mortgage finance also helped. Not owning SVB Financial Group, an index component that returned roughly -52%, was the largest individual relative contributor. The fund's non-index position in State Street gained approximately 7% and helped. Another notable relative contributor was an outsized stake in M&T Bank (-13%), which was one of our largest holdings. Conversely, the primary detractor from performance versus the industry index was stock picks in diversified banks. The fund's biggest individual relative detractor was an overweighting in Signature Bank, which returned -66% the past year. Also holding back performance was our outsized stake in PacWest Bancorp, which returned -42%. Avoiding Regions Financial, an index component that returned about 0%, also hurt relative performance. Notable changes in positioning include increased exposure to the diversified banks subindustry and a lower allocation to thrifts & mortgage finance.

Banking Portfolio

Top Holdings (% of Fund's net assets)

Wells Fargo & Co.	9.0
Bank of America Corp.	6.9
U.S. Bancorp	6.7
JPMorgan Chase & Co.	5.4
Citigroup, Inc.	5.1
Truist Financial Corp.	4.4
M&T Bank Corp.	4.1
KeyCorp	3.4
East West Bancorp, Inc.	3.1
Essent Group Ltd.	3.1
	51.2

Industries (% of Fund's net assets)

Banks	87.9
Thrifts & Mortgage Finance	6.3
Consumer Finance	2.8
Capital Markets	1.9
IT Services	0.6
Diversified Financial Services	0.0

Percentages shown as 0.0% may reflect amounts less than 0.05%.

Banking Portfolio

Showing Percentage of Net Assets

Common Stocks - 98.9%
	Shares	Value ($)
Banks - 87.9%
Diversified Banks - 33.1%
Bank of America Corp.	863,376	29,613,797
Citigroup, Inc.	434,000	21,999,460
JPMorgan Chase & Co.	160,500	23,007,675
U.S. Bancorp	606,800	28,962,564
Wells Fargo & Co.	821,992	38,444,566
		142,028,062
Regional Banks - 54.8%
1st Source Corp.	102,881	5,125,531
American National Bankshares, Inc.	131,886	4,437,964
Associated Banc-Corp.	489,100	11,322,665
BankUnited, Inc.	97,369	3,448,810
Cadence Bank	375,539	9,974,316
Comerica, Inc.	155,900	10,928,590
Community Trust Bancorp, Inc.	112,676	4,816,899
ConnectOne Bancorp, Inc.	103,300	2,505,025
East West Bancorp, Inc.	175,300	13,359,613
Eastern Bankshares, Inc.	127,200	1,994,496
First Citizens Bancshares, Inc.	14,000	10,272,640
First Hawaiian, Inc.	246,800	6,749,980
First Interstate Bancsystem, Inc.	286,234	10,172,756
Heartland Financial U.S.A., Inc.	179,100	8,854,704
Independent Bank Group, Inc.	47,000	2,766,420
KeyCorp	789,700	14,443,613
M&T Bank Corp.	112,560	17,479,442
Old National Bancorp, Indiana	203,454	3,595,032
PacWest Bancorp	275,336	7,640,574
PNC Financial Services Group, Inc.	19,800	3,126,816
Popular, Inc.	169,900	12,130,860
Preferred Bank, Los Angeles (a)	69,295	4,878,368
Sierra Bancorp	135,100	2,730,371
Signature Bank	63,590	7,316,030
Trico Bancshares	96,087	4,853,354
Truist Financial Corp.	406,200	19,071,090
UMB Financial Corp.	103,466	9,380,228
Univest Corp. of Pennsylvania	194,500	5,484,900
Wintrust Financial Corp.	95,300	8,779,989
Zions Bancorp NA	159,450	8,071,359
		235,712,435
TOTAL BANKS		377,740,497
Capital Markets - 1.9%
Asset Management & Custody Banks - 1.9%
Phoenix Vega Mezz PLC	330,200	16,415
State Street Corp.	95,300	8,451,204
		8,467,619
Consumer Finance - 2.8%
Consumer Finance - 2.8%
Capital One Financial Corp.	55,200	6,021,216
OneMain Holdings, Inc. (a)	143,900	6,200,651
		12,221,867
Diversified Financial Services - 0.0%
Other Diversified Financial Services - 0.0%
Sunrisemezz Ltd. (b)	47,171	6,421
Thrifts & Mortgage Finance - 6.3%
Thrifts & Mortgage Finance - 6.3%
Essent Group Ltd.	308,229	13,238,436
NMI Holdings, Inc. (b)	394,502	9,207,677
Radian Group, Inc.	162,236	3,463,739
Southern Missouri Bancorp, Inc. (a)	23,700	1,096,836
		27,006,688
TOTAL COMMON STOCKS (Cost $350,739,427)		425,443,092

Convertible Bonds - 0.6%
	Principal Amount (c)	Value ($)
IT Services - 0.6%
Data Processing & Outsourced Services - 0.6%
Affirm Holdings, Inc. 0% 11/15/26 (Cost $2,291,212)	3,658,000	2,439,520

Money Market Funds - 1.3%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (d)	1,486,764	1,487,061
Fidelity Securities Lending Cash Central Fund 4.63% (d)(e)	4,036,789	4,037,193
TOTAL MONEY MARKET FUNDS (Cost $5,524,254)		5,524,254

TOTAL INVESTMENT IN SECURITIES - 100.8% (Cost $358,554,893)	433,406,866
NET OTHER ASSETS (LIABILITIES) - (0.8)%	(3,522,827)
NET ASSETS - 100.0%	429,884,039

Legend

(a)	Security or a portion of the security is on loan at period end.

(b)	Non-income producing

(c)	Amount is stated in United States dollars unless otherwise noted.

(d)

(e)	Investment made with cash collateral received from securities on loan.

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	70,784	65,907,156	64,490,879	11,824	-	-	1,487,061	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	39,878,125	291,681,674	327,522,606	14,953	-	-	4,037,193	0.0%
Total	39,948,909	357,588,830	392,013,485	26,777	-	-	5,524,254

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	425,443,092	425,443,092	-	-

Convertible Bonds	2,439,520	-	2,439,520	-

Money Market Funds	5,524,254	5,524,254	-	-
Total Investments in Securities:	433,406,866	430,967,346	2,439,520	-

Banking Portfolio

Brokerage and Investment Management Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $3,913,304) - See accompanying schedule:
Unaffiliated issuers (cost $353,030,639)	$	427,882,612
Fidelity Central Funds (cost $5,524,254)		5,524,254


Total Investment in Securities (cost $358,554,893)			$	433,406,866
Receivable for investments sold				40,282
Receivable for fund shares sold				27,710
Dividends receivable				881,831
Distributions receivable from Fidelity Central Funds				1,081
Prepaid expenses				2,436
Total assets				434,360,206
Liabilities
Payable for fund shares redeemed	$	138,213
Accrued management fee		193,670
Other affiliated payables		72,244
Other payables and accrued expenses		34,847
Collateral on securities loaned		4,037,193
Total Liabilities				4,476,167
Net Assets			$	429,884,039
Net Assets consist of:
Paid in capital			$	345,505,777
Total accumulated earnings (loss)				84,378,262
Net Assets			$	429,884,039
Net Asset Value , offering price and redemption price per share ($429,884,039 ÷ 16,383,289 shares)			$	26.24

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	14,770,963
Interest				200,713
Income from Fidelity Central Funds (including $14,953 from security lending)				26,777
Total Income				14,998,453
Expenses
Management fee	$	2,593,092
Transfer agent fees		804,025
Accounting fees		176,905
Custodian fees and expenses		18,106
Independent trustees' fees and expenses		1,734
Registration fees		43,908
Audit		42,588
Legal		878
Interest		3,052
Miscellaneous		3,585
Total expenses before reductions		3,687,873
Expense reductions		(17,651)
Total expenses after reductions				3,670,222
Net Investment income (loss)				11,328,231
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		20,549,485
Foreign currency transactions		481
Total net realized gain (loss)				20,549,966
Change in net unrealized appreciation (depreciation) on investment securities				(115,880,770)
Net gain (loss)				(95,330,804)
Net increase (decrease) in net assets resulting from operations			$	(84,002,573)

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	11,328,231	$	12,596,370
Net realized gain (loss)		20,549,966		29,218,859
Change in net unrealized appreciation (depreciation)		(115,880,770)		75,273,957
Net increase (decrease) in net assets resulting from operations		(84,002,573)		117,089,186
Distributions to shareholders		(27,365,238)		(20,298,948)
Share transactions
Proceeds from sales of shares		86,486,325		519,785,682
Reinvestment of distributions		25,505,449		19,052,468
Cost of shares redeemed		(287,573,573)		(456,654,461)
Net increase (decrease) in net assets resulting from share transactions		(175,581,799)		82,183,689
Total increase (decrease) in net assets		(286,949,610)		178,973,927

Net Assets
Beginning of period		716,833,649		537,859,722
End of period	$	429,884,039	$	716,833,649

Other Information
Shares
Sold		3,179,002		17,252,319
Issued in reinvestment of distributions		1,010,981		659,756
Redeemed		(10,660,796)		(15,503,674)
Net increase (decrease)		(6,470,813)		2,408,401

Financial Highlights

Banking Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	31.37	$	26.31	$	23.37	$	26.42	$	36.82
Income from Investment Operations
Net investment income (loss) B,C		.61		.58		.54		.58		.49
Net realized and unrealized gain (loss)		(4.24)		5.48		4.32		(1.96)		(3.62)
Total from investment operations		(3.63)		6.06		4.86		(1.38)		(3.13)
Distributions from net investment income		(.67)		(.54)		(.55)		(.53)		(.54)
Distributions from net realized gain		(.83)		(.46)		(1.37)		(1.14)		(6.73)
Total distributions		(1.50)		(1.00)		(1.92)		(1.67)		(7.27)
Net asset value, end of period	$	26.24	$	31.37	$	26.31	$	23.37	$	26.42
Total Return D		(11.27)%		23.37%		25.90%		(6.05)%		(6.57)%
Ratios to Average Net Assets C,E,F
Expenses before reductions		.75%		.73%		.79%		.77%		.77%
Expenses net of fee waivers, if any		.74%		.73%		.79%		.77%		.77%
Expenses net of all reductions		.74%		.73%		.79%		.77%		.76%
Net investment income (loss)		2.29%		1.93%		2.84%		2.21%		1.54%
Supplemental Data
Net assets, end of period (000 omitted)	$	429,884	$	716,834	$	537,860	$	361,696	$	514,650
Portfolio turnover rate G		21%		34%		32%		31%		44%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

G Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Brokerage and Investment Management Portfolio	-2.98%	10.64%	11.64%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Brokerage and Investment Management Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Brokerage and Investment Management Portfolio

Market Recap:

Comments from Portfolio Manager Charles Ackerman:

For the fiscal year ending February 28, 2023, the fund returned -2.98%, outperforming the -4.33% result of the MSCI US IMI Capital Markets 5% Capped Linked Index, as well as the broad-based S&P 500 ® index. Versus the industry index, security selection was the primary contributor, led by the investment banking & brokerage sector. The fund's largest individual relative contributor was an overweighting in LPL Financial Holdings, which gained 38% the past 12 months. We decreased our investment in this company. Also adding value was our outsized stake in Ameriprise Financial, which gained 16%. Ameriprise Financial was among the fund's biggest holdings. Another key contributor was our out-of-index position in Apollo Global Management (+11%). We trimmed our stake. In contrast, the biggest detractor from performance versus the industry index was security selection in data processing & outsourced services. An underweighting in the outperforming investment banking & brokerage group and stock selection in diversified banks also modestly hindered the fund's relative performance. An underweighting in Jefferies Financial Group was the fund's largest individual relative detractor given the stock's 51% gain the past year. Also holding back performance was an underweighting in Federated Hermes, which gained about 24%. Federated Hermes was not held at period end. Also hampering performance was an underweighting in Goldman Sachs Group, which gained 6%.

Brokerage and Investment Management Portfolio

Top Holdings (% of Fund's net assets)

Ameriprise Financial, Inc.	6.1
Morgan Stanley	5.9
BlackRock, Inc. Class A	5.4
S&P Global, Inc.	5.3
Charles Schwab Corp.	5.3
LPL Financial	5.0
Intercontinental Exchange, Inc.	4.7
Bank of New York Mellon Corp.	4.4
KKR & Co. LP	4.1
MSCI, Inc.	3.5
	49.7

Industries (% of Fund's net assets)

Capital Markets	94.3
Diversified Financial Services	2.9
Banks	0.6
IT Services	0.2

Brokerage and Investment Management Portfolio

Showing Percentage of Net Assets

Common Stocks - 98.0%
	Shares	Value ($)
Banks - 0.6%
Diversified Banks - 0.6%
Wells Fargo & Co.	98,300	4,597,491
Capital Markets - 94.3%
Asset Management & Custody Banks - 40.7%
Affiliated Managers Group, Inc.	40,400	6,440,164
Ameriprise Financial, Inc.	144,100	49,407,567
Ares Management Corp.	347,400	28,010,862
Artisan Partners Asset Management, Inc.	46,500	1,533,105
Avantax, Inc. (a)	18,600	531,774
Bank of New York Mellon Corp.	710,600	36,155,328
BlackRock, Inc. Class A	63,600	43,847,748
Blackstone, Inc. (b)	211,500	19,204,200
Blue Owl Capital, Inc. Class A (b)	806,100	9,947,274
Bridge Investment Group Holdings, Inc.	93,500	1,270,665
Carlyle Group LP	353,900	12,174,160
Cohen & Steers, Inc.	16,128	1,167,022
Focus Financial Partners, Inc. Class A (a)	9,000	466,740
Franklin Resources, Inc. (b)	275,300	8,113,091
Invesco Ltd. (b)	345,100	6,094,466
Janus Henderson Group PLC (b)	135,600	3,723,576
KKR & Co. LP	591,800	33,347,930
Northern Trust Corp.	104,200	9,927,134
P10, Inc.	143,400	1,544,418
Patria Investments Ltd.	432,372	6,857,420
Petershill Partners PLC (c)	425,200	855,147
State Street Corp.	299,200	26,533,056
T. Rowe Price Group, Inc.	150,700	16,920,596
Virtus Investment Partners, Inc.	32,300	6,796,889
		330,870,332
Financial Exchanges & Data - 26.7%
Cboe Global Markets, Inc.	88,938	11,221,307
CME Group, Inc.	139,800	25,913,328
Coinbase Global, Inc. (a)(b)	79,000	5,121,570
FactSet Research Systems, Inc.	1,500	621,825
Intercontinental Exchange, Inc.	379,400	38,622,920
MarketAxess Holdings, Inc.	23,800	8,126,510
Moody's Corp.	77,200	22,399,580
MSCI, Inc.	54,100	28,248,315
NASDAQ, Inc.	463,100	25,961,386
Open Lending Corp. (a)	208,400	1,475,472
S&P Global, Inc.	127,300	43,434,760
Tradeweb Markets, Inc. Class A	86,800	6,153,252
		217,300,225
Investment Banking & Brokerage - 26.9%
BGC Partners, Inc. Class A	386,500	1,878,390
Charles Schwab Corp.	555,061	43,250,353
Goldman Sachs Group, Inc.	79,600	27,991,340
Interactive Brokers Group, Inc.	100,000	8,611,000
Jefferies Financial Group, Inc.	11,100	419,469
LPL Financial	164,300	41,002,708
Moelis & Co. Class A (b)	95,500	4,090,265
Morgan Stanley	492,516	47,527,794
Piper Jaffray Companies (b)	3,300	498,267
PJT Partners, Inc.	145,412	11,470,099
Raymond James Financial, Inc. (b)	216,000	23,427,360
Robinhood Markets, Inc. (a)(b)	322,700	3,249,589
Virtu Financial, Inc. Class A	270,400	4,969,952
		218,386,586
TOTAL CAPITAL MARKETS		766,557,143
Diversified Financial Services - 2.9%
Other Diversified Financial Services - 2.9%
Apollo Global Management, Inc.	333,900	23,673,510
IT Services - 0.2%
Data Processing & Outsourced Services - 0.2%
PayPal Holdings, Inc. (a)	21,900	1,611,840
TOTAL COMMON STOCKS (Cost $584,224,005)		796,439,984

Money Market Funds - 6.8%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (d)	16,323,202	16,326,467
Fidelity Securities Lending Cash Central Fund 4.63% (d)(e)	38,915,333	38,919,225
TOTAL MONEY MARKET FUNDS (Cost $55,245,692)		55,245,692

TOTAL INVESTMENT IN SECURITIES - 104.8% (Cost $639,469,697)	851,685,676
NET OTHER ASSETS (LIABILITIES) - (4.8)%	(38,712,731)
NET ASSETS - 100.0%	812,972,945

Legend

(a)	Non-income producing

(b)	Security or a portion of the security is on loan at period end.

(c)	Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $855,147 or 0.1% of net assets.

(d)

(e)	Investment made with cash collateral received from securities on loan.

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	8,617,943	90,194,816	82,486,292	130,279	-	-	16,326,467	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	47,542,900	621,049,140	629,672,815	129,568	-	-	38,919,225	0.1%
Total	56,160,843	711,243,956	712,159,107	259,847	-	-	55,245,692

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	796,439,984	796,439,984	-	-

Money Market Funds	55,245,692	55,245,692	-	-
Total Investments in Securities:	851,685,676	851,685,676	-	-

Brokerage and Investment Management Portfolio

Financial Services Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $38,510,858) - See accompanying schedule:
Unaffiliated issuers (cost $584,224,005)	$	796,439,984
Fidelity Central Funds (cost $55,245,692)		55,245,692


Total Investment in Securities (cost $639,469,697)			$	851,685,676
Receivable for fund shares sold				392,250
Dividends receivable				918,328
Distributions receivable from Fidelity Central Funds				72,094
Prepaid expenses				1,821
Other receivables				50,189
Total assets				853,120,358
Liabilities
Payable for fund shares redeemed	$	636,515
Accrued management fee		365,831
Other affiliated payables		141,350
Other payables and accrued expenses		84,492
Collateral on securities loaned		38,919,225
Total Liabilities				40,147,413
Net Assets			$	812,972,945
Net Assets consist of:
Paid in capital			$	676,147,635
Total accumulated earnings (loss)				136,825,310
Net Assets			$	812,972,945
Net Asset Value , offering price and redemption price per share ($812,972,945 ÷ 7,067,000 shares)			$	115.04

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	18,398,630
Income from Fidelity Central Funds (including $129,568 from security lending)				259,847
Total Income				18,658,477
Expenses
Management fee	$	4,728,555
Transfer agent fees		1,580,638
Accounting fees		281,702
Custodian fees and expenses		13,961
Independent trustees' fees and expenses		3,140
Registration fees		57,329
Audit		40,842
Legal		729
Interest		18,216
Miscellaneous		4,499
Total expenses before reductions		6,729,611
Expense reductions		(32,083)
Total expenses after reductions				6,697,528
Net Investment income (loss)				11,960,949
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		(74,755,629)
Foreign currency transactions		1,000
Total net realized gain (loss)				(74,754,629)
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		(8,919,201)
Assets and liabilities in foreign currencies		(1,534)
Total change in net unrealized appreciation (depreciation)				(8,920,735)
Net gain (loss)				(83,675,364)
Net increase (decrease) in net assets resulting from operations			$	(71,714,415)

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	11,960,949	$	8,497,410
Net realized gain (loss)		(74,754,629)		5,615,492
Change in net unrealized appreciation (depreciation)		(8,920,735)		42,391,470
Net increase (decrease) in net assets resulting from operations		(71,714,415)		56,504,372
Distributions to shareholders		(17,226,958)		(11,958,952)
Share transactions
Proceeds from sales of shares		189,388,454		1,076,173,907
Reinvestment of distributions		15,606,994		11,131,114
Cost of shares redeemed		(512,802,938)		(351,448,797)
Net increase (decrease) in net assets resulting from share transactions		(307,807,490)		735,856,224
Total increase (decrease) in net assets		(396,748,863)		780,401,644

Net Assets
Beginning of period		1,209,721,808		429,320,164
End of period	$	812,972,945	$	1,209,721,808

Other Information
Shares
Sold		1,678,022		8,446,490
Issued in reinvestment of distributions		142,147		92,249
Redeemed		(4,750,290)		(2,792,832)
Net increase (decrease)		(2,930,121)		5,745,907

Financial Highlights

Brokerage and Investment Management Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	121.01	$	100.99	$	74.99	$	71.71	$	84.47
Income from Investment Operations
Net investment income (loss) B,C		1.45		1.31		.93		1.01		.77
Net realized and unrealized gain (loss)		(5.19)		20.54		28.01		5.70		(7.60)
Total from investment operations		(3.74)		21.85		28.94		6.71		(6.83)
Distributions from net investment income		(1.83)		(.83)		(1.06)		(.98)		(.96)
Distributions from net realized gain		(.41)		(1.01)		(1.88)		(2.45)		(4.96)
Total distributions		(2.23) D		(1.83) D		(2.94)		(3.43)		(5.93) D
Net asset value, end of period	$	115.04	$	121.01	$	100.99	$	74.99	$	71.71
Total Return E		(2.98)%		21.70%		39.69%		9.28%		(8.04)%
Ratios to Average Net Assets C,F,G
Expenses before reductions		.75%		.74%		.76%		.77%		.78%
Expenses net of fee waivers, if any		.74%		.74%		.76%		.77%		.77%
Expenses net of all reductions		.74%		.74%		.76%		.77%		.77%
Net investment income (loss)		1.33%		1.06%		1.14%		1.33%		1.01%
Supplemental Data
Net assets, end of period (000 omitted)	$	812,973	$	1,209,722	$	429,320	$	309,088	$	327,128
Portfolio turnover rate H		4%		3%		11%		9%		30%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Total distributions per share do not sum due to rounding.

E Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

H Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Financial Services Portfolio	-3.30%	7.92%	11.14%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Financial Services Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Financial Services Portfolio

Market Recap:

Comments from Portfolio Manager Matthew Reed:

For the fiscal year ending February 28, 2023, the fund returned -3.30%, outperforming the -4.87% result of the MSCI US IMI Financials 5% Capped Linked Index, as well as the broad-based S&P 500 ® index. The primary contributor to performance versus the sector index was an overweighting among reinsurance firms. Stock picks and an underweighting in the financial exchanges & data industry, as well as security selection in the life & health insurance category, also helped. The biggest individual relative contributor was an overweight position in Reinsurance Group of America (+33%), one of the fund's largest holdings on February 28. Also boosting value was the portfolio's outsized stake in Arthur J. Gallaghar, which gained 20%. Another notable relative contributor was an overweighting in Primerica (+50%). In contrast, the largest detractor from performance versus the sector index was investment choices among property & casualty insurance providers. Security selection and an underweighting in the investment banking & brokerage group, in addition to an underweighting in the life & health insurance industry, further hampered relative performance. The biggest individual relative detractor was an overweight position in Signature Bank (-66%). Our second-largest relative detractor this period was the decision to avoid Progressive, an index component that gained 36%. An outsized stake in Virtu Financial (-45%) proved detrimental as well. Notable changes in positioning include decreased exposure to the consumer finance industry and a higher allocation to property & casualty insurance stocks.

Notes to shareholders:

On April 28, 2023, the fund's name will change to Fidelity Select Financials Portfolio, in alignment with an update to the Global Industry Classification Standard (GICS).

Financial Services Portfolio

Top Holdings (% of Fund's net assets)

Wells Fargo & Co.	6.4
Bank of America Corp.	5.2
JPMorgan Chase & Co.	4.7
Morgan Stanley	3.6
Chubb Ltd.	3.3
Citigroup, Inc.	3.2
State Street Corp.	3.2
U.S. Bancorp	2.9
Reinsurance Group of America, Inc.	2.7
Marsh & McLennan Companies, Inc.	2.6
	37.8

Industries (% of Fund's net assets)

Banks	39.2
Insurance	26.1
Capital Markets	18.9
Consumer Finance	4.3
Thrifts & Mortgage Finance	3.8
IT Services	3.3
Diversified Financial Services	2.9
Professional Services	0.7
Software	0.4

Geographic Diversification (% of Fund's net assets)

* Includes Short-Term investments and Net Other Assets (Liabilities).

Percentages are based on country or territory of incorporation and are adjusted for the effect of derivatives, if applicable.

Financial Services Portfolio

Showing Percentage of Net Assets

Common Stocks - 99.0%
	Shares	Value ($)
Banks - 39.2%
Diversified Banks - 22.4%
Bank of America Corp.	1,105,600	37,922,080
Citigroup, Inc.	457,900	23,210,951
JPMorgan Chase & Co.	241,300	34,590,355
U.S. Bancorp	443,600	21,173,028
Wells Fargo & Co.	1,009,090	47,195,141
		164,091,555
Regional Banks - 16.8%
Associated Banc-Corp. (a)	261,100	6,044,465
BankUnited, Inc.	98,200	3,478,244
Cadence Bank	202,530	5,379,197
Comerica, Inc.	68,700	4,815,870
East West Bancorp, Inc.	105,500	8,040,155
First Citizens Bancshares, Inc. (a)	12,600	9,245,376
First Interstate Bancsystem, Inc.	162,221	5,765,334
Heartland Financial U.S.A., Inc.	105,700	5,225,808
KeyCorp	570,200	10,428,958
M&T Bank Corp.	100,937	15,674,507
PacWest Bancorp	136,300	3,782,325
Popular, Inc.	125,100	8,932,140
Signature Bank	64,400	7,409,220
Truist Financial Corp.	278,700	13,084,965
UMB Financial Corp. (a)	49,800	4,514,868
Wintrust Financial Corp.	62,900	5,794,977
Zions Bancorp NA	100,600	5,092,372
		122,708,781
TOTAL BANKS		286,800,336
Capital Markets - 18.9%
Asset Management & Custody Banks - 9.1%
Affiliated Managers Group, Inc.	32,800	5,228,648
Bank of New York Mellon Corp.	222,200	11,305,536
Brookfield Asset Management Ltd. Class A (a)	31,628	1,063,333
Brookfield Corp. Class A	131,515	4,372,874
Carlyle Group LP	313,400	10,780,960
Northern Trust Corp.	50,100	4,773,027
Patria Investments Ltd.	391,600	6,210,776
State Street Corp.	261,600	23,198,688
		66,933,842
Financial Exchanges & Data - 3.5%
Bolsa Mexicana de Valores S.A.B. de CV	2,208,400	4,294,530
Cboe Global Markets, Inc.	29,300	3,696,781
CME Group, Inc.	94,600	17,535,056
		25,526,367
Investment Banking & Brokerage - 6.3%
Lazard Ltd. Class A	147,292	5,502,829
Morgan Stanley	271,300	26,180,450
Raymond James Financial, Inc.	91,100	9,880,706
Virtu Financial, Inc. Class A	229,300	4,214,534
		45,778,519
TOTAL CAPITAL MARKETS		138,238,728
Consumer Finance - 4.3%
Consumer Finance - 4.3%
Capital One Financial Corp.	158,200	17,256,456
FirstCash Holdings, Inc.	86,311	7,616,946
OneMain Holdings, Inc. (a)	157,300	6,778,057
		31,651,459
Diversified Financial Services - 2.9%
Multi-Sector Holdings - 0.8%
Cannae Holdings, Inc. (b)	253,890	5,732,836
Other Diversified Financial Services - 2.1%
Apollo Global Management, Inc.	219,500	15,562,550
TOTAL DIVERSIFIED FINANCIAL SERVICES		21,295,386
Insurance - 26.1%
Insurance Brokers - 4.4%
Arthur J. Gallagher & Co.	72,300	13,545,405
Marsh & McLennan Companies, Inc.	115,500	18,727,170
		32,272,575
Life & Health Insurance - 3.1%
Globe Life, Inc.	114,700	13,957,843
Primerica, Inc.	44,500	8,541,330
		22,499,173
Multi-Line Insurance - 1.9%
Hartford Financial Services Group, Inc.	179,200	14,027,776
Property & Casualty Insurance - 14.0%
American Financial Group, Inc.	59,700	8,006,367
Beazley PLC	908,100	7,460,464
Chubb Ltd.	112,900	23,824,158
Direct Line Insurance Group PLC	3,895,600	8,450,881
Fidelity National Financial, Inc.	216,600	8,633,676
First American Financial Corp.	192,100	10,907,438
Hiscox Ltd.	573,700	7,866,855
Lancashire Holdings Ltd.	882,400	6,506,350
Selective Insurance Group, Inc.	55,100	5,594,303
The Travelers Companies, Inc.	80,300	14,865,136
		102,115,628
Reinsurance - 2.7%
Reinsurance Group of America, Inc.	138,500	20,009,095
TOTAL INSURANCE		190,924,247
IT Services - 2.7%
Data Processing & Outsourced Services - 2.7%
Global Payments, Inc.	78,300	8,785,260
MasterCard, Inc. Class A	29,600	10,516,584
		19,301,844
Professional Services - 0.7%
Research & Consulting Services - 0.7%
Dun & Bradstreet Holdings, Inc.	431,300	5,179,913
Software - 0.4%
Application Software - 0.4%
Black Knight, Inc. (b)	49,600	2,956,160
Thrifts & Mortgage Finance - 3.8%
Thrifts & Mortgage Finance - 3.8%
Essent Group Ltd.	315,138	13,535,177
NMI Holdings, Inc. (b)	422,743	9,866,822
Walker & Dunlop, Inc.	46,800	4,082,364
		27,484,363
TOTAL COMMON STOCKS (Cost $605,283,373)		723,832,436

Convertible Bonds - 0.6%
	Principal Amount (c)	Value ($)
IT Services - 0.6%
Data Processing & Outsourced Services - 0.6%
Affirm Holdings, Inc. 0% 11/15/26 (Cost $3,952,686)	6,166,000	4,112,105

Money Market Funds - 1.4%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (d)	2,743,120	2,743,668
Fidelity Securities Lending Cash Central Fund 4.63% (d)(e)	7,671,008	7,671,775
TOTAL MONEY MARKET FUNDS (Cost $10,415,443)		10,415,443

TOTAL INVESTMENT IN SECURITIES - 101.0% (Cost $619,651,502)	738,359,984
NET OTHER ASSETS (LIABILITIES) - (1.0)%	(7,200,545)
NET ASSETS - 100.0%	731,159,439

Legend

(a)	Security or a portion of the security is on loan at period end.

(b)	Non-income producing

(c)	Amount is stated in United States dollars unless otherwise noted.

(d)

(e)	Investment made with cash collateral received from securities on loan.

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	3,554,184	182,834,592	183,645,108	73,718	-	-	2,743,668	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	19,553,600	222,511,087	234,392,912	17,171	-	-	7,671,775	0.0%
Total	23,107,784	405,345,679	418,038,020	90,889	-	-	10,415,443

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	723,832,436	723,832,436	-	-

Convertible Bonds	4,112,105	-	4,112,105	-

Money Market Funds	10,415,443	10,415,443	-	-
Total Investments in Securities:	738,359,984	734,247,879	4,112,105	-

Financial Services Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $7,430,650) - See accompanying schedule:
Unaffiliated issuers (cost $609,236,059)	$	727,944,541
Fidelity Central Funds (cost $10,415,443)		10,415,443


Total Investment in Securities (cost $619,651,502)			$	738,359,984
Cash				13,608
Receivable for fund shares sold				660,519
Dividends receivable				983,178
Distributions receivable from Fidelity Central Funds				12,254
Prepaid expenses				3,713
Other receivables				1,374
Total assets				740,034,630
Liabilities
Payable for fund shares redeemed	$	721,512
Accrued management fee		326,857
Other affiliated payables		119,444
Other payables and accrued expenses		35,603
Collateral on securities loaned		7,671,775
Total Liabilities				8,875,191
Net Assets			$	731,159,439
Net Assets consist of:
Paid in capital			$	606,732,787
Total accumulated earnings (loss)				124,426,652
Net Assets			$	731,159,439
Net Asset Value , offering price and redemption price per share ($731,159,439 ÷ 63,512,865 shares)			$	11.51

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	18,804,473
Interest				296,712
Income from Fidelity Central Funds (including $17,171 from security lending)				90,889
Total Income				19,192,074
Expenses
Management fee	$	3,524,239
Transfer agent fees		1,141,925
Accounting fees		223,748
Custodian fees and expenses		16,347
Independent trustees' fees and expenses		2,292
Registration fees		59,205
Audit		41,388
Legal		558
Interest		2,103
Miscellaneous		4,936
Total expenses before reductions		5,016,741
Expense reductions		(23,514)
Total expenses after reductions				4,993,227
Net Investment income (loss)				14,198,847
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		36,726,142
Foreign currency transactions		2,635
Total net realized gain (loss)				36,728,777
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		(79,393,122)
Assets and liabilities in foreign currencies		(130)
Total change in net unrealized appreciation (depreciation)				(79,393,252)
Net gain (loss)				(42,664,475)
Net increase (decrease) in net assets resulting from operations			$	(28,465,628)

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	14,198,847	$	15,691,678
Net realized gain (loss)		36,728,777		64,214,173
Change in net unrealized appreciation (depreciation)		(79,393,252)		59,571,315
Net increase (decrease) in net assets resulting from operations		(28,465,628)		139,477,166
Distributions to shareholders		(73,318,860)		(29,541,664)
Share transactions
Proceeds from sales of shares		247,678,669		634,993,625
Reinvestment of distributions		67,840,973		27,204,727
Cost of shares redeemed		(302,485,447)		(558,271,824)
Net increase (decrease) in net assets resulting from share transactions		13,034,195		103,926,528
Total increase (decrease) in net assets		(88,750,293)		213,862,030

Net Assets
Beginning of period		819,909,732		606,047,702
End of period	$	731,159,439	$	819,909,732

Other Information
Shares
Sold		21,744,109		48,475,233
Issued in reinvestment of distributions		6,070,885		2,146,844
Redeemed		(26,254,915)		(42,497,145)
Net increase (decrease)		1,560,079		8,124,932

Financial Highlights

Financial Services Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019 B
Selected Per-Share Data
Net asset value, beginning of period	$	13.23	$	11.26	$	9.49	$	9.65	$	11.67
Income from Investment Operations
Net investment income (loss) C,D		.24		.25		.20		.19		.14
Net realized and unrealized gain (loss)		(.74)		2.26		2.17		.26		(1.04)
Total from investment operations		(.50)		2.51		2.37		.45		(.90)
Distributions from net investment income		(.23)		(.26)		(.21)		(.16)		(.14)
Distributions from net realized gain		(.98)		(.28)		(.39)		(.45)		(.98)
Total distributions		(1.22) E		(.54)		(.60)		(.61)		(1.12)
Net asset value, end of period	$	11.51	$	13.23	$	11.26	$	9.49	$	9.65
Total Return F		(3.30)%		22.47%		27.89%		3.81%		(6.91)%
Ratios to Average Net Assets D,G,H
Expenses before reductions		.75%		.73%		.77%		.77%		.76%
Expenses net of fee waivers, if any		.75%		.72%		.77%		.77%		.76%
Expenses net of all reductions		.75%		.72%		.77%		.76%		.75%
Net investment income (loss)		2.12%		1.89%		2.36%		1.81%		1.28%
Supplemental Data
Net assets, end of period (000 omitted)	$	731,159	$	819,910	$	606,048	$	483,337	$	558,429
Portfolio turnover rate I		46%		53%		63%		61% J		49% J

A For the year ended February 29.

B Per share amounts have been adjusted to reflect the impact of the 10 for 1 share split that occurred on August 10, 2018.

C Calculated based on average shares outstanding during the period.

E Total distributions per share do not sum due to rounding.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

I Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

J Portfolio turnover rate excludes securities received or delivered in-kind.

FinTech Portfolio

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
FinTech Portfolio	-14.51%	2.54%	7.49%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in FinTech Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

FinTech Portfolio

Market Recap:

Comments from Portfolio Manager Ruth Nagle:

For the fiscal year ending February 28, 2023, the fund returned -14.51%, outperforming the -15.60% return of the FactSet Financial Technologies Linked Index, but underperforming the broad-based S&P 500 ® index. Versus the industry index, security selection was the primary contributor, led by the data processing & outsourced services group. Security selection in consumer finance also boosted the fund's relative result. The biggest individual relative contributor was an overweight position in MasterCard (-1%). MasterCard was the fund's biggest holding, on average, during the period. Also adding value was our lighter-than-index investment in Upstart Holdings, which returned about -88%. Upstart Holdings was not held at period end. Another notable relative contributor was an underweighting in Fidelity National Information Services (-32%). This period we decreased our stake. Conversely, the largest detractor from performance versus the industry index was an overweight in application software. Stock selection in regional banks and an underweight in asset management & custody banks also modestly hurt relative performance. The biggest individual relative detractor was an underweight position in Fiserv (+18%), which was among the fund's largest holdings. Our second-largest relative detractor this period was avoiding Wex, an index component that gained roughly 14%. Our out-of-index position in Nuvei (-45%) was a key detractor. We reduced our position the past year.

FinTech Portfolio

Top Holdings (% of Fund's net assets)

Visa, Inc. Class A	14.4
MasterCard, Inc. Class A	14.2
Intuit, Inc.	10.8
American Express Co.	8.0
Fiserv, Inc.	5.0
Block, Inc. Class A	4.9
Discover Financial Services	4.8
Capital One Financial Corp.	4.7
Global Payments, Inc.	4.3
Adyen BV	4.2
	75.3

Industries (% of Fund's net assets)

IT Services	63.9
Consumer Finance	18.6
Software	16.5
Banks	0.5

FinTech Portfolio

Showing Percentage of Net Assets

Common Stocks - 99.5%
	Shares	Value ($)
Banks - 0.5%
Diversified Banks - 0.5%
Wells Fargo & Co.	12,037	562,970
Consumer Finance - 18.6%
Consumer Finance - 18.6%
American Express Co.	49,303	8,578,229
Capital One Financial Corp.	46,171	5,036,333
Discover Financial Services	46,698	5,230,176
OneMain Holdings, Inc.	26,874	1,158,001
		20,002,739
IT Services - 63.9%
Data Processing & Outsourced Services - 63.9%
Adyen BV (a)(b)	3,219	4,562,708
Affirm Holdings, Inc. (a)(c)	12,234	166,627
AvidXchange Holdings, Inc. (a)	10,800	107,460
Block, Inc. Class A (a)	69,008	5,294,984
Dlocal Ltd. (a)	31,523	470,954
Edenred SA	43,585	2,458,044
Fidelity National Information Services, Inc.	26,430	1,674,869
Fiserv, Inc. (a)	46,422	5,342,708
FleetCor Technologies, Inc. (a)	15,140	3,251,921
Flywire Corp. (a)	58,576	1,448,584
Global Payments, Inc.	40,744	4,571,477
MasterCard, Inc. Class A	43,086	15,308,025
Nuvei Corp. (Canada) (a)(b)	10,046	307,601
PagSeguro Digital Ltd. (a)	59,646	517,131
PayPal Holdings, Inc. (a)	60,050	4,419,680
Repay Holdings Corp. (a)	45,774	388,164
Shift4 Payments, Inc. (a)(c)	16,547	1,067,282
Visa, Inc. Class A	70,660	15,540,958
Worldline SA (a)(b)	44,111	1,837,333
		68,736,510
Software - 16.5%
Application Software - 16.5%
Bill Holdings, Inc. (a)	14,899	1,260,902
Black Knight, Inc. (a)	43,031	2,564,648
EngageSmart, Inc. (a)	42,588	896,052
Guidewire Software, Inc. (a)	5,385	378,081
Intuit, Inc.	28,565	11,631,097
Lightspeed Commerce, Inc. (Canada) (a)	10,056	153,733
Workiva, Inc. (a)	10,182	908,234
		17,792,747
TOTAL COMMON STOCKS (Cost $120,895,764)		107,094,966

Money Market Funds - 0.7%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (d)	355,472	355,543
Fidelity Securities Lending Cash Central Fund 4.63% (d)(e)	376,955	376,993
TOTAL MONEY MARKET FUNDS (Cost $732,536)		732,536

TOTAL INVESTMENT IN SECURITIES - 100.2% (Cost $121,628,300)	107,827,502
NET OTHER ASSETS (LIABILITIES) - (0.2)%	(249,170)
NET ASSETS - 100.0%	107,578,332

Legend

(a)	Non-income producing

(b)	Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $6,707,642 or 6.2% of net assets.

(c)	Security or a portion of the security is on loan at period end.

(d)

(e)	Investment made with cash collateral received from securities on loan.

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	870,270	20,075,742	20,590,469	9,259	-	-	355,543	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	8,602,318	28,499,830	36,725,155	5,831	-	-	376,993	0.0%
Total	9,472,588	48,575,572	57,315,624	15,090	-	-	732,536

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	107,094,966	100,694,925	6,400,041	-

Money Market Funds	732,536	732,536	-	-
Total Investments in Securities:	107,827,502	101,427,461	6,400,041	-

FinTech Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $405,018) - See accompanying schedule:
Unaffiliated issuers (cost $120,895,764)	$	107,094,966
Fidelity Central Funds (cost $732,536)		732,536


Total Investment in Securities (cost $121,628,300)			$	107,827,502
Receivable for investments sold				619,770
Receivable for fund shares sold				16,352
Dividends receivable				64,217
Distributions receivable from Fidelity Central Funds				708
Prepaid expenses				355
Total assets				108,528,904
Liabilities
Payable for investments purchased	$	427,483
Payable for fund shares redeemed		37,437
Accrued management fee		49,080
Other affiliated payables		26,734
Other payables and accrued expenses		33,688
Collateral on securities loaned		376,150
Total Liabilities				950,572
Net Assets			$	107,578,332
Net Assets consist of:
Paid in capital			$	143,812,487
Total accumulated earnings (loss)				(36,234,155)
Net Assets			$	107,578,332
Net Asset Value , offering price and redemption price per share ($107,578,332 ÷ 7,836,303 shares)			$	13.73

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	1,016,352
Income from Fidelity Central Funds (including $5,831 from security lending)				15,090
Total Income				1,031,442
Expenses
Management fee	$	647,241
Transfer agent fees		311,131
Accounting fees		44,771
Custodian fees and expenses		3,757
Independent trustees' fees and expenses		430
Registration fees		30,932
Audit		40,048
Legal		952
Miscellaneous		(1,299)
Total expenses before reductions		1,077,963
Expense reductions		(4,444)
Total expenses after reductions				1,073,519
Net Investment income (loss)				(42,077)
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		(16,199,835)
Foreign currency transactions		6,292
Total net realized gain (loss)				(16,193,543)
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		(7,892,700)
Assets and liabilities in foreign currencies		(380)
Total change in net unrealized appreciation (depreciation)				(7,893,080)
Net gain (loss)				(24,086,623)
Net increase (decrease) in net assets resulting from operations			$	(24,128,700)

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	(42,077)	$	1,580,188
Net realized gain (loss)		(16,193,543)		42,675,935
Change in net unrealized appreciation (depreciation)		(7,893,080)		(51,830,285)
Net increase (decrease) in net assets resulting from operations		(24,128,700)		(7,574,162)
Distributions to shareholders		-		(37,026,602)
Share transactions
Proceeds from sales of shares		14,085,599		281,706,628
Reinvestment of distributions		-		33,727,405
Cost of shares redeemed		(44,229,846)		(253,862,105)
Net increase (decrease) in net assets resulting from share transactions		(30,144,247)		61,571,928
Total increase (decrease) in net assets		(54,272,947)		16,971,164

Net Assets
Beginning of period		161,851,279		144,880,115
End of period	$	107,578,332	$	161,851,279

Other Information
Shares
Sold		980,123		12,489,588
Issued in reinvestment of distributions		-		1,901,219
Redeemed		(3,218,612)		(11,797,499)
Net increase (decrease)		(2,238,489)		2,593,308

Financial Highlights

FinTech Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	16.06	$	19.37	$	16.23	$	15.80	$	16.29
Income from Investment Operations
Net investment income (loss) B,C		- D		.14 E		.34 F		.39		.24
Net realized and unrealized gain (loss)		(2.33)		.04 G,H		3.14		.35		.43
Total from investment operations		(2.33)		.18		3.48		.74		.67
Distributions from net investment income		-		(.25)		(.34)		(.31)		(.20)
Distributions from net realized gain		-		(3.24)		-		(.01)		(.95)
Total distributions		-		(3.49)		(.34)		(.31) I		(1.16) I
Net asset value, end of period	$	13.73	$	16.06	$	19.37	$	16.23	$	15.80
Total Return J		(14.51)%		(.75)% G		21.94%		4.54%		4.83%
Ratios to Average Net Assets C,K,L
Expenses before reductions		.87%		.81%		.89%		.86%		.87%
Expenses net of fee waivers, if any		.87%		.81%		.89%		.86%		.87%
Expenses net of all reductions		.87%		.81%		.89%		.85%		.86%
Net investment income (loss)		(.03)%		.63% E		2.35% F		2.29%		1.57%
Supplemental Data
Net assets, end of period (000 omitted)	$	107,578	$	161,851	$	144,880	$	148,247	$	102,334
Portfolio turnover rate M		15%		164%		25%		20%		32%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Amount represents less than $.005 per share.

F Net investment income per share reflects one or more large, non-recurring dividend(s) which amounted to $.07 per share. Excluding such non-recurring dividend(s), the ratio of net investment income (loss) to average net assets would have been 1.89%.

G Net realized and unrealized gain (loss) per share reflects proceeds received from litigation which amounted to $.01 per share. Excluding these litigation proceeds, the total return would have been (.78)%.

H The amount shown for a share outstanding does not correspond with the aggregate net gain (loss) on investments for the period due to the timing of sales and repurchases of shares in relation to fluctuating market values of the investments of the Fund.

I Total distributions per share do not sum due to rounding.

J Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

K Fees and expenses of any underlying mutual funds or exchange-traded funds (ETFs) are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of these expenses. For additional expense information related to investments in Fidelity Central Funds, please refer to the "Investments in Fidelity Central Funds" note found in the Notes to Financial Statements section of the most recent Annual or Semi-Annual report.

L Expense ratios reflect operating expenses of the class. Expenses before reductions do not reflect amounts reimbursed, waived, or reduced through arrangements with the investment adviser, brokerage services, or other offset arrangements, if applicable, and do not represent the amount paid by the class during periods when reimbursements, waivers or reductions occur.

M Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Insurance Portfolio

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Insurance Portfolio	8.75%	10.60%	12.71%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Insurance Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Insurance Portfolio

Market Recap:

Comments from Portfolio Manager Fahim Razzaque:

For the fiscal year ending February 28, 2023, the fund gained 8.75%, trailing the 10.25% advance of the MSCI US IMI Insurance 25/50 Index, but handily outperforming the broad-based S&P 500 ® index. Versus the industry index, market selection was the primary detractor, especially an overweighting within multi-line insurance. Weak stock picks in asset management & custody banks also hindered the fund's relative result. Our non-index position in Berkshire Hathaway (-5%) was the fund's largest individual relative detractor. The fund's non-index investment in Ares Management, a position not held at period end, returned approximately -11%. Also hurting performance was our outsized stake in Brown & Brown (-16%). We increased our position the past 12 months. Conversely, by sector, the biggest contributor to performance versus the industry index was stock selection in life & health insurance. Security selection in multi-line insurance and insurance brokers also bolstered the fund's relative result. Not owning Lincoln National, an index component that returned -51%, was the biggest individual relative contributor. Also boosting value was our overweight in Primerica, which gained 50%. We added to our stake the past year. Another notable relative contributor was an underweighting in Prudential Financial (-6%), a position not held at period end. Notable changes in positioning include reduced exposure to the multi-line insurance subindustry.

Insurance Portfolio

Top Holdings (% of Fund's net assets)

Chubb Ltd.	10.8
Marsh & McLennan Companies, Inc.	10.6
Progressive Corp.	8.5
The Travelers Companies, Inc.	6.5
Arthur J. Gallagher & Co.	5.9
Hartford Financial Services Group, Inc.	5.0
American International Group, Inc.	4.9
Aon PLC	4.7
Globe Life, Inc.	4.4
Unum Group	4.2
	65.5

Industries (% of Fund's net assets)

Insurance	97.3
Diversified Financial Services	1.9

Geographic Diversification (% of Fund's net assets)

* Includes Short-Term investments and Net Other Assets (Liabilities).

Percentages are based on country or territory of incorporation and are adjusted for the effect of derivatives, if applicable.

Insurance Portfolio

Showing Percentage of Net Assets

Common Stocks - 99.2%
	Shares	Value ($)
Diversified Financial Services - 1.9%
Multi-Sector Holdings - 1.9%
Berkshire Hathaway, Inc. Class B (a)	28,900	8,819,702
Insurance - 97.3%
Insurance Brokers - 25.7%
Aon PLC	73,200	22,256,460
Arthur J. Gallagher & Co.	150,800	28,252,380
Brown & Brown, Inc.	220,900	12,385,863
Marsh & McLennan Companies, Inc.	309,200	50,133,688
Willis Towers Watson PLC	37,628	8,818,498
		121,846,889
Life & Health Insurance - 15.2%
CNO Financial Group, Inc.	283,500	7,263,270
Globe Life, Inc.	171,600	20,882,004
Primerica, Inc.	56,700	10,882,998
Principal Financial Group, Inc.	146,000	13,075,760
Unum Group	450,100	20,051,955
		72,155,987
Multi-Line Insurance - 11.0%
American International Group, Inc.	377,950	23,096,525
Assurant, Inc.	41,700	5,312,163
Hartford Financial Services Group, Inc.	301,500	23,601,420
		52,010,108
Property & Casualty Insurance - 40.7%
Allstate Corp.	149,800	19,291,244
American Financial Group, Inc.	200	26,822
Arch Capital Group Ltd. (a)	240,000	16,800,000
Assured Guaranty Ltd.	57,600	3,594,816
Chubb Ltd.	242,105	51,088,997
Cincinnati Financial Corp. (b)	26,100	3,150,270
Fidelity National Financial, Inc.	106,700	4,253,062
First American Financial Corp.	89,200	5,064,776
Loews Corp.	143,100	8,741,979
Markel Corp. (a)	3,620	4,814,093
Mercury General Corp.	200	6,810
Progressive Corp.	279,900	40,171,248
Selective Insurance Group, Inc.	51,500	5,228,795
The Travelers Companies, Inc.	167,800	31,063,136
		193,296,048
Reinsurance - 4.7%
Everest Re Group Ltd.	16,000	6,143,520
Reinsurance Group of America, Inc.	86,900	12,554,443
RenaissanceRe Holdings Ltd.	17,800	3,825,220
		22,523,183
TOTAL INSURANCE		461,832,215
TOTAL COMMON STOCKS (Cost $342,466,535)		470,651,917

Money Market Funds - 1.6%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (c)	4,179,419	4,180,255
Fidelity Securities Lending Cash Central Fund 4.63% (c)(d)	3,210,679	3,211,000
TOTAL MONEY MARKET FUNDS (Cost $7,391,255)		7,391,255

TOTAL INVESTMENT IN SECURITIES - 100.8% (Cost $349,857,790)	478,043,172
NET OTHER ASSETS (LIABILITIES) - (0.8)%	(3,581,801)
NET ASSETS - 100.0%	474,461,371

Legend

(a)	Non-income producing

(b)	Security or a portion of the security is on loan at period end.

(c)

(d)	Investment made with cash collateral received from securities on loan.

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	1,824,492	219,013,538	216,657,775	107,289	-	-	4,180,255	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	550	15,439,439	12,228,989	723	-	-	3,211,000	0.0%
Total	1,825,042	234,452,977	228,886,764	108,012	-	-	7,391,255

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	470,651,917	470,651,917	-	-

Money Market Funds	7,391,255	7,391,255	-	-
Total Investments in Securities:	478,043,172	478,043,172	-	-

Insurance Portfolio

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $3,138,200) - See accompanying schedule:
Unaffiliated issuers (cost $342,466,535)	$	470,651,917
Fidelity Central Funds (cost $7,391,255)		7,391,255


Total Investment in Securities (cost $349,857,790)			$	478,043,172
Foreign currency held at value (cost $3)				3
Receivable for fund shares sold				575,128
Dividends receivable				337,602
Distributions receivable from Fidelity Central Funds				9,069
Prepaid expenses				1,074
Total assets				478,966,048
Liabilities
Payable for fund shares redeemed	$	959,148
Accrued management fee		208,801
Other affiliated payables		90,434
Other payables and accrued expenses		35,294
Collateral on securities loaned		3,211,000
Total Liabilities				4,504,677
Net Assets			$	474,461,371
Net Assets consist of:
Paid in capital			$	332,981,780
Total accumulated earnings (loss)				141,479,591
Net Assets			$	474,461,371
Net Asset Value , offering price and redemption price per share ($474,461,371 ÷ 6,292,242 shares)			$	75.40

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	5,549,633
Income from Fidelity Central Funds (including $723 from security lending)				108,012
Total Income				5,657,645
Expenses
Management fee	$	1,758,172
Transfer agent fees		660,418
Accounting fees		120,715
Custodian fees and expenses		10,429
Independent trustees' fees and expenses		1,083
Registration fees		105,027
Audit		40,049
Legal		156
Interest		2,321
Miscellaneous		1,614
Total expenses before reductions		2,699,984
Expense reductions		(11,132)
Total expenses after reductions				2,688,852
Net Investment income (loss)				2,968,793
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		14,737,111
Foreign currency transactions		(753)
Total net realized gain (loss)				14,736,358
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		5,173,256
Assets and liabilities in foreign currencies		(2,745)
Total change in net unrealized appreciation (depreciation)				5,170,511
Net gain (loss)				19,906,869
Net increase (decrease) in net assets resulting from operations			$	22,875,662

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	2,968,793	$	2,475,589
Net realized gain (loss)		14,736,358		6,591,336
Change in net unrealized appreciation (depreciation)		5,170,511		35,822,023
Net increase (decrease) in net assets resulting from operations		22,875,662		44,888,948
Distributions to shareholders		(2,977,551)		(17,750,181)
Share transactions
Proceeds from sales of shares		393,392,705		71,913,727
Reinvestment of distributions		2,747,103		16,623,368
Cost of shares redeemed		(187,507,051)		(54,446,500)
Net increase (decrease) in net assets resulting from share transactions		208,632,757		34,090,595
Total increase (decrease) in net assets		228,530,868		61,229,362

Net Assets
Beginning of period		245,930,503		184,701,141
End of period	$	474,461,371	$	245,930,503

Other Information
Shares
Sold		5,401,580		1,054,727
Issued in reinvestment of distributions		37,851		256,213
Redeemed		(2,667,446)		(810,083)
Net increase (decrease)		2,771,985		500,857

Financial Highlights

Insurance Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	69.86	$	61.17	$	58.44	$	59.27	$	78.49
Income from Investment Operations
Net investment income (loss) B,C		.63		.78		.88		.87		.98
Net realized and unrealized gain (loss)		5.46		13.73		6.99		2.77		(2.40)
Total from investment operations		6.09		14.51		7.87		3.64		(1.42)
Distributions from net investment income		(.55)		(.89)		(.94)		(.91)		(1.16)
Distributions from net realized gain		-		(4.93)		(4.20)		(3.56)		(16.63)
Total distributions		(.55)		(5.82)		(5.14)		(4.47)		(17.80) D
Net asset value, end of period	$	75.40	$	69.86	$	61.17	$	58.44	$	59.27
Total Return E		8.75%		24.68%		15.54%		5.95%		(.29)%
Ratios to Average Net Assets C,F,G
Expenses before reductions		.81%		.78%		.83%		.81%		.82%
Expenses net of fee waivers, if any		.81%		.78%		.83%		.81%		.81%
Expenses net of all reductions		.81%		.78%		.83%		.80%		.81%
Net investment income (loss)		.90%		1.16%		1.68%		1.37%		1.48%
Supplemental Data
Net assets, end of period (000 omitted)	$	474,461	$	245,931	$	184,701	$	219,539	$	223,081
Portfolio turnover rate H		48%		15%		18%		28%		9%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Total distributions per share do not sum due to rounding.

E Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

H Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Report of Independent Registered Public Accounting Firm

For the period ended February 28, 2023

1. Organization.

Banking Portfolio, Brokerage and Investment Management Portfolio, Financial Services Portfolio, FinTech Portfolio and Insurance Portfolio (the Funds) are non-diversified funds of Fidelity Select Portfolios (the Trust). The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust. The Funds invest primarily in securities of companies whose principal business activities fall within specific industries. Each Fund is authorized to issue an unlimited number of shares. Share transactions on the Statement of Changes in Net Assets may contain exchanges between affiliated funds.

In January 2023 the Board of Trustees approved a change in the name of Financial Services Portfolio to Financials Portfolio effective April 28, 2023.

2. Investments in Fidelity Central Funds.

Fidelity Central Fund	Investment Manager	Investment Objective	Investment Practices	Expense Ratio A
Fidelity Money Market Central Funds	Fidelity Management & Research Company LLC (FMR)	Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity.	Short-term Investments	Less than .005%

A Expenses expressed as a percentage of average net assets and are as of each underlying Central Fund's most recent annual or semi-annual shareholder report.

3. Significant Accounting Policies.

Each Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:

Level 1 - unadjusted quoted prices in active markets for identical investments

Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)

Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value each Fund's investments by major category are as follows:

Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing services or from brokers who make markets in such securities. Corporate bonds are valued by pricing services who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing services. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.

Investment Transactions and Income. For financial reporting purposes, the Funds' investment holdings and NAV include trades executed through the end of the last business day of the period. The NAV per share for processing shareholder transactions is calculated as of the close of business of the New York Stock Exchange (NYSE), normally 4:00 p.m. Eastern time and includes trades executed through the end of the prior business day. Gains and losses on securities sold are determined on the basis of identified cost and for certain Funds include proceeds received from litigation. Commissions paid to certain brokers with whom the investment adviser, or its affiliates, places trades on behalf of a fund include an amount in addition to trade execution, which may be rebated back to a fund. Any such rebates are included in net realized gain (loss) on investments in the Statement of Operations. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities where the ex-dividend date may have passed, which are recorded as soon as the Funds are informed of the ex-dividend date. Non-cash dividends included in dividend income, if any, are recorded at the fair market value of the securities received. Income and capital gain distributions from Fidelity Central Funds, if any, are recorded on the ex-dividend date. Certain distributions received by the Funds represent a return of capital or capital gain. The Funds determine the components of these distributions subsequent to the ex-dividend date, based upon receipt of tax filings or other correspondence relating to the underlying investment. These distributions are recorded as a reduction of cost of investments and/or as a realized gain. Interest income is accrued as earned and includes coupon interest and amortization of premium and accretion of discount on debt securities as applicable. Investment income is recorded net of foreign taxes withheld where recovery of such taxes is uncertain. Funds may file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. Any withholding tax reclaims income is included in the Statement of Operations in dividends. Any receivables for withholding tax reclaims are included in the Statement of Assets and Liabilities in dividends receivable.

Brokerage and Investment Management Portfolio

$50,189

Distributions are declared and recorded on the ex-dividend date. Income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP. In addition, certain Funds claimed a portion of the payment made to redeeming shareholders as a distribution for income tax purposes.

Book-tax differences are primarily due to foreign currency transactions, passive foreign investment companies (PFIC), deferred Trustee compensation, net operating losses, partnerships, capital loss carryforwards and losses deferred due to wash sales and excise tax regulations.

As of period end, the cost and unrealized appreciation (depreciation) in securities, and derivatives if applicable, for federal income tax purposes were as follows for each Fund:

	Tax cost	Gross unrealized appreciation	Gross unrealized depreciation	Net unrealized appreciation (depreciation)
Banking Portfolio	$360,943,658	$88,065,024	$(15,601,816)	$72,463,208
Brokerage and Investment Management Portfolio	640,361,716	261,687,029	(50,363,069)	211,323,960
Financial Services Portfolio	622,803,456	141,240,830	(25,684,302)	115,556,528
FinTech Portfolio	122,064,043	24,169,564	(38,406,105)	(14,236,541)
Insurance Portfolio	351,792,227	133,103,830	(6,852,885)	126,250,945

The tax-based components of distributable earnings as of period end were as follows for each Fund:

	Undistributed ordinary income	Undistributed long-term capital gain	Capital loss carryforward	Net unrealized appreciation (depreciation) on securities and other investments
Banking Portfolio	$1,684,994	$10,230,061	$-	$72,463,208
Brokerage and Investment Management Portfolio	-	-	(74,446,146)	211,322,364
Financial Services Portfolio	2,197,325	6,673,975	-	115,555,352
FinTech Portfolio	-	-	(21,997,614)	(14,236,541)
Insurance Portfolio	-	15,230,446	-	126,249,144

	Short-term	Long-term	Total capital loss carryforward
Brokerage and Investment Management Portfolio	(74,446,146)	(-)	(74,446,146)
FinTech Portfolio	(21,997,614)	(-)	(21,997,614)

The tax character of distributions paid was as follows:

February 28, 2023
	Ordinary Income	Long-term Capital Gains	Total
Banking Portfolio	$11,563,840	$15,801,398	$27,365,238
Brokerage and Investment Management Portfolio	13,893,658	3,333,300	17,226,958
Financial Services Portfolio	14,414,547	58,904,313	73,318,860
FinTech Portfolio	-	-	-
Insurance Portfolio	2,977,551	-	2,977,551

February 28, 2022
	Ordinary Income	Long-term Capital Gains	Total
Banking Portfolio	$10,967,463	$9,331,485	$20,298,948
Brokerage and Investment Management Portfolio	7,406,134	4,552,818	11,958,952
Financial Services Portfolio	15,183,491	14,358,173	29,541,664
FinTech Portfolio	3,215,617	33,810,985	37,026,602
Insurance Portfolio	2,910,816	14,839,365	17,750,181

4. Purchases and Sales of Investments.

Purchases and sales of securities, other than short-term securities and in-kind transactions, as applicable, are noted in the table below.

	Purchases ($)	Sales ($)
Banking Portfolio	105,972,044	293,602,359
Brokerage and Investment Management Portfolio	37,829,108	359,862,620
Financial Services Portfolio	308,990,905	353,640,986
FinTech Portfolio	18,324,727	46,555,622
Insurance Portfolio	369,184,926	161,478,550

5. Fees and Other Transactions with Affiliates.

	Individual Rate	Group Rate	Total
Banking Portfolio	.30%	.23%	.52%
Brokerage and Investment Management Portfolio	.30%	.23%	.53%
Financial Services Portfolio	.30%	.23%	.53%
FinTech Portfolio	.30%	.23%	.53%
Insurance Portfolio	.30%	.23%	.53%

Banking Portfolio	.16%
Brokerage and Investment Management Portfolio	.18%
Financial Services Portfolio	.17%
FinTech Portfolio	.25%
Insurance Portfolio	.20%

	% of Average Net Assets
Banking Portfolio	.04
Brokerage and Investment Management Portfolio	.03
Financial Services Portfolio	.03
FinTech Portfolio	.04
Insurance Portfolio	.04

	Amount
Banking Portfolio	$3,948
Brokerage and Investment Management Portfolio	1,770
Financial Services Portfolio	5,032
FinTech Portfolio	190
Insurance Portfolio	2,281

	Borrower or Lender	Average Loan Balance	Weighted Average Interest Rate	Interest Expense
Banking Portfolio	Borrower	$4,813,400	4.57%	$3,052
Brokerage and Investment Management Portfolio	Borrower	$4,922,128	3.01%	$16,040
Financial Services Portfolio	Borrower	$8,406,400	1.80%	$2,103
Insurance Portfolio	Borrower	$9,918,000	3.12%	$1,721

	Purchases ($)	Sales ($)	Realized Gain (Loss) ($)
Banking Portfolio	2,195,220	10,254,750	(686,955)
Brokerage and Investment Management Portfolio	521,795	11,761,351	(494,769)
Financial Services Portfolio	13,519,173	19,425,362	3,728,865
FinTech Portfolio	1,207,696	46,801	14,984
Insurance Portfolio	28,784,056	13,945,703	3,832,914

6. Committed Line of Credit.

	Amount
Banking Portfolio	$956
Brokerage and Investment Management Portfolio	1,720
Financial Services Portfolio	1,210
FinTech Portfolio	239
Insurance Portfolio	519

7. Security Lending.

	Total Security Lending Fees Paid to NFS	Security Lending Income From Securities Loaned to NFS	Value of Securities Loaned to NFS at Period End
Banking Portfolio	$1,488	$11	$-
Brokerage and Investment Management Portfolio	$13,416	$1,587	$-
Financial Services Portfolio	$1,721	$-	$-
FinTech Portfolio	$581	$-	$-
Insurance Portfolio	$76	$-	$-

8. Bank Borrowings.

	Average Loan Balance	Weighted Average Interest Rate	Interest Expense
Brokerage and Investment Management Portfolio	$944,406	2.59%	$2,176
Insurance Portfolio	$10,389,000	2.08%	$600

9. Expense Reductions.

During the period the investment adviser or an affiliate reimbursed and/or waived a portion of operating expenses as follows:

	Amount
Banking Portfolio	$17,651
Brokerage and Investment Management Portfolio	32,083
Financial Services Portfolio	23,514
FinTech Portfolio	4,444
Insurance Portfolio	11,132

10. Other.

11. Risk and Uncertainties.

To the Board of Trustees of Fidelity Select Portfolios and the Shareholders of Banking Portfolio, Brokerage and Investment Management Portfolio, Financial Services Portfolio, FinTech Portfolio and Insurance Portfolio

Opinions on the Financial Statements

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of Banking Portfolio, Brokerage and Investment Management Portfolio, Financial Services Portfolio, FinTech Portfolio and Insurance Portfolio (five of the funds constituting Fidelity Select Portfolios, hereafter collectively referred to as the "Funds") as of February 28, 2023, the related statements of operations for the year ended February 28, 2023, the statements of changes in net assets for each of the two years in the period ended February 28, 2023, including the related notes, and the financial highlights for each of the five years in the period ended February 28, 2023 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Funds as of February 28, 2023, the results of each of their operations for the year then ended, the changes in each of their net assets for each of the two years in the period ended February 28, 2023 and each of the financial highlights for each of the five years in the period ended February 28, 2023 in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinions

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of February 28, 2023 by correspondence with the custodian and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinions.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

April 12, 2023

We have served as the auditor of one or more investment companies in the Fidelity group of funds since 1932.

TRUSTEES AND OFFICERS

The funds' Statement of Additional Information (SAI) includes more information about the Trustees. To request a free copy, call Fidelity at 1-800-544-8544.

Interested Trustees*:

Correspondence intended for a Trustee who is an interested person may be sent to Fidelity Investments, 245 Summer Street, Boston, Massachusetts 02210.

Name, Year of Birth; Principal Occupations and Other Relevant Experience+

Bettina Doulton (1964)

Year of Election or Appointment: 2020

Trustee

Robert A. Lawrence (1952)

Year of Election or Appointment: 2020

Trustee

Chair of the Board of Trustees

* Determined to be an "Interested Trustee" by virtue of, among other things, his or her affiliation with the trust or various entities under common control with FMR.

Independent Trustees:

Correspondence intended for an Independent Trustee may be sent to Fidelity Investments, P.O. Box 55235, Boston, Massachusetts 02205-5235.

Name, Year of Birth; Principal Occupations and Other Relevant Experience+

Thomas P. Bostick (1956)

Year of Election or Appointment: 2021

Trustee

Dennis J. Dirks (1948)

Year of Election or Appointment: 2018

Trustee

Donald F. Donahue (1950)

Year of Election or Appointment: 2018

Trustee

Vicki L. Fuller (1957)

Year of Election or Appointment: 2020

Trustee

Patricia L. Kampling (1959)

Year of Election or Appointment: 2020

Trustee

Thomas A. Kennedy (1955)

Year of Election or Appointment: 2021

Trustee

Oscar Munoz (1959)

Year of Election or Appointment: 2021

Trustee

David M. Thomas (1949)

Year of Election or Appointment: 2018

Trustee

Lead Independent Trustee

Susan Tomasky (1953)

Year of Election or Appointment: 2020

Trustee

Michael E. Wiley (1950)

Year of Election or Appointment: 2008

Trustee

Advisory Board Members and Officers:

Name, Year of Birth; Principal Occupation

Peter S. Lynch (1944)

Year of Election or Appointment: 2018

Member of the Advisory Board

Heather Bonner (1977)

Year of Election or Appointment: 2023

Assistant Treasurer

Craig S. Brown (1977)

Year of Election or Appointment: 2022

Deputy Treasurer

John J. Burke III (1964)

Year of Election or Appointment: 2018

Chief Financial Officer

Margaret Carey (1973)

Year of Election or Appointment: 2023

Secretary and Chief Legal Officer (CLO)

William C. Coffey (1969)

Year of Election or Appointment: 2019

Assistant Secretary

Timothy M. Cohen (1969)

Year of Election or Appointment: 2018

Vice President

Jonathan Davis (1968)

Year of Election or Appointment: 2010

Assistant Treasurer

Laura M. Del Prato (1964)

Year of Election or Appointment: 2018

Assistant Treasurer

Colm A. Hogan (1973)

Year of Election or Appointment: 2020

Assistant Treasurer

Pamela R. Holding (1964)

Year of Election or Appointment: 2018

Vice President

Chris Maher (1972)

Year of Election or Appointment: 2020

Deputy Treasurer

Jason P. Pogorelec (1975)

Year of Election or Appointment: 2020

Chief Compliance Officer

Brett Segaloff (1972)

Year of Election or Appointment: 2021

Anti-Money Laundering (AML) Officer

Stacie M. Smith (1974)

Year of Election or Appointment: 2018

President and Treasurer

Jim Wegmann (1979)

Year of Election or Appointment: 2019

Assistant Treasurer

The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (September 1, 2022 to February 28, 2023).

Actual Expenses

Hypothetical Example for Comparison Purposes

	Annualized Expense Ratio- A	Beginning Account Value September 1, 2022	Ending Account Value February 28, 2023	Expenses Paid During Period- C September 1, 2022 to February 28, 2023

Banking Portfolio	.75%
Actual		$ 1,000	$ 1,048.80	$ 3.81
Hypothetical- B		$ 1,000	$ 1,021.08	$ 3.76

Brokerage and Investment Management Portfolio	.75%
Actual		$ 1,000	$ 1,096.10	$ 3.90
Hypothetical- B		$ 1,000	$ 1,021.08	$ 3.76

Financial Services Portfolio	.74%
Actual		$ 1,000	$ 1,093.40	$ 3.84
Hypothetical- B		$ 1,000	$ 1,021.12	$ 3.71

FinTech Portfolio	.88%
Actual		$ 1,000	$ 1,001.50	$ 4.37
Hypothetical- B		$ 1,000	$ 1,020.43	$ 4.41

Insurance Portfolio	.81%
Actual		$ 1,000	$ 1,133.40	$ 4.28
Hypothetical- B		$ 1,000	$ 1,020.78	$ 4.06

A Annualized expense ratio reflects expenses net of applicable fee waivers.

B 5% return per year before expenses

Distributions (Unaudited)

The dividend and capital gains distributions for the fund(s) are available on Fidelity.com or Institutional.Fidelity.com.

Banking Portfolio	$21,316,509
Financial Services Portfolio	$37,414,936
Insurance Portfolio	$16,255,082

A percentage of the dividends distributed during the fiscal year for the following funds qualify for the dividends-received deduction for corporate shareholders:

Banking Portfolio
April 2022	100%
December 2022	100%
Brokerage and Investment Management Portfolio
April 2022	100%
December 2022	100%
Financial Services Portfolio
April 2022	100%
December 2022	100%
FinTech Portfolio
April 2022	-
December 2022	-
Insurance Portfolio
April 2022	-
December 2022	100%

Banking Portfolio
April 2022	100%
December 2022	100%
Brokerage and Investment Management Portfolio
April 2022	100%
December 2022	100%
Financial Services Portfolio
April 2022	100%
December 2022	100%
FinTech Portfolio
April 2022	-
December 2022	-
Insurance Portfolio
April 2022 December 2022	- 100%

	April, 2022	December, 2022
Banking Portfolio	-	-
Brokerage and Investment Management Portfolio	100%	-
Financial Services Portfolio	-	-
FinTech Portfolio	-	-
Insurance Portfolio	-	-

The funds will notify shareholders in January 2024 of amounts for use in preparing 2023 income tax returns.

Highly liquid investments - cash or convertible to cash within three business days or less
Moderately liquid investments - convertible to cash in three to seven calendar days
Less liquid investments - can be sold or disposed of, but not settled, within seven calendar days
Illiquid investments - cannot be sold or disposed of within seven calendar days

1.813663.118

SELFIN-ANN-0423

Fidelity® Select Portfolios®

Energy Sector

Energy Portfolio

Annual Report

February 28, 2023

Contents

Report of Independent Registered Public Accounting Firm

You may also call 1-800-544-8544 to request a free copy of the proxy voting guidelines.

Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.

Other third-party marks appearing herein are the property of their respective owners.

This report and the financial statements contained herein are submitted for the general information of the shareholders of the Fund. This report is not authorized for distribution to prospective investors in the Fund unless preceded or accompanied by an effective prospectus.

NOT FDIC INSURED •MAY LOSE VALUE •NO BANK GUARANTEE

Neither the Fund nor Fidelity Distributors Corporation is a bank.

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Energy Portfolio	24.63%	8.51%	3.70%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Energy Portfolio on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Market Recap:

Comments from Portfolio Manager Maurice FitzMaurice:

For the fiscal year ending February 28, 2023, the fund gained 24.63%, outperforming the 24.10% advance of the MSCI US IMI Energy 25/50 Index, as well as the broad-based S&P 500 ® index. The top contributors to performance versus the sector index were stock selection and an underweighting in oil & gas storage & transportation. Security selection in integrated oil & gas and an overweighting in oil & gas equipment & services also helped. The fund's biggest individual relative contributor was an overweighting in TechnipFMC, which gained 124% the past 12 months. We increased the position the past year. Also boosting value was an underweighting in Chevron, which gained roughly 15%. Despite an underweighting, the company was among the fund's largest holdings. Avoiding Williams Companies, an index component that gained about 1%, also helped relative performance. In contrast, the largest detractor from performance versus the sector index were stock picks in oil & gas exploration & production. Weak stock selection in oil & gas equipment & services and independent power producers & energy traders also hurt relative performance. Our non-index investment in Canadian National Resources was the fund's biggest individual relative detractor this period, due to its approximate 6% gain. This was among our largest holdings this period. Also hindering performance was untimely positioning in EQT, which gained roughly 46%. This was a stake we established during the period. Also hurting performance was our outsized stake in PDC Energy, which gained 7%. Notable changes in positioning include a higher allocation to the oil & gas equipment & services and oil & gas refining & marketing subindustries.

Top Holdings (% of Fund's net assets)

Exxon Mobil Corp.	24.6
Chevron Corp.	6.6
Valero Energy Corp.	5.2
ConocoPhillips Co.	4.6
Schlumberger Ltd.	4.5
Halliburton Co.	4.4
Marathon Petroleum Corp.	4.3
Hess Corp.	3.6
Occidental Petroleum Corp.	3.5
Cheniere Energy, Inc.	3.5
	64.8

Industries (% of Fund's net assets)

Oil, Gas & Consumable Fuels	83.8
Energy Equipment & Services	15.7
Independent Power and Renewable Electricity Producers	0.4

Geographic Diversification (% of Fund's net assets)

* Includes Short-Term investments and Net Other Assets (Liabilities).

Percentages are based on country or territory of incorporation and are adjusted for the effect of derivatives, if applicable.

Showing Percentage of Net Assets

Common Stocks - 99.9%
	Shares	Value ($)
Energy Equipment & Services - 15.7%
Oil & Gas Drilling - 1.6%
Nabors Industries Ltd. (a)	8,999	1,352,640
Nabors Industries Ltd. warrants 6/11/26 (a)	36,999	1,032,272
Noble Corp. PLC (a)	210,700	8,784,083
Odfjell Drilling Ltd. (a)	1,535,318	3,969,579
Shelf Drilling Ltd. (a)(b)	1,347,589	4,009,755
Valaris Ltd. (a)	410,300	27,592,675
		46,741,004
Oil & Gas Equipment & Services - 14.1%
Cactus, Inc.	48,586	2,232,527
Halliburton Co.	3,420,700	123,931,961
Nextier Oilfield Solutions, Inc. (a)	4,239,500	38,706,635
NOV, Inc.	787,200	17,223,936
Oceaneering International, Inc. (a)	897,530	18,749,402
ProPetro Holding Corp. (a)	1,333,701	11,749,906
Schlumberger Ltd.	2,429,569	129,277,366
TechnipFMC PLC (a)	3,765,172	57,569,480
		399,441,213
TOTAL ENERGY EQUIPMENT & SERVICES		446,182,217
Independent Power and Renewable Electricity Producers - 0.4%
Independent Power Producers & Energy Traders - 0.4%
Vistra Corp.	421,300	9,264,387
Oil, Gas & Consumable Fuels - 83.8%
Coal & Consumable Fuels - 0.3%
Arch Resources, Inc.	49,000	7,710,150
Integrated Oil & Gas - 40.2%
Cenovus Energy, Inc.:
warrants (a)	97,500	1,326,000
(Canada)	4,627,106	85,319,155
Chevron Corp.	1,168,303	187,828,073
Exxon Mobil Corp.	6,356,746	698,669,955
Imperial Oil Ltd.	484,100	23,944,235
Occidental Petroleum Corp.	1,701,815	99,658,286
Occidental Petroleum Corp. warrants 8/3/27 (a)	99,550	3,669,413
Suncor Energy, Inc. (c)	1,203,200	40,438,807
		1,140,853,924
Oil & Gas Exploration & Production - 26.9%
Antero Resources Corp. (a)	1,134,300	29,718,660
APA Corp.	1,012,500	38,859,750
Callon Petroleum Co. (a)	108,100	4,189,956
Canadian Natural Resources Ltd.	1,688,900	95,442,344
Canadian Natural Resources Ltd.	25,780	1,456,828
Chord Energy Corp.	74,152	9,982,342
Civitas Resources, Inc.	221,054	15,511,359
ConocoPhillips Co.	1,274,166	131,685,056
Coterra Energy, Inc. (c)	468,098	11,688,407
Devon Energy Corp.	815,800	43,987,936
Diamondback Energy, Inc.	169,500	23,828,310
EOG Resources, Inc.	294,464	33,280,321
EQT Corp.	278,700	9,247,266
Hess Corp.	764,000	102,910,800
Magnolia Oil & Gas Corp. Class A	460,900	10,070,665
National Energy Services Reunited Corp. (a)	1,711,418	11,055,760
Northern Oil & Gas, Inc.	140,560	4,362,982
Ovintiv, Inc.	729,400	31,196,438
PDC Energy, Inc.	1,011,107	67,855,391
Pioneer Natural Resources Co.	226,666	45,426,133
Range Resources Corp.	1,318,000	35,506,920
SM Energy Co.	258,900	7,640,139
		764,903,763
Oil & Gas Refining & Marketing - 11.3%
Marathon Petroleum Corp.	992,392	122,659,651
Phillips 66 Co.	514,273	52,743,839
Valero Energy Corp.	1,116,700	147,102,891
		322,506,381
Oil & Gas Storage & Transport - 5.1%
Cheniere Energy, Inc.	622,612	97,961,772
Energy Transfer LP	2,990,200	37,855,932
Golar LNG Ltd. (a)	382,733	8,737,794
	��	144,555,498
TOTAL OIL, GAS & CONSUMABLE FUELS		2,380,529,716
TOTAL COMMON STOCKS (Cost $1,717,013,668)		2,835,976,320

Money Market Funds - 1.6%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (d)	613	613
Fidelity Securities Lending Cash Central Fund 4.63% (d)(e)	46,143,793	46,148,408
TOTAL MONEY MARKET FUNDS (Cost $46,149,021)		46,149,021

TOTAL INVESTMENT IN SECURITIES - 101.5% (Cost $1,763,162,689)	2,882,125,341
NET OTHER ASSETS (LIABILITIES) - (1.5)%	(41,415,579)
NET ASSETS - 100.0%	2,840,709,762

Legend

(a)	Non-income producing

(b)	Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $4,009,755 or 0.1% of net assets.

(c)	Security or a portion of the security is on loan at period end.

(d)

(e)	Investment made with cash collateral received from securities on loan.

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	7,528,525	437,616,346	445,144,258	143,542	-	-	613	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	23,406,482	1,096,817,177	1,074,075,251	134,767	-	-	46,148,408	0.1%
Total	30,935,007	1,534,433,523	1,519,219,509	278,309	-	-	46,149,021

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	2,835,976,320	2,835,976,320	-	-

Money Market Funds	46,149,021	46,149,021	-	-
Total Investments in Securities:	2,882,125,341	2,882,125,341	-	-

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $43,430,465) - See accompanying schedule:
Unaffiliated issuers (cost $1,717,013,668)	$	2,835,976,320
Fidelity Central Funds (cost $46,149,021)		46,149,021


Total Investment in Securities (cost $1,763,162,689)			$	2,882,125,341
Receivable for investments sold				7,007,336
Receivable for fund shares sold				1,948,241
Dividends receivable				12,230,628
Distributions receivable from Fidelity Central Funds				3,155
Prepaid expenses				6,356
Other receivables				390,326
Total assets				2,903,711,383
Liabilities
Payable for fund shares redeemed	$	7,827,551
Accrued management fee		1,307,883
Notes payable to affiliates		6,854,000
Other affiliated payables		488,686
Other payables and accrued expenses		375,701
Collateral on securities loaned		46,147,800
Total Liabilities				63,001,621
Net Assets			$	2,840,709,762
Net Assets consist of:
Paid in capital			$	2,937,158,169
Total accumulated earnings (loss)				(96,448,407)
Net Assets			$	2,840,709,762
Net Asset Value , offering price and redemption price per share ($2,840,709,762 ÷ 51,706,133 shares)			$	54.94

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	100,859,156
Income from Fidelity Central Funds (including $134,767 from security lending)				278,309
Total Income				101,137,465
Expenses
Management fee	$	15,345,560
Transfer agent fees		4,730,354
Accounting fees		780,816
Custodian fees and expenses		41,315
Independent trustees' fees and expenses		9,769
Registration fees		228,445
Audit		60,663
Legal		2,943
Interest		132,773
Miscellaneous		8,769
Total expenses before reductions		21,341,407
Expense reductions		(100,733)
Total expenses after reductions				21,240,674
Net Investment income (loss)				79,896,791
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		62,610,001
Foreign currency transactions		(59,395)
Total net realized gain (loss)				62,550,606
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		379,247,000
Assets and liabilities in foreign currencies		(4,963)
Total change in net unrealized appreciation (depreciation)				379,242,037
Net gain (loss)				441,792,643
Net increase (decrease) in net assets resulting from operations			$	521,689,434

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	79,896,791	$	37,737,303
Net realized gain (loss)		62,550,606		(5,935,534)
Change in net unrealized appreciation (depreciation)		379,242,037		661,757,391
Net increase (decrease) in net assets resulting from operations		521,689,434		693,559,160
Distributions to shareholders		(76,651,144)		(31,460,812)
Share transactions
Proceeds from sales of shares		2,107,751,018		1,435,953,793
Net asset value of shares issued in exchange for the net assets of the Target Fund(s) (see Merger Information note)		-		388,960,944
Reinvestment of distributions		71,674,644		29,620,722
Cost of shares redeemed		(2,191,394,921)		(1,089,636,722)
Net increase (decrease) in net assets resulting from share transactions		(11,969,259)		764,898,737
Total increase (decrease) in net assets		433,069,031		1,426,997,085

Net Assets
Beginning of period		2,407,640,731		980,643,646
End of period	$	2,840,709,762	$	2,407,640,731

Other Information
Shares
Sold		39,822,947		39,603,793
Issued in exchange for the shares of the Target Fund(s) (see Merger Information note)		-		11,161,009
Issued in reinvestment of distributions		1,340,218		884,794
Redeemed		(42,677,565)		(31,953,761)
Net increase (decrease)		(1,514,400)		19,695,835

Financial Highlights

Energy Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	45.24	$	29.25	$	26.79	$	37.50	$	41.01
Income from Investment Operations
Net investment income (loss) B,C		1.46		.96		.99 D		.71		.49
Net realized and unrealized gain (loss)		9.64		15.82		2.27		(10.76)		(3.51)
Total from investment operations		11.10		16.78		3.26		(10.05)		(3.02)
Distributions from net investment income		(1.40)		(.79)		(.80)		(.64)		(.48)
Distributions from net realized gain		-		-		-		(.02)		(.01)
Total distributions		(1.40)		(.79)		(.80)		(.66)		(.49)
Net asset value, end of period	$	54.94	$	45.24	$	29.25	$	26.79	$	37.50
Total Return E		24.63%		58.37%		13.03%		(27.24)%		(7.30)%
Ratios to Average Net Assets C,F,G
Expenses before reductions		.73%		.77%		.85%		.81%		.78%
Expenses net of fee waivers, if any		.73%		.77%		.85%		.81%		.78%
Expenses net of all reductions		.73%		.77%		.84%		.80%		.77%
Net investment income (loss)		2.75%		2.79%		4.50% D		2.00%		1.12%
Supplemental Data
Net assets, end of period (000 omitted)	$	2,840,710	$	2,407,641	$	980,644	$	676,312	$	1,152,173
Portfolio turnover rate H		43%		56% I		31%		79%		59%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Net investment income per share reflects one or more large, non-recurring dividend(s) which amounted to $.15 per share. Excluding such non-recurring dividend(s), the ratio of net investment income (loss) to average net assets would have been 3.82%.

E Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

H Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

I The portfolio turnover rate does not include the assets acquired in the merger.

Report of Independent Registered Public Accounting Firm

For the period ended February 28, 2023

1. Organization.

Energy Portfolio (the Fund) is a non-diversified fund of Fidelity Select Portfolios (the Trust) and is authorized to issue an unlimited number of shares. Share transactions on the Statement of Changes in Net Assets may contain exchanges between affiliated funds. The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust. The Fund invests primarily in securities of companies whose principal business activities fall within specific industries.

2. Investments in Fidelity Central Funds.

Fidelity Central Fund	Investment Manager	Investment Objective	Investment Practices	Expense Ratio A
Fidelity Money Market Central Funds	Fidelity Management & Research Company LLC (FMR)	Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity.	Short-term Investments	Less than .005%

A Expenses expressed as a percentage of average net assets and are as of each underlying Central Fund's most recent annual or semi-annual shareholder report.

3. Significant Accounting Policies.

The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:

Level 1 - unadjusted quoted prices in active markets for identical investments

Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)

Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value the Fund's investments by major category are as follows:

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.

Investment Transactions and Income. For financial reporting purposes, the Fund's investment holdings and NAV include trades executed through the end of the last business day of the period. The NAV per share for processing shareholder transactions is calculated as of the close of business of the New York Stock Exchange (NYSE), normally 4:00 p.m. Eastern time and includes trades executed through the end of the prior business day. Gains and losses on securities sold are determined on the basis of identified cost and include proceeds received from litigation. Commissions paid to certain brokers with whom the investment adviser, or its affiliates, places trades on behalf of a fund include an amount in addition to trade execution, which may be rebated back to a fund. Any such rebates are included in net realized gain (loss) on investments in the Statement of Operations. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities where the ex-dividend date may have passed, which are recorded as soon as the Fund is informed of the ex-dividend date. Non-cash dividends included in dividend income, if any, are recorded at the fair market value of the securities received. Income and capital gain distributions from Fidelity Central Funds, if any, are recorded on the ex-dividend date. Certain distributions received by the Fund represent a return of capital or capital gain. The Fund determines the components of these distributions subsequent to the ex-dividend date, based upon receipt of tax filings or other correspondence relating to the underlying investment. These distributions are recorded as a reduction of cost of investments and/or as a realized gain. Investment income is recorded net of foreign taxes withheld where recovery of such taxes is uncertain. Funds may file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. Any withholding tax reclaims income is included in the Statement of Operations in dividends. Any receivables for withholding tax reclaims are included in the Statement of Assets and Liabilities in dividends receivable.

Energy Portfolio

$336,105

Book-tax differences are primarily due to foreign currency transactions, passive foreign investments companies (PFIC), partnerships, deferred Trustee compensation, capital loss carryforwards and losses deferred due to wash sales.

As of period end, the cost and unrealized appreciation (depreciation) in securities, and derivatives if applicable, for federal income tax purposes were as follows:

Gross unrealized appreciation	$1,131,819,264
Gross unrealized depreciation	(25,206,828)
Net unrealized appreciation (depreciation)	$1,106,612,436)
Tax Cost	$1,775,512,905

The tax-based components of distributable earnings as of period end were as follows:

Capital loss carryforward	$(1,200,162,975)
Net unrealized appreciation (depreciation) on securities and other investments	$1,104,063,112

Due to a merger in a prior period, approximately $390,759,990 of the Fund's realized losses are subject to limitation. Due to this limitation, the Fund will only be permitted to use approximately $2,077,904 of those capital losses per year to offset gains. These realized losses were acquired from Select Natural Gas Portfolio when it merged into the Fund on November 19, 2021.

Due to a merger in a prior period, approximately $320,127,296 of the Fund's realized losses and a portion of the Fund's unrealized losses are subject to limitation. Due to this limitation, the Fund will only be permitted to use approximately $3,367,549 of those capital losses per year to offset gains. These realized and unrealized losses were acquired from Select Energy Service Portfolio when it merged into the Fund on November 19, 2021.

Short-term	$(463,978,664)
Long-term	(736,184,311)
Total capital loss carryforward	$(1,200,162,975)

The tax character of distributions paid was as follows:

	February 28, 2023	February 28, 2022
Ordinary Income	$76,651,144	$ 31,460,812

Purchases and Sales of Investments.

Purchases and sales of securities, other than short-term securities and in-kind transactions, as applicable, are noted in the table below.

	Purchases ($)	Sales ($)
Energy Portfolio	1,245,039,230	1,236,016,778

4. Fees and Other Transactions with Affiliates.

	% of Average Net Assets
Energy Portfolio	.03

	Amount
Energy Portfolio	$33,462

Interfund Lending Program. Pursuant to an Exemptive Order issued by the Securities and Exchange Commission (the SEC), the Fund, along with other registered investment companies having management contracts with Fidelity Management & Research Company LLC (FMR), or other affiliated entities of FMR, may participate in an interfund lending program. This program provides an alternative credit facility allowing the Fund to borrow from, or lend money to, other participating affiliated funds. Any open loans, including accrued interest, at period end are presented as Notes payable to affiliates in the Statement of Assets and Liabilities. Activity in this program during the period for which loans were outstanding was as follows:

	Borrower or Lender	Average Loan Balance	Weighted Average Interest Rate	Interest Expense
Energy Portfolio	Borrower	$11,772,827	2.86%	$130,182

	Purchases ($)	Sales ($)	Realized Gain (Loss) ($)
Energy Portfolio	67,861,814	145,361,073	2,659,746

5. Committed Line of Credit.

	Amount
Energy Portfolio	$4,852

6. Security Lending.

	Total Security Lending Fees Paid to NFS	Security Lending Income From Securities Loaned to NFS	Value of Securities Loaned to NFS at Period End
Energy Portfolio	$13,861	$-	$-

7. Bank Borrowings.

The Fund is permitted to have bank borrowings for temporary or emergency purposes to fund shareholder redemptions or for other short-term liquidity requirements. The Fund has established borrowing arrangements with certain banks. The interest rate on the borrowings is the bank's base rate, as revised from time to time. Any open loans, including accrued interest, at period end are presented under the caption "Notes payable" in the Statement of Assets and Liabilities, if applicable. Activity in this program during the period for which loans were outstanding was as follows:

	Average Loan Balance	Weighted Average Interest Rate	Interest Expense
Energy Portfolio	$4,316,125	2.70%	$2,591

8. Expense Reductions.

During the period the investment adviser or an affiliate reimbursed and/or waived a portion of operating expenses in the amount of $100,733.

9. Other.

10. Risk and Uncertainties.

11. Prior Fiscal Year Merger Information.

On November 19, 2021, the Fund acquired all of the assets and assumed all of the liabilities of each Target Fund listed in the below table pursuant to an Agreement and Plan of Reorganization approved by the Board of Trustees ("The Board"). The securities held by each Target Fund were the primary assets acquired by the Fund. The acquisition was accomplished by an exchange of shares of the Fund for shares then outstanding of each Target Fund at their respective net asset value on the acquisition date. The reorganization provides shareholders of each Target Fund access to a larger portfolio with a similar investment objective and lower projected expenses. For financial reporting purposes, the assets and liabilities of each Target Fund and shares issued by the Fund were recorded at fair value; however, the cost basis of the investments received from each Target Fund were carried forward and will be utilized for purposes of the Fund's ongoing reporting of realized and unrealized gains and losses to more closely align subsequent reporting of realized gains with amounts distributable to shareholders for tax purposes. The reorganization qualified as a tax-free reorganization for federal income tax purposes with no gain or loss recognized to the funds or their shareholders.

Target Fund	Investments $	Unrealized appreciation (depreciation) $	Net Assets $	Shares Exchanged	Shares Exchanged Ratio
Energy Service Portfolio	239,225,585	(29,042,821)	240,539,236	6,902,147	.5578794835
Natural Gas Portfolio	148,458,051	3,907,464	148,421,708	4,258,862	.4453142037

Surviving Fund	Net Assets $	Total net assets after the acquisition $
Energy Portfolio	1,269,646,810	1,658,607,754

Pro forma results of operations of the combined entity for the entire period ended February 28, 2022, as though the acquisition had occurred as of the beginning of the year (rather than on the actual acquisition date), are as follows:

Net investment income (loss)	$41,213,855
Total net realized gain (loss)	31,547,962
Total change in net unrealized appreciation (depreciation)	637,928,213
Net increase (decrease) in net assets resulting from operations	$710,690,030

Because the combined investment portfolios have been managed as a single portfolio since the acquisitions were completed, it is not practicable to separate the amounts of revenue and earnings of the acquired funds that have been included in the Fund's Statement of Operations since November 19, 2021.

To the Board of Trustees of Fidelity Select Portfolios and Shareholders of Energy Portfolio

Opinion on the Financial Statements

We have audited the accompanying statement of assets and liabilities, including the schedule of investments, of Energy Portfolio (one of the funds constituting Fidelity Select Portfolios, referred to hereafter as the "Fund") as of February 28, 2023, the related statement of operations for the year ended February 28, 2023, the statement of changes in net assets for each of the two years in the period ended February 28, 2023, including the related notes, and the financial highlights for each of the five years in the period ended February 28, 2023 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund as of February 28, 2023, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended February 28, 2023 and the financial highlights for each of the five years in the period ended February 28, 2023 in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Fund's management. Our responsibility is to express an opinion on the Fund's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of February 28, 2023 by correspondence with the custodian and brokers. We believe that our audits provide a reasonable basis for our opinion.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

April 13, 2023

We have served as the auditor of one or more investment companies in the Fidelity group of funds since 1932.

TRUSTEES AND OFFICERS

The Trustees, Members of the Advisory Board (if any), and officers of the trust and fund, as applicable, are listed below. The Board of Trustees governs the fund and is responsible for protecting the interests of shareholders. The Trustees are experienced executives who meet periodically throughout the year to oversee the fund's activities, review contractual arrangements with companies that provide services to the fund, oversee management of the risks associated with such activities and contractual arrangements, and review the fund's performance. Each of the Trustees oversees 318 funds.

The Trustees hold office without limit in time except that (a) any Trustee may resign; (b) any Trustee may be removed by written instrument, signed by at least two-thirds of the number of Trustees prior to such removal; (c) any Trustee who requests to be retired or who has become incapacitated by illness or injury may be retired by written instrument signed by a majority of the other Trustees; and (d) any Trustee may be removed at any special meeting of shareholders by a two-thirds vote of the outstanding voting securities of the trust. Each Trustee who is not an interested person (as defined in the 1940 Act) of the trust and the fund is referred to herein as an Independent Trustee. Each Independent Trustee shall retire not later than the last day of the calendar year in which his or her 75th birthday occurs. The Independent Trustees may waive this mandatory retirement age policy with respect to individual Trustees. Officers and Advisory Board Members hold office without limit in time, except that any officer or Advisory Board Member may resign or may be removed by a vote of a majority of the Trustees at any regular meeting or any special meeting of the Trustees. Except as indicated, each individual has held the office shown or other offices in the same company for the past five years.

The fund's Statement of Additional Information (SAI) includes more information about the Trustees. To request a free copy, call Fidelity at 1-800-544-8544.

In determining that a particular Trustee was and continues to be qualified to serve as a Trustee, the Board has considered a variety of criteria, none of which, in isolation, was controlling. The Board believes that, collectively, the Trustees have balanced and diverse experience, qualifications, attributes, and skills, which allow the Board to operate effectively in governing the fund and protecting the interests of shareholders. Information about the specific experience, skills, attributes, and qualifications of each Trustee, which in each case led to the Board's conclusion that the Trustee should serve (or continue to serve) as a trustee of the fund, is provided below.

Board Structure and Oversight Function. Robert A. Lawrence is an interested person and currently serves as Chair. The Trustees have determined that an interested Chair is appropriate and benefits shareholders because an interested Chair has a personal and professional stake in the quality and continuity of services provided to the fund. Independent Trustees exercise their informed business judgment to appoint an individual of their choosing to serve as Chair, regardless of whether the Trustee happens to be independent or a member of management. The Independent Trustees have determined that they can act independently and effectively without having an Independent Trustee serve as Chair and that a key structural component for assuring that they are in a position to do so is for the Independent Trustees to constitute a substantial majority for the Board. The Independent Trustees also regularly meet in executive session. David M. Thomas serves as Lead Independent Trustee and as such (i) acts as a liaison between the Independent Trustees and management with respect to matters important to the Independent Trustees and (ii) with management prepares agendas for Board meetings.

Fidelity ® funds are overseen by different Boards of Trustees. The fund's Board oversees Fidelity's high income and certain equity funds, and other Boards oversee Fidelity's alternative investment, investment-grade bond, money market, asset allocation, and other equity funds. The asset allocation funds may invest in Fidelity ® funds overseen by the fund's Board. The use of separate Boards, each with its own committee structure, allows the Trustees of each group of Fidelity ® funds to focus on the unique issues of the funds they oversee, including common research, investment, and operational issues. On occasion, the separate Boards establish joint committees to address issues of overlapping consequences for the Fidelity ® funds overseen by each Board.

The Trustees operate using a system of committees to facilitate the timely and efficient consideration of all matters of importance to the Trustees, the fund, and fund shareholders and to facilitate compliance with legal and regulatory requirements and oversight of the fund's activities and associated risks. The Board, acting through its committees, has charged FMR and its affiliates with (i) identifying events or circumstances the occurrence of which could have demonstrably adverse effects on the fund's business and/or reputation; (ii) implementing processes and controls to lessen the possibility that such events or circumstances occur or to mitigate the effects of such events or circumstances if they do occur; and (iii) creating and maintaining a system designed to evaluate continuously business and market conditions in order to facilitate the identification and implementation processes described in (i) and (ii) above. Because the day-to-day operations and activities of the fund are carried out by or through FMR, its affiliates, and other service providers, the fund's exposure to risks is mitigated but not eliminated by the processes overseen by the Trustees. While each of the Board's committees has responsibility for overseeing different aspects of the fund's activities, oversight is exercised primarily through the Operations, Audit, and Compliance Committees. Appropriate personnel, including but not limited to the fund's Chief Compliance Officer (CCO), FMR's internal auditor, the independent accountants, the fund's Treasurer and portfolio management personnel, make periodic reports to the Board's committees, as appropriate, including an annual review of Fidelity's risk management program for the Fidelity ® funds. The responsibilities of each standing committee, including their oversight responsibilities, are described further under "Standing Committees of the Trustees."

Interested Trustees*:

Correspondence intended for a Trustee who is an interested person may be sent to Fidelity Investments, 245 Summer Street, Boston, Massachusetts 02210.

Name, Year of Birth; Principal Occupations and Other Relevant Experience+

Bettina Doulton (1964)

Year of Election or Appointment: 2020

Trustee

Robert A. Lawrence (1952)

Year of Election or Appointment: 2020

Trustee

Chair of the Board of Trustees

* Determined to be an "Interested Trustee" by virtue of, among other things, his or her affiliation with the trust or various entities under common control with FMR.

Independent Trustees:

Correspondence intended for an Independent Trustee may be sent to Fidelity Investments, P.O. Box 55235, Boston, Massachusetts 02205-5235.

Name, Year of Birth; Principal Occupations and Other Relevant Experience+

Thomas P. Bostick (1956)

Year of Election or Appointment: 2021

Trustee

Dennis J. Dirks (1948)

Year of Election or Appointment: 2018

Trustee

Donald F. Donahue (1950)

Year of Election or Appointment: 2018

Trustee

Vicki L. Fuller (1957)

Year of Election or Appointment: 2020

Trustee

Patricia L. Kampling (1959)

Year of Election or Appointment: 2020

Trustee

Thomas A. Kennedy (1955)

Year of Election or Appointment: 2021

Trustee

Oscar Munoz (1959)

Year of Election or Appointment: 2021

Trustee

David M. Thomas (1949)

Year of Election or Appointment: 2018

Trustee

Lead Independent Trustee

Susan Tomasky (1953)

Year of Election or Appointment: 2020

Trustee

Michael E. Wiley (1950)

Year of Election or Appointment: 2008

Trustee

Advisory Board Members and Officers:

Name, Year of Birth; Principal Occupation

Peter S. Lynch (1944)

Year of Election or Appointment: 2018

Member of the Advisory Board

Heather Bonner (1977)

Year of Election or Appointment: 2023

Assistant Treasurer

Craig S. Brown (1977)

Year of Election or Appointment: 2022

Deputy Treasurer

John J. Burke III (1964)

Year of Election or Appointment: 2018

Chief Financial Officer

Margaret Carey (1973)

Year of Election or Appointment: 2023

Secretary and Chief Legal Officer (CLO)

William C. Coffey (1969)

Year of Election or Appointment: 2019

Assistant Secretary

Timothy M. Cohen (1969)

Year of Election or Appointment: 2018

Vice President

Jonathan Davis (1968)

Year of Election or Appointment: 2010

Assistant Treasurer

Laura M. Del Prato (1964)

Year of Election or Appointment: 2018

Assistant Treasurer

Colm A. Hogan (1973)

Year of Election or Appointment: 2020

Assistant Treasurer

Pamela R. Holding (1964)

Year of Election or Appointment: 2018

Vice President

Chris Maher (1972)

Year of Election or Appointment: 2020

Deputy Treasurer

Jason P. Pogorelec (1975)

Year of Election or Appointment: 2020

Chief Compliance Officer

Brett Segaloff (1972)

Year of Election or Appointment: 2021

Anti-Money Laundering (AML) Officer

Stacie M. Smith (1974)

Year of Election or Appointment: 2018

President and Treasurer

Jim Wegmann (1979)

Year of Election or Appointment: 2019

Assistant Treasurer

The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (September 1, 2022 to February 28, 2023).

Actual Expenses

Hypothetical Example for Comparison Purposes

	Annualized Expense Ratio- A	Beginning Account Value September 1, 2022	Ending Account Value February 28, 2023	Expenses Paid During Period- C September 1, 2022 to February 28, 2023

Energy Portfolio	.73%
Actual		$ 1,000	$ 1,062.50	$ 3.73
Hypothetical- B		$ 1,000	$ 1,021.17	$ 3.66

A Annualized expense ratio reflects expenses net of applicable fee waivers.

B 5% return per year before expenses

Distributions (Unaudited)

The dividend and capital gains distributions for the fund(s) are available on Fidelity.com or Institutional.Fidelity.com .

The fund designates 100% of the dividends distributed during the fiscal year as qualifying for the dividends-received deduction for corporate shareholders.

The fund designates 100% of the dividends distributed during the fiscal year as amounts which may be taken into account as a dividend for the purposes of the maximum rate under section 1(h)(11) of the Internal Revenue Code.

The fund will notify shareholders in January 2024 of amounts for use in preparing 2023 income tax returns.

Fidelity® Environment and Alternative Energy Fund

The Fund has adopted and implemented a liquidity risk management program (the Program) reasonably designed to assess and manage the Fund's liquidity risk and to comply with the requirements of the Liquidity Rule. The Fund's Board of Trustees (the Board) has designated the Fund's investment adviser as administrator of the Program. The Fidelity advisers have established a Liquidity Risk Management Committee (the LRM Committee) to manage the Program for each of the Fidelity Funds. The LRM Committee monitors the adequacy and effectiveness of implementation of the Program and on a periodic basis assesses each Fund's liquidity risk based on a variety of factors including (1) the Fund's investment strategy, (2) portfolio liquidity and cash flow projections during normal and reasonably foreseeable stressed conditions, (3) shareholder redemptions, (4) borrowings and other funding sources and (5) certain factors specific to ETFs including the effect of the Fund's prices and spreads, market participants, and basket compositions on the overall liquidity of the Fund's portfolio, as applicable.

Highly liquid investments - cash or convertible to cash within three business days or less
Moderately liquid investments - convertible to cash in three to seven calendar days
Less liquid investments - can be sold or disposed of, but not settled, within seven calendar days
Illiquid investments - cannot be sold or disposed of within seven calendar days

1.813649.118

SELNR-ANN-0423

Fidelity® Environment and Alternative Energy Fund

Fidelity® Natural Resources Fund

Annual Report

February 28, 2023

Contents

Fidelity® Natural Resources Fund

Report of Independent Registered Public Accounting Firm

Fidelity® Environment and Alternative Energy Fund

You may also call 1-800-544-8544 to request a free copy of the proxy voting guidelines.

Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.

Other third-party marks appearing herein are the property of their respective owners.

NOT FDIC INSURED •MAY LOSE VALUE •NO BANK GUARANTEE

Neither the Funds nor Fidelity Distributors Corporation is a bank.

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Fidelity® Environment and Alternative Energy Fund	-9.46%	6.49%	9.79%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Fidelity® Environment and Alternative Energy Fund on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Fidelity® Environment and Alternative Energy Fund

Market Recap:

Comments from Portfolio Manager Julia Pei:

For the fiscal year ending February 28, 2023, the fund returned -9.46%, trailing the -3.95% result of the FTSE EO & Alternative Energy Index, as well as the broad-based S&P 500 ® index. The largest detractor from performance versus the industry index was stock selection in specialty chemicals. Also hindering performance was positioning in automobile manufacturers and environmental & facilities services. The fund's largest individual relative detractor was untimely positioning in Tesla, which returned -29% the past year. The company was among our biggest holdings. Another notable relative detractor was our outsized stake in Waste Management (-11%), a position we established this period. Also hampering performance was untimely positioning in IBM, which gained roughly 10%. We added to our position the past 12 months. The fund's foreign holdings also detracted overall, partly due to a broadly strong U.S. dollar. In contrast, the biggest contributor to performance versus the industry index were stock picks in semiconductors. An overweighting in industrial gases and stock picks in building products also boosted the fund's relative result. The fund's largest individual relative contributor was an overweighting in Linde, which gained 20% the past year. The company was among the fund's largest holdings. Another key contributor was our out-of-index position in onsemi (+23%). We reduced our stake this period. The fund's non-index investment in Deere gained roughly 18%. We decreased our position in the company the past 12 months. Notable changes in positioning include a higher allocation to the industrial gases and semiconductors subindustries.

Note to shareholders: On January 30, 2023, Asher Anolic came off the fund, leaving Julie Pei as sole manager.

Application of FMR's environmental, social, and governance (ESG) ratings process and/or its sustainable investing exclusion criteria may affect the Fund's exposure to certain issuers, sectors, regions, and countries and may affect the Fund's performance.

Fidelity® Environment and Alternative Energy Fund

Top Holdings (% of Fund's net assets)

Microsoft Corp.	13.2
Tesla, Inc.	9.3
Linde PLC	8.0
Danaher Corp.	7.2
Analog Devices, Inc.	4.9
IBM Corp.	4.9
Prologis (REIT), Inc.	4.7
Eaton Corp. PLC	4.3
Waste Management, Inc.	3.7
Cummins, Inc.	2.8
	63.0

Industries (% of Fund's net assets)

Software	13.5
Semiconductors & Semiconductor Equipment	12.3
Automobiles	9.3
Chemicals	8.4
Life Sciences Tools & Services	8.4
Electrical Equipment	6.8
Commercial Services & Supplies	5.2
Independent Power and Renewable Electricity Producers	5.1
IT Services	4.9
Equity Real Estate Investment Trusts (Reits)	4.7
Building Products	4.5
Machinery	4.2
Electric Utilities	3.4
Construction & Engineering	2.6
Containers & Packaging	1.8
Oil, Gas & Consumable Fuels	1.7
Energy Equipment & Services	0.9
Electronic Equipment & Components	0.7
Metals & Mining	0.6
Aerospace & Defense	0.3
Professional Services	0.1

Geographic Diversification (% of Fund's net assets)

* Includes Short-Term investments and Net Other Assets (Liabilities).

Percentages are based on country or territory of incorporation and are adjusted for the effect of derivatives, if applicable.

Fidelity® Environment and Alternative Energy Fund

Showing Percentage of Net Assets

Common Stocks - 99.4%
	Shares	Value ($)
Aerospace & Defense - 0.3%
Aerospace & Defense - 0.3%
BWX Technologies, Inc.	22,600	1,381,086
Woodward, Inc.	1,900	188,100
		1,569,186
Automobiles - 9.3%
Automobile Manufacturers - 9.3%
Tesla, Inc. (a)	214,280	44,079,539
Building Products - 4.5%
Building Products - 4.5%
Owens Corning	54,020	5,282,616
The AZEK Co., Inc. (a)(b)	134,380	3,237,214
Trane Technologies PLC	69,800	12,910,906
		21,430,736
Chemicals - 8.4%
Industrial Gases - 8.0%
Linde PLC	108,440	37,777,243
Specialty Chemicals - 0.4%
Aspen Aerogels, Inc. (a)	197,880	2,146,998
TOTAL CHEMICALS		39,924,241
Commercial Services & Supplies - 5.2%
Environmental & Facility Services - 5.2%
Clean Harbors, Inc. (a)	29,590	3,907,951
Tetra Tech, Inc.	23,140	3,167,635
Waste Management, Inc.	117,870	17,652,211
		24,727,797
Construction & Engineering - 2.6%
Construction & Engineering - 2.6%
AECOM	98,300	8,489,188
Quanta Services, Inc.	23,210	3,746,094
		12,235,282
Containers & Packaging - 1.8%
Metal & Glass Containers - 1.8%
Ball Corp.	148,390	8,341,002
Electric Utilities - 3.4%
Electric Utilities - 3.4%
ORSTED A/S (c)	68,040	5,922,410
PG&E Corp. (a)	647,250	10,110,045
		16,032,455
Electrical Equipment - 6.8%
Electrical Components & Equipment - 6.1%
Acuity Brands, Inc.	5,320	1,031,867
Eaton Corp. PLC	115,880	20,270,888
Fluence Energy, Inc. (a)(b)	123,670	2,308,919
Hubbell, Inc. Class B	8,230	2,070,174
Plug Power, Inc. (a)(b)	63,690	947,070
Sunrun, Inc. (a)	87,510	2,103,740
		28,732,658
Heavy Electrical Equipment - 0.7%
Bloom Energy Corp. Class A (a)(b)	96,400	2,090,916
NuScale Power Corp. (a)(b)	129,300	1,338,255
		3,429,171
TOTAL ELECTRICAL EQUIPMENT		32,161,829
Electronic Equipment & Components - 0.7%
Electronic Equipment & Instruments - 0.7%
Badger Meter, Inc.	1,120	136,214
Itron, Inc. (a)	53,600	2,989,272
		3,125,486
Energy Equipment & Services - 0.9%
Oil & Gas Equipment & Services - 0.9%
Baker Hughes Co. Class A	137,030	4,193,118
Equity Real Estate Investment Trusts (REITs) - 4.7%
Industrial REITs - 4.7%
Prologis (REIT), Inc.	180,820	22,313,188
Independent Power and Renewable Electricity Producers - 5.1%
Independent Power Producers & Energy Traders - 3.6%
RWE AG	214,500	9,129,516
The AES Corp.	312,980	7,724,346
		16,853,862
Renewable Electricity - 1.5%
Brookfield Renewable Corp.	195,320	5,439,662
Energy Absolute PCL NVDR	742,250	1,648,976
		7,088,638
TOTAL INDEPENDENT POWER AND RENEWABLE ELECTRICITY PRODUCERS		23,942,500
IT Services - 4.9%
IT Consulting & Other Services - 4.9%
IBM Corp.	179,030	23,148,579
Life Sciences Tools & Services - 8.4%
Life Sciences Tools & Services - 8.4%
Agilent Technologies, Inc.	39,740	5,641,888
Danaher Corp.	137,210	33,963,591
		39,605,479
Machinery - 4.2%
Agricultural & Farm Machinery - 0.8%
Deere & Co.	9,290	3,894,740
Construction Machinery & Heavy Trucks - 2.8%
Cummins, Inc.	53,622	13,034,436
Industrial Machinery - 0.6%
Timken Co.	36,100	3,084,745
TOTAL MACHINERY		20,013,921
Metals & Mining - 0.6%
Diversified Metals & Mining - 0.6%
Lynas Rare Earths Ltd. (a)	500,804	2,750,417
Oil, Gas & Consumable Fuels - 1.7%
Oil & Gas Exploration & Production - 0.9%
Denbury, Inc. (a)	49,510	4,127,649
Oil & Gas Refining & Marketing - 0.8%
Neste OYJ	80,000	3,866,105
TOTAL OIL, GAS & CONSUMABLE FUELS		7,993,754
Professional Services - 0.1%
Research & Consulting Services - 0.1%
KBR, Inc.	4,260	234,769
Semiconductors & Semiconductor Equipment - 12.3%
Semiconductor Equipment - 3.3%
AEHR Test Systems (a)	8,890	296,482
Enphase Energy, Inc. (a)	36,100	7,600,133
Entegris, Inc.	6,100	519,903
SolarEdge Technologies, Inc. (a)	22,310	7,092,795
		15,509,313
Semiconductors - 9.0%
Allegro MicroSystems LLC (a)	93,470	4,082,770
Analog Devices, Inc.	126,910	23,284,178
NXP Semiconductors NV	20,220	3,608,866
onsemi (a)	150,350	11,638,594
		42,614,408
TOTAL SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT		58,123,721
Software - 13.5%
Application Software - 0.3%
Aspen Technology, Inc. (a)	6,230	1,320,822
Systems Software - 13.2%
Microsoft Corp.	250,920	62,584,466
TOTAL SOFTWARE		63,905,288
TOTAL COMMON STOCKS (Cost $414,381,496)		469,852,287

Convertible Preferred Stocks - 0.0%
	Shares	Value ($)
Electronic Equipment & Components - 0.0%
Electronic Components - 0.0%
CelLink Corp. Series D (a)(d)(e) (Cost $295,699)	14,200	184,884

Money Market Funds - 1.2%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (f)	480,542	480,638
Fidelity Securities Lending Cash Central Fund 4.63% (f)(g)	5,109,814	5,110,325
TOTAL MONEY MARKET FUNDS (Cost $5,590,963)		5,590,963

TOTAL INVESTMENT IN SECURITIES - 100.6% (Cost $420,268,158)	475,628,134
NET OTHER ASSETS (LIABILITIES) - (0.6)%	(3,024,304)
NET ASSETS - 100.0%	472,603,830

Legend

(a)	Non-income producing

(b)	Security or a portion of the security is on loan at period end.

(c)	Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $5,922,410 or 1.3% of net assets.

(d)	Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $184,884 or 0.0% of net assets.

(e)	Level 3 security

(f)

(g)	Investment made with cash collateral received from securities on loan.

Additional information on each restricted holding is as follows:
Security	Acquisition Date	Acquisition Cost ($)
CelLink Corp. Series D	1/20/22	295,699

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	620,575	67,251,993	67,391,930	39,672	-	-	480,638	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	1,297,050	85,681,854	81,868,579	90,570	-	-	5,110,325	0.0%
Total	1,917,625	152,933,847	149,260,509	130,242	-	-	5,590,963

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	469,852,287	461,179,460	8,672,827	-

Convertible Preferred Stocks	184,884	-	-	184,884

Money Market Funds	5,590,963	5,590,963	-	-
Total Investments in Securities:	475,628,134	466,770,423	8,672,827	184,884

Fidelity® Environment and Alternative Energy Fund

Fidelity® Natural Resources Fund

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $4,979,104) - See accompanying schedule:
Unaffiliated issuers (cost $414,677,195)	$	470,037,171
Fidelity Central Funds (cost $5,590,963)		5,590,963


Total Investment in Securities (cost $420,268,158)			$	475,628,134
Foreign currency held at value (cost $5)				5
Receivable for investments sold				2,534,870
Receivable for fund shares sold				392,830
Dividends receivable				862,834
Distributions receivable from Fidelity Central Funds				14,280
Prepaid expenses				971
Total assets				479,433,924
Liabilities
Payable for investments purchased	$	938,726
Payable for fund shares redeemed		431,903
Accrued management fee		211,529
Other affiliated payables		109,366
Other payables and accrued expenses		28,245
Collateral on securities loaned		5,110,325
Total Liabilities				6,830,094
Net Assets			$	472,603,830
Net Assets consist of:
Paid in capital			$	546,618,489
Total accumulated earnings (loss)				(74,014,659)
Net Assets			$	472,603,830
Net Asset Value , offering price and redemption price per share ($472,603,830 ÷ 16,968,880 shares)			$	27.85

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	7,913,482
Income from Fidelity Central Funds (including $90,570 from security lending)				130,242
Total Income				8,043,724
Expenses
Management fee	$	3,228,120
Transfer agent fees		1,318,834
Accounting fees		209,780
Custodian fees and expenses		19,239
Independent trustees' fees and expenses		2,143
Registration fees		35,306
Audit		47,712
Legal		2,510
Interest		6,784
Miscellaneous		3,135
Total expenses before reductions		4,873,563
Expense reductions		(22,188)
Total expenses after reductions				4,851,375
Net Investment income (loss)				3,192,349
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers (net of foreign taxes of $24,438)		(103,176,826)
Foreign currency transactions		(9,970)
Total net realized gain (loss)				(103,186,796)
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers (net of decrease in deferred foreign taxes of $15,075)		14,332,944
Assets and liabilities in foreign currencies		(5,090)
Total change in net unrealized appreciation (depreciation)				14,327,854
Net gain (loss)				(88,858,942)
Net increase (decrease) in net assets resulting from operations			$	(85,666,593)

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	3,192,349	$	2,066,511
Net realized gain (loss)		(103,186,796)		45,207,872
Change in net unrealized appreciation (depreciation)		14,327,854		(30,454,510)
Net increase (decrease) in net assets resulting from operations		(85,666,593)		16,819,873
Distributions to shareholders		(3,228,177)		(64,644,758)
Share transactions
Proceeds from sales of shares		106,568,582		631,087,095
Reinvestment of distributions		3,006,815		61,338,201
Cost of shares redeemed		(303,818,497)		(262,840,215)
Net increase (decrease) in net assets resulting from share transactions		(194,243,100)		429,585,081
Total increase (decrease) in net assets		(283,137,870)		381,760,196

Net Assets
Beginning of period		755,741,700		373,981,504
End of period	$	472,603,830	$	755,741,700

Other Information
Shares
Sold		3,656,658		18,010,951
Issued in reinvestment of distributions		111,940		1,802,725
Redeemed		(11,200,238)		(7,814,961)
Net increase (decrease)		(7,431,640)		11,998,715

Financial Highlights

Fidelity® Environment and Alternative Energy Fund

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	30.97	$	30.16	$	23.80	$	24.92	$	26.31
Income from Investment Operations
Net investment income (loss) B,C		.15		.11		.24		.27		.24
Net realized and unrealized gain (loss)		(3.09)		3.46		8.02		(.81)		(.25)
Total from investment operations		(2.94)		3.57		8.26		(.54)		(.01)
Distributions from net investment income		(.18)		(.10)		(.26)		(.23)		(.22)
Distributions from net realized gain		-		(2.66)		(1.64)		(.35)		(1.16)
Total distributions		(.18)		(2.76)		(1.90)		(.58)		(1.38)
Net asset value, end of period	$	27.85	$	30.97	$	30.16	$	23.80	$	24.92
Total Return D		(9.46)%		11.02%		38.97%		(2.35)%		.39%
Ratios to Average Net Assets C,E,F
Expenses before reductions		.79%		.79%		.85%		.85%		.87%
Expenses net of fee waivers, if any		.79%		.79%		.85%		.85%		.87%
Expenses net of all reductions		.79%		.79%		.85%		.85%		.87%
Net investment income (loss)		.52%		.33%		.95%		1.08%		.96%
Supplemental Data
Net assets, end of period (000 omitted)	$	472,604	$	755,742	$	373,982	$	181,456	$	160,960
Portfolio turnover rate G		34%		89%		28%		49%		62%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

G Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Fidelity® Natural Resources Fund	19.78%	9.58%	3.68%

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Fidelity® Natural Resources Fund on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Fidelity® Natural Resources Fund

Market Recap:

Comments from Portfolio Manager Ashley Fernandes:

For the fiscal year ending February 28, 2023, the fund gained 19.78%, notably outpacing the 10.19% advance of the S&P North American Natural Resources Sector Index and outperforming the broad-based S&P 500 ® index by a wide margin. The top contributors to performance versus the industry index were stock picks and an overweighting in oil & gas exploration & production. Stock picks and an overweighting in oil & gas equipment & services and an underweighting in gold also bolstered the fund's relative result. The fund's biggest individual relative contributor was an outsized stake in Exxon Mobil, which gained 45% the past year and was the fund's largest holding. Also boosting value was our overweight in Hess, which gained 35% and was another of our biggest holdings. An outsized stake in Weatherford International (+133%) also added notable value. This period we increased our stake in the company. In contrast, the largest detractors from performance versus the industry index were an overweighting and stock selection in copper. An overweighting and stock picks in diversified metals & mining also hampered the fund's relative performance. The fund's largest individual relative detractor was an overweighting in Freeport-McMoRan, which returned -12% the past 12 months. The company was among our biggest holdings. Our second-largest relative detractor was avoiding Marathon Petroleum, an index component that gained roughly 63%. An out-of-index investment in First Quantum Minerals (-25%) also hurt. Notable changes in positioning include a higher allocation to the oil & gas equipment & services and oil & gas refining & marketing subindustries.

Fidelity® Natural Resources Fund

Top Holdings (% of Fund's net assets)

Exxon Mobil Corp.	19.0
Hess Corp.	8.4
Canadian Natural Resources Ltd.	7.9
Imperial Oil Ltd.	6.3
Freeport-McMoRan, Inc.	4.7
Phillips 66 Co.	4.6
Schlumberger Ltd.	4.6
Valero Energy Corp.	4.5
MEG Energy Corp.	4.3
Kosmos Energy Ltd.	3.3
	67.6

Industries (% of Fund's net assets)

Oil, Gas & Consumable Fuels	64.7
Energy Equipment & Services	12.9
Metals & Mining	11.7
Chemicals	4.2
Containers & Packaging	4.1

Geographic Diversification (% of Fund's net assets)

* Includes Short-Term investments and Net Other Assets (Liabilities).

Percentages are based on country or territory of incorporation and are adjusted for the effect of derivatives, if applicable.

Fidelity® Natural Resources Fund

Showing Percentage of Net Assets

Common Stocks - 97.6%
	Shares	Value ($)
Chemicals - 4.2%
Commodity Chemicals - 1.7%
Chemtrade Logistics Income Fund	828,800	5,575,950
LyondellBasell Industries NV Class A	89,600	8,600,704
		14,176,654
Diversified Chemicals - 0.5%
The Chemours Co. LLC	109,800	3,752,964
Fertilizers & Agricultural Chemicals - 0.5%
CF Industries Holdings, Inc.	48,900	4,200,021
Industrial Gases - 1.1%
Linde PLC	24,900	8,674,413
Specialty Chemicals - 0.4%
Celanese Corp. Class A	30,600	3,556,638
TOTAL CHEMICALS		34,360,690
Containers & Packaging - 4.1%
Metal & Glass Containers - 2.3%
Aptargroup, Inc.	85,400	9,967,888
Crown Holdings, Inc.	9,600	830,496
Greif, Inc. Class A	107,200	7,616,560
		18,414,944
Paper Packaging - 1.8%
Avery Dennison Corp.	55,200	10,056,888
Sealed Air Corp.	94,100	4,575,142
		14,632,030
TOTAL CONTAINERS & PACKAGING		33,046,974
Energy Equipment & Services - 12.9%
Oil & Gas Drilling - 0.7%
Diamond Offshore Drilling, Inc. (a)	100,900	1,198,692
Valaris Ltd. (a)	58,800	3,954,300
		5,152,992
Oil & Gas Equipment & Services - 12.2%
Expro Group Holdings NV (a)	1,083,300	24,623,409
Schlumberger Ltd.	701,000	37,300,210
TechnipFMC PLC (a)	902,500	13,799,225
Weatherford International PLC (a)	355,164	23,661,026
		99,383,870
TOTAL ENERGY EQUIPMENT & SERVICES		104,536,862
Metals & Mining - 11.7%
Copper - 7.1%
First Quantum Minerals Ltd.	880,500	19,236,134
Freeport-McMoRan, Inc.	934,700	38,294,659
		57,530,793
Diversified Metals & Mining - 3.4%
Glencore PLC	3,422,800	20,406,274
Horizonte Minerals PLC (a)	1,579,600	2,764,532
Ivanhoe Mines Ltd. (a)	551,000	4,603,444
		27,774,250
Gold - 1.2%
Franco-Nevada Corp.	77,900	9,943,454
TOTAL METALS & MINING		95,248,497
Oil, Gas & Consumable Fuels - 64.7%
Coal & Consumable Fuels - 0.6%
Cameco Corp. (b)	180,553	4,936,319
Integrated Oil & Gas - 27.3%
Equinor ASA sponsored ADR	536,600	16,371,666
Exxon Mobil Corp.	1,402,800	154,181,747
Imperial Oil Ltd.	1,032,400	51,063,889
		221,617,302
Oil & Gas Exploration & Production - 27.1%
Africa Oil Corp.	5,977,121	12,221,449
Canadian Natural Resources Ltd.	1,131,200	63,924,112
Deltic Energy PLC (a)	24,667,915	697,287
Eco Atlantic Oil & Gas Ltd. (a)	3,803,000	1,031,228
Hess Corp.	505,800	68,131,260
Kosmos Energy Ltd. (a)	3,452,500	27,171,175
MEG Energy Corp. (a)	2,194,012	34,666,837
Talos Energy, Inc. (a)	103,900	1,850,459
Tourmaline Oil Corp.	242,100	10,610,172
		220,303,979
Oil & Gas Refining & Marketing - 9.7%
Delek U.S. Holdings, Inc.	65,200	1,641,084
PBF Energy, Inc. Class A	82,900	3,623,559
Phillips 66 Co.	366,616	37,600,137
Valero Energy Corp.	276,100	36,370,653
		79,235,433
TOTAL OIL, GAS & CONSUMABLE FUELS		526,093,033
TOTAL COMMON STOCKS (Cost $561,836,770)		793,286,056

Money Market Funds - 1.7%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (c)	8,696,194	8,697,934
Fidelity Securities Lending Cash Central Fund 4.63% (c)(d)	5,143,736	5,144,250
TOTAL MONEY MARKET FUNDS (Cost $13,842,184)		13,842,184

TOTAL INVESTMENT IN SECURITIES - 99.3% (Cost $575,678,954)	807,128,240
NET OTHER ASSETS (LIABILITIES) - 0.7%	5,300,840
NET ASSETS - 100.0%	812,429,080

Legend

(a)	Non-income producing

(b)	Security or a portion of the security is on loan at period end.

(c)

(d)	Investment made with cash collateral received from securities on loan.

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	5,185,303	220,931,359	217,418,728	197,425	-	-	8,697,934	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	18,439,385	152,215,332	165,510,467	39,015	-	-	5,144,250	0.0%
Total	23,624,688	373,146,691	382,929,195	236,440	-	-	13,842,184

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	793,286,056	772,879,782	20,406,274	-

Money Market Funds	13,842,184	13,842,184	-	-
Total Investments in Securities:	807,128,240	786,721,966	20,406,274	-

Fidelity® Natural Resources Fund

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $4,934,870) - See accompanying schedule:
Unaffiliated issuers (cost $561,836,770)	$	793,286,056
Fidelity Central Funds (cost $13,842,184)		13,842,184


Total Investment in Securities (cost $575,678,954)			$	807,128,240
Foreign currency held at value (cost $19)				24
Receivable for investments sold				7,205,808
Receivable for fund shares sold				5,706,694
Dividends receivable				2,250,622
Distributions receivable from Fidelity Central Funds				55,230
Prepaid expenses				2,774
Other receivables				82,424
Total assets				822,431,816
Liabilities
Payable for investments purchased	$	3,485,880
Payable for fund shares redeemed		749,305
Accrued management fee		362,016
Other affiliated payables		143,227
Other payables and accrued expenses		118,058
Collateral on securities loaned		5,144,250
Total Liabilities				10,002,736
Net Assets			$	812,429,080
Net Assets consist of:
Paid in capital			$	853,225,602
Total accumulated earnings (loss)				(40,796,522)
Net Assets			$	812,429,080
Net Asset Value , offering price and redemption price per share ($812,429,080 ÷ 20,321,529 shares)			$	39.98

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	22,061,786
Income from Fidelity Central Funds (including $39,015 from security lending)				236,440
Total Income				22,298,226
Expenses
Management fee	$	3,952,551
Transfer agent fees		1,371,619
Accounting fees		243,740
Custodian fees and expenses		32,889
Independent trustees' fees and expenses		2,488
Registration fees		93,794
Audit		50,627
Legal		788
Interest		10,132
Miscellaneous		3,735
Total expenses before reductions		5,762,363
Expense reductions		(25,812)
Total expenses after reductions				5,736,551
Net Investment income (loss)				16,561,675
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		16,006,711
Foreign currency transactions		(73,780)
Total net realized gain (loss)				15,932,931
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		64,591,935
Assets and liabilities in foreign currencies		(1,683)
Total change in net unrealized appreciation (depreciation)				64,590,252
Net gain (loss)				80,523,183
Net increase (decrease) in net assets resulting from operations			$	97,084,858

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	16,561,675	$	7,161,576
Net realized gain (loss)		15,932,931		22,873,313
Change in net unrealized appreciation (depreciation)		64,590,252		124,171,738
Net increase (decrease) in net assets resulting from operations		97,084,858		154,206,627
Distributions to shareholders		(18,584,123)		(5,734,164)
Share transactions
Proceeds from sales of shares		634,417,680		383,163,467
Reinvestment of distributions		17,432,108		5,352,192
Cost of shares redeemed		(515,954,973)		(231,841,612)
Net increase (decrease) in net assets resulting from share transactions		135,894,815		156,674,047
Total increase (decrease) in net assets		214,395,550		305,146,510

Net Assets
Beginning of period		598,033,530		292,887,020
End of period	$	812,429,080	$	598,033,530

Other Information
Shares
Sold		16,884,073		13,086,738
Issued in reinvestment of distributions		466,676		199,634
Redeemed		(14,503,991)		(8,430,799)
Net increase (decrease)		2,846,758		4,855,573

Financial Highlights

Fidelity® Natural Resources Fund

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	34.22	$	23.21	$	20.59	$	25.55	$	27.51
Income from Investment Operations
Net investment income (loss) B,C		.83		.51		.30		.30		.29
Net realized and unrealized gain (loss)		5.87		10.91		2.69		(4.88)		(1.97)
Total from investment operations		6.70		11.42		2.99		(4.58)		(1.68)
Distributions from net investment income		(.94)		(.41)		(.37)		(.30)		(.28)
Distributions from net realized gain		-		-		-		(.08)		- D
Total distributions		(.94)		(.41)		(.37)		(.38)		(.28)
Net asset value, end of period	$	39.98	$	34.22	$	23.21	$	20.59	$	25.55
Total Return E		19.78%		49.71%		14.76%		(18.25)%		(6.06)%
Ratios to Average Net Assets C,F,G
Expenses before reductions		.77%		.82%		.89%		.84%		.81%
Expenses net of fee waivers, if any		.77%		.81%		.89%		.84%		.81%
Expenses net of all reductions		.77%		.81%		.88%		.84%		.80%
Net investment income (loss)		2.21%		1.84%		1.62%		1.18%		1.02%
Supplemental Data
Net assets, end of period (000 omitted)	$	812,429	$	598,034	$	292,887	$	315,533	$	424,167
Portfolio turnover rate H		74%		98%		90%		8%		26%

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Amount represents less than $.005 per share.

E Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

H Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

Report of Independent Registered Public Accounting Firm

For the period ended February 28, 2023

1. Organization.

Fidelity Environment and Alternative Energy Fund and Fidelity Natural Resources Fund (the Funds) are non-diversified funds of Fidelity Select Portfolios (the Trust). Each Fund is authorized to issue an unlimited number of shares. Share transactions on the Statement of Changes in Net Assets may contain exchanges between affiliated funds. The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust. The Funds invest primarily in securities of companies whose principal business activities fall within specific industries. Fidelity Natural Resources Fund may also invest in certain precious metals.

2. Investments in Fidelity Central Funds.

Fidelity Central Fund	Investment Manager	Investment Objective	Investment Practices	Expense Ratio A
Fidelity Money Market Central Funds	Fidelity Management & Research Company LLC (FMR)	Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity.	Short-term Investments	Less than .005%

A Expenses expressed as a percentage of average net assets and are as of each underlying Central Fund's most recent annual or semi-annual shareholder report.

3. Significant Accounting Policies.

Each Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:

Level 1 - unadjusted quoted prices in active markets for identical investments

Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)

Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value each Fund's investments by major category are as follows:

Investments in open-end mutual funds ,including the Fidelity Central Funds, are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.

Investment Transactions and Income. For financial reporting purposes, the Funds' investment holdings and NAV include trades executed through the end of the last business day of the period. The NAV per share for processing shareholder transactions is calculated as of the close of business of the New York Stock Exchange (NYSE), normally 4:00 p.m. Eastern time and includes trades executed through the end of the prior business day. Gains and losses on securities sold are determined on the basis of identified cost and for certain Funds include proceeds received from litigation. Commissions paid to certain brokers with whom the investment adviser, or its affiliates, places trades on behalf of a fund include an amount in addition to trade execution, which may be rebated back to a fund. Any such rebates are included in net realized gain (loss) on investments in the Statement of Operations. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities where the ex-dividend date may have passed, which are recorded as soon as the Funds are informed of the ex-dividend date. Non-cash dividends included in dividend income, if any, are recorded at the fair market value of the securities received. Income and capital gain distributions from Fidelity Central Funds, if any, are recorded on the ex-dividend date. Certain distributions received by the Funds represent a return of capital or capital gain. The Funds determine the components of these distributions subsequent to the ex-dividend date, based upon receipt of tax filings or other correspondence relating to the underlying investment. These distributions are recorded as a reduction of cost of investments and/or as a realized gain. Interest income is accrued as earned and includes coupon interest and amortization of premium and accretion of discount on debt securities as applicable. Investment income is recorded net of foreign taxes withheld where recovery of such taxes is uncertain. Funds may file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. Any withholding tax reclaims income is included in the Statement of Operations in dividends. Any receivables for withholding tax reclaims are included in the Statement of Assets and Liabilities in dividends receivable.

Fidelity Natural Resources Fund

$ 82,424

Distributions are declared and recorded on the ex-dividend date. Income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP. In addition, certain Funds claimed a portion of the payment made to redeeming shareholders as a distribution for income tax purposes.

Book-tax differences are primarily due to foreign currency transactions, partnerships, certain foreign taxes, passive foreign investment companies (PFIC), deferred Trustee compensation and capital loss carryforwards and losses deferred due to wash sales and excise tax regulations.

As of period end, the cost and unrealized appreciation (depreciation) in securities, and derivatives if applicable, for federal income tax purposes were as follows for each Fund:

	Tax cost	Gross unrealized appreciation	Gross unrealized depreciation	Net unrealized appreciation (depreciation)
Fidelity Environment and Alternative Energy Fund	$423,925,811	$75,132,570	$(23,430,247)	$51,702,323
Fidelity Natural Resources Fund	581,345,367	238,158,794	(12,375,921)	225,782,873

The tax-based components of distributable earnings as of period end were as follows for each Fund:

	Undistributed ordinary income	Capital loss carryforward	Net unrealized appreciation (depreciation) on securities and other investments
Fidelity Environment and Alternative Energy Fund	$-	$(125,059,440)	$51,696,755
Fidelity Natural Resources Fund	1,175,087	(267,670,186)	225,782,763

	Short-term	Long-term	Total capital loss carryforward
Fidelity Environment and Alternative Energy Fund	$(90,583,038)	$(34,476,402)	$(125,059,440)
Fidelity Natural Resources Fund	(93,181,409)	(174,488,777)	(267,670,186)

Certain of the Funds intend to elect to defer to the next fiscal year ordinary losses recognized during the period January 1, 2023 to February 28, 2023. Loss deferrals were as follows:

	Ordinary Losses
Fidelity Environment and Alternative Energy Fund	$(657,360)

The tax character of distributions paid was as follows:

February 28, 2023
	Ordinary Income	Long-term Capital Gains	Total
Fidelity Environment and Alternative Energy Fund	$3,228,177	$ -	$3,228,177
Fidelity Natural Resources Fund	18,584,123	-	18,584,123

February 28, 2022
	Ordinary Income	Long-term Capital Gains	Total
Fidelity Environment and Alternative Energy Fund	$6,756,801	$57,887,957	$64,644,758
Fidelity Natural Resources Fund	5,734,164	-	5,734,164

4. Purchases and Sales of Investments.

Purchases and sales of securities, other than short-term securities, and in-kind transactions, as applicable, are noted in the table below.

	Purchases ($)	Sales ($)
Fidelity Environment and Alternative Energy Fund	210,397,570	404,970,986
Fidelity Natural Resources Fund	665,954,799	545,714,598

5. Fees and Other Transactions with Affiliates.

	Individual Rate	Group Rate	Total
Fidelity Environment and Alternative Energy Fund	.30%	.23%	.52%
Fidelity Natural Resources Fund	.30%	.23%	.53%

Fidelity Environment and Alternative Energy Fund	.21%
Fidelity Natural Resources Fund	.18%

	% of Average Net Assets
Fidelity Environment and Alternative Energy Fund	.03
Fidelity Natural Resources Fund	.03

	Amount
Fidelity Environment and Alternative Energy Fund	$ 5,887
Fidelity Natural Resources Fund	20,032

	Borrower or Lender	Average Loan Balance	Weighted Average Interest Rate	Interest Expense
Fidelity Environment and Alternative Energy Fund	Borrower	$ 10,524,286	3.32%	$ 6,784
Fidelity Natural Resources Fund	Borrower	$ 5,503,371	1.74%	$ 9,289

	Purchases ($)	Sales ($)	Realized Gain (Loss) ($)
Fidelity Environment and Alternative Energy Fund	3,320,455	14,369,538	(3,803,443)
Fidelity Natural Resources Fund	51,481,080	50,979,009	(689,613)

6. Committed Line of Credit.

	Amount
Fidelity Environment and Alternative Energy Fund	$ 1,182
Fidelity Natural Resources Fund	1,230

7. Security Lending.

	Total Security Lending Fees Paid to NFS	Security Lending Income From Securities Loaned to NFS	Value of Securities Loaned to NFS at Period End
Fidelity Environment and Alternative Energy Fund	$ 9,625	$ 436	$257,715
Fidelity Natural Resources Fund	$ 4,006	$ -	$-

8. Bank Borrowings.

	Average Loan Balance	Weighted Average Interest Rate	Interest Expense
Fidelity Natural Resources Fund	$ 1,824,000	2.08%	$ 843

9. Expense Reductions.

	Custodian credits
Fidelity Natural Resources Fund	43

In addition, during the period the investment adviser or an affiliate reimbursed and/or waived a portion of operating expenses as follows:

	Amount
Fidelity Environment and Alternative Energy Fund	$ 22,188
Fidelity Natural Resources Fund	25,769

10. Other.

11. Risk and Uncertainties.

To the Board of Trustees of Fidelity Select Portfolios and Shareholders of Fidelity Environment and Alternative Energy Fund and Fidelity Natural Resources Fund

Opinions on the Financial Statements

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of Fidelity Environment and Alternative Energy Fund and Fidelity Natural Resources Fund (two of the funds constituting Fidelity Select Portfolios, hereafter collectively referred to as the "Funds") as of February 28, 2023, the related statements of operations for the year ended February 28, 2023, the statements of changes in net assets for each of the two years in the period ended February 28, 2023, including the related notes, and the financial highlights for each of the five years in the period ended February 28, 2023 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Funds as of February 28, 2023, the results of each of their operations for the year then ended, the changes in each of their net assets for each of the two years in the period ended February 28, 2023 and each of the financial highlights for each of the five years in the period ended February 28, 2023 in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinions

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of February 28, 2023 by correspondence with the custodian, issuer of privately offered securities and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinions.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

April 13, 2023

We have served as the auditor of one or more investment companies in the Fidelity group of funds since 1932.

TRUSTEES AND OFFICERS

The funds' Statement of Additional Information (SAI) includes more information about the Trustees. To request a free copy, call Fidelity at 1-800-544-8544.

Interested Trustees*:

Correspondence intended for a Trustee who is an interested person may be sent to Fidelity Investments, 245 Summer Street, Boston, Massachusetts 02210.

Name, Year of Birth; Principal Occupations and Other Relevant Experience+

Bettina Doulton (1964)

Year of Election or Appointment: 2020

Trustee

Robert A. Lawrence (1952)

Year of Election or Appointment: 2020

Trustee

Chair of the Board of Trustees

* Determined to be an "Interested Trustee" by virtue of, among other things, his or her affiliation with the trust or various entities under common control with FMR.

Independent Trustees:

Correspondence intended for an Independent Trustee may be sent to Fidelity Investments, P.O. Box 55235, Boston, Massachusetts 02205-5235.

Name, Year of Birth; Principal Occupations and Other Relevant Experience+

Thomas P. Bostick (1956)

Year of Election or Appointment: 2021

Trustee

Dennis J. Dirks (1948)

Year of Election or Appointment: 2018

Trustee

Donald F. Donahue (1950)

Year of Election or Appointment: 2018

Trustee

Vicki L. Fuller (1957)

Year of Election or Appointment: 2020

Trustee

Patricia L. Kampling (1959)

Year of Election or Appointment: 2020

Trustee

Thomas A. Kennedy (1955)

Year of Election or Appointment: 2021

Trustee

Oscar Munoz (1959)

Year of Election or Appointment: 2021

Trustee

David M. Thomas (1949)

Year of Election or Appointment: 2018

Trustee

Lead Independent Trustee

Susan Tomasky (1953)

Year of Election or Appointment: 2020

Trustee

Michael E. Wiley (1950)

Year of Election or Appointment: 2008

Trustee

Advisory Board Members and Officers:

Name, Year of Birth; Principal Occupation

Peter S. Lynch (1944)

Year of Election or Appointment: 2018

Member of the Advisory Board

Heather Bonner (1977)

Year of Election or Appointment: 2023

Assistant Treasurer

Craig S. Brown (1977)

Year of Election or Appointment: 2022

Deputy Treasurer

John J. Burke III (1964)

Year of Election or Appointment: 2018

Chief Financial Officer

Margaret Carey (1973)

Year of Election or Appointment: 2023

Secretary and Chief Legal Officer (CLO)

William C. Coffey (1969)

Year of Election or Appointment: 2019

Assistant Secretary

Timothy M. Cohen (1969)

Year of Election or Appointment: 2018

Vice President

Jonathan Davis (1968)

Year of Election or Appointment: 2010

Assistant Treasurer

Laura M. Del Prato (1964)

Year of Election or Appointment: 2018

Assistant Treasurer

Colm A. Hogan (1973)

Year of Election or Appointment: 2020

Assistant Treasurer

Pamela R. Holding (1964)

Year of Election or Appointment: 2018

Vice President

Chris Maher (1972)

Year of Election or Appointment: 2020

Deputy Treasurer

Jason P. Pogorelec (1975)

Year of Election or Appointment: 2020

Chief Compliance Officer

Brett Segaloff (1972)

Year of Election or Appointment: 2021

Anti-Money Laundering (AML) Officer

Stacie M. Smith (1974)

Year of Election or Appointment: 2018

President and Treasurer

Jim Wegmann (1979)

Year of Election or Appointment: 2019

Assistant Treasurer

The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (September 1, 2022 to February 28, 2023).

Actual Expenses

Hypothetical Example for Comparison Purposes

	Annualized Expense Ratio- A	Beginning Account Value September 1, 2022	Ending Account Value February 28, 2023	Expenses Paid During Period- C September 1, 2022 to February 28, 2023

Fidelity® Environment and Alternative Energy Fund	.81%
Actual		$ 1,000	$ 993.60	$ 4.00
Hypothetical- B		$ 1,000	$ 1,020.78	$ 4.06

Fidelity® Natural Resources Fund	.76%
Actual		$ 1,000	$ 1,136.40	$ 4.03
Hypothetical- B		$ 1,000	$ 1,021.03	$ 3.81

A Annualized expense ratio reflects expenses net of applicable fee waivers.

B 5% return per year before expenses

Distributions (Unaudited)

The dividend and capital gains distributions for the fund(s) are available on Fidelity.com or Institutional.Fidelity.com.

A percentage of the dividends distributed during the fiscal year for the following funds qualify for the dividends-received deduction for corporate shareholders:


Fidelity Environment and Alternative Energy Fund
December 2022	100%
Fidelity Natural Resources Fund
April 2022	40%
December 2022	54%


Fidelity Environment and Alternative Energy Fund
December 2022	100%
Fidelity Natural Resources Fund
April 2022	100%
December 2022	100%

The funds will notify shareholders in January 2024 of amounts for use in preparing 2023 income tax returns.

Highly liquid investments - cash or convertible to cash within three business days or less
Moderately liquid investments - convertible to cash in three to seven calendar days
Less liquid investments - can be sold or disposed of, but not settled, within seven calendar days
Illiquid investments - cannot be sold or disposed of within seven calendar days

1.9901475.101

EAE-NRF-ANN-0423

Fidelity® Select Portfolios®

Consumer Staples Sector

Consumer Staples Portfolio

Annual Report

February 28, 2023

Includes Fidelity and Fidelity Advisor share classes

Contents

Report of Independent Registered Public Accounting Firm

Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.

Other third-party marks appearing herein are the property of their respective owners.

NOT FDIC INSURED •MAY LOSE VALUE •NO BANK GUARANTEE

Neither the Fund nor Fidelity Distributors Corporation is a bank.

Average Annual Total Returns

Periods ended February 28, 2023	Past 1 year	Past 5 years	Past 10 years
Class A (incl.5.75% sales charge)	-7.15%	6.26%	6.84%
Class M (incl.3.50% sales charge)	-5.18%	6.47%	6.80%
Class C (incl. contingent deferred sales charge)	-3.18%	6.72%	6.84%
Consumer Staples Portfolio	-1.21%	7.83%	7.78%
Class I	-1.22%	7.82%	7.76%
Class Z	-1.09%	7.94%	7.83%

Class C shares' contingent deferred sales charges included in the past one year, past five years and past ten years total return figures are 1%, 0% and 0%, respectively.

The initial offering of Class Z shares took place on October 2, 2018. Returns prior to October 2, 2018, are those of Class I.

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Consumer Staples Portfolio, a class of the fund, on February 28, 2013.

The chart shows how the value of your investment would have changed, and also shows how the S&P 500® Index performed over the same period.

Market Recap:

U.S. equities returned -7.69% for the 12 months ending February 28, 2023, according to the S&P 500® index. The new year began with an encouraging upturn in January (+6.28%), but stocks lost momentum in February (-2.44%) amid higher-than-expected inflation and strong jobs data. Investors took these as signs that the economy continued to run hot, even after a year of historic policy adjustment by the Federal Reserve aimed at cooling economic growth. Record inflation in 2022 prompted the Fed to aggressively tighten monetary policy, and market interest rates eclipsed their highest level in a decade, stoking recession fears and sending stocks into bear market territory. Since March 2022, the central bank has hiked its benchmark rate eight times, by 4.5 percentage points - the fastest-ever pace of monetary tightening - while also shrinking its massive asset portfolio. The latest bump came on February 2, along with a signal that the Fed plans to lift rates in March while it considers whether and when to pause increases. Against this dynamic backdrop, stocks struggled to gain traction until a strong rally ignited heading into the summer. But in September, the index returned -9.21%, one of its worst monthly results ever, before advancing 7.56% in Q4, as risky assets regained favor. For the full 12 months, value stocks handily outpaced growth. The headwind for the latter was most pronounced in the growth-oriented communication services (-25%) and consumer discretionary (-18%) sectors. In sharp contrast, energy gained 24%.

Comments from Portfolio Manager Ben Shuleva:

For the fiscal year ending February 28, 2023, the fund's share classes (excluding sales charges, if applicable) returned about -2% to -1%, versus the -1.01% result of the MSCI U.S. IMI Consumer Staples 25/50 Index, and well ahead of the broad-based S&P 500® index. The largest detractor from performance relative to the sector index was security selection in the personal products category. Stock picks in advertising also notably hindered the fund's relative result. The fund's biggest individual relative detractor was an overweight in Herbalife Nutrition, which returned -46% the past 12 months. We pared our stake. Another notable relative detractor was an out-of-index investment in Advantage Solutions (-72%). The fund's non-index position in Olaplex Holdings, which we established this period, returned roughly -63%. In contrast, stock picks in the packaged foods & meats segment gave the biggest boost to the fund's performance versus the sector index. Security selection in the hypermarkets & super centers group and household products category also bolstered the fund's relative result. The fund's biggest individual relative contributor was an outsized stake in Monster Beverage, which gained 20% the past 12 months. Though we reduced our shares in the company, it was among our largest holdings at period end. Also lifting the fund's performance was our overweight in Lamb Weston Holdings, which gained approximately 51%. Lamb Weston was not held at period end. Another notable relative contributor was an underweight in Costco Wholesale (-4%), a stake we established the past year. Notable changes in positioning include reduced exposure to the tobacco group and an increased weight in distillers & vintners.

Top Holdings (% of Fund's net assets)

Procter & Gamble Co.	14.2
The Coca-Cola Co.	14.2
Walmart, Inc.	6.5
Mondelez International, Inc.	5.9
Altria Group, Inc.	5.5
Constellation Brands, Inc. Class A (sub. vtg.)	4.4
Monster Beverage Corp.	4.3
Philip Morris International, Inc.	4.3
PepsiCo, Inc.	4.2
Keurig Dr. Pepper, Inc.	4.1
	67.6

Industries (% of Fund's net assets)

Beverages	35.8
Household Products	21.6
Food Products	17.2
Food & Staples Retailing	11.7
Tobacco	9.8
Personal Products	2.4
Internet & Direct Marketing Retail	0.8
Household Durables	0.4
Media	0.3
Hotels, Restaurants & Leisure	0.0

Showing Percentage of Net Assets

Common Stocks - 100.0%
	Shares	Value ($)
Beverages - 35.8%
Brewers - 2.9%
Boston Beer Co., Inc. Class A (a)	139,100	45,040,580
Distillers & Vintners - 5.5%
Brown-Forman Corp. Class B (non-vtg.)	27,400	1,777,438
Constellation Brands, Inc. Class A (sub. vtg.)	304,384	68,090,701
Diageo PLC	372,624	15,812,847
Pernod Ricard SA	1,600	334,572
		86,015,558
Soft Drinks - 27.4%
Celsius Holdings, Inc. (a)	15,000	1,362,000
Keurig Dr. Pepper, Inc.	1,841,827	63,635,123
Monster Beverage Corp. (a)	657,013	66,857,643
PepsiCo, Inc.	375,604	65,178,562
Primo Water Corp.	433,500	6,710,580
The Coca-Cola Co.	3,698,018	220,069,051
The Vita Coco Co., Inc. (a)	8,800	148,808
		423,961,767
TOTAL BEVERAGES		555,017,905
Food & Staples Retailing - 11.7%
Drug Retail - 0.2%
Walgreens Boots Alliance, Inc.	59,100	2,099,823
Food Distributors - 2.9%
Performance Food Group Co. (a)	144,800	8,194,232
Sysco Corp.	276,956	20,652,609
U.S. Foods Holding Corp. (a)	441,674	16,576,025
		45,422,866
Food Retail - 1.3%
Albertsons Companies, Inc.	557,100	11,075,148
Alimentation Couche-Tard, Inc. Class A (multi-vtg.)	14,400	675,518
Grocery Outlet Holding Corp. (a)	74,050	2,003,053
Kroger Co.	144,600	6,238,044
		19,991,763
Hypermarkets & Super Centers - 7.3%
Costco Wholesale Corp.	26,900	13,024,442
Walmart, Inc.	705,900	100,329,567
		113,354,009
TOTAL FOOD & STAPLES RETAILING		180,868,461
Food Products - 17.2%
Agricultural Products - 3.4%
Archer Daniels Midland Co.	113,600	9,042,560
Bunge Ltd.	303,993	29,031,332
Darling Ingredients, Inc. (a)	197,961	12,524,992
Ingredion, Inc.	16,000	1,590,400
		52,189,284
Packaged Foods & Meats - 13.8%
Conagra Brands, Inc.	354,541	12,908,838
Freshpet, Inc. (a)(b)	269,600	16,763,728
Laird Superfood, Inc. (a)(b)	220,582	247,052
McCormick & Co., Inc. (non-vtg.)	119,900	8,910,968
Mondelez International, Inc.	1,409,497	91,871,014
Nomad Foods Ltd. (a)	1,876,159	33,620,769
Pilgrim's Pride Corp. (a)	32,200	753,158
Sovos Brands, Inc. (a)	292,298	3,820,335
The Hain Celestial Group, Inc. (a)	125,700	2,241,231
The Kraft Heinz Co.	27,000	1,051,380
The Real Good Food Co. LLC:
Class B (c)	58,667	1
Class B unit (d)	58,667	226,455
The Simply Good Foods Co. (a)	113,800	4,357,402
TreeHouse Foods, Inc. (a)	402,708	19,648,123
Tyson Foods, Inc. Class A	286,166	16,952,474
		213,372,928
TOTAL FOOD PRODUCTS		265,562,212
Hotels, Restaurants & Leisure - 0.0%
Restaurants - 0.0%
Compass Group PLC	4	92
Household Durables - 0.4%
Household Appliances - 0.3%
Helen of Troy Ltd. (a)	41,500	4,676,635
Housewares & Specialties - 0.1%
Tupperware Brands Corp. (a)	276,662	1,134,314
TOTAL HOUSEHOLD DURABLES		5,810,949
Household Products - 21.6%
Household Products - 21.6%
Church & Dwight Co., Inc.	30,300	2,538,534
Colgate-Palmolive Co.	124,700	9,140,510
Energizer Holdings, Inc. (b)	913,144	33,083,207
Kimberly-Clark Corp.	164,533	20,574,852
Procter & Gamble Co.	1,600,282	220,134,790
Reckitt Benckiser Group PLC	82,200	5,703,448
Reynolds Consumer Products, Inc. (b)	412,339	11,314,582
Spectrum Brands Holdings, Inc.	275,000	17,605,500
The Clorox Co.	94,174	14,638,407
		334,733,830
Internet & Direct Marketing Retail - 0.8%
Internet & Direct Marketing Retail - 0.8%
Amazon.com, Inc. (a)	128,800	12,136,824
Media - 0.3%
Advertising - 0.3%
Advantage Solutions, Inc. Class A (a)(b)	2,060,867	4,533,907
Personal Products - 2.4%
Personal Products - 2.4%
BellRing Brands, Inc. (a)	151,700	4,684,496
Edgewell Personal Care Co. (b)	26,100	1,114,470
Estee Lauder Companies, Inc. Class A	27,155	6,600,023
Herbalife Nutrition Ltd. (a)(b)	749,050	14,494,118
Olaplex Holdings, Inc. (a)(b)	2,198,100	10,814,652
		37,707,759
Tobacco - 9.8%
Tobacco - 9.8%
Altria Group, Inc.	1,847,617	85,784,857
Philip Morris International, Inc.	685,182	66,668,209
		152,453,066
TOTAL COMMON STOCKS (Cost $1,234,376,846)		1,548,825,005

Money Market Funds - 2.4%
	Shares	Value ($)
Fidelity Cash Central Fund 4.63% (e)	691,479	691,618
Fidelity Securities Lending Cash Central Fund 4.63% (e)(f)	36,894,714	36,898,404
TOTAL MONEY MARKET FUNDS (Cost $37,590,022)		37,590,022

TOTAL INVESTMENT IN SECURITIES - 102.4% (Cost $1,271,966,868)	1,586,415,027
NET OTHER ASSETS (LIABILITIES) - (2.4)%	(37,601,127)
NET ASSETS - 100.0%	1,548,813,900

Legend

(a)	Non-income producing

(b)	Security or a portion of the security is on loan at period end.

(c)	Level 3 security

(d)	Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $226,455 or 0.0% of net assets.

(e)

(f)	Investment made with cash collateral received from securities on loan.

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Affiliate	Value, beginning of period ($)	Purchases ($)	Sales Proceeds ($)	Dividend Income ($)	Realized Gain (loss) ($)	Change in Unrealized appreciation (depreciation) ($)	Value, end of period ($)	% ownership, end of period
Fidelity Cash Central Fund 4.63%	14,588,277	206,081,384	219,978,043	87,644	-	-	691,618	0.0%
Fidelity Securities Lending Cash Central Fund 4.63%	13,163,424	344,789,252	321,054,272	39,959	-	-	36,898,404	0.1%
Total	27,751,701	550,870,636	541,032,315	127,603	-	-	37,590,022

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Common Stocks	1,548,825,005	1,527,308,617	21,516,387	1

Money Market Funds	37,590,022	37,590,022	-	-
Total Investments in Securities:	1,586,415,027	1,564,898,639	21,516,387	1

Statement of Assets and Liabilities
				February 28, 2023

Assets
Investment in securities, at value (including securities loaned of $35,485,524) - See accompanying schedule:
Unaffiliated issuers (cost $1,234,376,846)	$	1,548,825,005
Fidelity Central Funds (cost $37,590,022)		37,590,022


Total Investment in Securities (cost $1,271,966,868)			$	1,586,415,027
Receivable for investments sold				470,148
Receivable for fund shares sold				432,262
Dividends receivable				1,120,560
Distributions receivable from Fidelity Central Funds				2,412
Prepaid expenses				6,674
Other receivables				272,512
Total assets				1,588,719,595
Liabilities
Payable for investments purchased	$	564,298
Payable for fund shares redeemed		1,021,497
Accrued management fee		696,239
Distribution and service plan fees payable		157,714
Other affiliated payables		255,154
Other payables and accrued expenses		312,618
Collateral on securities loaned		36,898,175
Total Liabilities				39,905,695
Net Assets			$	1,548,813,900
Net Assets consist of:
Paid in capital			$	1,240,880,615
Total accumulated earnings (loss)				307,933,285
Net Assets			$	1,548,813,900

Net Asset Value and Maximum Offering Price
Class A :
Net Asset Value and redemption price per share ($297,850,131 ÷ 3,264,269 shares) (a)			$	91.25
Maximum offering price per share (100/94.25 of $91.25)			$	96.82
Class M :
Net Asset Value and redemption price per share ($62,869,916 ÷ 697,735 shares) (a)			$	90.11
Maximum offering price per share (100/96.50 of $90.11)			$	93.38
Class C :
Net Asset Value and offering price per share ($78,496,964 ÷ 889,750 shares) (a)			$	88.22
Consumer Staples :
Net Asset Value , offering price and redemption price per share ($862,837,178 ÷ 9,334,961 shares)			$	92.43
Class I :
Net Asset Value , offering price and redemption price per share ($158,018,769 ÷ 1,714,573 shares)			$	92.16
Class Z :
Net Asset Value , offering price and redemption price per share ($88,740,942 ÷ 964,084 shares)			$	92.05
(a)Redemption price per share is equal to net asset value less any applicable contingent deferred sales charge.

Statement of Operations
				Year ended February 28, 2023
Investment Income
Dividends			$	40,213,248
Income from Fidelity Central Funds (including $39,959 from security lending)				127,603
Total Income				40,340,851
Expenses
Management fee	$	8,428,642
Transfer agent fees		2,631,292
Distribution and service plan fees		1,872,304
Accounting fees		455,820
Custodian fees and expenses		24,854
Independent trustees' fees and expenses		5,474
Registration fees		138,871
Audit		49,914
Legal		4,059
Interest		13,604
Miscellaneous		9,878
Total expenses before reductions		13,634,712
Expense reductions		(55,573)
Total expenses after reductions				13,579,139
Net Investment income (loss)				26,761,712
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		557,787
Foreign currency transactions		(48,065)
Total net realized gain (loss)				509,722
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers		(58,457,249)
Assets and liabilities in foreign currencies		(4,462)
Total change in net unrealized appreciation (depreciation)				(58,461,711)
Net gain (loss)				(57,951,989)
Net increase (decrease) in net assets resulting from operations			$	(31,190,277)

Statement of Changes in Net Assets

		Year ended February 28, 2023		Year ended February 28, 2022
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	26,761,712	$	23,869,410
Net realized gain (loss)		509,722		117,808,690
Change in net unrealized appreciation (depreciation)		(58,461,711)		106,519,256
Net increase (decrease) in net assets resulting from operations		(31,190,277)		248,197,356
Distributions to shareholders		(52,925,514)		(153,414,832)
Share transactions - net increase (decrease)		(73,640,667)		254,802,169
Total increase (decrease) in net assets		(157,756,458)		349,584,693

Net Assets
Beginning of period		1,706,570,358		1,356,985,665
End of period	$	1,548,813,900	$	1,706,570,358

Financial Highlights

Fidelity Advisor® Consumer Staples Fund Class A

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	95.55	$	89.40	$	79.57	$	76.88	$	87.07
Income from Investment Operations
Net investment income (loss) B,C		1.38		1.40		1.34		1.40		2.08 D
Net realized and unrealized gain (loss)		(2.79)		14.98		11.24		3.54		(2.64)
Total from investment operations		(1.41)		16.38		12.58		4.94		(.56)
Distributions from net investment income		(1.36)		(1.55)		(1.42)		(1.35)		(2.11)
Distributions from net realized gain		(1.53)		(8.68)		(1.33)		(.90)		(7.53)
Total distributions		(2.89)		(10.23)		(2.75)		(2.25)		(9.63) E
Net asset value, end of period	$	91.25	$	95.55	$	89.40	$	79.57	$	76.88
Total Return F,G		(1.49)%		18.83%		16.00%		6.17%		(.32)%
Ratios to Average Net Assets C,H,I
Expenses before reductions		1.01%		1.01%		1.04%		1.04%		1.05%
Expenses net of fee waivers, if any		1.01%		1.01%		1.04%		1.04%		1.05%
Expenses net of all reductions		1.01%		1.01%		1.03%		1.04%		1.04%
Net investment income (loss)		1.51%		1.45%		1.57%		1.67%		2.65% D
Supplemental Data
Net assets, end of period (000 omitted)	$	297,850	$	293,276	$	248,234	$	239,067	$	232,020
Portfolio turnover rate J		46%		61%		51%		40%		41% K

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Net investment income per share reflects one or more large, non-recurring dividend(s) which amounted to $.69 per share. Excluding such non-recurring dividend(s), the ratio of net investment income (loss) to average net assets would have been 1.78%.

E Total distributions per share do not sum due to rounding.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

G Total returns do not include the effect of the sales charges.

J Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

K Portfolio turnover rate excludes securities received or delivered in-kind.

Fidelity Advisor® Consumer Staples Fund Class M

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	94.39	$	88.43	$	78.74	$	76.13	$	86.30
Income from Investment Operations
Net investment income (loss) B,C		1.13		1.13		1.10		1.16		1.85 D
Net realized and unrealized gain (loss)		(2.76)		14.81		11.11		3.50		(2.61)
Total from investment operations		(1.63)		15.94		12.21		4.66		(.76)
Distributions from net investment income		(1.12)		(1.30)		(1.19)		(1.15)		(1.88)
Distributions from net realized gain		(1.53)		(8.68)		(1.33)		(.90)		(7.53)
Total distributions		(2.65)		(9.98)		(2.52)		(2.05)		(9.41)
Net asset value, end of period	$	90.11	$	94.39	$	88.43	$	78.74	$	76.13
Total Return E,F		(1.74)%		18.51%		15.69%		5.88%		(.59)%
Ratios to Average Net Assets C,G,H
Expenses before reductions		1.27%		1.28%		1.31%		1.31%		1.33%
Expenses net of fee waivers, if any		1.27%		1.28%		1.31%		1.31%		1.32%
Expenses net of all reductions		1.27%		1.28%		1.30%		1.31%		1.31%
Net investment income (loss)		1.25%		1.18%		1.30%		1.40%		2.37% D
Supplemental Data
Net assets, end of period (000 omitted)	$	62,870	$	64,707	$	56,664	$	55,954	$	60,069
Portfolio turnover rate I		46%		61%		51%		40%		41% J

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

D Net investment income per share reflects one or more large, non-recurring dividend(s) which amounted to $.68 per share. Excluding such non-recurring dividend(s), the ratio of net investment income (loss) to average net assets would have been 1.50%.

E Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

F Total returns do not include the effect of the sales charges.

I Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

J Portfolio turnover rate excludes securities received or delivered in-kind.

Fidelity Advisor® Consumer Staples Fund Class C

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	92.48	$	86.73	$	77.27	$	74.79	$	84.85
Income from Investment Operations
Net investment income (loss) B,C		.67		.65		.68		.75		1.46 D
Net realized and unrealized gain (loss)		(2.69)		14.51		10.87		3.44		(2.57)
Total from investment operations		(2.02)		15.16		11.55		4.19		(1.11)
Distributions from net investment income		(.71)		(.79)		(.80)		(.81)		(1.43)
Distributions from net realized gain		(1.53)		(8.62)		(1.30)		(.90)		(7.53)
Total distributions		(2.24)		(9.41)		(2.09) E		(1.71)		(8.95) E
Net asset value, end of period	$	88.22	$	92.48	$	86.73	$	77.27	$	74.79
Total Return F,G		(2.23)%		17.92%		15.14%		5.39%		(1.05)%
Ratios to Average Net Assets B,H,I
Expenses before reductions		1.77%		1.77%		1.79%		1.79%		1.79%
Expenses net of fee waivers, if any		1.76%		1.76%		1.79%		1.79%		1.79%
Expenses net of all reductions		1.76%		1.76%		1.78%		1.79%		1.78%
Net investment income (loss)		.76%		.70%		.83%		.92%		1.91% D
Supplemental Data
Net assets, end of period (000 omitted)	$	78,497	$	88,645	$	104,955	$	117,328	$	150,822
Portfolio turnover rate J		46%		61%		51%		40%		41% K

A For the year ended February 29.

B Net investment income (loss) is affected by the timing of the declaration of dividends by any underlying mutual funds or exchange-traded funds (ETFs). Net investment income (loss) of any mutual funds or ETFs is not included in the Fund's net investment income (loss) ratio.

C Calculated based on average shares outstanding during the period.

D Net investment income per share reflects one or more large, non-recurring dividend(s) which amounted to $.67 per share. Excluding such non-recurring dividend(s), the ratio of net investment income (loss) to average net assets would have been 1.04%.

E Total distributions per share do not sum due to rounding.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

G Total returns do not include the effect of the contingent deferred sales charge.

J Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

K Portfolio turnover rate excludes securities received or delivered in-kind.

Consumer Staples Portfolio

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	96.75	$	90.40	$	80.42	$	77.63	$	87.85
Income from Investment Operations
Net investment income (loss) B,C		1.66		1.69		1.60		1.66		2.34 D
Net realized and unrealized gain (loss)		(2.84)		15.16		11.39		3.59		(2.67)
Total from investment operations		(1.18)		16.85		12.99		5.25		(.33)
Distributions from net investment income		(1.61)		(1.81)		(1.68)		(1.55)		(2.36)
Distributions from net realized gain		(1.53)		(8.68)		(1.33)		(.90)		(7.53)
Total distributions		(3.14)		(10.50) E		(3.01)		(2.46) E		(9.89)
Net asset value, end of period	$	92.43	$	96.75	$	90.40	$	80.42	$	77.63
Total Return F		(1.21)%		19.16%		16.34%		6.48%		(.03)%
Ratios to Average Net Assets C,G,H
Expenses before reductions		.73%		.73%		.75%		.75%		.77%
Expenses net of fee waivers, if any		.73%		.73%		.75%		.75%		.76%
Expenses net of all reductions		.73%		.73%		.74%		.75%		.75%
Net investment income (loss)		1.79%		1.74%		1.86%		1.96%		2.94% D
Supplemental Data
Net assets, end of period (000 omitted)	$	862,837	$	1,032,956	$	770,644	$	773,437	$	814,350
Portfolio turnover rate I		46%		61%		51%		40%		41% J

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

E Total distributions per share do not sum due to rounding.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

I Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

J Portfolio turnover rate excludes securities received or delivered in-kind.

Fidelity Advisor® Consumer Staples Fund Class I

Years ended February 28,		2023		2022		2021		2020 A		2019
Selected Per-Share Data
Net asset value, beginning of period	$	96.48	$	90.17	$	80.23	$	77.45	$	87.68
Income from Investment Operations
Net investment income (loss) B,C		1.65		1.67		1.60		1.65		2.33 D
Net realized and unrealized gain (loss)		(2.83)		15.13		11.34		3.58		(2.68)
Total from investment operations		(1.18)		16.80		12.94		5.23		(.35)
Distributions from net investment income		(1.61)		(1.80)		(1.67)		(1.55)		(2.36)
Distributions from net realized gain		(1.53)		(8.68)		(1.33)		(.90)		(7.53)
Total distributions		(3.14)		(10.49) E		(3.00)		(2.45)		(9.88) E
Net asset value, end of period	$	92.16	$	96.48	$	90.17	$	80.23	$	77.45
Total Return F		(1.22)%		19.15%		16.32%		6.48%		(.04)%
Ratios to Average Net Assets C,G,H
Expenses before reductions		.74%		.74%		.76%		.76%		.77%
Expenses net of fee waivers, if any		.74%		.74%		.75%		.76%		.77%
Expenses net of all reductions		.74%		.74%		.75%		.76%		.76%
Net investment income (loss)		1.78%		1.72%		1.86%		1.95%		2.93% D
Supplemental Data
Net assets, end of period (000 omitted)	$	158,019	$	149,160	$	132,898	$	149,514	$	159,614
Portfolio turnover rate I		46%		61%		51%		40%		41% J

A For the year ended February 29.

B Calculated based on average shares outstanding during the period.

E Total distributions per share do not sum due to rounding.

F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

I Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

J Portfolio turnover rate excludes securities received or delivered in-kind.

Fidelity Advisor® Consumer Staples Fund Class Z

Years ended February 28,		2023		2022		2021		2020 A		2019 B
Selected Per-Share Data
Net asset value, beginning of period	$	96.36	$	90.08	$	80.14	$	77.36	$	81.61
Income from Investment Operations
Net investment income (loss) C,D		1.76		1.79		1.71		1.78		.05 E
Net realized and unrealized gain (loss)		(2.82)		15.10		11.35		3.56		.33
Total from investment operations		(1.06)		16.89		13.06		5.34		.38
Distributions from net investment income		(1.73)		(1.93)		(1.79)		(1.66)		(2.23)
Distributions from net realized gain		(1.53)		(8.68)		(1.33)		(.90)		(2.40)
Total distributions		(3.25) F		(10.61)		(3.12)		(2.56)		(4.63)
Net asset value, end of period	$	92.05	$	96.36	$	90.08	$	80.14	$	77.36
Total Return G,H		(1.09)%		19.29%		16.49%		6.61%		.79%
Ratios to Average Net Assets D,I,J
Expenses before reductions		.61%		.61%		.62%		.63%		.63% K
Expenses net of fee waivers, if any		.61%		.61%		.62%		.63%		.62% K
Expenses net of all reductions		.61%		.61%		.62%		.62%		.61% K
Net investment income (loss)		1.91%		1.85%		1.99%		2.08%		.16% E,K
Supplemental Data
Net assets, end of period (000 omitted)	$	88,741	$	77,826	$	43,591	$	41,629	$	8,052
Portfolio turnover rate L		46%		61%		51%		40%		41% M

A For the year ended February 29.

B For the period October 2, 2018 (commencement of sale of shares) through February 28, 2019.

C Calculated based on average shares outstanding during the period.

E Net investment income per share reflects one or more large, non-recurring dividend(s) which amounted to $.26 per share. Excluding such non-recurring dividend(s), the ratio of net investment income (loss) to average net assets would have been (.69)%.

F Total distributions per share do not sum due to rounding.

G Total returns for periods of less than one year are not annualized.

H Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

K Annualized.

L Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

M Portfolio turnover rate excludes securities received or delivered in-kind.